ID	Species	ncRNA	ncRNA type	Environmental factor (EF)	Phenotype	Sample	Condition of EF	Evidence	PubMed ID
1	Rat	rno-let-7	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	endotoxin treatment	upregulated	26137246
2	Rat	rno-let-7	miRNA	"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)"	colorectal cancer (CRC)	rat tumors; colonic mucosa tissues	"2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) treatment"	the let-7/c-Myc/Lin28 axis is dysregulated in heterocyclic amine-induced colon carcinogenesis	22641368
3	Rat	rno-let-7	miRNA	pilocarpine	epilepsy	adult male rats brain tissue and heart tissue	50 days of pilocarpine treatment	downregulated in heart tissue	24530830
4	Rat	rno-let-7	miRNA	curcumin (Cur)	neuroinflammation	neuroinflammatory rat	"co- of both compounds (Cur or VPA, 200 mg/kg) for 4 weeks treatment"	upregulated	25374508
5	Rat	rno-let-7a	miRNA	sevoflurane (SEV)	acute lung injury (ALI)	lung tissues	sevoflurane treatment	downregulated	28617947
6	Rat	rno-let-7a	miRNA	infarct the LV free wall	acute myocardial infarction (AMI)	heart tissues	left anterior descending coronary artery (LAD) was ligated using a 5/0 silk thread treatment	downregulated	24758696
7	Rat	rno-let-7a	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal rat ventricular myocytes (NRVMs)	angiotensin II (Ang II) treatment	downregulated	28123343
8	Rat	rno-let-7a	miRNA	formaldehyde	formaldehyde inducted immune/inflammation	rats	were exposed to formaldehyde treatment	downregulated	24304932
9	Rat	rno-let-7a	miRNA	vein graft model	intimal hyperplasia (IH)	rat	vein graft treatment	downregulated	24953987
10	Rat	rno-let-7a	miRNA	enoxacin	major depressive disorder (MDD)	rats	with 10 or 25 mg/kg enoxacin for 1 week treatment	upregulated	24575053
11	Rat	rno-let-7a	miRNA	hypoxia	myocardial ischaemic injury	neonatal rat ventricular myocytes	hypoxia treatment	downregulated	26655604
12	Rat	rno-let-7a	miRNA	high fat diet (HFD)	obesity	rats	high fat diet (HFD) feed	dysregulated	24517225
13	Rat	rno-let-7a	miRNA	rotenone (ROT)	parkinson's disease (PD)	striatum of parkinsonian rats	rotenone exposure treatment	upregulated	30267378
14	Rat	rno-let-7a	miRNA	single dose irradiation	radiation-induced lung injury (RILI)	male Wistar rats lung tissues	subjected to single dose irradiation with 20 Gy using 6 MV x-rays to the right lung treatment	upregulated	24886372
15	Rat	rno-let-7a-1	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
16	Rat	rno-let-7a-2-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
17	Rat	rno-let-7a-5p	miRNA	alcohol	brain damage due to chronic heavy alcohol	hippocampal tissues	chronic alcohol administration	upregulated	33228793
18	Rat	rno-let-7a-5p	miRNA	high fat diet (HFD)	obesity	white adipose tissues	high fat diet (HFD) feed	upregulated	32366215
19	Rat	rno-let-7a-5p	miRNA	FK506	osteogenesis	rat bone marrow stromal cells (BMSCs)	FK506 treatment	downregulated	28560399
20	Rat	rno-let-7a-5p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
21	Rat	rno-let-7b	miRNA	oxygen	oxygen-induced retinopathy (OIR)	choroid and the retinal pigment epithelium	oxygen treatment	upregulated	31430465
22	Rat	rno-let-7b	miRNA	burn injury	burn-induced hyperglycemia	rats serum	30% total body surface area (TBSA)	upregulated	29069833
23	Rat	rno-let-7b	miRNA	adriamycin (ADR)	chronic myeloid leukemia (CML)	K562 cells; KA cells	adriamycin (ADR) treatment	let-7b was downregulated in K562/ADM (KA) cells.	32856506
24	Rat	rno-let-7b	miRNA	cisplatin (DDP)	cisplatin (DDP)-induced nephrotoxicity	renal tissue homogenate	cisplatin treatment	downregulated	32777238
25	Rat	rno-let-7b	miRNA	pentoxifylline (PTX)	cisplatin (DDP)-induced nephrotoxicity	renal tissue homogenate	pentoxifylline (PTX) treatment	upregulated	32777238
26	Rat	rno-let-7b	miRNA	antibiotics	dysbacteria	Sprague Dawley (SD) rats faeces	treat with a combination of antibiotics for 8 week	downregulated	29264965
27	Rat	rno-let-7b	miRNA	kainic acid (KA)	epilepsy	rat hippocampus neurons	kainic acid treatment	LncRNA H19 could competitively bind to let-7b to promote hippocampal glial cell activation and epileptic seizures by targeting Stat3 in a rat model of temporal lobe epilepsy.	32648622
28	Rat	rno-let-7b	miRNA	hypoxia	hypoxic pulmonary hypertension (HPH)	lung tissues and pulmonary artery smooth muscle cells (PASMCs)	hypoxia induce	upregulated	30628484
29	Rat	rno-let-7b	miRNA	verapamil	male fertility	testis	verapamil treatment	downregulated	32725937
30	Rat	rno-let-7b	miRNA	ethanol (EtOH)	neuroimmune	rat hippocampal-entorhinal cortex (HEC)	ethanol treatment	upregulated	28118842
31	Rat	rno-let-7b	miRNA	estradiol-17¦Â (E2)	osteogenesis	primary bone marrow mesenchymal stem cells from rats (rBMSCs)	estradiol-17¦Â (E2) treatment	upregulated	31089333
32	Rat	rno-let-7b	miRNA	hypoxia	pulmonary hypertension (PH)	Sprague-Dawley (SD) rats remodeled pulmonary artery	were exposed to hypoxia (10% O2) for 21days	downregulated in remodeled pulmonary artery	27889560
33	Rat	rno-let-7b	miRNA	TGF-¦Â1	renal fibrosis	Rat proximal tubular epithelial cells (NRK52E)	Transforming growth factor-¦Â1 treatment	downregulated	24088962
34	Rat	rno-let-7b	miRNA	TGF-¦Â1	renal fibrosis	NRK52E cells	TGF-¦Â1 treatment	downregulated	24088962
35	Rat	rno-let-7b-5p	miRNA	"2,5-hexanedione (HD)"	"2,5-hexanedione (HD) toxicity"	spinal cord tissues	"2,5-hexanedione (HD) treatment"	upregulated	31760062
36	Rat	rno-let-7b-5p	miRNA	electroacupuncture (EA)	analgesic effects	brain tissues	Electroacupuncture (EA) treatment	MicroRNA Let-7b-5p Induces Electroacupuncture Tolerance by Downregulating the MKP-1 Gene in Rats Subjected to CFA-induced Inflammatory Nociception.	32240501
37	Rat	rno-let-7b-5p	miRNA	electroacupuncture (EA)	chronic nociception	hypothalamus	electroacupuncture (EA) treatment	Let-7b-5p promotes electroacupuncture tolerance by downregulating Penk1 gene in CFA-induced inflammatory nociception rats.	32184167
38	Rat	rno-let-7b-5p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	upregulated	26997989
39	Rat	rno-let-7b-5p	miRNA	smoking	smoke inhalation injury (SII)	bronchoalveolar lavage fluid (BALF)	Smoke inhalation treatment	upregulated	30139538
40	Rat	rno-let-7c	miRNA	infarct the LV free wall	acute myocardial infarction (AMI)	heart tissues	left anterior descending coronary artery (LAD) was ligated using a 5/0 silk thread treatment	downregulated	24758696
41	Rat	rno-let-7c	miRNA	aluminum (Al)	Alzheimer's disease (AD)	PC-12 cells	aluminum treatment	downregulated	28222524
42	Rat	rno-let-7c	miRNA	curcumin (Cur)	Alzheimer's disease (AD)	aluminum-induced PC-12 cells	curcumin treatment	upregulated	28222524
43	Rat	rno-let-7c	miRNA	resveratrol	Alzheimer's disease (AD)	aluminum-induced PC-12 cells	resveratrol treatment	upregulated	28222524
44	Rat	rno-let-7c	miRNA	formaldehyde	formaldehyde inducted immune/inflammation	rats	were exposed to formaldehyde treatment	downregulated	24304932
45	Rat	rno-let-7c	miRNA	collagenase	intracerebral haemorrhage (ICH)	brain tissues	harvested hemorrhagic brain 24 hours aftercollagenase induced ICH in the rat treatment	upregulated	24959881
46	Rat	rno-let-7c	miRNA	hypoxia/reoxygenation (H/R)	ischemia/reperfusion (I/R) injury	mesenchymal stem cell (MSC) exosome	hypoxia-reoxygenation (H/R) treatment	upregulated	32719674
47	Rat	rno-let-7c	miRNA	single dose irradiation	radiation-induced lung injury (RILI)	male Wistar rats lung tissues	subjected to single dose irradiation with 20 Gy using 6 MV x-rays to the right lung treatment	upregulated	24886372
48	Rat	rno-let-7c-1-3p	miRNA	methylprednisolone	steroid-induced osteonecrosis of femoral head (ONFH)	bone microvascular endothelial cells (BMECs)	methylprednisolone treatment	downregulated	29408208
49	Rat	rno-let-7c-5p	miRNA	lipopolysaccharide (LPS)	pulpitis	Dental pulp stem cells (DPSCs)	lipopolysaccharide (LPS) treatment	downregulated	30238933
50	Rat	rno-let-7c-5p	miRNA	lipopolysaccharide (LPS)	pulpitis	dental pulp stem cells (DPSCs)	lipopolysaccharide (LPS) treatment	downregulated	30575977
51	Rat	rno-let-7c-5p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	upregulated	26997989
52	Rat	rno-let-7c-5p	miRNA	smoking	smoke inhalation injury (SII)	bronchoalveolar lavage fluid (BALF)	Smoke inhalation treatment	upregulated	30139538
53	Rat	rno-let-7d	miRNA	infarct the LV free wall	acute myocardial infarction (AMI)	heart tissues	left anterior descending coronary artery (LAD) was ligated using a 5/0 silk thread treatment	downregulated	24758696
54	Rat	rno-let-7d	miRNA	TGF-¦Â1	diabetic nephropathy (DN)	NRK-52E cells	TGF-¦Â1 treatment	downregulated	27693697
55	Rat	rno-let-7d	miRNA	ethanol (EtOH)	ethanol-related behaviors	NAc tissues	ethanol treatment	Lentiviral-mediated upregulated of let-7d microRNA decreases alcohol intake through down-regulating the dopamine D3 receptor	32646740
56	Rat	rno-let-7d	miRNA	high amplitude mechanical stretching	lung fibrosis	alveolar type II (ATII) cells and lung fibroblasts	high amplitude mechanical stretching treatment	upregulated	31290711
57	Rat	rno-let-7d-5p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
58	Rat	rno-let-7e	miRNA	infarct the LV free wall	acute myocardial infarction (AMI)	heart tissues	left anterior descending coronary artery (LAD) was ligated using a 5/0 silk thread treatment	downregulated	24758696
59	Rat	rno-let-7e	miRNA	paraquat (PQ)	apoptosis	PC 12 cells	paraquat (PQ) treatment	downregulated	25174400
60	Rat	rno-let-7e	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
61	Rat	rno-let-7e-5p	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	upregulated	27919821
62	Rat	rno-let-7f	miRNA	formaldehyde	formaldehyde inducted immune/inflammation	rats	were exposed to formaldehyde treatment	downregulated	24304932
63	Rat	rno-let-7f-1-3p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
64	Rat	rno-let-7f-2-3p	miRNA	doxorubicin (DOX)	cardiotoxicity	H9c2 cells	doxorubicin (Dox)?treatment	"let-7f-2-3p inhibition in mice alleviated Dox-induced cardiotoxicity and preserved the antitumor efficacy. Together, let-7f-2-3p regulated by lncRNA NEAT1 aggravates Dox-induced cardiotoxicity through inhibiting XPO1-mediated HAX-1 nuclear export"	31570982
65	Rat	rno-let-7f-5p	miRNA	plastrum testudinis extracts (PTE)	osteogenesis	bone marrow mesenchymal stem cells (BMSCs)	plastrum testudinis extracts (PTE) treatment	upregulated	29975930
66	Rat	rno-let-7g	miRNA	hypoxia	pulmonary hypertension (PH)	PASMCs	hypoxia treatment	downregulated	27889560
67	Rat	rno-let-7g	miRNA	hypoxia	pulmonary hypertension (PH)	Sprague-Dawley (SD) rats remodeled pulmonary artery	were exposed to hypoxia (10% O2) for 21days	downregulated in remodeled pulmonary artery	27889560
68	Rat	rno-let-7g	miRNA	hypoxia	pulmonary hypertension (PH)	SD Rats pulmonary arteries	"were exposed to hypoxia (10% O2, 3 weeks)"	downregulated in pulmonary arteries	28108289
69	Rat	rno-let-7g	miRNA	rapamycin	repair of epidermal growth factor (EGF)	IEC-6 cells	Rapamycin treatment	downregulated	32301281
70	Rat	rno-let-7g-5p	miRNA	gentamicin	acute kidney injury (AKI)	urine	gentamicin treatment	upregulated	33263228
71	Rat	rno-let-7i	miRNA	sevoflurane (SEV)	acute lung injury (ALI)	lung tissues	sevoflurane treatment	downregulated	28617947
72	Rat	rno-let-7i	miRNA	infarct the LV free wall	acute myocardial infarction (AMI)	heart tissues	left anterior descending coronary artery (LAD) was ligated using a 5/0 silk thread treatment	downregulated	24758696
73	Rat	rno-let-7i	miRNA	icariside II (ICA II)	erectile dysfunction (ED)	adipose tissue-derived stem cells (ADSCs)	IcarisideII (ICAII) treatment	downregulated	31581950
74	Rat	rno-let-7i	miRNA	dioscin	liver fibrosis	NRK-52E and HK-2 cells	dioscin treatment	upregulated	27431331
75	Rat	rno-let-7i	miRNA	penetrating ballistic-like brain injury	penetrating ballistic-like brain injury (PBBI)	male Sprague-Dawley rats brain tissue	a unilateral frontal 10% PBBI treatment	upregulated in brain tissue	28452880
76	Rat	rno-let-7i	miRNA	single dose irradiation	radiation-induced lung injury (RILI)	male Wistar rats lung tissues	subjected to single dose irradiation with 20 Gy using 6 MV x-rays to the right lung treatment	upregulated	24886372
77	Rat	rno-let-7i	miRNA	blast	traumatic brain injury (TBI)	Blood and cerebrospinal fluid of rats	blast treatment	upregulated	22352906
78	Rat	rno-let-8	miRNA	lipopolysaccharide (LPS)	neuroinflammation	neuroinflammatory rat	injection of (250 ¦Ìg/kg) lipopolysaccharide-stimulated neuroinflammatory rat treatment	downregulated	25374508
79	Rat	rno-miR-1	miRNA	infusion of oleic acid (OA)	acute lung injury (ALI)	lung tissues	OA (200 ?l/kg) suspended in 20% ethyl alcohol was injected through the tail vein for 20 min treatment	dysregulated	24736893
80	Rat	rno-miR-1	miRNA	coronary artery ligation	acute myocardial infarction (AMI)	heart	subjected to coronary artery ligation	"serum miR-1 is quickly increased after AMI with a peak at 6 h, in which an increase in miR-1 of over 200-fold was demonstrated."	20218970
81	Rat	rno-miR-1	miRNA	glucose	apoptosis	?rat cardiomyocyte cell line H9C2	glucose treatment	upregulated	18801338
82	Rat	rno-miR-1	miRNA	doxycycline	atrial fibrillation (AF)	heart tissues	doxycycline treatment	downregulated	30470910
83	Rat	rno-miR-1	miRNA	doxycycline	atrial fibrillation (AF)	heart sissues	doxycycline treatment	upregulated	30470910
84	Rat	rno-miR-1	miRNA	astragaloside IV (AS-IV)	cardiac dysfunction	heart tissue of rats treated with LPS	astragaloside (AS-IV) treatment	downregulated	33774032
85	Rat	rno-miR-1	miRNA	lipopolysaccharide (LPS)	cardiac dysfunction	heart tissue	lipopolysaccharide (LPS) treatment	upregulated	33774032
86	Rat	rno-miR-1	miRNA	angiotensin II (Ang II)	cardiac fibroblast proliferation	primary ventricular fibroblasts	angiotensin II (Ang II) treatment	downregulated	31157242
87	Rat	rno-miR-1	miRNA	TGF-¦Â	cardiac fibroblast proliferation	adult rat ventricular fibroblasts	TGF¦Â treatment	downregulated	31157242
88	Rat	rno-miR-1	miRNA	T3	cardiac hypertrophy	neonatal rat cardiac myocytes (NRCMs)	treat with T3 for 24 hr treatment	upregulated	28063219
89	Rat	rno-miR-1	miRNA	hexabromocyclododecane (HBCD)	cardiac hypertrophy and arrhythmia	rat cardiomyocyte cells	Hexabromocyclododecane (HBCD) treatment	"miR-1, which was depressed by Nkx2.5, might play a fundamental role in mediating cardiac hypertrophy and arrhythmia via its target genes Mef2a and Irx5 after HBCD treatment"	26476318
90	Rat	rno-miR-1	miRNA	ionizing radiation (IR)	cardiogenic stress	hearts	ionizing radiation treatment	downregulated	27643935
91	Rat	rno-miR-1	miRNA	doxorubicin (DOX)	cardiomyocyte apoptosis	H9c2 cells	doxorubicin treatment	upregulated	27284328
92	Rat	rno-miR-1	miRNA	ischemia	cardiomyocyte apoptosis	cardiomyocytes	Ischemic postconditioning (IPost)treatment	upregulated	21406115
93	Rat	rno-miR-1	miRNA	daunorubicin	cardiomyopathy	rats	"daunorubicin (DAU-A, 3 mg/kg, every 48 h)"	downregulated	28303410
94	Rat	rno-miR-1	miRNA	acute and long-term aerobic exercise	cardiorespiratory fitness	young men	acute and long-term aerobic exercise treatment	downregulated	27895662
95	Rat	rno-miR-1	miRNA	isoproterenol and doxorubicin	cardiotoxicity	rats plasma	isoproterenol and doxorubicin treatment	upregulated after treatment with doxorubicin	25092230
96	Rat	rno-miR-1	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	H9c2 cells	high glucose (HG) treatment	upregulated	30186406
97	Rat	rno-miR-1	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	cardiomyocytes	high glucose (HG) treatment	upregulated	27306406
98	Rat	rno-miR-1	miRNA	ivabradine	electrophysiological cardiac remodelling	heart of rat	?ivabradine treatment	upregulated	21838751
99	Rat	rno-miR-1	miRNA	pilocarpine	epilepsy	adult male rats brain tissue and heart tissue	50 days of pilocarpine treatment	downregulated in heart tissue	24530830
100	Rat	rno-miR-1	miRNA	angiotensin II (Ang II)	hemorrhagic shock	vascular smooth muscle cells (VSMCs)	angiotensin II (Ang II) treatment	AngII treatment reverses the upregulated of miR-1.	30419280
101	Rat	rno-miR-1	miRNA	angiotensin II (Ang II)	hemorrhagic shock	hypoxia-induced vascular smooth muscle cells (VSMCs)	angiotensin II (Ang II) treatment	downregulated	30419280
102	Rat	rno-miR-1	miRNA	hypoxia	hemorrhagic shock	vascular smooth muscle cells (VSMCs)	hypoxia induce	upregulated	30419280
103	Rat	rno-miR-1	miRNA	aloe-emodin (AE)	HFD-induced cardiac electrical remodeling	high-fat diet (HFD) rats hearts	intragastrically administered with 100 mg/kg AE each day for 6 weeks	downregulated in the hearts	29055952
104	Rat	rno-miR-1	miRNA	ionizing radiation (IR)	irradiation-induced heart damage	rat myocardium	Single irradiation of 10 Gy (4¨C5 Gy/min.) of rat¡¯s mediastinum area	upregulated	30830529
105	Rat	rno-miR-1	miRNA	molecular hydrogen-rich water (HRW)	irradiation-induced heart damage	irradiation-induced rat myocardium	molecular hydrogen-rich water (HRW) treatment	downregulated	30830529
106	Rat	rno-miR-1	miRNA	tanshinone IIA (Tan IIA)	ischemic arrhythmias	?rat isolated ventricular myocytes	Tanshinone IIA? treatment	downregulated	19775284
107	Rat	rno-miR-1	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	primary cultured cardiomyocyte	hypoxia induce	upregulated	31369209
108	Rat	rno-miR-1	miRNA	hypoxia/reoxygenation (H/R)	ischemia/reperfusion (I/R) injury	cardiomyocytes of neonatal rats	hypoxia/reoxygenation (HR) injury treatment	upregulated	25008997
109	Rat	rno-miR-1	miRNA	losartan	ischemia/reperfusion (I/R) injury	heart tissues	losartan treatment	upregulated	26168042
110	Rat	rno-miR-1	miRNA	telmisartan	ischemia/reperfusion (I/R) injury	hypoxia-induced primary cultured cardiomyocyte	telmisartan treatment	downregulated	31369209
111	Rat	rno-miR-1	miRNA	dantonic	isoproterenol-induced myocardial ischemia (ISO-AMI)	plasma	dantonic treatment	miR-1 level was significantly lower in both dantonic-administrated groups compared to LAD- AMI group.	30319429
112	Rat	rno-miR-1	miRNA	scopolamine	memory loss	"prefrontal cortex (PFC), the hippocampus and the amygdala tissues"	scopolamine treatment	upregulated	31400468
113	Rat	rno-miR-1	miRNA	carvedilol	myocardial infarction (MI)	H2O2 treated primary cultured cardiomyocyte	carvedilol treatment	downregulated	30896796
114	Rat	rno-miR-1	miRNA	H2O2	myocardial infarction (MI)	primary cultured cardiomyocyte	H2O2 treatment	upregulated	30896796
115	Rat	rno-miR-1	miRNA	H2O2	myocardial infarction (MI)	primary cultured rat?cardiomyocytes	H2O2 treatment	upregulated	31702064
116	Rat	rno-miR-1	miRNA	metoprolol	myocardial infarction (MI)	cardiomyocytes; heart tissues	metoprolol treatment	Pretreatment of metoprolol reversed these changes by decreasing miR-1 and increasing Cx43 expression.	31702064
117	Rat	rno-miR-1	miRNA	metoprolol	myocardial infarction (MI)	H2O2 treated primary cultured rat?cardiomyocytes	Metoprolol treatment	downregulated	31702064
118	Rat	rno-miR-1	miRNA	hypoxia	myocardial ischaemic injury	H9c2 cells	hypoxia treatment	downregulated	32030815
119	Rat	rno-miR-1	miRNA	sciatic nerve partial ligation	peripheral nerve injury (PNI)	dorsal root ganglion (DRG)	sciatic nerve partial ligation therapy treatment	downregulated in the injured nerve	27381812
120	Rat	rno-miR-1	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	lung tissues	hypoxia induce	upregulated	29717493
121	Rat	rno-miR-1	miRNA	Su5416	pulmonary arterial hypertension (PAH)	lung tissues	Su5416 treatment	upregulated	29717493
122	Rat	rno-miR-1	miRNA	exercise training (ET)	pulmonary arterial stenosis (PAS)	PAS rats	PAS rats treatment	miR-1 downregulated and miR-21 upregulation	27994552
123	Rat	rno-miR-1	miRNA	hypoxia/reoxygenation (H/R)	pyroptosis	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	MiRNA-1 promoted pyroptosis of cardiomyocytes and release of inflammatory factors by downregulating the expression level of PIK3R1.	33215443
124	Rat	rno-miR-1	miRNA	aerobic exercise	sinus bradycardia	rats	aerobic exercise training (AET) treatment	upregulated	24825544
125	Rat	rno-miR-1	miRNA	perfluorooctane sulfonic acid (PFOS)	perfluorooctane sulfonate (PFOS)-induced toxic action	rat liver tissue	dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 13) treatment	different expression	24420840
126	Rat	rno-miR-1	miRNA	isoproterenol	¦Â-adrenoceptor intervention	rat heart tissues	isoproterenol (ISO)  treatment	downregulated	22847192
127	Rat	rno-miR-10	miRNA	scopolamine	memory loss	"prefrontal cortex (PFC), the hippocampus and the amygdala tissues"	scopolamine treatment	upregulated	31400468
128	Rat	rno-miR-100	miRNA	TGF-¦Â	adaptation of tendons to mechanical loading	rat Tendon fibroblasts	Transforming growth factor-¦Â(TGF-¦Â) treatment	upregulated	22539168
129	Rat	rno-miR-100	miRNA	isoproterenol	cardiac hypertrophy	H9c2 cells	isoproterenol treatment	miR-100 was upregulated during ISO- induced pathological hypertrophy.	29481791
130	Rat	rno-miR-100	miRNA	H2O2	glaucoma	Rat RGC-5 cells	H2O2 was added to induce oxidative stress treatment	upregulated	25406880
131	Rat	rno-miR-100	miRNA	phosphodiesterase 5 (PDE5) inhibitor	nonalcoholic fatty liver disease (NAFLD)	plasma exosomes	phosphodiesterase 5 (PDE5) inhibitor treatment	upregulated	33396535
132	Rat	rno-miR-100	miRNA	hypoxia	pulmonary hypertension (PH)	pulmonary artery smooth muscle cells (PASMCs)	hypoxia treatment	downregulated	26409044
133	Rat	rno-miR-100	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	primary cultured microglia were extracted from 3-day-old neonatal rats	lipopolysaccharide (LPS) treatment	downregulated	31696457
134	Rat	rno-miR-101	miRNA	hypoxia/reoxygenation (H/R)	autophagy	H9c2 cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	"the inhibition of miR-101 attenuated H/R-induced apoptosis, at least partially, via the induction of autophagy."	25606826
135	Rat	rno-miR-101	miRNA	hypoxia	bladder fibrosis	Bladder Smooth Muscle Cells	hypoxia treatment	Hypoxia could promote the expression of extracellular matrix subtypes and microRNA-101 in BSMCs.	30549198
136	Rat	rno-miR-101	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	hypertrophic cardiac myocytes	angiotensin II (Ang II) treatment	downregulated	25850725
137	Rat	rno-miR-101	miRNA	chronic unpredictable mild stress (CUMS)	depression	rats ventrolateral orbital cortex (VLO)	chronic unpredictable mild stress (CUMS) treatment	downregulated in ventrolateral orbital cortex (VLO)	28549965
138	Rat	rno-miR-101	miRNA	hypoxia	fibrosis	bladder smooth muscle cells (BSMCs)	hypoxia induce	upregulated	30549198
139	Rat	rno-miR-101	miRNA	hypoxia	myocardial infarction (MI)	H9C2 cells	hypoxia treatment	downregulated	32072912
140	Rat	rno-miR-101	miRNA	lipopolysaccharide (LPS)	neuropathic pain (NP)	rat spinal microglia cells	lipopolysaccharide (LPS) treatment	downregulated	31526851
141	Rat	rno-miR-101	miRNA	lipopolysaccharide (LPS)	neuropathic pain (NP)	Rat spinal microglia cells	lipopolysaccharide (LPS) treatment	downregulated	31526851
142	Rat	rno-miR-101	miRNA	IL-1¦Â	osteoarthritis (OA)	Chondrocytes	IL-1¦Â treatment	The expression of Sox9 was likewise negatively regulated by miR-101 in rat chondrocytes	23227940
143	Rat	rno-miR-101	miRNA	salvianolic acid A (Sal A)	spinal cord injury (SCI)	RBMECs under hypoxia	RBMECs under hypoxia treatment	upregulation	28011395
144	Rat	rno-miR-101-1	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
145	Rat	rno-miR-101-3p	miRNA	complete freund's adjuvant (CFA)	adjuvant-induced arthritis (AIA)	Synovium and fibroblast-like synoviocytes (FLS)	complete Freund¡¯s adjuvant treatment	downregulated	29626254
146	Rat	rno-miR-101-3p	miRNA	type II collagen	rheumatoid arthritis (RA)	synovial tissues	type II collagen treatment	miR-101-3p was highly expressed in synovial tissues of RA rats.	31894846
147	Rat	rno-miR-101-3p	miRNA	zinc	testicular ischemia-reperfusion injury (IRI)	rat testicular tissue	Zinc treatment	downregulated	31692452
148	Rat	rno-miR-101a	miRNA	infusion of oleic acid (OA)	acute lung injury (ALI)	lung tissues	OA (200 ?l/kg) suspended in 20% ethyl alcohol was injected through the tail vein for 20 min treatment	dysregulated	24736893
149	Rat	rno-miR-101a	miRNA	hypoxia	cerebral ischemia injury (CII)	hypoxia-injured rat adrenal pheochromocytoma (PC-12) cells	hypoxia induce	"?lncRNA EFNA3 was highly expressed in response to hypoxia. Deletion of lncRNA EFNA3 significantly aggravated hypoxia-induced injury in PC-12 cells, as the impairment of cell viability, migration, and invasion, and the inducement of apoptosis. LncRNA EFNA3 worked as a sponging molecule for miR-101a and miR-101a suppression-protected PC-12 cells against hypoxia-induced injury even when lncRNA EFNA3 was silenced."	30125989
150	Rat	rno-miR-101a	miRNA	mongolian medicine warm acupuncture	insomnia	rats brain tissues	Mongolian medicine warm acupuncture treatment	upregulated in the brain tissue	28672928
151	Rat	rno-miR-101a	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	upregulated	27074745
152	Rat	rno-miR-101a	miRNA	H2O2	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	H2O2 treatment	MiR-101a was upregulated in H9c2 cell after H2O2 treatment.	32655807
153	Rat	rno-miR-101a	miRNA	hypoxia	cerebral ischemia injury (CII)	PC-12 cells	hypoxia treatment	downregulated	30125989
154	Rat	rno-miR-101a-3p	miRNA	pilocarpine	epilepsy	hippocampus tissues	pilocarpine treatment	MiR-101a-3p was downregulated while c-FOS was increased in hippocampus tissues of Rat model of pilocarpine-induced epilepsy	33559830
155	Rat	rno-miR-101a-3p	miRNA	hypoxia/reoxygenation (H/R)	ischemia/reperfusion (I/R) injury	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	upregulated	31746349
156	Rat	rno-miR-101a-3p	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cell	hypoxia induce	upregulated	31746349
157	Rat	rno-miR-101a-3p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	upregulated	26997989
158	Rat	rno-miR-101b	miRNA	hypoxia	cortical injury	rat cortex tisssues	hypoxia treatment	downregulated	23272113
159	Rat	rno-miR-101b	miRNA	TGF-¦Â1	diabetic nephropathy (DN)	rat renal mesangial cells (MCs)	Transforming growth factor-¦Â1 (TGF-¦Â) trreatment treatment	upregulated	31266808
160	Rat	rno-miR-101b	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	upregulated	27074745
161	Rat	rno-miR-101b	miRNA	WNT family of secreted lipoglycoproteins(Wnt-5a)	Wnt-5a effect on hippocampal neurons	primary hippocampal neurons of 18-day-old Sprague-Dawley rat embryos	Wnt-5a treatment	downregulated	26895946
162	Rat	rno-miR-101b-3p	miRNA	monocrotaline (MCT)	liver sinusoidal endothelial cells (LSEC) injury	serum	monocrotaline treatment	upregulated	30019166
163	Rat	rno-miR-101b-3p	miRNA	FK506	osteogenesis	rat bone marrow stromal cells (BMSCs)	FK506 treatment	upregulated	28560399
164	Rat	rno-miR-103	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	primary cultured myocardial cells from neonatal rats	angiotensin II (Ang II) treatment	downregulated	30604587
165	Rat	rno-miR-103	miRNA	6-Gingerol (6-G)	cerebral ischemia injury (CII)	PC-12 cells	6-Gingerols (6G) treatment	hypoxia administration upregulated miR-103 expression and 6G could further increase miR-103 expression in hypoxia-stimulated PC-12 cells.	31043087
166	Rat	rno-miR-103	miRNA	hypoxia	cerebral ischemia injury (CII)	rat PC-12 cells	hypoxia induce	upregulated	31043087
167	Rat	rno-miR-103	miRNA	repeated binge-EtOH exposure	ethanol addiction	dorsal and ventral hippocampus of male Wistar rats	repeated binge-EtOH exposure treatment	different regulation	24416161
168	Rat	rno-miR-103	miRNA	acetaminophen (APAP)	liver damage	plasma of rats	acetaminophen (APAP) treatment	miR-103 as suitable reference gene for plasma miRNAs analysis for acetaminophen-induced liver injury.	23558424
169	Rat	rno-miR-103	miRNA	ethanol (EtOH)	liver regeneration	rat liver tissue	Chronic Ethanol Feeding treatment	upregulated	22823254
170	Rat	rno-miR-103	miRNA	nerve growth factor (Ngf)	neurodegenerative diseases	PC12 cells	100 ng/ml Ngf treatment	different regulation	24492999
171	Rat	rno-miR-103	miRNA	high fat diet (HFD) and streptozotocin (STZ)	prediabetes state	Peripheral blood mononuclear cells (PBMCs)	high fat diet/streptozotocin (STZ) treatment	upregulated	26164754
172	Rat	rno-miR-103	miRNA	zinc oxide nanoparticles (ZnONPs) and DPP-IV inhibitor (Vildagliptin)	type 2 diabetes mellitus (T2DM)	type 2 diabetes rats	type 2 diabetes rats treatment	downregulated	27723572
173	Rat	rno-miR-103/107	miRNA	hypoxia	hypoxic pulmonary hypertension (HPH)	PASMCs	hypoxia treatment	downregulated	26827991
174	Rat	rno-miR-103a	miRNA	oxygen glucose deprivation (OGD)	cerebral ischemia injury (CII)	brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation (OGD) treatment	downregulated of microRNA-103a reduces microvascular endothelial cell injury in a rat model of cerebral ischemia by targeting AXIN2	31650542
175	Rat	rno-miR-103a	miRNA	hypoxia	cerebral ischemia injury (CII)	brain microvascular endothelial cells (BMECs)	middle cerebral artery occlusion (MCAO) induce	upregulated	31650542
176	Rat	rno-miR-103a	miRNA	lithium chloride and pilocarpine	epilepsy	hippocampus tissues of epilepsy rats	lithium chloride-pilocarpine treatment	upregulated	31049031
177	Rat	rno-miR-106a	miRNA	tamoxifen (TAM)	hepatocellular carcinoma (HCC)	rat liver	tamoxifen? treatment	upregulated	17343880
178	Rat	rno-miR-106b-5p	miRNA	lipopolysaccharide (LPS)	cardiac dysfunction	H9C2 cells	lipopolysaccharide (LPS) treatment	downregulated	33341669
179	Rat	rno-miR-106b-5p	miRNA	matrine	cardiac dysfunction	LPS-treated H9C2 cells	matrine treatment	upregulated	33341669
180	Rat	rno-miR-106b-5p	miRNA	matrine	cardiac dysfunction	H9c2 cells	Matrine treatment	upregulated	33341669
181	Rat	rno-miR-106b-5p	miRNA	pentylenetetrazol (PTZ)	epilepsy	brain tissues	pentylenetetrazol (PTZ) treatment	upregulated	32779334
182	Rat	rno-miR-106b-5p	miRNA	FK506	osteogenesis	rat bone marrow stromal cells (BMSCs)	FK506 treatment	upregulated	28560399
183	Rat	rno-miR-106b-5p	miRNA	matrine	oxidative stress	H9c2 cells	matrine treatment	Matrine modulated H2O2-induced myocardial oxidative stress repair through HOTAIR/miR-106b-5p axis via AKT and STAT3 signaling pathway.	32395744
184	Rat	rno-miR-107	miRNA	6-hydroxydopamine (6-OHDA)	Alzheimer's disease (AD)	PC12 cells	6-hydroxydopamine (6-OHDA) treatment	downregulated	31778666
185	Rat	rno-miR-107	miRNA	6-hydroxydopamine (6-OHDA)	Alzheimer's disease (AD)	PC-12 cells	6-hydroxydopamine (6-OHDA) treatment	6-OHDA suppressed miR-107 expression.	31778666
186	Rat	rno-miR-107	miRNA	osthole	Alzheimer's disease (AD)	hippocampal and cortex region of the brain	osthole treatment	upregulated	27143098
187	Rat	rno-miR-107	miRNA	ketamine	anesthesia-induced neural cytotoxicity	rat brain embryonic stem cell (ESC)-derived neurons	Ketamine treatment	upregulated	30308117
188	Rat	rno-miR-107	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	colitis	male Wistar rats inflamed colon	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	downregulated in inflamed colon	28572713
189	Rat	rno-miR-107	miRNA	ketamine	ketamine-induced neurotoxicity	rat brain embryonic stem cell (ESC)-derived neurons	ketamine treatment	"Ketamine induced apoptosis, neurite degeneration, and upregulated miR-107 in NSC-derived neurons."	30308117
190	Rat	rno-miR-107	miRNA	ethanol (EtOH)	liver regeneration	rat liver tissue	Chronic Ethanol Feeding treatment	upregulated	22823254
191	Rat	rno-miR-107	miRNA	penetrating ballistic-like brain injury	penetrating ballistic-like brain injury (PBBI)	male Sprague-Dawley rats brain tissue	a unilateral frontal 10% PBBI treatment	upregulated in brain tissue	28452880
192	Rat	rno-miR-107	miRNA	doxorubicin (DOX)	renal interstitial fibrosis (RIF)	kidneys	doxorubicin (ADR) induction	downregulated	32606425
193	Rat	rno-miR-107	miRNA	"kangxianling (KXL, anti-fibrin)"	renal interstitial fibrosis (RIF)	kidneys	"Kangxianling (KXL, anti-fibrin) treatment"	upregulated	32606425
194	Rat	rno-miR-107-3p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
195	Rat	rno-miR-107-5p	miRNA	hypoxia	stroke	middle cerebral artery occlusion (MCAO) Sprague-Dawley rat	middle cerebral artery occlusion (MCAO) treatment	upregulated	29113076
196	Rat	rno-miR-10a	miRNA	retinoic acid receptor-¦Á (RAR¦Á)- and retinoid X receptor-¦Á (RXR¦Á)-specific agonists	atherosclerosis (AS)	inner curvature (OS region) of aortic arch in rats	retinoic acid receptor-¦Á (RAR¦Á)- and retinoid X receptor-¦Á (RXR¦Á)-specific agonists dual treatment	upregulated	29459264
197	Rat	rno-miR-10a	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal rat cardiomyocytes	angiotensin II (Ang II) treatment	upregulated	28100873
198	Rat	rno-miR-10a	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	downregulated	22156553
199	Rat	rno-miR-10a	miRNA	verapamil	male fertility	testis	verapamil treatment	downregulated	32725937
200	Rat	rno-miR-10a	miRNA	naringin	renal ischemia/reperfusion (I/R) injury	IR injury rat renal tissues	naringin (NAR) treatment	downregulated	30780111
201	Rat	rno-miR-10a	miRNA	trimetazidine (TMZ)	renal ischemia/reperfusion (I/R) injury	IR injury rat renal tissues	trimetazidine (TMZ) treatment	downregulated	30780111
202	Rat	rno-miR-10a	miRNA	pegylated rat leptin antagonist (pRLA)	type 2 diabetes mellitus (T2DM)	rat muscle and liver	pegylated rat leptin antagonist (pRLA) treatment	"upregulation of rno-miR-10a at d28 and rno-miR-200a, rno-miR-409-5p, and rno-miR-125a-3p following HFD challenge"	23576026
203	Rat	rno-miR-10a	miRNA	"high concentrations of lipid and glucose, and cytokines"	vascular hyper-reactivity	VSMC	"incubat high glucose (25mmol/L) or lipid (palmitic acid 50 ¦Ì mol/L) and 200ng/ml of TNF-¦Á,IL-1¦Â and IL-6 for 24h treatment"	downregulated	25425000
204	Rat	rno-miR-10a-5p	miRNA	acarbose	diabetes mellitus (DM)	blood	acarbose? treatment	upregulated	24260283
205	Rat	rno-miR-10a-5p	miRNA	repeated binge-EtOH exposure	ethanol addiction	dorsal and ventral hippocampus of male Wistar rats	repeated binge-EtOH exposure treatment	different regulation	24416161
206	Rat	rno-miR-10a-5p	miRNA	fluorine combined with aluminum (FA)	fluorine combined with aluminum (FA)-induced developmental neurotoxicity	hippocampi	fluorine combined with aluminum (FA) treatment	upregulated	30033483
207	Rat	rno-miR-10a-5p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
208	Rat	rno-miR-10a-5p	miRNA	fluorine combined with aluminum (FA)	neurotoxicity	hippocampi in the offspring of rats	fluorine combined with aluminum (FA) exposure	upregulated	30033483
209	Rat	rno-miR-10a-5p	miRNA	steroids	osteonecrosis of femoral head (ONFH)	serum	steroid treatment	upregulated	29887962
210	Rat	rno-miR-10b	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	downregulated	22156553
211	Rat	rno-miR-10b	miRNA	formaldehyde	formaldehyde inducted immune/inflammation	rats	were exposed to formaldehyde treatment	downregulated	24304932
212	Rat	rno-miR-10b	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	27910957
213	Rat	rno-miR-10b	miRNA	ferulic acid (FA)	oxidative stress	PC-12 cells	Ferulic Acid (FA) treatment	"miR-10b was induced by H2O2 in PC12 cells, whereas FA inhibited H2O2-induced miR-10b."	33379243
214	Rat	rno-miR-10b	miRNA	bisphenol S (BPS)	pheochromocytoma (PCC)	PC12 cells	bisphenol S (BPS) treatment	upregulated	30140998
215	Rat	rno-miR-10b	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	downregulated	21094214
216	Rat	rno-miR-10b-5p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	rat hippocampal tissues	amyloid ¦Â1-42?(A¦Â) treatment	"MiR-10b-5p was upregulated while HOXD10 was downregulated, and the Rho/ROCK signalling pathway was activated in hippocampal tissues of rats with AD."	33307856
217	Rat	rno-miR-10b-5p	miRNA	anisakis complete extract (CE)	anisakiasis	sera	anisakis complete extract (CE) treatment	"mmu-miR-1b-5p and mmu-miR-10b-5p (a cancer-related miRNA) were significantly decreased (P?<?.05) in sera from the rats inoculated with Anisakis CE, compared with control rats inoculated with saline."	30006808
218	Rat	rno-miR-10b-5p	miRNA	cadmium (Cd)	cadmium (Cd)-induced reproductive toxicity	testes	cadmium (Cd) treatment	"For the expression of miR-10b-5p, at PND 21, the expression of miR-10b-5p in the testes of the F1 rats was significantly upregulated in the 2.0 mg/kg Cd treatment group. At PND 56, the expression of miR-10b-5p was significantly increased in the 8.0 mg/kg Cd treatment group."	31654709
219	Rat	rno-miR-10b-5p	miRNA	dexamethasone (DEX)	neuronal cell injury	brain tissues	dexamethasone (Dex) treatment	downregulated	32323054
220	Rat	rno-miR-10b-5p	miRNA	hypoxia	neuronal cell injury	brain tissues	middle cerebral artery occlusion (MCAO) surgery	upregulated	32323054
221	Rat	rno-miR-10b-5p	miRNA	escitalopram	stress-induced depression	nucleus accumbens (NAc) tissues	escitalopram treatment	dysregulated	31856805
222	Rat	rno-miR-1193-3p	miRNA	TGF-¦Â1	lung fibrosis	lung fibroblasts	TGF-¦Â1 treatment	downregulated	32464548
223	Rat	rno-miR-1207-5p	miRNA	lipopolysaccharide (LPS)	steroid-induced necrosis of femoral head (SNFH)	necrotic femoral head tissue	lipopolysaccharide treatment	upregulated	31002120
224	Rat	rno-miR-1207-5p	miRNA	methylprednisolone	steroid-induced necrosis of femoral head (SNFH)	necrotic femoral head tissue	methylprednisolone treatment	upregulated	31002120
225	Rat	rno-miR-122	miRNA	ethanol (EtOH)	acute alcoholic liver injury	liver tissues	50% ethanol at 8 mL/kg treatment	upregulated	31398934
226	Rat	rno-miR-122	miRNA	portulaca oleracea extract (POE)	acute alcoholic liver injury	acute alcoholic liver injury rats liver tissues	Portulaca oleracea extract (POE) treatment	downregulated	31398934
227	Rat	rno-miR-122	miRNA	carbon tetrachloride (CCl4)	acute liver failure (ALF)	rats	CCl4 treatment	upregulated	28616908
228	Rat	rno-miR-122	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia induce	upregulated	30458344
229	Rat	rno-miR-122	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia induce	upregulated	30458344
230	Rat	rno-miR-122	miRNA	lycium barbarum polysaccharide (LBP)	acute myocardial infarction (AMI)	hypoxia-induced H9c2 cells	Lycium barbarum polysaccharides (LBPs) treatment	downregulated	30458344
231	Rat	rno-miR-122	miRNA	lycium barbarum polysaccharide (LBP)	acute myocardial infarction (AMI)	hypoxia-induced H9c2 cells	Lycium barbarum polysaccharides (LBPs) treatment	downregulated	30458344
232	Rat	rno-miR-122	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	acute myocardial infarction (AMI)	H9c2 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	31669130
233	Rat	rno-miR-122	miRNA	grape seed proanthocyanidins (GSPs)	cardiovascular disease (CVD)	healthy rats liver	chronic (3 weeks) of grape seed proanthocyanidins (GSPE) treatment	downregulated	24445039
234	Rat	rno-miR-122	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	colonic tissue of rat	azoxymethane (AOM) treatment	downregulated	23049818
235	Rat	rno-miR-122	miRNA	high-copper diet	crohn disease (CD)	serum	high-copper diet?treatment	upregulated	23125884
236	Rat	rno-miR-122	miRNA	exercise intervention	diabetes mellitus (DM)	liver tissues	exercise intervention treatment	upregulated	30318957
237	Rat	rno-miR-122	miRNA	acetaminophen (APAP)	drug-induced liver injury (DILI)	serum	acetaminophen (APAP) treatment	dysregulated	22624025
238	Rat	rno-miR-122	miRNA	dioscorea bulbifera (DB)	drug-induced liver injury (DILI)	serum	dioscorea bulbifera (DB) treatment	upregulated	22624025
239	Rat	rno-miR-122	miRNA	cafeteria diet	dyslipidemia	liver of rat	cafeteria diet feed	upregulated	23922812
240	Rat	rno-miR-122	miRNA	grape seed proanthocyandin extract (GSPE)	dysregulated fatty acid and cholesterol metabolism	rat liver cells	grape seed proanthocyanidins extracts (GSPE) treatment	downregulated	22965541
241	Rat	rno-miR-122	miRNA	TGF-¦Â	epithelial-mesenchymal transition (EMT)	rat hepatic stellate cells HSC-T6	TGF-¦Â1 treatment	miRNA-122 inhibit the activation and EMT of HSCs stimulated by TGF-¦Â1	30651793
242	Rat	rno-miR-122	miRNA	chromium (Cr)	hepatic ischemia/reperfusion injury (HIRI)	serum	Cr treatment	downregulated	28963950
243	Rat	rno-miR-122	miRNA	zinc sulfate (ZnSO4)	hepatic ischemia/reperfusion injury (HIRI)	ischemia-reperfusion (IR) injuried rats liver tissues	zinc sulfate (ZnSO4) treatment	downregulated	30014282
244	Rat	rno-miR-122	miRNA	zinc sulfate (ZnSO4)	hepatic ischemia/reperfusion injury (HIRI)	ischemia-reperfusion (IR) rats serum	zinc sulfate (ZnSO4) treatment	downregulated	30014282
245	Rat	rno-miR-122	miRNA	zinc sulfate (ZnSO4)	hepatic ischemia/reperfusion injury (HIRI)	serum	ZnSO4 treatment	downregulated	28963950
246	Rat	rno-miR-122	miRNA	silybin	hepatic steatosis	oleate/palmitate induced FaO cells	silybin treatment	upregulated	31816412
247	Rat	rno-miR-122	miRNA	¦Â-ionone (¦ÂI)	hepatocellular carcinoma (HCC)	rats hepatocyte	¦ÂI (16 mg/100 g body weight) treatment	"upregulated(miR-122 , miR-34a) ;downregulated (miR-181b , miR-708)"	27061051
248	Rat	rno-miR-122	miRNA	bisphenol A (BPA)	hepatotoxicity	Wistar rats liver	bisphenol A (BPA) treatment	upregulated in liver	28689058
249	Rat	rno-miR-122	miRNA	thioacetamide or carbon tetrachloride	hepatotoxicity	Adult male Wistar rats	thioacetamide or carbon tetrachloride treatment	downregulated	24388909
250	Rat	rno-miR-122	miRNA	dexamethasone (DEX)	hormonal regulation	adrenals?tissues	dexamethasone (DEX) treatment	downregulated	24205079
251	Rat	rno-miR-122	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	downregulated	24205079
252	Rat	rno-miR-122	miRNA	high fat diet (HFD)	hypercholesterolemia	liver tissues of IUGR female rats exposed to a maternal HFD	high fat diet (HFD) feed	upregulated	29896121
253	Rat	rno-miR-122	miRNA	trichostatin A (TSA)	hepatocellular carcinoma (HCC)	rat primary hepatocytes	Trichostatin A (TSA)treatment treatment	"miR-122, miR-143 and miR-379 could be related to the inhibitory effects of TSA on hepatocellular proliferation"	21513791
254	Rat	rno-miR-122	miRNA	silymarin (Sm)	liver damage	thioacetamide (TAA) treated rat Blood and liver tissues	silymarin (Sm) treatment	upregulated	31811641
255	Rat	rno-miR-122	miRNA	thioacetamide (TAA)	liver damage	blood and liver tissues	thioacetamide (TAA) treatment	downregulated	31811641
256	Rat	rno-miR-122	miRNA	atorvastatin	liver fibrosis	liver tissues	atorvastatin treatment	upregulated	32822719
257	Rat	rno-miR-122	miRNA	curcumin (Cur)	liver fibrosis	liver tissues	curcumin treatment	upregulated	32822717
258	Rat	rno-miR-122	miRNA	quercetin	liver fibrosis	liver tissues	quercetin treatment	upregulated	32822718
259	Rat	rno-miR-122	miRNA	TGF-¦Â1	liver fibrosis	HSC-T6 cells	TGF-¦Â1 treatment	upregulated	30651793
260	Rat	rno-miR-122	miRNA	acetaminophen (APAP) and methapyrilene (MP)	liver damage	rats pericentral and periportal regions	acetaminophen (APAP) and methapyrilene (MP) treatment	upregulated	24863736
261	Rat	rno-miR-122	miRNA	lipopolysaccharide (LPS)	liver damage	plasma	lipopolysaccharide (LPS) treatment	upregulated	31026554
262	Rat	rno-miR-122	miRNA	xian-Ling-Gu-Bao (XLGB)	liver damage	plasma	Xian-Ling-Gu-Bao (XLGB) treatment	upregulated	31026554
263	Rat	rno-miR-122	miRNA	ethanol (EtOH)	liver regeneration	rat liver tissue	Chronic Ethanol Feeding treatment	upregulated	22823254
264	Rat	rno-miR-122	miRNA	ellagic acid (EA)	breast cancer	female rat mammary tissue	ellagic acid treatment	"ellagic acid, which inhibited E2-induced mammary tumorigenesis in our previous study, reversed the dysregulation of miR-375, miR-206, miR-182, miR-122, miR-127 and miR-183 detected with E2treatment"	23791885
265	Rat	rno-miR-122	miRNA	granulocyte-colony stimulating factor (G-CSF)	neuropathic pain (NP)	dorsal root ganglia (DRGs)	Granulocyte colony-stimulating factor?treatment	upregulated	32664488
266	Rat	rno-miR-122	miRNA	high-fat high-fructose diet (HFHFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high-fat high-fructose diet (HFHFD) feed	downregulated	30318957
267	Rat	rno-miR-122	miRNA	high-intensity interval training (HIIT)	nonalcoholic fatty liver disease (NAFLD)	diabetic rats liver tissues	high-intensity interval training (HIIT) treatment	upregulated	30318957
268	Rat	rno-miR-122	miRNA	proanthocyanidin	obesity	livers of obese rats	proanthocyanidin treatment	3 weeks of supplementation with grape seed proanthocyanidin extract normalized the overexpression of miR-33a and miR-122 in obese rats' liver for all doses studied	25769350
269	Rat	rno-miR-122	miRNA	grape seed proanthocyandin extract (GSPE)	obesity and metabolic syndrome	rat hepatoma Fao cells	grape seed proanthocyanidins extracts (GSPE) treatment	"although GSPE reduced both miR-122 and miR-33a levels, GPE reduced miR-122 but upregulated miR-33a expression. The expression of miR-122 and miR-33a was not altered by the DF fraction in either Fao or HepG2 cells"	24165878
270	Rat	rno-miR-122	miRNA	phenobarbital (PB)	phenobarbital (PB)-mediated tumours	B13/H cells	Phenobarbital (PB) treatment	downregulated	27427493
271	Rat	rno-miR-122	miRNA	grape seed proanthocyandin extract (GSPE)	reduced postprandial lipemia	rat liver tissues and lipid extraction	grape seed proanthocyanidins extracts (GSPE) treatment	GSPE repressed miR-33a and miR-122 liver expression and reduced postprandial lipemia in a dose-dependent manner.	24445039
272	Rat	rno-miR-122	miRNA	high sodium/low potassium (Japanese-style) diet (JD)	stroke	spontaneously hypertensive rat (SHRSP) brain	high sodium/low potassium (Japanese-style) diet (JD) for one month	downregulated	28751928
273	Rat	rno-miR-122	miRNA	proanthocyanidins or docosahexaenoic acid	dyslipidemia	liver of rat	proanthocyanidins or docosahexaenoic acid?treatment treatment	downregulated	23922812
274	Rat	rno-miR-122-3p	miRNA	sorafenib (SOR)	hepatocellular carcinoma (HCC)	pulmonary metastatic tissue	sorafenib treatment	downregulated	26026584
275	Rat	rno-miR-1224	miRNA	resveratrol	 lipogenesis	perirenal adipose tissue	resveratrol (RS) treatment	upregulated	26952965
276	Rat	rno-miR-1225-5p	miRNA	streptozocin (STZ)	type 1 diabetes mellitus (T1DM)	INS-1 cells	streptozocin (STZ) treatment	Secretions of miR-1225-5p was in streptozotocin-treated INS-1 cells	29370422
277	Rat	rno-miR-122-5p	miRNA	hypoxia	cardiac injury	H9c2 cardiomyocyte	hypoxia induce	Hypoxic H9c2 cells demonstrated an increase in the extent of their apoptosis and expression of microRNA-122-5p.	31887421
278	Rat	rno-miR-122-5p	miRNA	hypoxia	cardiac injury	H9c2 cells	hypoxia treatment	upregulated	31887421
279	Rat	rno-miR-122-5p	miRNA	cisplatin and gentamicin	drug-induced acute kidney injury (DIKI)	plasma	"cisplatin (CSP, 6?mg/kg) and gentamicin (GEN, 120?mg/kg) treatment"	downregulated	30682439
280	Rat	rno-miR-122-5p	miRNA	aflatoxin B1 (AFB1)	epatocarcinogenesis	serum	aflatoxin (AFB1 ) treatment	upregulated	31373075
281	Rat	rno-miR-122-5p	miRNA	aflatoxin B1 (AFB1)	hepatocellular carcinoma (HCC)	F344 rats liver tissues	aflatoxin B1 (AFB2) treatment	upregulated	28218475
282	Rat	rno-miR-122-5p	miRNA	sorafenib (SOR)	hepatocellular carcinoma (HCC)	pulmonary metastatic tissue	sorafenib treatment	downregulated	26026584
283	Rat	rno-miR-122-5p	miRNA	perfluorooctane sulfonic acid (PFOS)	hepatotoxicity	liver tissues	Perfluorooctanesulfonate (PFOS) treatment	downregulated	26724606
284	Rat	rno-miR-122-5p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
285	Rat	rno-miR-122-5p	miRNA	high fat diet (HFD)	insulin resistance (IR)	liver tissues	high fat diet (HFD) feed	upregulated	30958584
286	Rat	rno-miR-122-5p	miRNA	streptozocin (STZ)	insulin resistance (IR)	liver tissues	streptozotocin (STZ) treatment	upregulated	30958584
287	Rat	rno-miR-122-5p	miRNA	cadmium (Cd)	kidney damage	NRK-52E cells	cadmium (Cd) treatment	miR-122-5p and miR-326-3p might enhance cadmium-induced NRK-52E cell apoptosis through downregulating PLD1 expression.	32697411
288	Rat	rno-miR-122-5p	miRNA	perfluorooctane sulfonic acid (PFOS)	liver damage	liver tissues	Perfluorooctanesulfonate (PFOS) treatment	downregulated	26724606
289	Rat	rno-miR-122-5p	miRNA	monocrotaline (MCT)	liver sinusoidal endothelial cells (LSEC) injury	serum	monocrotaline treatment	upregulated	30019166
290	Rat	rno-miR-122-5p	miRNA	salvianolate	myocardial Infarction (MI)	MI rats myocardial tissues	salvianolate treatment	downregulated in rat myocardial tissues	29076429
291	Rat	rno-miR-122-5p	miRNA	cadmium (Cd)	renal toxic	"NRK-52E cells, rat kidney, serum and urine samples"	cadmium (Cd) treatment	upregulated	31626960
292	Rat	rno-miR-122-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
293	Rat	rno-miR-1236-3p	miRNA	Propylthiouracil	congenital hypothyroidism (CH)	Propylthiouracil (50 mg/day) was injected intraperitoneally into pregnant rats to generate pups with CH. hippocampus tissues of CH rats was collected.	Propylthiouracil treatment	upregulated	31885695
294	Rat	rno-miR-124	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	upregulated	27535721
295	Rat	rno-miR-124	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	PC-12 cells	amyloid ¦Â1-42?(A¦Â) treatment	downregulated	31014193
296	Rat	rno-miR-124	miRNA	astaxanthin	Alzheimer's disease (AD)	AD-like rats cortex and hippocampus	astaxanthin (ATX) treatment	upregulated	33575874
297	Rat	rno-miR-124	miRNA	hydrated aluminum chloride (AlCl3.6H2O)	Alzheimer's disease (AD)	cortex and hippocampus	hydrated aluminum chloride (AlCl3.6H2O) treatment	downregulated	33575874
298	Rat	rno-miR-124	miRNA	curcumin (Cur)	breast cancer	renal cortex of diabetic rats £» cultured podocytes	curcumin treatment	downregulated	24556741
299	Rat	rno-miR-124	miRNA	arsenic trioxide (ATO)	cardiac injury	H9c2 cells	arsenic trioxide (As2O3) treatment	NEAT1 regulated the expression of inflammatory factors to protect cardiomyocytes from As2O3 damage by inhibiting miR-124/NF-kappa B signaling pathway.	32096187
300	Rat	rno-miR-124	miRNA	hypoxia	cell damage	H9c2 cells	hypoxia treatment	upregulated	29864957
301	Rat	rno-miR-124	miRNA	hypoxia	cerebral ischemia/reperfusion (I/R) injury	brain tissue of rats	Middle cerebral artery occlusion (MCAO) treatment	upregulated	30906474
302	Rat	rno-miR-124	miRNA	hepatocyte growth factor (HGF)	chemotactic migration	rat MSCs (rMSCs)	rat MSCs (rMSCs) treatment	downregulated	27377850
303	Rat	rno-miR-124	miRNA	chronic unpredictable mild stress (CUMS)	depression	hippocampus	chronic unpredictable mild stress (CUMS) treatment	miR-124 expression was upregulated in the hippocampus of CUMS -induced depression model rats.	32189593
304	Rat	rno-miR-124	miRNA	corticosterone	depression	prefrontal cortex	corticosterone (CORT) treatment	upregulated	26575223
305	Rat	rno-miR-124	miRNA	amadori-glycated albumin (AGA)	diabetes mellitus (DM)	retinal ganglion cells (RGCs)	amadori-glycated albumin (AGA) treatment	downregulated	26348633
306	Rat	rno-miR-124	miRNA	curcumin (Cur)	diabetic nephropathy (DN)	enal cortex of diabetic rats and podocytes	curcumin treatment	downregulated	24556741
307	Rat	rno-miR-124	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	upregulated	22156553
308	Rat	rno-miR-124	miRNA	streptozocin (STZ)	glaucoma	renal cortex cells	streptozotocin (STZ) treatment	miR-124 upregulated	24247359
309	Rat	rno-miR-124	miRNA	hypoxia	hepatic ischemia/reperfusion injury (HIRI)	human hepatic L02 cells	hepatic ischemia-reperfusion (HIR)	downregulated	24875359
310	Rat	rno-miR-124	miRNA	astragaloside IV (AS-IV)	hypoxia-induced injury	hypoxia-induced PC-12 cells	astragaloside IV (AS-IV) treatment	downregulated	29990829
311	Rat	rno-miR-124	miRNA	hypoxia	hypoxia-induced injury	PC-12 cells	hypoxia induce	upregulated	29990829
312	Rat	rno-miR-124	miRNA	ischemia	ichemia/reperfusion (I/R)-induced brain injury	brain tissues	2 h of MCAO using a nylon monofilament suture as described previously treatment	downregulated	24166354
313	Rat	rno-miR-124	miRNA	collagenase	intracerebral haemorrhage (ICH)	plasma	collagenase treatment	"miR-124 was significantly elevated at the acute injury phase (day 1 and 2), gradually decreased during the delayed recovery phase (day 7, 14 and 30), and finally restored to normal levels at late recovery phase (day 60)."	29101647
314	Rat	rno-miR-124	miRNA	collagenase	intracerebral haemorrhage (ICH)	rats plasma and brain tissue	collagenase treatment	dysregulated in rat plasma and brain tissue	29101647
315	Rat	rno-miR-124	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	Primary cortical astrocytes	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31004734
316	Rat	rno-miR-124	miRNA	enoxacin	major depressive disorder (MDD)	rats	with 10 or 25 mg/kg enoxacin for 1 week treatment	upregulated	24575053
317	Rat	rno-miR-124	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	rat neonatal cardiomyocytes(NCMs)	angiotensin II (Ang II) treatment	upregulated	28478799
318	Rat	rno-miR-124	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	primary rat cardiomyocytes	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	31486506
319	Rat	rno-miR-124	miRNA	oxygen glucose deprivation (OGD)	neonatal hypoxic-ischemic encephalopathy 	PC12 cells; Primary Cortical Neurons	oxygen glucose deprivation (OGD) treatment	downregulated	31916069
320	Rat	rno-miR-124	miRNA	dexmedetomidine (DEX)	neuroinflammation	"adult Wistar rats brain ,plasma,"	dexmedetomidine (Dex) treatment	downregulated	28832497
321	Rat	rno-miR-124	miRNA	high fat diet (HFD)	neuroinflammation	hippocampus	high fat diet (HFD) feed	upregulated	30134248
322	Rat	rno-miR-124	miRNA	lipopolysaccharide (LPS)	neuroinflammation	adult Wistar rats brain regions	lipopolysaccharide (LPS) treatment	upregulated in both brain regions	28832497
323	Rat	rno-miR-124	miRNA	isoflurane	neurological deficits	neonatal rats and primary hippocampal neurons	isoflurane exposure	downregulated	31131895
324	Rat	rno-miR-124	miRNA	physical EE	neuropsychiatric disorders	hippocampal	physical EE treatment	upregulated	26132842
325	Rat	rno-miR-124	miRNA	(+)-cholesten-3-one (CN)	osteoblastic differentiation	mesenchymal stem cells (MSCs)	(+)-cholesten-3-one (CN) treatment	upregulated	30373531
326	Rat	rno-miR-124	miRNA	platelet-derived growth factor (PDGF)	cell proliferation	pulmonary arterial smooth muscle cell (PASMC) of Sprague-Dawley rats	platelet-derived growth factor-BB (PDGF-BB) treatment	downregulated	28867608
327	Rat	rno-miR-124	miRNA	single dose irradiation	radiation-induced lung injury (RILI)	male Wistar rats lung tissues	subjected to single dose irradiation with 20 Gy using 6 MV x-rays to the right lung treatment	upregulated	24886372
328	Rat	rno-miR-124	miRNA	paeonol (PAE)	renal interstitial fibrosis (RIF)	renal tissues or NRK-49F cells	paeonol (PAE) treatment	PAE was found to decrease HOTAIR and Notch1 expression but to increase the miR-124 expression in RIF rats.	30714138
329	Rat	rno-miR-124	miRNA	docosahexaenoic acid (DHA)	spinal cord injury (SCI)	"rat spinal primary microglia cultures, SCI rats Iba1-positive or P2Y12-positive cells"	Docosahexaenoic acid (DHA) treatment	upregulated	30972415
330	Rat	rno-miR-124-3p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	32391561
331	Rat	rno-miR-124-3p	miRNA	ethanol (EtOH)	alcohol use disorders (AUDs)	nucleus accumbens shell (NAcsh)	ethanol treatment	upregulated	32353460
332	Rat	rno-miR-124-3p	miRNA	ethanol (EtOH)	alcohol use disorders (AUDs)	nucleus accumbens core (NAcc)	ethanol treatment	upregulated	32353460
333	Rat	rno-miR-124-3p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	hippocampus	amyloid ¦Â1-42?(A¦Â) treatment	downregulated	29706607
334	Rat	rno-miR-124-3p	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	H9C2 cells	hypoxia induce	upregulated	31432169
335	Rat	rno-miR-124-3p	miRNA	chronic exogenous corticosterone (CORT)	major depressive disorder (MDD)	Sprague¨CDawley rats	CORT-treated (50?mg/kg; intraperitoneal injections for 21 days; n=9) rats	upregulated	27577603
336	Rat	rno-miR-124-3p	miRNA	ischemia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	heart tissues	the proximal left anteriordescending coronaryartery (LAD) was loosely ligated by a 6¨C0 silk suture	"miR-124-3p was significantly downregulated in both MIRI rat model and H/R treated HCMs.?Overexpression of miR-124-3p reversed the H/R-induced cell apoptosis and upregulation of TNF-¦Á, IL-6, and IL-1¦Â."	31768721
337	Rat	rno-miR-124-3p	miRNA	6-hydroxydopamine (6-OHDA)	parkinson's disease (PD)	PC12 cells	6-hydroxydopamine (6-OHDA) treatment	downregulated	28543594
338	Rat	rno-miR-124-3p	miRNA	6-hydroxydopamine (6-OHDA)	parkinson's disease (PD)	PC12 cells	6-hydroxydopamine (6-OHDA) treatment	downregulated	28543594
339	Rat	rno-miR-124-3p	miRNA	Total glucosides of paeony (TGP)	renal ischemia/reperfusion (I/R) injury	NRK-52E?cells	Total glucosides of paeony (TGP) treatment	TGP inhibited XIST expression to modulate the miR-124-3p/ITGB1 axis	33299380
340	Rat	rno-miR-124-3p	miRNA	N-methyl-N-nitrosourea (MNU)	retinal lesions	serum	N-methyl-N-nitrosourea (MNU) treatment	"MNU at 50?mg/kg induced photoreceptor cell death, with elevation in serum miR-124-3p levels."	30336191
341	Rat	rno-miR-124-3p	miRNA	N-methyl-D-aspartate (NMDA)	retinal toxicity	serum	N-methyl-d-aspartate (NMDA) treatment	upregulated	30336191
342	Rat	rno-miR-124-3p	miRNA	N-methyl-N-nitrosourea (MNU)	retinal toxicity	serum	N-methyl-N-nitrosourea (MNU) treatment	upregulated	30336191
343	Rat	rno-miR-124-4p	miRNA	fluoxetine (Prozac)	major depressive disorder (MDD)	Sprague¨CDawley rats	"were treated with fluoxetine (10?mg/kg, intraperitoneal for 60 days; n=5)"	downregulated	27577603
344	Rat	rno-miR-124-5p	miRNA	tanshinone IIA (Tan IIA)	acute myocardial infarction (AMI)	H9c2 cells	Tanshinone IIA (TSA) treatment	"TSA exerts the protective role against H/R induced apoptosis, oxidative and MMP loss of cardiomyocytes via regulating AK003290 and miR-124-5p signaling"	32220226
345	Rat	rno-miR-1247	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
346	Rat	rno-miR-1247-5p	miRNA	bleomycin (BLM)	lung fibrosis	lung tissues	bleomycin (BLM) treatment	upregulated	33193637
347	Rat	rno-miR-1249	miRNA	hypoxia	apoptosis	myocardial tissue and H9C2 cells	Chronic intermittent hypoxia (CIH) induce	upregulated	30293354
348	Rat	rno-miR-1249	miRNA	grape seed procyanidin extract (GSPE)	pancreatic islet injury	rat islets	grape seed procyanidin extract (GSPE)treatment	"GSPE altered significantly the expression of miR-1249, miR-483, miR-30c-1*, and miR-3544."	23215023
349	Rat	rno-miR-124a	miRNA	forced swim stress (FSS)	acute stress	Wistar rats hippocampus	forced swim stress (FSS; 15 min in 25¡ãC water)	upregulated in the hippocampus	27054829
350	Rat	rno-miR-124a	miRNA	all-trans retinoic acid (ATRA)	congenital spina bifida	rats	all-trans retinoic acid (ATRA) treatment	downregulated	26611840
351	Rat	rno-miR-124a	miRNA	all-trans retinoic acid (ATRA)	congenital spina bifida	spina	all-trans retinoic acid (ATRA) treatment	downregulated	26611840
352	Rat	rno-miR-124a	miRNA	dexamethasone (DEX)	depression	prefrontal cortex and hippocampus of adolescent rats	dexamethasone (DEX) treatment	upregulated	30469088
353	Rat	rno-miR-124a	miRNA	dexamethasone (DEX)	depression	prefrontal cortex and hippocampus of adolescent rats	dexamethasone (DEX) treatment	upregulated	30469088
354	Rat	rno-miR-124a	miRNA	high glucose (HG)	diabetic nephropathy (DN)	rat podocytes	high glucose (HG) treatment	upregulated	31190436
355	Rat	rno-miR-124a	miRNA	alcohol	ethanol addiction	rat dorsal striatum tissue	alcohol exposure	miR124a was downregulated in the dorso-lateral striatum (DLS) following alcohol drinking. brain-derived neurotrophic factor (BDNF) as a direct target of miR124a	23601049
356	Rat	rno-miR-124a	miRNA	high glucose (HG)	diabetic nephropathy (DN)	podocytes	high glucose (HG) treatment	upregulated	31190436
357	Rat	rno-miR-124a	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	upregulated	27074745
358	Rat	rno-miR-124a	miRNA	penetrating ballistic-like brain injury	penetrating ballistic-like brain injury (PBBI)	male Sprague-Dawley rats brain tissue	a unilateral frontal 10% PBBI treatment	upregulated in brain tissue	28452880
359	Rat	rno-miR-124a	miRNA	chronic unpredictable mild stress (CUMS)	permanent depressive-like behaviours and memory impairment	adolescent rats basolateral amygdala (BLA)	chronic unpredictable mild stress (CUMS) treatment	upregulated in the basolateral amygdala (BLA)	28826069
360	Rat	rno-miR-124a	miRNA	retinal toxicant pan-CDK inhibitors	retinal toxicity	rats in renal	a single intravitreal (IVT) injection treatment	upregulated	24114799
361	Rat	rno-miR-124a	miRNA	lipopolysaccharide (LPS)	sepsis-induced myocardial injury	BALB/c rats hearts	lipopolysaccharide (LPS) treatment	downregulated in hearts	28560580
362	Rat	rno-miR-124a	miRNA	retinoic acid (RA)	spina bifida	spinal cord of rat	Retinoic acid treatment	downregulated	17962954
363	Rat	rno-miR-124a	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
364	Rat	rno-miR-124a	miRNA	D-4F	type 1 diabetes mellitus (T1DM)	T1DM rats	D-4F (1 mg/kg i.p.)	upregulated	29221142
365	Rat	rno-miR-124a	miRNA	exercise training (ET)	vascular relaxation	arteries	exercise training	downregulated	32301852
366	Rat	rno-miR-125	miRNA	H2O2	ischemia/reperfusion (I/R) injury	H9c2 cells	H2O2 treatment	miR-125 expression level was significantly increased after H2O2 treatment in a dose-dependent manner.	30239560
367	Rat	rno-miR-125-3p	miRNA	light	focal retinal degeneration	right eye	light treatment	upregulated	25921151
368	Rat	rno-miR-125-3p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	lung tissues	monocrotaline treatment	downregulated	28000863
369	Rat	rno-miR-125-5p	miRNA	platelet-derived growth factor (PDGF)	intimal hyperplasia (IH)	vascular smooth muscle cell (VSMCs)	Platelet derived growth factor (PDGF)-BB treatment	PDGF-BB increased the expressionof miR-125a-5p and HDAC4	30156956
370	Rat	rno-miR-125a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	endotoxin treatment	upregulated	26137246
371	Rat	rno-miR-125a	miRNA	high glucose (HG)	atherosclerosis (AS)	vascular smooth muscle cells (VSMC)	high glucose treatment	MicroRNA-125a-mediated regulation of the mevalonate signaling pathway contributes to high glucose-induced proliferation and migration of vascular smooth muscle cells.	32319638
372	Rat	rno-miR-125a	miRNA	agmatine (AGM)	hyperoxia-induced acute lung injury (HALI)	rat lung tissues	agmatine (AGM) treatment	"AGM decreased the upregulated expression of lncRNA gadd7 caused by hyperoxia and due to the presence of the competitive binding of lncRNA gadd7 and MFN1 to miR-125a, AGM indirectly decreased MFN1 protein expression to inhibit the cells apoptosis."	31196629
373	Rat	rno-miR-125a	miRNA	massive small bowel resection	lung cancer	rat jejunum and IEC-6 cells	massive small bowel resection treatment	upregulated	22418008
374	Rat	rno-miR-125a	miRNA	glucagon-like peptide-2 (GLP-2)	short bowel syndrome (SBS)	intestinal exosomes	Glucagon-like peptide-2 (GLP-2) treatment	downregulated	32685005
375	Rat	rno-miR-125a	miRNA	H2O2	spinal cord injury (SCI)	rat PC-12 cells	H2O2 treatment	upregulated	28609843
376	Rat	rno-miR-125a	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
377	Rat	rno-miR-125a	miRNA	hypoxia	stroke	brain tissues	middle cerebral artery occlusion (MCAO) treatment	upregulated	29039453
378	Rat	rno-miR-125a-3p	miRNA	"2,5-hexanedione (HD)"	"2,5-hexanedione (HD) toxicity"	spinal cord tissues	"2,5-hexanedione (HD) treatment"	downregulated	31760062
379	Rat	rno-miR-125a-3p	miRNA	alcohol	brain damage due to chronic heavy alcohol	hippocampal tissues	chronic alcohol administration	upregulated	33228793
380	Rat	rno-miR-125a-3p	miRNA	complete freund's adjuvant (CFA)	orofacial inflammatory pain	male Sprague¨CDawley rats	CFA treatment	downregulated	25380251
381	Rat	rno-miR-125a-3p	miRNA	perfluorooctane sulfonic acid (PFOS)	perfluorooctane sulfonate (PFOS)-induced toxic action	rat liver tissue	dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 10) treatment	different expression	24420840
382	Rat	rno-miR-125a-3p	miRNA	pegylated rat leptin antagonist (pRLA)	type 2 diabetes mellitus (T2DM)	rat muscle and liver	pegylated rat leptin antagonist (pRLA) treatment	"upregulation of rno-miR-10a at d28 and rno-miR-200a, rno-miR-409-5p, and rno-miR-125a-3p following HFD challenge"	23576026
383	Rat	rno-miR-125a-3p	miRNA	inorganic phosphate (Pi)	vascular calcification (VC)	Vascular Smooth Muscle Cells	Inorganic phosphate (Pi) treatment	upregulated	31790973
384	Rat	rno-miR-125a-5p	miRNA	CoCl2	blood-spinal cord barrier (BSCB)	Rat spinal cord microvascular endothelial cells (SCMECs) and astrocyte	"CoCl2 was added to the medium in the upper chambers at a final concentration of 200 ¦ÌM to induce chemical hypoxia, and the cells were incubated for 24 h."	downregulated	31696327
385	Rat	rno-miR-125a-5p	miRNA	hypoxia	disruption of the blood-spinal cord barrier (BSCB)	rat spinal cord microvascular endothelial cells (SCMECs)	hypoxia treatment	"MiRNA-125a-5p appears to reduce the permeability of the BSCB by up regulating the expression of ZO-1, occludin, and VE-cadherin and their mRNA, and against hypoxia-induced apoptosis of spinal cord microvascular endothelial cells."	31696327
386	Rat	rno-miR-125a-5p	miRNA	Pentylenetetrazol (PTZ)	epilepsy	hippocampus tissues	Pentylenetetrazol (PTZ) treatment	downregulated	31490757
387	Rat	rno-miR-125a-5p	miRNA	platelet derived growth factor-BB (PDGF-BB)	ischemia/reperfusion (I/R) injury	vascular smooth muscle cell (VSMCs)	Platelet derived growth factor (PDGF)-BB treatment	upregulated	30156956
388	Rat	rno-miR-125a-5p	miRNA	enoxacin	major depressive disorder (MDD)	rats	with 10 or 25 mg/kg enoxacin for 1 week treatment	upregulated	24575053
389	Rat	rno-miR-125a-5p	miRNA	hypoxia/reoxygenation (H/R)	myocardial hypoxia/reoxygenation (H/R) injury	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	"Compared with the blank control group, the expression of miR-125a-5p in the hypoxia/reoxygenation group was significantly increased."	32820512
390	Rat	rno-miR-125a-5p	miRNA	binge drinking	neurodegeneration (ND)	rats	binge drinking treatment	downregulated in prefrontal cortex (PFC)	27085842
391	Rat	rno-miR-125a-5p	miRNA	high fat diet (HFD)	obesity	white adipose tissues	high fat diet (HFD) feed	upregulated	32366215
392	Rat	rno-miR-125a-5p	miRNA	IL-6	pulmonary arterial hypertension (PAH)	rat pulmonary artery smooth muscle cells (PASMCs)	IL-6 treatment	upregulated	29700287
393	Rat	rno-miR-125a-5p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	pulmonary artery (PA) tissues and rat pulmonary artery smooth muscle cells (PASMCs)	monocrotaline (MCT) treatment	downregulated	29700287
394	Rat	rno-miR-125a-5p	miRNA	TGF-¦Â1	pulmonary arterial hypertension (PAH)	rat pulmonary artery smooth muscle cells (PASMCs)	TGF-¦Â1 treatment	upregulated	29700287
395	Rat	rno-miR-125a-5p	miRNA	oxidized low density lipoprotein (ox-LDL)	stroke-prone spontaneously hypertensive	rat VECs	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	20531225
396	Rat	rno-miR-125a-5p	miRNA	dioscin	type 2 diabetes mellitus (T2DM)	high-fat diet- and streptozotocin- induced T2DM rats liver tissues	dioscin treatment	upregulated	31881477
397	Rat	rno-miR-125a-5p	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	liver tissues	streptozotocin treatment	downregulated	31881477
398	Rat	rno-miR-125b	miRNA	hypoxia	acute myocardial infarction (AMI)	Neonatal rat cardiomyocytes	hypoxia induce	downregulated	31595551
399	Rat	rno-miR-125b	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	nerve growth factor (NGF) stimulated PC 12 cells and primary cerebral cortex neurons of rat embryo	amyloid ¦Â1-42?(A¦Â) treatment	upregulated	31345147
400	Rat	rno-miR-125b	miRNA	¦Â-mercaptoethanol (BME)	cell differentiation	rat bone marrow mesenchymal stem cells (BMSCs)	¦Â-mercaptoethanol (BME) treatment	miR-125b can promote BME to induce rat BMSCs differentiation into neuron-like cells	23536218
401	Rat	rno-miR-125b	miRNA	hypoxia	cardiac injury	H9c2 cells	hypoxia exposure	upregulated	32415544
402	Rat	rno-miR-125b	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	PC-12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	29510389
403	Rat	rno-miR-125b	miRNA	hypoxia	dementia	brain tissues	hypoxia induce	downregulated	31000329
404	Rat	rno-miR-125b	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	downregulated	24205079
405	Rat	rno-miR-125b	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	CCl4 treatment	downregulated	31548167
406	Rat	rno-miR-125b	miRNA	cecal ligation and puncture (CLP)	sepsis	rats	cecal ligation and puncture (CLP) treatment	downregulated	29227823
407	Rat	rno-miR-125b	miRNA	retinoic acid (RA)	spina bifida	spinal cord of rat	Retinoic acid treatment	downregulated	17962954
408	Rat	rno-miR-125b	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
409	Rat	rno-miR-125b	miRNA	phosphorus (Pi)	vascular calcification (VC)	rat aortic vascular smooth muscle cells	high levels of phosphate treatment	downregulated	28522697
410	Rat	rno-miR-125b-1-3p	miRNA	prenatal stress (PNS)	schizophrenia (SZ)	hippocampus tissue	"pregnant dams, during the last week of gestation, were restrained in a transparent Plexiglas cylinder, under bright light, for 45 min, three times a day for 1 week. Control pregnant females were left undisturbed in their home cages."	downregulated	30057098
411	Rat	rno-miR-125b-2-3p	miRNA	ethylenethiourea (ETU)	anorectal malformations (ARM)	Hindgut tissue was isolated from the gestational day 14 and day 15 fetuses	ethylenethiourea (ETU) treatment	upregulated	30106085
412	Rat	rno-miR-125b-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis and hypertension	cardiac fibroblasts (CFs) of rats	angiotensin II (Ang II) treatment	upregulated	23007623
413	Rat	rno-miR-125b-5p	miRNA	hypoxia	acute myocardial infarction (AMI)	heart tissues	ligation of the left anterior descending coronary artery	downregulated	32010261
414	Rat	rno-miR-125b-5p	miRNA	¦Â3-adrenoceptors(¦Â3-AR) inhibitor SR 59230A	chronic heart failure (CHF)	CHF rats	1 ml SR 59230A(85 mmoL/L in 0.9% saline)twice a day for seven weeks by intraperitoneal injection treatment	upregulated	29926593
415	Rat	rno-miR-125b-5p	miRNA	sevoflurane (SEV)	cognitive impairment	rats hippocampus tissue	Sevoflurane treatment	upregulated	31490755
416	Rat	rno-miR-125b-5p	miRNA	dexmedetomidine (DEX)	diabetic nephropathy (DN)	PC-12 cells	dexamethasone (DEX) treatment	DEX displays neuroprotective effects on PC-12 cells under high glucose through regulating miR-125b-5p/VDR axis.	32538430
417	Rat	rno-miR-125b-5p	miRNA	palmitate	insulin resistance (IR)	H9c2 cardiomyoblasts	palmitate treatment	downregulated	30632304
418	Rat	rno-miR-125b-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	PC-12?cells	oxygen and glucose deprivation (OGD) treatment	upregulated	29777774
419	Rat	rno-miR-125b-5p	miRNA	oxidized low density lipoprotein (ox-LDL)	stroke-prone spontaneously hypertensive	rat VECs	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	20531225
420	Rat	rno-miR-126	miRNA	CoCl2	acute myocardial infarction (AMI)	rat embryonic heart-derived H9c2 cells	CoCl2 treatment	upregulated	30597234
421	Rat	rno-miR-126	miRNA	CoCl2	acute myocardial infarction (AMI)	H9C2 rat cardiomyocytes	CoCl2 treatment	upregulated	30597234
422	Rat	rno-miR-126	miRNA	H2O2	acute myocardial infarction (AMI)	H9C2 rat cardiomyocytes	H2O2 treatment	upregulated	30597234
423	Rat	rno-miR-126	miRNA	H2O2	acute myocardial infarction (AMI)	rat embryonic heart-derived H9c2 cells	H2O2 treatment	upregulated	30597234
424	Rat	rno-miR-126	miRNA	H2O2	acute myocardial infarction (AMI)	bone marrow-derived endothelial progenitor cells	H2O2 treatment	Treatment with H2O2 decreased miR-126 expression in EPCs in a dose-dependent manner.	31999938
425	Rat	rno-miR-126	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	allergic contact dermatitis (ACD)	ear tissues of rats with allergic contact dermatitis	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	upregulated	30186504
426	Rat	rno-miR-126	miRNA	IgE	allergic contact dermatitis (ACD)	rat peritoneal mast cells (RPMCs)	IgE treatment	upregulated	30186504
427	Rat	rno-miR-126	miRNA	swimming	angiogenesis	the heart and soleus muscle tissue of rat	Swimming Training treatment	upregulated	22330028
428	Rat	rno-miR-126	miRNA	heat stress	apoptosis	primary cultured cardiomyocytes	heat stress induce	upregulated	30296408
429	Rat	rno-miR-126	miRNA	crocin	cardiovascular disease (CVD)	Wistar rats heart tissue	crocin treatment	upregulated	28678929
430	Rat	rno-miR-126	miRNA	high-intensity interval training (HIIT)	diabetes mellitus (DM)	heart sissues	high-intensity interval training (HIIT) treatment	HIIT gave rise to a significant enhancement in expression of miR-126 heart tissues.	33520826
431	Rat	rno-miR-126	miRNA	alloxan	diabetes mellitus (DM)	plasma	alloxan treatment	downregulated	31508175
432	Rat	rno-miR-126	miRNA	gambogic acid (GA)	diabetes mellitus (DM)	plasma	Gallic acid (GA) treatment	upregulated	31508175
433	Rat	rno-miR-126	miRNA	garlic	diabetes mellitus (DM)	myocardium	garlic feed	upregulated	30570073
434	Rat	rno-miR-126	miRNA	garlic	diabetes mellitus (DM)	diabetic rats heart tissues	Garlic treatment	upregulated	30570073
435	Rat	rno-miR-126	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	heart tissues	streptozotocin (STZ) treatment	downregulated	30570073
436	Rat	rno-miR-126	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	myocardium	streptozotocin treatment	downregulated	30570073
437	Rat	rno-miR-126	miRNA	voluntary exercise	diabetes mellitus (DM)	myocardium	voluntary exercise treatment	upregulated	30570073
438	Rat	rno-miR-126	miRNA	voluntary exercise	diabetes mellitus (DM)	diabetic rats heart tissues	voluntary exercise treatment	upregulated	30570073
439	Rat	rno-miR-126	miRNA	testosterone	diabetic cardiomyopathy (DCM)	type 1 diabetic rats	testosterone and exercise treatment	upregulated	31149186
440	Rat	rno-miR-126	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin (STZ) treatment	"miR-126 expression was downregulated in model of diabetic nephropathy, compared with control group"	32449863
441	Rat	rno-miR-126	miRNA	hypoxia	diabetic retinopathy (DR)	RF/6A cells	Hypoxia treatment	The expression of miR-126 was also reduced in the retina tissue of streptozotocin-induced dia-betic rats.	24396282
442	Rat	rno-miR-126	miRNA	hypoxia	diabetic retinopathy (DR)	chorioretinal vessel endothelial cells	Hypoxia treatment	A significantly decreased expression of miR-126 was found in hypoxia-treated RF/6A cells in a time-dependent manner compared with normoxic condition.	24396282
443	Rat	rno-miR-126	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retinal tissue	streptozotocin (STZ) treatment	The diabetic rats were found to exhibit downregulated serum and retinal miR-126 levels compared with the non-diabetic rats	33416109
444	Rat	rno-miR-126	miRNA	negative pressure wound therapy	diabetic wound repair	diabetic wound repair	Negative pressure wound therapy treatment	"In the NPWT group, miR-126 expression was significantly increased on days 3, 5, 7, and 9 (P<0.05)."	31564936
445	Rat	rno-miR-126	miRNA	trimetazidine (TMZ)	endothelial dysfunction	plasma	Trimetazidine (TMZ) treatment	"Trimetazidine Increases Plasma MicroRNA-24 and MicroRNA-126 Levels and Improves Dyslipidemia, Inflammation and Hypotension in Diabetic Rats"	33680027
446	Rat	rno-miR-126	miRNA	hypoxia	F. novicida?infection	rat cardiac myocytes	Hypoxia treatment	upregulated	23201405
447	Rat	rno-miR-126	miRNA	formaldehyde	formaldehyde inducted immune/inflammation	rats	were exposed to formaldehyde treatment	downregulated	24304932
448	Rat	rno-miR-126	miRNA	collagenase	intracerebral haemorrhage (ICH)	rats	intracerebral injection of collagenase	downregulated	28112373
449	Rat	rno-miR-126	miRNA	4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)	lung cancer	rat lung tissue	4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) treatment	downregulated	18780894
450	Rat	rno-miR-126	miRNA	TGF-¦Â1	lung cancer	rat bone marrow-derived EPCs	TGF¦Â1?treatment treatment	downregulated	24349482
451	Rat	rno-miR-126	miRNA	exercise training (ET)	myocardial angiogenesis	heart sissues	Exercise training (ET)	4-week ET could significantly increase the expression of HIF-1¦Á and miR-126.	32939968
452	Rat	rno-miR-126	miRNA	H2O2	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	H2O2 treatment	HOTAIR aggravates myocardial IR by competitively binding SRSF1 with microRNA-126.	32964995
453	Rat	rno-miR-126	miRNA	hypoxia/reoxygenation (H/R)	perivascular fibrosis	NRK52E cells	hypoxia/reoxygenation (H/R) treatment	MiR-126 was downregulated in NRK52E cells subjected to hypoxia/reoxygenation (H/R).	31862188
454	Rat	rno-miR-126	miRNA	contrast medium (CM)	preeclampsia (PE)	preeclampsia rats placenta and fetuses	contrast-enhanced ultrasound treatment	downregulated	24239158
455	Rat	rno-miR-126	miRNA	ginkgolide B (GB)	cell proliferation	endothelial progenitor cells (EPCs) of Sprague-Dawley rats	"various concentrations of ginkgolide B (0, 1.25, 5, 20, 80 or 160 ?g/ml) for 24 or 48 h"	upregulated	28849170
456	Rat	rno-miR-126	miRNA	carbon black (CB) particles	lung fibrosis	rat lung tissues	carbon black (CB) particles treatment	downregulated	31502903
457	Rat	rno-miR-126	miRNA	Yishen Huoxue prescription	renal fibrosis	unilateral ureteral obstruction (UUO) rats renal tissues	Yishen Huoxue prescription treatment	upregulated	30439324
458	Rat	rno-miR-126	miRNA	hypoxia	renal ischemia/reperfusion (I/R) injury	NRK52E cells	hypoxia induce	downregulated	31862188
459	Rat	rno-miR-126	miRNA	hesperidin	testicular toxicity	testicular	hesperidin (HSP) treatment	upregulated	32050098
460	Rat	rno-miR-1262	miRNA	diethylnitrosamine and 2-acetylaminofluorene	precancerous lesion (PCL)	liver tissues	diethylnitrosamine and 2-acetylaminofluorene treatment	downregulated	31009125
461	Rat	rno-miR-1262	miRNA	pantoprazole	precancerous lesion (PCL)	liver tissues	pantoprazole treatment	upregulated	31009125
462	Rat	rno-miR-126-3p	miRNA	Type VII collagenase	intracerebral haemorrhage (ICH)	serum and hemorrhagic area	Type VII collagenase treatment	downregulated	31474826
463	Rat	rno-miR-126-5p	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia induce	downregulated	33365067
464	Rat	rno-miR-126-5p	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia treatment	miR-126-5p regulates H9c2 cell proliferation and apoptosis under hypoxic conditions by targeting IL-17A.	33365067
465	Rat	rno-miR-126-5p	miRNA	dehydroepiandrosterone (DHEA)	polycystic ovarian syndrome (PCOS)	rats' ovarian tissues	DHEA treatment	downregulated in rats' ovarian tissues	28673204
466	Rat	rno-miR-126a	miRNA	NOX inhibitor VAS2870	acute ischemic stroke (AIS)	tMCAO rats	intravenous treatment with NOX inhibitor VAS2870	upregulated	27325364
467	Rat	rno-miR-126a-3p	miRNA	estradiol benzoate (EB)	chronic inflammatory diseases	dorsolateral prostate	estradiol benzoate (EB) treatment	upregulated	33332750
468	Rat	rno-miR-126a-3p	miRNA	L-nitro-arginine methylester	preeclampsia (PE)	placenta of pre-eclampsia-like female rats	L-nitro-arginine methylester treatment	downregulated	31789346
469	Rat	rno-miR-126a-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
470	Rat	rno-miR-126a-5p	miRNA	hypoxia	persistent pulmonary hypertension of the newborn (PPHN)	newborn rats lung tissues	exposed to hypoxia (10-12%) or room air for 2 weeks	upregulated in lung tissue	28148930
471	Rat	rno-miR-127	miRNA	taurocholate	acute pancreatitis (AP) with lung injury (LI)	rats lungs	administrated with retrograde cholangiopancreatography injection of 0.5% or 3.5% sodium taurocholate to induce AP with mild or severe LI treatment	upregulated in the lungs	29434409
472	Rat	rno-miR-127	miRNA	circadian disruption (CD)	breast cancer	mammary	circadian disruption (CD) treatment	downregulated	26097876
473	Rat	rno-miR-127	miRNA	methyl-deficient diet	hepatocellular carcinoma (HCC)	liver tissues	methyl-deficient diet feed	downregulated	18942116
474	Rat	rno-miR-127	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	rat adrenal medulla-derived pheochromocytoma cell line PC-12	oxygen-glucose deprivation (OGD) induce treatment	"Furthermore, ANRIL negatively regulated miR-127 expression miR-127 overexpression significantly enhanced OGD-induced PC-12 cell injury"	31174432
475	Rat	rno-miR-127	miRNA	SiO2	lung injury	lung	SiO2 treatment	upregulated	27689473
476	Rat	rno-miR-127	miRNA	ellagic acid (EA)	breast cancer	female rat mammary tissue	ellagic acid treatment	"ellagic acid, which inhibited E2-induced mammary tumorigenesis in our previous study, reversed the dysregulation of miR-375, miR-206, miR-182, miR-122, miR-127 and miR-183 detected with E2treatment"	23791885
477	Rat	rno-miR-127	miRNA	astragalus polysaccharide (APS)	myocarditis	H9c2 cells	astragalus polysaccharide (APS) treatment	"APS could protect H9c2 cells against LPS-induced inflammation injury, which might be partially due to miR-127 downregulated and regulation of NF-¦ÊB, JNK, and PI3K/AKT signaling pathways."	29451405
478	Rat	rno-miR-127	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	27910957
479	Rat	rno-miR-127	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC-12 cells	lipopolysaccharide (LPS) treatment	upregulated	29198922
480	Rat	rno-miR-1273g-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	DR rat retinal pigment epithelial (RPE) cells	streptozotocin (STZ) treatment	upregulated	29197896
481	Rat	rno-miR-127-5p	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
482	Rat	rno-miR-128	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia induce	upregulated	30265647
483	Rat	rno-miR-128	miRNA	HspB1	breast cancer	cortical neurons of rats	HspB1 treatment	upregulated	24141048
484	Rat	rno-miR-128	miRNA	hypoxia/reoxygenation (H/R)	cardiac injury	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	upregulated	30372838
485	Rat	rno-miR-128	miRNA	homocysteine (Hcy)	cardiac microvascular endothelial cells (CMECs) injury	cardiac microvascular endothelial cells (CMECs)	homocysteine (HCY) treatment	downregulated	30701536
486	Rat	rno-miR-128	miRNA	astragaloside IV (AS-IV)	diabetes mellitus (DM)	retinal pigment epithelial (RPE) cells	astragaloside IV (AS-IV) treatment	"miR-128 expression in RPE cells from dM rats treated with AIV (60 mg/kg) for 11 weeks increased significantly, compared with that in RPE cells from rats with dM."	32626913
487	Rat	rno-miR-128	miRNA	"(2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (2R,4R-APDC)"	epilepsy	hippocampus	"(2R,4R)-4-aminopyrrolidine-2,4-dicarboxylate (2R,4R-APDC) treatment"	"2R,4R-APDC upregulated miR-128 expression levels in the hippocampus."	29497903
488	Rat	rno-miR-128	miRNA	lithium chloride (LiCl)	epilepsy	hippocampus	lithium chloride treatment	upregulated	31173166
489	Rat	rno-miR-128	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	myocardial ischemia/reperfusion (I/R) injury (MIRI)	Antimycin A-treated H9c2 cells	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	31902745
490	Rat	rno-miR-128	miRNA	antimycin A (AA)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	antimycin A (AA) treatment	downregulated	31902745
491	Rat	rno-miR-128-3p	miRNA	hypoxia	cerebral ischemia/reperfusion (I/R) injury	brain tissues and primary cultured neural stem cells (NSCs)	hypoxia induce	upregulated	31638230
492	Rat	rno-miR-128-3p	miRNA	theaflavin (TF)	cerebral ischemia/reperfusion (I/R) injury	hypoxia-induced brain tissues and primary cultured neural stem cells (NSCs)	Theaflavin treatment	downregulated	31638230
493	Rat	rno-miR-128-3p	miRNA	melamine and cyanuric acid (MEL&CYA)	kidney damage	serum	melamine and cyanuric acid (MEL&CYA) treatment	downregulated	27621052
494	Rat	rno-miR-128-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
495	Rat	rno-miR-128-3p	miRNA	electroacupuncture (EA)	spinal cord injury (SCI)	spinal cords	electroacupuncture (EA) treatment	downregulated	32468009
496	Rat	rno-miR-128-3p	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	islet tissues	"Rats in the T2DM group were fed with a high sugar and high fat diet containing 20% sucrose, 10% lard, 2.5% cholesterol, 1.0% bile salts, and 66.5% normal diets. After 4 weeks of feeding with a high sugar and high fat diet for rats in the T2DM group and a fast for 12 hr, the rats in the T2DM group were injected with 2% streptozotocin. treatment"	upregulated	30341898
497	Rat	rno-miR-128-3p	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	islet tissues	streptozotocin (STZ) treatment	upregulated	30341898
498	Rat	rno-miR-128a-3p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
499	Rat	rno-miR-128a-3p	miRNA	¦Ä-opioid receptor (DOR)	hypoxic/ischemic injury	hearts	¦Ä-opioid receptor (DOR) activation treatment	upregulated	27576463
500	Rat	rno-miR-128a-3p	miRNA	pilocarpine	mesial temporal lobe epilepsy (MTLE)	hippocampi	pilocarpine treatment	downregulated	27695061
501	Rat	rno-miR-129	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	PC12 cells	amyloid-¦Â (A¦Â) 25-35 treatment	"Elevated H19, HMGB1 and decreased miR-129 were found in A¦Â25-35-treated PC12 cells as well as in brain tissues of AD mice."	33410377
502	Rat	rno-miR-129	miRNA	resveratrol	breast cancer	matched tumor/normal tissues	resveratrol (RS) treatment	upregulated	24447120
503	Rat	rno-miR-129	miRNA	ochratoxin A (OTA)	ochratoxin A (OTA) nephrotoxicity	kidney?tissues	OTA nephrotoxicity treatment	suppressed in mid dose but then elevated in high dose	24885635
504	Rat	rno-miR-129-1-3p	miRNA	cyclic mechanical stretch (CMS)	cell differentiation	Bone marrow-derived Endothelial progenitor cells (EPCs)	Bone marrow-derived EPCs were exposed to cyclic stretch with a magnitude of 5% (which mimics physiological mechanical stress) at a constant frequency of 1.25?Hz for 24?hours.	downregulated	30320897
505	Rat	rno-miR-129-1-3p	miRNA	pirarubicin (THP)	pirarubicin (THP) cardiotoxicity	H9c2 cells	Pirarubicin (THP) treatment	downregulated	31957170
506	Rat	rno-miR-129-1-3p	miRNA	cyclic mechanical stretch (CMS)	vessel injury	Endothelial progenitor cells (EPCs)	cyclic stretch treatment	Cyclic stretch significantly decreased miR-129-1-3p expression.	30320897
507	Rat	rno-miR-129-3p	miRNA	palmitic acid (PA)	inflammation	H9c2 cells	palmitic acid (PA) treatment	upregulated	30820195
508	Rat	rno-miR-129-3p	miRNA	tetrahydroxy stilbene glucoside (TSG)	inflammation	palmitic acid (PA)-treated H9c2 cells	Tetrahydroxy stilbene glucoside (TSG) treatment	downregulated	30820195
509	Rat	rno-miR-129-5p	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	brain tissues	amyloid-¦Â (A¦Â) 25-35 treatment	upregulated	31564203
510	Rat	rno-miR-129-5p	miRNA	IL-1¦Â	epilepsy	CTX-TNA cells	IL-1¦Â treatment	The expression of miR-129-5p was decreased in the model cells compared with normal astrocytes.	31948324
511	Rat	rno-miR-129-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	serum	carbon tetrachloride (CCl4) treatment	RT-qPCR revealed that miR-129-5p was poorly expressed and PEG3 was highly expressed in hepatic fibrosis tissues.	33743102
512	Rat	rno-miR-129-5p	miRNA	collagenase	intracerebral haemorrhage (ICH)	Sprague Dawley (SD) rats brain	collagenase treatment	downregulated	28645008
513	Rat	rno-miR-129-5p	miRNA	H2O2	ischemic heart disease (IHD)	H9c2 cells	H2O2 treatment	downregulated	30348524
514	Rat	rno-miR-1298	miRNA	fluorine combined with aluminum (FA)	fluorine combined with aluminum (FA)-induced developmental neurotoxicity	hippocampi	fluorine combined with aluminum (FA) treatment	upregulated	30033483
515	Rat	rno-miR-1298	miRNA	Diethylnitrosamine and 2-acetylaminofluorene	hepatic precancerous lesion (HPC)	Liver tissues and blood samples	diethylnitrosamine and 2-acetylaminofluorene treatment	downregulated	31489981
516	Rat	rno-miR-1298	miRNA	hesperidin	hepatic precancerous lesion (HPC)	hepatic precancerous lesion (HPC) rat liver tissues and blood samples	Hesperidin treatment	upregulated	31489981
517	Rat	rno-miR-130	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia induce	upregulated	29761875
518	Rat	rno-miR-130a	miRNA	molidustat	anemia	plasma samples	Molidustat treatment	upregulated	30657053
519	Rat	rno-miR-130a	miRNA	thrombin	acute spontaneous intracerebral hemorrhage (ICH)	primary brain microvascular endothelial cells (BMECs) of Sprague-Dawley rats	primary brain microvascular endothelial cells (BMECs) of Sprague-Dawley rats treatment	upregulation	25631713
520	Rat	rno-miR-130a	miRNA	nicotine	allergic asthma (AA)	lung tissues	nicotine injections	downregulated	28381639
521	Rat	rno-miR-130a	miRNA	hypoxia	apoptosis	H9C2 cells	hypoxia induce	upregulated	29399759
522	Rat	rno-miR-130a	miRNA	hypoxia/reoxygenation (H/R)	hypoxia/reoxygenation (H/R) injury	cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	upregulated	28352363
523	Rat	rno-miR-130a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	PC12 cells or brain tissues	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31226635
524	Rat	rno-miR-130a	miRNA	hypoxia/reoxygenation (H/R)	myocardial hypoxia/reoxygenation (H/R) injury	rat cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	upregulated	28352363
525	Rat	rno-miR-130a	miRNA	ochratoxin A (OTA)	ochratoxin A (OTA) nephrotoxicity	kidney?tissues	OTA nephrotoxicity treatment	suppressed in mid dose but then elevated in high dose	24885635
526	Rat	rno-miR-130a	miRNA	dehydro-isoandrosterone	polycystic ovarian syndrome (PCOS)	ovarian tissues and granulosa cells	dehydro-isoandrosterone treatment	LncRNA HOTAIR up-regulates the expression of IGF1 and aggravates the endocrine disorders and granulosa cell apoptosis through competitive binding to miR-130a in rat models of PCOS.	31733099
527	Rat	rno-miR-130a	miRNA	dehydro-isoandrosterone	polycystic ovarian syndrome (PCOS)	ovarian tissues	dehydro-isoandrosterone treatment	downregulated	31733099
528	Rat	rno-miR-130a	miRNA	hypoxia	cell proliferation	pulmonary smooth muscle cell	hypoxia treatment	miRNA family miR-130 plays an important role in the repression of CDKN1A by hypoxia. miR-130 enhances hypoxia-induced smooth muscle proliferation and might be involved in the development of right ventricular hypertrophy and vascular remodeling in pulmonary hypertension.	25681685
529	Rat	rno-miR-130a	miRNA	metformin (Met)	vascular endothelial dysfunction	palmitic acid (PA)-treated bone marrow-derived endothelial progenitor cells (EPCs)	metformin treatment	upregulated	30896786
530	Rat	rno-miR-130a	miRNA	palmitic acid (PA)	vascular endothelial dysfunction	bone marrow-derived endothelial progenitor cells (EPCs)	palmitic acid (PA) treatment	downregulated	30896786
531	Rat	rno-miR-130a-3p	miRNA	norepinephrine (NE)	cardiac hypertrophy	rat cardiomyocytes (NRCMs); H9c2 cells	norepinephrine (NE) treatment	downregulated	32329288
532	Rat	rno-miR-130a-3p	miRNA	aflatoxin B1 (AFB1)	hepatotoxicant and genotoxicant	liver	aflatoxin B1 (AFB1) treatment	downregulated	26385312
533	Rat	rno-miR-130a-5p	miRNA	nitrofen	congenital diaphragmatic hernia (CDH)	fetal lungs	"Nitrofen was orally administrated on embryonic day (E) 8.5 to establish a rat CDH model, and fetal lungs were collected on E13.5, E15.5, E17.5, E19.5 and E21.5."	upregulated	31843527
534	Rat	rno-miR-130a-5p	miRNA	high fat diet (HFD)	obesity	white adipose tissues	high fat diet (HFD) feed	upregulated	32366215
535	Rat	rno-miR-130b	miRNA	oxygen glucose deprivation (OGD)	cerebral ischemia/reperfusion (I/R) injury	primary astrocytes	anoxic conditions (1% O2) for 6 h (OGD) treatment	downregulated	28804561
536	Rat	rno-miR-130b	miRNA	ochratoxin A (OTA)	ochratoxin A (OTA) nephrotoxicity	kidney?tissues	OTA nephrotoxicity treatment	suppressed in mid dose but then elevated in high dose	24885635
537	Rat	rno-miR-130b	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
538	Rat	rno-miR-130b	miRNA	"1,25-dihydroxyvitamin D 3 (calcitriol)"	renal fibrosis	kidney tissues of streptozotocin-induced diabetic nephropathy (DN) rats	"1,25-dihydroxyvitamin D 3 (calcitriol) treatment"	upregulated	31781203
539	Rat	rno-miR-130b	miRNA	TGF-¦Â1	renal fibrosis	kidney tissues of streptozotocin-induced diabetic nephropathy (DN) rats	TGF-¦Â1 treatment	downregulated	31781203
540	Rat	rno-miR-130b-3p	miRNA	particulate matter (PM2.5)	allergic rhinitis (AR)	nasal mucosa	particulate matter 2.5 (PM2.5) treatment	downregulated	32192351
541	Rat	rno-miR-130b-5p	miRNA	ginsenoside Rb1	spinal cord injury (SCI)	?spinal cord injury (SCI) rat spinal cord tissues; oxygen-glucose deprivation/reoxygenation (OGD/R)-treated microglia cell	Ginsenoside Rb1 (GRb1) treatment	upregulated	32761843
542	Rat	rno-miR-130b-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	spinal cord injury (SCI)	Rat immortalized microglia cell line highly aggressively proliferating immortalized (HAPI)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	32761843
543	Rat	rno-miR-130b-5p	miRNA	hypoxia	acute spinal cord injury (ASCI)	AGE1.HN cells; PC12 cells	hypoxia treatment	"BDNF-AS, PRDM5 and c-caspase 3 expression were significantly upregulated, while miR-130b-5p was suppressed in the ASCI group and neuronal cells following hypoxia treatment."	29995562
544	Rat	rno-miR-130b-5p	miRNA	ginsenoside Rb1	spinal cord injury (SCI)	Rat immortalized micro- glia cells	Ginsenoside Rb1 (GRb1) treatment	GRb1 alleviated SCI through inhibiting neuronal apoptosis and proinflammatory factor expression via increasing miR-130b-5p.	32761843
545	Rat	rno-miR-132	miRNA	NOX inhibitor VAS2870	acute ischemic stroke (AIS)	tMCAO rats	intravenous treatment with NOX inhibitor VAS2870	upregulated	27325364
546	Rat	rno-miR-132	miRNA	isoproterenol	agonism	heart tissues	isoproterenol treatment	upregulated	25925428
547	Rat	rno-miR-132	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	Primary hippocampal neuron	amyloid-¦Â (A¦Â) 25-35 treatment	A¦Â25-35 treatment decreased miR-132 expression.	31949779
548	Rat	rno-miR-132	miRNA	angiotensin II (Ang II)	atrial fibrillation (AF)	cardiac fibroblasts of adult rats	angiotensin II (Ang II) treatment	upregulated	28731126
549	Rat	rno-miR-132	miRNA	angiotensin II (Ang II)	cardiac fibrosis	heart tissues	angiotensin II (Ang II) treatment	MicroRNA-132 attenuated cardiac fibrosis in myocardial infarction-induced heart failure rats	32885809
550	Rat	rno-miR-132	miRNA	angiotensin II (Ang II)	cardiac fibrosis and hypertension	cardiac fibroblasts (CFs) of rats	angiotensin II (Ang II) treatment	upregulated	23007623
551	Rat	rno-miR-132	miRNA	CREB-inhibitor 666-15	cardiac hypertrophy	H2O2-treated primary cultured cardiomyocytes	The CREB inhibitor 666-15 treatment	downregulated	30403388
552	Rat	rno-miR-132	miRNA	H2O2	cardiac hypertrophy	primary cultured cardiomyocytes	H2O2 treatment	upregulated	30403388
553	Rat	rno-miR-132	miRNA	isoproterenol	cardiac hypertrophy	primary cultured cardiomyocytes	Isoproterenol (ISO) treatment	upregulated	30403388
554	Rat	rno-miR-132	miRNA	mitochondrial ATP-dependent K+ channel (mitoKATP) channel-opener Dzx	cardiac hypertrophy	Isoproterenol (ISO)-treated primary cultured cardiomyocytes	The mitochondrial ATP-dependent K+ channel (mitoKATP) channel-opener Dzx treatment	downregulated	30403388
555	Rat	rno-miR-132	miRNA	angiotensin II (Ang II)	cardiac remodeling	cultured cardiomyocytes and cardiac fibroblasts	angiotensin II (Ang II) treatment	upregulated	31325434
556	Rat	rno-miR-132	miRNA	klotho	cardiac remodeling	Ang II-treated cultured cardiomyocytes and cardiac fibroblasts	klotho treatment	downregulated	31325434
557	Rat	rno-miR-132	miRNA	TGF-¦Â1 inhibitor LY364947	cardiac remodeling	Ang II-treated cultured cardiomyocytes and cardiac fibroblasts	TGF-¦Â1 inhibitor LY364947 treatment	downregulated	31325434
558	Rat	rno-miR-132	miRNA	high glucose (HG)	cardiovascular disease (CVD)	vascular smooth muscle cells (VSMCs)	high glucose (HG) treatment	downregulated	31257477
559	Rat	rno-miR-132	miRNA	nimodipine	chronic cerebral hypoperfusion (CCH)	Chronic cerebral hypofusion (CCH) rats hippocampus tissues	Nimodipine treatment	upregulated	29042207
560	Rat	rno-miR-132	miRNA	nimodipine	chronic cerebral hypoperfusion (CCH)	brain tissues	nimodipine treatment	downregulated	29042207
561	Rat	rno-miR-132	miRNA	permanent bilateral common carotid artery occlusion (2VO)	chronic cerebral hypoperfusion (CCH)	rats hippocampus and cortex	2VO treatment	upregulated in the hippocampus and cortex	29090669
562	Rat	rno-miR-132	miRNA	hypoxia	chronic cerebral hypoperfusion (CCH)-induced learning and memory impairments	hippocampus and cortex	bilateral common carotid artery occlusion (2VO) induce	downregulated	30885820
563	Rat	rno-miR-132	miRNA	cocaine hydrochloride	cocaine addiction	rats brain structures	cocaine hydrochloride was dissolved in sterile 0.9 % NaCl and administered intravenously	upregulated	26944283
564	Rat	rno-miR-132	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	rat colon Epithelial cells	azoxymethane (AOM) treatment	"Of the 27 miRNAs expressed at higher (P < 0.05) levels in tumors, miR-34a, 132, 223 and 224 were overexpressed at >10-fold. In contrast, the expression levels of miR-192, 194, 215 and 375 were dramatically reduced (?0.32-fold) in adenocarcinomas."	19825969
565	Rat	rno-miR-132	miRNA	doxorubicin (DOX)	dilated cardiomyopathy (DCM)	heart tissues	doxorubicin treatment	downregulated	30216493
566	Rat	rno-miR-132	miRNA	testosterone	heart angiogenesis	heart tissue	testosterone treatment	upregulated	30907089
567	Rat	rno-miR-132	miRNA	H2O2	heart failure (HF)	H9c2 cells	H2O2 treatment	downregulated	29682535
568	Rat	rno-miR-132	miRNA	luteolin	hepatitis C virus (HCV) infection	PC12 cells	Luteolin treatment	upregulated	22916239
569	Rat	rno-miR-132	miRNA	adreno-cortico-tropic-hormone (ACTH)	hormonal regulation	adrenals?tissues	adreno-cortico-tropic-hormone (ACTH) treatment	upregulated	24205079
570	Rat	rno-miR-132	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	upregulated	24205079
571	Rat	rno-miR-132	miRNA	angiotensin II (Ang II)	hypertension	heart tissues	angiotensin II (Ang II) treatment	upregulated	23712358
572	Rat	rno-miR-132	miRNA	oxygen glucose deprivation (OGD)	hypoxic/ischemic brain damage (HIBD)	fetal rat hippocampal neurons	oxygen-glucose deprivation (OGD) treatment	upregulated	28627974
573	Rat	rno-miR-132	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	upregulated	27074745
574	Rat	rno-miR-132	miRNA	propofol (PPF)	learning and memory deficits	neonatal rats hippocampus	propofol treatment	downregulated in the hippocampus	28109866
575	Rat	rno-miR-132	miRNA	enoxacin	major depressive disorder (MDD)	rats	with 10 or 25 mg/kg enoxacin for 1 week treatment	upregulated	24575053
576	Rat	rno-miR-132	miRNA	hypoxia	myocardial infarction (MI)	cardiomyocyte	The left anterior descending branch of LCA was ligated.	downregulated	31621911
577	Rat	rno-miR-132	miRNA	oxygen glucose deprivation (OGD)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	oxygen-glucose deprivation (OGD) treatment	upregulated	31210352
578	Rat	rno-miR-132	miRNA	oxygen glucose deprivation (OGD)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	oxygen glucose deprivation (OGD) treatment	OGD disposition obviously enhanced miR-132 expression in H9c2 cells.	31210352
579	Rat	rno-miR-132	miRNA	hypoxia	nerve injury	Schwann cells (SCs) after peripheral nerve injury	Hypoxia treatment	upregulated	26399639
580	Rat	rno-miR-132	miRNA	dexmedetomidine (DEX)	neuroinflammation	"adult Wistar rats brain ,plasma,"	dexmedetomidine (Dex) treatment	downregulated	28832497
581	Rat	rno-miR-132	miRNA	high fat diet (HFD)	neuroinflammation	hippocampus	high fat diet (HFD) feed	downregulated	30134248
582	Rat	rno-miR-132	miRNA	lipopolysaccharide (LPS)	neuroinflammation	adult Wistar rats brain regions	lipopolysaccharide (LPS) treatment	upregulated in both brain regions	28832497
583	Rat	rno-miR-132	miRNA	dexamethasone (DEX)	neuronal function	cortical neurons	dexamethasone (DEX) treatment	downregulated	19958814
584	Rat	rno-miR-132	miRNA	physical EE	neuropsychiatric disorders	hippocampal	physical EE treatment	upregulated	26132842
585	Rat	rno-miR-132	miRNA	polychlorinated biphenyls (PCBs)	neuropsychological disorders	postnatal day 1¨C2 (P1¨CP2) Sprague¨CDawley rats hippocampal cultures	nanomolar concentrations of PCB 95 treatment	upregulated	24431430
586	Rat	rno-miR-132	miRNA	high fat diet (HFD)	obesity	rats	high fat diet (HFD) feed	dysregulated	24517225
587	Rat	rno-miR-132	miRNA	glucagon-like peptide-1 (GLP-1)	pancreatic ¦Â-cell dysfunction	INS-1 832/3 cells	glucagon-like peptide 1 (GLP-1) treatment	upregulated	26218441
588	Rat	rno-miR-132	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	lung and pulmonary arterial tissues	monocrotaline treatment	upregulated	30896881
589	Rat	rno-miR-132	miRNA	IL-6 and TNF-¦Á	rheumatoid arthritis (RA)	Schwann cells	0.1 ng/mL IL-6 and 20 ng/mL TNF-¦Á treatment	downregulated	30456455
590	Rat	rno-miR-132	miRNA	sciatic nerve partial ligation	nerve regeneration	dorsal root ganglion (DRG)	sciatic nerve partial ligation therapy treatment	upregulation	26399639
591	Rat	rno-miR-132	miRNA	lipopolysaccharide (LPS)	sepsis-induced lung injury	rat alveolar macrophage cell line NR8383	lipopolysaccharide (LPS) treatment	upregulated	26052826
592	Rat	rno-miR-132	miRNA	sevoflurane (SEV)	sevoflurane-induced neuronal apoptosis	brain tissues	sevoflurane treatment	miRNA-132 was downregulated in sevoflurane-induced rats	30272258
593	Rat	rno-miR-132	miRNA	aluminum (Al)	spatial learning and memory impairment	offspring rats hippocampus	exposure to aluminium during the embryonic stage	upregulated	30172012
594	Rat	rno-miR-132	miRNA	fluoride	spatial learning and memory impairment	offspring rats hippocampus	exposure to fluorine during the embryonic stage	upregulated	30172012
595	Rat	rno-miR-132	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC-12 cells	lipopolysaccharide (LPS) treatment	downregulated	30691440
596	Rat	rno-miR-132	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC-12 cell	lipopolysaccharide (LPS) treatment	downregulated	31062615
597	Rat	rno-miR-132	miRNA	notoginsenoside R1 (NGR1)	spinal cord injury (SCI)	LPS-treated PC-12 cell	notoginsenoside R1 (NGR1) treatment	upregulated	31062615
598	Rat	rno-miR-132	miRNA	resveratrol	spinal cord injury (SCI)	LPS-treated PC-12 cells	resveratrol (RSV) treatment	upregulated	30691440
599	Rat	rno-miR-132	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
600	Rat	rno-miR-132	miRNA	lithium chloride (LiCl)	temporal lobe epilepsy (TLE)	Temporal lobe? tissues	TGF-¦Â treatment	upregulated	24995086
601	Rat	rno-miR-132	miRNA	cilostazol	vascular smooth muscle cell (VSMC) differentiation	vascular smooth muscle cell (VSMC)	cilostazol treatment	Treatment of cultured rat VSMCs with cilostazol resulted in the upregulated of PTEN mRNA and the downregulated of miR-132.	29738818
602	Rat	rno-miR-132	miRNA	brain-derived neurotrophic factor (BDNF)	neuronal function	cortical neurons	brain-derived neurotrophic factor (BDNF) treatment	upregulated	19958814
603	Rat	rno-miR-132-3p	miRNA	angiostrongylus cantonensis (A. cantonensis)	inflammation	healthy male SD rats	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24142286
604	Rat	rno-miR-132-3p	miRNA	N-methyl-D-aspartate receptor	long-term potentiation (LTP) persistence	rat dentate gyrus	rat dentate gyrus 20 min post-LTP induction in vivo treatment	downregulated	25538559
605	Rat	rno-miR-132-3p	miRNA	di(2-ethylhexyl) phthalate (DEHP)	neurotoxicity	female Long Evans rats hippocampal	di(2-ethylhexyl) phthalate (DEHP) treatment	upregulated	28192093
606	Rat	rno-miR-132-3p	miRNA	di(2-ethylhexyl) phthalate (DEHP)	neurotoxicity	male Long Evans rats hippocampal	di(2-ethylhexyl) phthalate (DEHP) treatment	downregulated	28192093
607	Rat	rno-miR-132-3p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31915454
608	Rat	rno-miR-132-3p	miRNA	Shenling Baizhu San (SLBZS)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	Shenling Baizhu San (SLBZS) treatment	the expression levels were reversed by SLBZS administration	31915454
609	Rat	rno-miR-132-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
610	Rat	rno-miR-132-3p	miRNA	methylprednisolone	steroid-induced osteonecrosis of femoral head (ONFH)	bone microvascular endothelial cells (BMECs)	methylprednisolone treatment	upregulated	29408208
611	Rat	rno-miR-132-5p	miRNA	nicotine	neuroprotective effects	PC12 cells	nicotine treatment	miR-132-5p was increased upon nicotine treatment.	32174265
612	Rat	rno-miR-132-5p	miRNA	di(2-ethylhexyl) phthalate (DEHP)	neurotoxicity	female Long Evans rats hippocampal	di(2-ethylhexyl) phthalate (DEHP) treatment	upregulated	28192093
613	Rat	rno-miR-132-5p	miRNA	di(2-ethylhexyl) phthalate (DEHP)	neurotoxicity	male Long Evans rats hippocampal	di(2-ethylhexyl) phthalate (DEHP) treatment	downregulated	28192093
614	Rat	rno-miR-132-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
615	Rat	rno-miR-132-5p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	downregulated	28246536
616	Rat	rno-miR-133	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	downregulated	29938673
617	Rat	rno-miR-133	miRNA	human growth hormone (hGH)	cardiac hypertrophy	ventricular muscle	recombinant human growth hormone (r-hGH) treatment	upregulated	30842884
618	Rat	rno-miR-133	miRNA	human growth hormone (hGH)	cardiac hypertrophy	heart tissues	swimming exercise plus r-hGH treatment	upregulated	30842884
619	Rat	rno-miR-133	miRNA	swimming	cardiac hypertrophy	ventricular muscle	swimming induce treatment	upregulated	30842884
620	Rat	rno-miR-133	miRNA	swimming	cardiac hypertrophy	heart tissues	The exercise groups completed a 1-h swimming exercise 5 times a week for 8 weeks. treatment	upregulated	30842884
621	Rat	rno-miR-133	miRNA	thyroid hormone	cardiac hypertrophy	Cardiomyocytes	thyroid hormone (TH) treatment	downregulated	26202011
622	Rat	rno-miR-133	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	renal tissue	streptozotocin (STZ) treatment	upregulated	31858564
623	Rat	rno-miR-133	miRNA	ivabradine	electrophysiological cardiac remodelling	heart of rat	?ivabradine treatment	upregulated	21838751
624	Rat	rno-miR-133	miRNA	tanshinone IIA (Tan IIA)	H2O2-induced cell death	H9c2 cells	tanshinone IIA treatment	downregulated	27446335
625	Rat	rno-miR-133	miRNA	aloe-emodin (AE)	myocardial infarction (MI)	H2O2-treated neonatal rat ventricular myocytes (NRVMs)	aloe-emodin (AE) treatment	upregulated	31207343
626	Rat	rno-miR-133	miRNA	H2O2	myocardial infarction (MI)	neonatal rat ventricular myocytes (NRVMs)	H2O2 treatment	downregulated	31207343
627	Rat	rno-miR-133	miRNA	oxygen glucose deprivation (OGD)	myocardial infarction (MI)	H9c2 cells	Oxygen-glucose deprivation (OGD) treatment	circMAT2B knockdown works as an inflammatory inhibitor in OGD-induced H9c2 cells inflammatory injury through up-regulating miR-133	32897801
628	Rat	rno-miR-133	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	The expression of miR-133 was significantly decreased in H/R-treated H9c2 cells.	32685535
629	Rat	rno-miR-133	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	downregulated	32685535
630	Rat	rno-miR-133	miRNA	doxorubicin (DOX)	oxidative stress	rat heart cell H9c2	doxorubicin (DOX) treatment	downregulated	28867607
631	Rat	rno-miR-133	miRNA	H2O2	oxidative stress	rat heart cell H9c2	H2O2 treatment	downregulated	28867607
632	Rat	rno-miR-133	miRNA	tanshinone IIA (Tan IIA)	oxidative stress	rat heart cell H9c2 treated by either H2O2 or doxorubicin (DOX)	Tanshinone ¢òA treatment	upregulated	28867607
633	Rat	rno-miR-133a	miRNA	doxycycline	atrial fibrillation (AF)	heart tissues	doxycycline treatment	downregulated	30470910
634	Rat	rno-miR-133a	miRNA	doxycycline	atrial fibrillation (AF)	heart sissues	doxycycline treatment	upregulated	30470910
635	Rat	rno-miR-133a	miRNA	TGF-¦Â1	bladder outlet obstruction (BOO)	bladder smooth muscle cells (BSMCs)	TGF-¦Â1 treatment	downregulated	25451078
636	Rat	rno-miR-133a	miRNA	"3,5-diiodo-L-thyronine (T2)"	browning of white adipocytes	subcutaneous white adipose tissue (sWAT)	receiving a high fat diet for 10 weeks and being subsequently treated for four weeks with an HFD together with the administration of T?	downregulated	30889829
637	Rat	rno-miR-133a	miRNA	high fat diet (HFD)	browning of white adipocytes	subcutaneous white adipose tissue (sWAT)	high fat diet (HFD) feed	upregulated	30889829
638	Rat	rno-miR-133a	miRNA	norepinephrine (NE)	cardiac hypertrophy	neonatal rat ventricular cardiomyocytes	norepinephrine treatment	downregulated	28795305
639	Rat	rno-miR-133a	miRNA	phenanthrene (Phe)	cardiac hypertrophy	H9C2 cells	phenanthrene (Phe) treatment	downregulated	26830171
640	Rat	rno-miR-133a	miRNA	ischemia	cardiomyocyte apoptosis	cardiomyocytes	Ischemic postconditioning (IPost)treatment	upregulated	21406115
641	Rat	rno-miR-133a	miRNA	daunorubicin	cardiomyopathy	rats	"daunorubicin (DAU-A, 3 mg/kg, every 48 h)"	downregulated	28303410
642	Rat	rno-miR-133a	miRNA	acute and long-term aerobic exercise	cardiorespiratory fitness	young men	acute and long-term aerobic exercise treatment	downregulated	27895662
643	Rat	rno-miR-133a	miRNA	isoproterenol and doxorubicin	cardiotoxicity	rats plasma	isoproterenol and doxorubicin treatment	upregulated after treatment with doxorubicin	25092230
644	Rat	rno-miR-133a	miRNA	dexamethasone (DEX)	glucocorticoid-induced osteoporosis (GIOP)	mesenchymal stem cells (MSCs)	dexamethasone (DEX) treatment	qRT-PCR analysis indicated that glucocorticoid induced high miR-133a expression in MSCs and animal models.	33781345
645	Rat	rno-miR-133a	miRNA	losartan	ischemia/reperfusion (I/R) injury	heart tissues	losartan treatment	upregulated	26168042
646	Rat	rno-miR-133a	miRNA	hypoxia	myocardial hypoxia injury	H9c2 cells	hypoxia treatment	downregulated	25421410
647	Rat	rno-miR-133a	miRNA	hydrogen sulfide (H2S)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	I/R-induced H9c2 cells	hydrogen sulfide (H2S) treatment	upregulated	30326468
648	Rat	rno-miR-133a	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia induce	downregulated	30326468
649	Rat	rno-miR-133a	miRNA	hydrogen sulfide (H2S)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hydrogen sulfide (H2S) treatment	miR-133a expression levels were significantly lower than those in the control group.	30326468
650	Rat	rno-miR-133a	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	hypoxia/reoxygenation (H/R) induce	downregulated	31734557
651	Rat	rno-miR-133a	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
652	Rat	rno-miR-133a	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC-12 cells	MPP+ (1-methyl-4-phenylpyridinium) treatment	Low miR-133a expression was detected in a cell model of MPP?-induced PD.	32713934
653	Rat	rno-miR-133a	miRNA	epigallocatechin-3-gallate (EGCG)	prostatic hyperplasia (BPH)	prostatic hyperplasia (BPH) rats prostate tissue	Epigallocatechin-3-gallate (EGCG) treatment	upregulated	30179845
654	Rat	rno-miR-133a	miRNA	testosterone	prostatic hyperplasia (BPH)	Prostate tissue	testosterone treatment	downregulated	30179845
655	Rat	rno-miR-133a	miRNA	estrogen (ES)	pulmonary arterial hypertension (PAH)	"PAH rats blood vessels, rat pulmonary smooth muscle cell (RPASMC)"	estrogen (ES) treatment	upregulated	31562386
656	Rat	rno-miR-133a	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	blood vessels	monocrotaline (MCT) treatment	downregulated	31562386
657	Rat	rno-miR-133a	miRNA	quinone compounds P3H4	renal cell carcinoma (RCC)	renal cancer tissue	P3H4 treatment	miR-133a was significantly upregulated in rat renal cancer tissue after the treatment of P3H4	30178839
658	Rat	rno-miR-133a	miRNA	berberine (BBR)	vascular dementia in diabetes	diabetic rats vascular endothelium	berberine (BBR) treatment	downregulated	30472896
659	Rat	rno-miR-133a	miRNA	berberine (BBR)	vascular dementia in diabetes	diabetic rats vascular endothelium	berberine (BBR) treatment	downregulated	30472896
660	Rat	rno-miR-133a	miRNA	streptozocin (STZ)	vascular dementia in diabetes	vascular endothelium	streptozotocin (STZ) treatment	upregulated	30472896
661	Rat	rno-miR-133a	miRNA	streptozocin (STZ)	vascular dementia in diabetes	vascular endothelium	streptozotocin treatment	upregulated	30472896
662	Rat	rno-miR-133a3p	miRNA	muscle contraction	diabetes mellitus (DM)	muscle tissues	"stimulated to contract in vitro for twitch tension analysis (0.5 Hz), 30 min later for tetanic analysis (100 Hz)"	upregulated	28000044
663	Rat	rno-miR-133a-3p	miRNA	pentoxifylline (PTX)	cardiac injury	heart sissues	Pentoxifylline (PTX) treatment	Pentoxifylline (PTX) treatment produced a dose-dependent increase in miRNA-133a-3p expressions	31972363
664	Rat	rno-miR-133a-3p	miRNA	ioversol	contrast-induced nephropathy (CIN)	kidney tissues	ioversol treatment	downregulated	33387208
665	Rat	rno-miR-133a-3p	miRNA	H2O2	coronary artery disease (CAD)	H9c2 cells	H2O2 treatment	Lower miR-133a-3p level was found in H2O2-induced H9c2 cells.	32764884
666	Rat	rno-miR-133a-3p	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	downregulated	32893733
667	Rat	rno-miR-133a-3p	miRNA	electrode	cardiac fibrosis	atrium tissues of rats	electrode stimulation	downregulated	32130618
668	Rat	rno-miR-133a-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
669	Rat	rno-miR-133a-3p	miRNA	notexin	skeletal muscle atrophy	plasma	notexin treatment	upregulated	26952641
670	Rat	rno-miR-133a-5p	miRNA	methamphetamine (METH)	drug addiction	heart tissues	Methamphetamine treatment	downregulated	31825931
671	Rat	rno-miR-133a-5p	miRNA	Rhynchophylline	drug addiction	methamphetamine-treated rats heart tissues	Rhynchophylline treatment	upregulated	31825931
672	Rat	rno-miR-133a-5p	miRNA	Rhynchophylline	drug addiction	heart sissues	Rhynchophylline treatment	Rhynchophylline could significantly increase the expression of miR-133a-5p	31825931
673	Rat	rno-miR-133a-5p	miRNA	ischemia	hepatic ischemia/reperfusion injury (HIRI)	liver tissues	ischemia for 1 h and reperfusion for 2 h	downregulated	28198596
674	Rat	rno-miR-133a-5p	miRNA	propofol (PPF)	hepatic ischemia/reperfusion injury (HIRI)	Sprague-Dawley rats liver	(I/R) injury rats treatment	upregulated	28198596
675	Rat	rno-miR-133a-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
676	Rat	rno-miR-133b	miRNA	Sodium iodate (NaIO3)	retinal injury	eyes tissues	Sodium iodate (NaIO3) treatment	upregulated	23143922
677	Rat	rno-miR-133b	miRNA	TGF-¦Â1	bladder outlet obstruction (BOO)	bladder smooth muscle cells (BSMCs)	TGF-¦Â1 treatment	downregulated	25451078
678	Rat	rno-miR-133b	miRNA	vitamin D receptor activators (VDRAs)	chronic renal failure (CRF)	nephrectomized Wistar rats	equivalent doses of two VDRAs: calcitriol and paricalcitol treatment	upregulated	28460073
679	Rat	rno-miR-133b	miRNA	caffeic acid	diabetic nephropathy (DN)	high-fat diet and streptozotocin-induced (HFD-STZ) diabetic rats	caffeic acid (CA) treatment	downregulated	28536471
680	Rat	rno-miR-133b	miRNA	morphine	dopaminergic (DA) neuron differentiation	mature rat hippocampal neurons	Morphine treatment	downregulated	20716624
681	Rat	rno-miR-133b	miRNA	hypoxia	hypoxia-induced injury	H9c2 cell	hypoxia induce	downregulated of miR-133b aggravated the cell injury induced by hypoxia.	31885905
682	Rat	rno-miR-133b	miRNA	losartan	ischemia/reperfusion (I/R) injury	heart tissues	losartan treatment	upregulated	26168042
683	Rat	rno-miR-133b	miRNA	epigallocatechin-3-gallate (EGCG)	prostatic hyperplasia (BPH)	prostatic hyperplasia (BPH) rats prostate tissue	Epigallocatechin-3-gallate (EGCG) treatment	upregulated	30179845
684	Rat	rno-miR-133b	miRNA	testosterone	prostatic hyperplasia (BPH)	Prostate tissue	testosterone treatment	downregulated	30179845
685	Rat	rno-miR-133b	miRNA	high inorganic phosphate (Pi)	vascular calcification (VC)	vascular smooth muscle	high-phosphorous treatment	downregulated	26187577
686	Rat	rno-miR-133b	miRNA	high inorganic phosphate (Pi)	vascular calcification (VC)	vascular smooth muscle	high-phosphorous treatment	lower levels of miR-133b and miR-211 and higher levels of miR-29b	26187577
687	Rat	rno-miR-133b-3p	miRNA	muscle contraction	diabetes mellitus (DM)	muscle tissues	"stimulated to contract in vitro for twitch tension analysis (0.5 Hz), 30 min later for tetanic analysis (100 Hz)"	upregulated	28000044
688	Rat	rno-miR-133b-3p	miRNA	cannabinoid receptor type II (CB2R)	parkinson's disease (PD)	PC12 cells	cannabinoid receptor type II (CB2R) treatment	CB2 receptor agonist AM1241 alleviated PD via regulation of the Xist/miR-133b-3p/Pitx3 axis.	31989652
689	Rat	rno-miR-133b-3p	miRNA	notexin	skeletal muscle atrophy	plasma	notexin treatment	upregulated	26952641
690	Rat	rno-miR-133b-5p	miRNA	morphine	cardiomyocytes against H/R injury	H9c2 cells	morphine treatment	upregulated	26919791
691	Rat	rno-miR-133b-5p	miRNA	hypoxia	HPC-induced cardioprotection	rat cardiomyocytes	hypoxia preconditioning (HPC) treatment	upregulated	29568969
692	Rat	rno-miR-133b-5p	miRNA	hypoxia/reoxygenation (H/R)	HPC-induced cardioprotection	rat cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	downregulated	29568969
693	Rat	rno-miR-133b-5p	miRNA	morphine	hypoxia/reoxygenation (H/R) injury	cardiomyocytes	morphine treatment	"After H/R injury, the decrease in miR-133b-5p and a contemporaneous rise in Fas mRNA and protein levels in adult rat cardiomyocytes were prevented by MPC treatment."	26919791
694	Rat	rno-miR-133b-5p	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	downregulated	27919821
695	Rat	rno-miR-133b-5p	miRNA	human immunodeficiency virus (HIV)-1 gp120 V3 Loop peptide	neuron apoptosis	cortical neurons	HIV-1 gp120 V3 Loop peptide treatment	upregulated	26280272
696	Rat	rno-miR-133b-5p	miRNA	human immunodeficiency virus (HIV)-1	neuronal cell dysfunction and apoptosis	primary rat cortical neurons	HIV-1 treatment	upregulated	26280272
697	Rat	rno-miR-133c	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	downregulated	32893733
698	Rat	rno-mir-133c	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
699	Rat	rno-miR-134	miRNA	CoCl2	autophagy	PC12 cells	CoCl2 treatment	downregulated	33410125
700	Rat	rno-miR-134	miRNA	propofol (PPF)	autophagy	CoCl2-treated PC12 cells	propofol treatment	upregulated	33410125
701	Rat	rno-miR-134	miRNA	soluble ¦Â-amyloid (sA¦Â) oligomers	Alzheimer's disease (AD)	cortical neurons were isolated from E17 embryos of Sprague Dawley rats	sA¦Â treatment	upregulated	24595404
702	Rat	rno-miR-134	miRNA	adeno-associated virus (AAV)	cerebral ischemia injury (CII)	neuron death induced by OGD/reoxygenation	adeno-associated virus (AAV) Doxorubicin (DOX)	upregulated	25316150
703	Rat	rno-miR-134	miRNA	resveratrol	cognitive impairment	primary cultured hippocampus neurons	resveratrol (RS) treatment	downregulated	29715537
704	Rat	rno-miR-134	miRNA	chronic unpredictable mild stress (CUMS)	depression	hippocampal tissues	chronic unpredictable mild stress (CUMS) treatment	upregulated	30716615
705	Rat	rno-miR-134	miRNA	enriched environment (EE)	depression	Chronic unpredictable mild stress (CUMS) treated rat hippocampal tissues	Enriched environment (EE) treatment	downregulated	30716615
706	Rat	rno-miR-134	miRNA	ginsenoside Rg1	depression	basolateral amygdala (BLA)	Ginsenoside Rg1 treatment	upregulated	30121663
707	Rat	rno-miR-134	miRNA	unpredictable chronic mild stress (UCMS)	depression	ventromedial prefrontal cortex (vmPFC)	unpredictable chronic mild stress (UCMS) induce treatment	upregulated	29329879
708	Rat	rno-miR-134	miRNA	kainic acid (KA)	epilepsy	brain tissue and serum	kainic acid treatment	downregulated	29917202
709	Rat	rno-miR-134	miRNA	kainic acid (KA)	epilepsy	hippocampus tissue	kainic acid (KA) treatment	upregulated	31031600
710	Rat	rno-miR-134	miRNA	ethylene glycol monomethyl ether (EGME)	hyperglycemia	?testicle of rat	Ethylene glycol monomethyl ether (EGME) treatment	"miR-449a and miR-92a decreased obviously and, miR-320, miR-134 and miR-188 increased"	22008535
711	Rat	rno-miR-134	miRNA	brain-derived neurotrophic factor (BDNF)	hypoxic/ischemic brain damage (HIBD)	rats hippocampalwith hypoxic-hypoglycemic neuron injury	brain-derived neurotrophic factor (BDNF) treatment	downregulated	28343294
712	Rat	rno-miR-134	miRNA	freund¡¯s complete adjuvant (FCA)	Insulin resistance and nonalcoholic steatohepatitis (NASH)	rat dorsal root ganglia (DRG)	Freund's adjuvant (CFA) treatment	downregulated of miR-134 and upregulated of MOR1	22865422
713	Rat	rno-miR-134	miRNA	electroacupuncture (EA)	ischemic stroke (IS)	middle cerebral artery occlusion induced cognitive deficit (MICD) rats hippocampal	electroacupuncture (EA) treatment	downregulated	28116173
714	Rat	rno-miR-134	miRNA	bile duct ligation (BDL)	liver fibrosis	liver tissues	bile duct ligation (BDL) treatment	downregulated	30645141
715	Rat	rno-miR-134	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	30645141
716	Rat	rno-miR-134	miRNA	dimethylnitrosamine (DMN)	liver fibrosis	liver tissues	dimethylnitrosamine (DMN) treatment	downregulated	30645141
717	Rat	rno-miR-134	miRNA	TGF-¦Â1	liver fibrosis	The rat hepatic stellate cell line HSC-T6	TGF-¦Â1 treatment	downregulated	30645141
718	Rat	rno-miR-134	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	hypoxia/reoxygenation (H/R) induce	upregulated	31618402
719	Rat	rno-miR-134	miRNA	dexmedetomidine (DEX)	neuroinflammation	"adult Wistar rats brain ,plasma,"	dexmedetomidine (Dex) treatment	downregulated	28832497
720	Rat	rno-miR-134	miRNA	lipopolysaccharide (LPS)	neuroinflammation	adult Wistar rats brain regions	lipopolysaccharide (LPS) treatment	upregulated in both brain regions	28832497
721	Rat	rno-miR-134	miRNA	H2O2	neuron survival	retinal ganglion cell (RGC)	H2O2 treatment	upregulated	25744098
722	Rat	rno-miR-134	miRNA	magnesium (Mg2+ )	neuroprotective effects	hippocampus of the SE rats	low Mg2+-exposed	upregulated	28942448
723	Rat	rno-miR-134	miRNA	propofol (PPF)	neuroprotective effects	primary hippocampal neurons under OGD condition	propofol treatment	downregulated	26884981
724	Rat	rno-miR-134	miRNA	paliperidone	neurotoxicity	SH-SY5Y cells	SH-SY5Y cells treatment	downregulated	26055227
725	Rat	rno-miR-134	miRNA	magnesium (Mg2+ )	satus epilepticus (SE)	rat hippocampal neurons	low Mg2+ treatment	upregulated	24810882
726	Rat	rno-miR-134	miRNA	Safflor yellow B (SYB)	stroke	cortical cells	Safflor yellow B (SYB) treatment	Safflor Yellow B Attenuates Ischemic Brain Injury via downregulated of Long Noncoding AK046177 and Inhibition of MicroRNA-134 Expression in Rats	32566081
727	Rat	rno-miR-134	miRNA	"fenoldopam, dopamine and midodrine"	vascular injury	rat mesentery cells	"Fenoldopam, dopamine and midodrine treatment"	upregulated	22627061
728	Rat	rno-miR-134-5p	miRNA	H2O2	acute myocardial infarction (AMI)	H9c2 cells	H2O2 treatment	H2O2-induced cardiomyocyte injury upregulated miR-134-5p expression.	32689640
729	Rat	rno-miR-134-5p	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia treatment	Hypoxia-induced cardiomyocyte injury upregulated miR-134-5p expression.	32689640
730	Rat	rno-miR-134-5p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	hippocampus tissues	amyloid ¦Â1-42?(A¦Â) treatment	upregulated	31625272
731	Rat	rno-miR-134-5p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	hippocampus	amyloid ¦Â1-42?(A¦Â) treatment	upregulated	31625272
732	Rat	rno-miR-134-5p	miRNA	potentiates inorganic phosphate (Pi)	calcium deposition	A10 cells	potentiates inorganic phosphate (Pi) treatment	upregulated	32783377
733	Rat	rno-miR-134-5p	miRNA	¦Ä-opioid receptor (DOR)	hypoxic/ischemic injury	hearts	¦Ä-opioid receptor (DOR) activation treatment	upregulated	27576463
734	Rat	rno-miR-134-5p	miRNA	oxygen glucose deprivation (OGD)	hypoxic/ischemic brain damage (HIBD)	PC-12 cells	oxygen glucose deprivation (OGD) treatment	The expression of miR-134-5p was elevated in PC12 cells following OGD.	32814091
735	Rat	rno-miR-134-5p	miRNA	X-rays	large intestine cancer	SW620 cells; HT29 cells	X-ray radiation treatment	LncRNA TTN-AS1/miR-134-5p/PAK3 axis regulates the radiosensitivity of human large intestine cancer cells through the P21 pathway and AKT/GSK-3¦Â/¦Â-catenin pathway	32749739
736	Rat	rno-miR-134-5p	miRNA	permanent bilateral common carotid artery occlusion (2VO)	vascular dementia (VD)	brain cortex tissues	Permanent bilateral occlusion of the common carotid artery (2-VO) induce treatment	upregulated	31545395
737	Rat	rno-miR-135a	miRNA	cerulein	acute pancreatitis (AP)	AR42J cells	cerulein treatment	upregulated	31729558
738	Rat	rno-miR-135a	miRNA	schisandrin B (Sch B)	asthma	lung	Schisandrin B treatment	upregulated	26916957
739	Rat	rno-miR-135a	miRNA	Streptococcus pneumoniae (Sp)	bacterial meningitis (BM)	astrocytes	Streptococcus pneumoniae?infection treatment	downregulated	30726113
740	Rat	rno-miR-135a	miRNA	astragaloside IV (AS-IV)	cardiac fibrosis	heart tissues	astragaloside IV (AS-IV) treatment	upregulated	31739105
741	Rat	rno-miR-135a	miRNA	isoproterenol	cardiac fibrosis	cardiac fibroblasts (CFs)	isoprenaline (ISO) tteatment	downregulated	29775892
742	Rat	rno-miR-135a	miRNA	hypoxia	cerebral ischemia/reperfusion (I/R) injury	Primary rat cerebral cortical neurons	hypoxia induce	downregulated	29719095
743	Rat	rno-miR-135a	miRNA	pilocarpine	epilepsy	adult male rats brain tissue and heart tissue	50 days of pilocarpine treatment	downregulated in the brain tissue	24530830
744	Rat	rno-miR-135a	miRNA	¦Ä-opioid receptor (DOR)	hypoxic/ischemic injury	hearts	¦Ä-opioid receptor (DOR) activation treatment	upregulated	27576463
745	Rat	rno-miR-135a	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia induce	downregulated	30644128
746	Rat	rno-miR-135a	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	neurotoxicity	brain tissues of rats	RDX at a dose(47 mg/kg) for 48 h treatment	upregulated	25559034
747	Rat	rno-miR-135a	miRNA	H2O2	oxidative stress	rat cardiomyoblast cells H9c2	H2O2	upregulated	28123342
748	Rat	rno-miR-135a	miRNA	stress	post-traumatic stress disorder (PTSD)	Wistar rats HIP	controlled lighting (light on 07:00¨C19:00 hr) and temperature (25 ¡À 2¡ãC) conditions with ad libitum access to food and water treatment	upregulated	28944448
749	Rat	rno-miR-135a	miRNA	"paroxetine hydrochloride and corticotropin-releasing factor antagonist (CP-154,526)"	post-traumatic stress disorder (PTSD)	PTSD Wistar rats HIP	"CP-154,526 treatment"	downregulated	28944448
750	Rat	rno-miR-135a	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	lung tissues	monocrotaline (MCT) treatment	upregulated	31773709
751	Rat	rno-miR-135a	miRNA	acute stress (AS) and chronic stress (CS)	stress-induced myocardial injury	rat	Rats were bound and suspended treatment	downregulated	24669248
752	Rat	rno-miR-135a-5p	miRNA	kainic acid (KA)	epilepsy	primary hippocampal neuron	kainic acid (KA) treatment	"lncRNA GAS5 functions as a competitive endogenous RNA of miR-135a-5p to increase expression of KCNQ3, and lncRNA GAS5 silencing inhibited the occurrence and progression of epilepsy."	31373759
753	Rat	rno-miR-135a-5p	miRNA	magnesium-free extracellular fluid	epilepsy	primary hippocampal neurons from newborn rats	magnesium-free medium culture	upregulated	31091851
754	Rat	rno-miR-135a-5p	miRNA	magnesium-free extracellular fluid	epilepsy	primary hippocampal neuron	magnesium-free extracellular fluid culture	"lncRNA GAS5 functions as a competitive endogenous RNA of miR-135a-5p to increase expression of KCNQ3, and lncRNA GAS5 silencing inhibited the occurrence and progression of epilepsy."	31373759
755	Rat	rno-miR-135a-5p	miRNA	hypoxia	ischemic stroke (IS)	PC12 cells	hypoxia induce	downregulated	31632583
756	Rat	rno-miR-135a-5p	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	pulmonary artery smooth muscle cells (PASMCs)	hypoxia induce	downregulated	30038339
757	Rat	rno-miR-135a-5p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	lung tissues	monocrotaline (MCT) treatment	downregulated	30038339
758	Rat	rno-miR-135a-5p	miRNA	H2O2	spinal cord injury (SCI)	PC-12 cells	H2O2 treatment	downregulated	33294293
759	Rat	rno-miR-135a-5p	miRNA	Jianpi Xiaoke (JPXK)	type 2 diabetes mellitus (T2DM)	rat	Jianpi Xiaoke (JPXK) treatment	downregulated	33456489
760	Rat	rno-miR-135b	miRNA	radiation	breast cancer	rat mammary cancer tissues	radiation treatment	upregulated	23273170
761	Rat	rno-miR-135b	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	rat PC-12 cells	1-methyl-4-phenylpyridinium (MPP+) treatment	downregulated	31036506
762	Rat	rno-miR-135b-5p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
763	Rat	rno-miR-136	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	27910957
764	Rat	rno-miR-136-3p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	hippocampus	amyloid ¦Â1-42?(A¦Â) treatment	downregulated	29706607
765	Rat	rno-miR-136-3p	miRNA	high fat diet (HFD) and injection of pituitrin	coronary artery disease (CAD)	myocardial tissues	high-fat diet and injection of pituitrin	downregulated	32434208
766	Rat	rno-miR-136-3p	miRNA	homocysteine (Hcy)	coronary artery disease (CAD)	cardiac microvascular endothelial cells (CMECs)	homocysteine (HCY) treatmemt	downregulated	32434208
767	Rat	rno-miR-136-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	PC-12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	30546117
768	Rat	rno-miR-136-5p	miRNA	sulfasalazine	multiple sclerosis (MS)	OLN-93 cells	sulfasalazine (SF) treatment	SF downregulated lncRNA HOTAIR but upregulated miR-136-5p	29944870
769	Rat	rno-miR-136-5p	miRNA	electroacupuncture (EA)	spinal cord injury (SCI)	spinal cords	electroacupuncture (EA) treatment	downregulated	32468009
770	Rat	rno-miR-137	miRNA	ethanol (EtOH)	alcohol exposure	amygdala tissues	Adolescent rats were exposed to 2 g/kg ethanol (2 d on/off; AIE) or adolescent intermittent saline (AIS) during postnatal days (PND)28-PND41 and allowed to grow to adulthood.	upregulated	31740576
771	Rat	rno-miR-137	miRNA	hypoxia	apoptosis	GC-5 cells; HEK-293 cells	"5% O2, 90% N2 and 5% CO2,"	downregulated	29286063
772	Rat	rno-miR-137	miRNA	hypoxia	apoptosis	The rat retinal ganglion cell line RGC-5	hypoxia induce	downregulated	29286063
773	Rat	rno-miR-137	miRNA	propofol (PPF)	cell apoptosis and autophagy	PC-12 cells	Propofol treatment	upregulated	31678238
774	Rat	rno-miR-137	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozocin (STZ) treatment	downregulated	28695984
775	Rat	rno-miR-137	miRNA	triptolide (TPL)	diabetic nephropathy (DN)	the kidney tissues of the diabetic rats	triptolide (TPL) treatment	upregulated	28695984
776	Rat	rno-miR-137	miRNA	ketamine	hippocampal neurodegeneration	hippocampal neurons	administrat ketamine (75 mg/kg) for 3 days treatment	downregulated	25197371
777	Rat	rno-miR-137	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic injury	rat hippocampal neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-137 expression reduced in hippocampal neurons after OGD treatment.	31961204
778	Rat	rno-miR-137	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	neural ischemia/reperfusion (I/R) injury	hippocampal neurons isolated from neonatal Sprague-Dawley rats	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	28132879
779	Rat	rno-miR-137	miRNA	chronic constriction injury (CCI)	neuropathic pain (NP)	rats	chronic constriction injury (CCI) induce	downregulated	29115665
780	Rat	rno-miR-137	miRNA	heme oxygenase-1 (HMOX1)	oxidative stress	primary spinal cord neurons of E16 rat embryos	HO-1	upregulated	27864650
781	Rat	rno-miR-137	miRNA	lead (Pb)	spatial memory impairment	hippocampal tissues	developmental lead (Pb) exposure	upregulated	31511494
782	Rat	rno-miR-137	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC12 cells	lipopolysaccharide (LPS) treatment	miR-137 effectively inhibited the apoptosis of LPS-challenged PC12 cells	33499717
783	Rat	rno-miR-137-5p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	primary microglia were isolated from the spinal cord of newborn rats	lipopolysaccharide (LPS) treatment	downregulated	31210303
784	Rat	rno-miR-138	miRNA	hypoxia	ischemic heart disease (IHD)	H9c2 cells	hypoxia induce	"miR-138 was a downstream effector of lncRNA-LET, that miR-138 was highly expressed in lncRNA-LET-overexpressed cell. The cardioprotective effects of lncRNA-LET were abolished when miR-138 was silenced."	31222827
785	Rat	rno-miR-138	miRNA	hypoxia	psoriasis	H9C2 cells	hypoxia treatment	upregulated	24211202
786	Rat	rno-miR-138	miRNA	IL-6 and lipopolysaccharide (LPS)	advanced periodontal disease	periodontal ligament (PDL) cells	IL-6 and lipopolysaccharide (LPS) treatment	upregulated	26518300
787	Rat	rno-miR-138	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	hippocampus primary neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	29614311
788	Rat	rno-miR-138	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	AC16 cardiomyocytes	high glucose (HG) treatment	GAS5 expression was upregulated in HG-treated AC16 cardiomyocytes and the rat diabetic myocardial injury model	33682891
789	Rat	rno-miR-138	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	downregulated	24205079
790	Rat	rno-miR-138	miRNA	hyperoside	hypoxia-induced cardiac dysfunctions	H9C2 cells	Hyperoside (Hyp) treatment	The expression levels of miR-138 were increased in the hypoxic myocardium in the presence of Hyp	33649812
791	Rat	rno-miR-138	miRNA	astragalus polysaccharide (APS)	hypoxia-induced injury	hypoxia-induced neural stem cells (NSCs)	astragalus polysaccharide (APS) treatment	upregulated	29567543
792	Rat	rno-miR-138	miRNA	hypoxia	hypoxia-induced injury	neural stem cells (NSCs)	hypoxia induce	upregulated	29567543
793	Rat	rno-miR-138	miRNA	hypoxia	ischemic heart disease (IHD)	H9c2 cells	hypoxia treatment	upregulated	31222827
794	Rat	rno-miR-138	miRNA	emodin	myocardial infarction (MI)	hypoxia-induced H9c2 cells	emodin treatment	upregulated	30810622
795	Rat	rno-miR-138	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia induce	downregulated	30810622
796	Rat	rno-miR-138	miRNA	lipopolysaccharide (LPS)	myocarditis	H9c2 cells	lipopolysaccharide (LPS) treatment	downregulated	31442445
797	Rat	rno-miR-138-5p	miRNA	hypoxia/reoxygenation (H/R)	acute myocardial infarction (AMI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	MiR-138-5p was downregulated in H/R-induced H9C2 cells.	33219594
798	Rat	rno-miR-138-5p	miRNA	metformin (Met)	acute respiratory distress syndrome (ARDS)	NR8383 cells	metformin treatment	downregulated	30178862
799	Rat	rno-miR-138-5p	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2cells	hypoxia/reoxygenation (H/R) treatment	downregulated	32231469
800	Rat	rno-miR-138-5p	miRNA	gan-jiang-ling-zhu decoction (GJLZ)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	Gan-Jiang-Ling-Zhu decoction (GJLZ) treatment	"MiR-138?5p expression was significantly increased in the model group, and GJLZ decoction downregulated the expression."	32325349
801	Rat	rno-miR-138-5p	miRNA	MgSO4	osteogenesis	rat primary bone marrow stromal cells	MgSO4 treatment	downregulated	31081160
802	Rat	rno-miR-138-5p	miRNA	insulin-like growth factor 1 (IGF-1)	spinal cord injury (SCI)	Neural stem cells were obtained from E15 fetal rat cerebral cortex cultured supernatant exosomes	insulin growth factor-1 (IFG-1) treatment	upregulated	31848325
803	Rat	rno-miR-139	miRNA	monomethyl fumarate (MF)	intracerebral haemorrhage (ICH)	intracerebral hemorrhage (ICH) rat brain tissues	Monomethyl fumarate (MF) treatment	upregulated	31210338
804	Rat	rno-miR-139-3p	miRNA	acute eccentric exercise	exercise-induced muscle damage (EIMD)	Sprague-Dawley (SD) rats	a downhill running treatment at -16? gradient	dysregulated	28638919
805	Rat	rno-miR-139-5p	miRNA	hypoxic/ischemic	neuron apoptosis	neurons;rat brain tissues	hypoxia-ischemia treatment	downregulated	24333693
806	Rat	rno-miR-139-5p	miRNA	liraglutide	antiapoptotic	INS-1 cells	liraglutide (100 nM) for 48 h	downregulated	28346520
807	Rat	rno-miR-139-5p	miRNA	spontaneous recurrent epileptiform discharges (SREDs)	epilepsy	rat primary hippocampal neurons	spontaneous recurrent epileptiform discharges (SREDs) treatment	miR-139-5p upregulation alleviated SREDs-induced oxidative stress and cell apoptosis via regulating the Notch pathway	33247610
808	Rat	rno-miR-139-5p	miRNA	phenylephrine (PE)	refractory epilepsy	hippocampus	phenobarbitone injection treatment	microRNA-139-5p confers sensitivity to antiepileptic drugs in refractory epilepsy by inhibition of MRP1	31750616
809	Rat	rno-miR-139-5p	miRNA	fluid-percussion injury (FPI)	traumatic brain injury (TBI)	Sprague-Dawley rats	FPI	downregulated	28273100
810	Rat	rno-miR-139-5-p	miRNA	H2O2	cardiomyocytes injury	H9c2 cells	H2O2 treatment	downregulated	26884911
811	Rat	rno-miR-139b	miRNA	"high concentrations of lipid and glucose, and cytokines"	vascular hyper-reactivity	VSMC	"incubat high glucose (25mmol/L) or lipid (palmitic acid 50 ¦Ì mol/L) and 200ng/ml of TNF-¦Á,IL-1¦Â and IL-6 for 25h treatment"	downregulated	25425000
812	Rat	rno-miR-1-3p	miRNA	isoproterenol	acute cardiac injury	heart tissues	isoproterenol treatment	upregulated	27605421
813	Rat	rno-miR-1-3p	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	downregulated	27535721
814	Rat	rno-miR-1-3p	miRNA	muscle contraction	diabetes mellitus (DM)	muscle tissues	"stimulated to contract in vitro for twitch tension analysis (0.5 Hz), 30 min later for tetanic analysis (100 Hz)"	upregulated	28000044
815	Rat	rno-miR-1-3p	miRNA	butorphanol	ischemic arrhythmias	myocardial tissues	butorphanol treatment	Butorphanol significantly reduced the level of miR-1-3p in myocardium.	33210593
816	Rat	rno-miR-1-3p	miRNA	notexin	skeletal muscle atrophy	plasma	notexin treatment	upregulated	26952641
817	Rat	rno-miR-1-3p	miRNA	Jianpi Xiaoke (JPXK)	type 2 diabetes mellitus (T2DM)	rat	Jianpi Xiaoke (JPXK) treatment	upregulated	33456489
818	Rat	rno-miR-140	miRNA	paclitaxel (PTX)	lung fibrosis	lung tisssue of rats	paclitaxel? treatment	low-dose PTX prevents pulmonary fibrosis by suppressing the TGF-¦Â1/Smad3 pathway via upregulating miR-140	23967091
819	Rat	rno-miR-140	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	plasma and lungs	lipopolysaccharide (LPS) treatment	downregulated	30233718
820	Rat	rno-miR-140	miRNA	food restriction	malnutrition	rats serum	10 days of 40% food restriction (RES) treatment	downregulated	24456162
821	Rat	rno-miR-140	miRNA	ormeloxifene	ormeloxifene-induced inhibition of embryo implantation	uterine tissues	ormeloxifene treatment	miR-140 expression was found to be elevated in ormeloxifene administered groups.	29330027
822	Rat	rno-miR-140	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	27910957
823	Rat	rno-miR-140	miRNA	atorvastatin	pericardial patch angioplasty	patch isolated from surrounding vascular tissue	atorvastatin treatment	upregulated	30662650
824	Rat	rno-miR-140*	miRNA	aflatoxin B1 (AFB1)	hepatocellular carcinoma (HCC)	7-week-old Fischer344 male rats liver	aflatoxin B1 (AFB6) treatment	upregulated	24472605
825	Rat	rno-miR-140*	miRNA	nicotine	nicotine addiction	rat PC12 cell	nicotine treatment	upregulated	18845019
826	Rat	rno-miR-140-3p	miRNA	fetal bovine serum (FBS)	liver fibrosis	HSC-T6 cells	Cells were incubated with 5% FBS for 48 h	upregulated	31124340
827	Rat	rno-miR-140-3p	miRNA	platelet derived growth factor-BB (PDGF-BB)	liver fibrosis	HSC-T6 cells	Cells were treated with 10 ng/mL of PDGF-BB for 48 h treatment	upregulated	31124340
828	Rat	rno-miR-140-3p	miRNA	TGF-¦Â1	liver fibrosis	HSC-T6 cells	TGF-¦Â2 treatment	upregulated	31124340
829	Rat	rno-miR-140-5p	miRNA	shikonin	acute lung injury (ALI)	rat lung tissues	Shikonin treatment	Shikonin has effective treatment effects on acute lung injury via regulation of microRNA-140-5p/toll-like receptor 4 (miRNA-140-5p/TLR4) in the in vivo study	31769066
830	Rat	rno-miR-140-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	H9c2 cells	doxorubicin (DOX) treatment	upregulated	29304479
831	Rat	rno-miR-140-5p	miRNA	dioscin	doxorubicin (DOX)-induced cardiotoxicity	H9c2 cells	dioscin treatment	downregulated	29524841
832	Rat	rno-miR-140-5p	miRNA	dexmedetomidine (DEX)	hypoxic/ischemic brain damage (HIBD)	Hypoxia-ischaemia (HI)-treated neonatal rats?brain tissues	dexamethasone (DEX) treatment	upregulated	29536658
833	Rat	rno-miR-140-5p	miRNA	doxorubicin (DOX)	cardiomyocytes injury	SD rats heart tissue	treat with DOX	upregulated	29304479
834	Rat	rno-miR-140-5p	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	The expression of miR-140-5p in H/R-induced H9c2 cells was higher than that in the control group.	32572928
835	Rat	rno-miR-140-5p	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	rats pulmonary artery smooth muscle cells (PASMCs)	hypoxia induce	downregulated	30367500
836	Rat	rno-miR-140-5p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	lung tissues	monocrotaline (MCT) treatment	downregulated	30367500
837	Rat	rno-miR-141	miRNA	paraquat (PQ)	lung injury	lung tissues; RLE-6TN cells	paraquat (PQ) treatment	downregulated	33015978
838	Rat	rno-miR-141	miRNA	thalidomide	lung injury	lung tissues; RLE-6TN cells	thalidomide treatment	upregulated	33015978
839	Rat	rno-miR-141	miRNA	glucose fluctuations (GF)	cardiovascular complications of diabetes mellitus (DM)	heart	glucose fluctuations (GF) treatment	upregulated	26497329
840	Rat	rno-miR-141	miRNA	N-acetyl-L-cysteine (NAC)	chronic nonbacterial prostatitis (CNP)	carrageenan-induced CNP rats	N-acetyl-L-cysteine (NAC) treatment	upregulation	26941030
841	Rat	rno-miR-141	miRNA	antibiotics	dysbacteria	Sprague Dawley (SD) rats faeces	treat with a combination of antibiotics for 8 week	downregulated	29264965
842	Rat	rno-miR-141	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
843	Rat	rno-miR-141	miRNA	hypoxia	hypoxia-induced injury	PC12 cells	hypoxia induce	downregulated	31273531
844	Rat	rno-miR-141	miRNA	cisplatin (DDP)	kidney damage	male Wistar rats	cisplatin treatment	upregulated	24880025
845	Rat	rno-miR-141	miRNA	TGF-¦Â1	liver fibrosis	HSC-T6 cells	TGF-¦Â1 treatment	downregulated of miR-141 deactivates hepatic stellate cells by targeting the PTEN/AKT/mTOR pathway	32319536
846	Rat	rno-miR-141	miRNA	chronic constriction injury (CCI)	neuropathic pain (NP)	dorsal root ganglion	chronic constriction injury (CCI) treatment	downregulated	26398163
847	Rat	rno-miR-141	miRNA	ochratoxin A (OTA)	ochratoxin A (OTA) nephrotoxicity	kidney?tissues	OTA nephrotoxicity treatment	suppressed in mid dose but then elevated in high dose	24885635
848	Rat	rno-miR-141	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC12 cells	N-methyl-4-phenylpyridinium (MPP +) treatment	"MPP+ toxicity significantly caused upregulated in miR-34a, miR-141, and miR-9."	29631008
849	Rat	rno-miR-141	miRNA	lipopolysaccharide (LPS)	rheumatoid arthritis (RA)	chondrocyte	lipopolysaccharide (LPS) treatment	"miR-141 was upregulated in LPS-treated chondrocyte. Inhibitory effects of MEG3 overexpression, mentioned above, were partially abolished by overexpressed miR-141."	31411001
850	Rat	rno-miR-141	miRNA	dexamethasone (DEX)	steroid-induced avascular necrosis of femoral head (SANFH)	Bone marrow mesenchymal stem cells (BMSC)	dexamethasone (DEX) treatment	The mRNA expression of miR-141 was higher in the DEX group compared with the control group.	31916393
851	Rat	rno-miR-141	miRNA	acute stress (AS) and chronic stress (CS)	stress-induced myocardial injury	rat	Rats were bound and suspended treatment	upregulated	24669248
852	Rat	rno-miR-141-3p	miRNA	particulate matter (PM2.5)	allergic rhinitis (AR)	nasal mucosa	particulate matter 2.5 (PM2.5) treatment	downregulated	32192351
853	Rat	rno-miR-141-3p	miRNA	high fat diet (HFD)	cardiac dysfunction	myocardium	high fat diet (HFD) feed	upregulated	32346302
854	Rat	rno-miR-141-3p	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	H/R remarkably reduces the expression of miR-141-3p.	32123560
855	Rat	rno-miR-141-3p	miRNA	propofol (PPF)	neurodegeneration (ND)	rats neural stem cells (NSCs)	propofol treatment	upregulated	27796156
856	Rat	rno-miR-141-3p	miRNA	propofol (PPF)	neurodegenerative diseases	neural stem cells (NSCs)	propofol treatment	upregulated	27796156
857	Rat	rno-miR-141-3p	miRNA	hypoxia	oxidative stress	H9c2 rat cardiomyoblasts	hypoxia induce	upregulated	31532760
858	Rat	rno-miR-141-3p	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC-12 cells	MPP+ (1-methyl-4-phenylpyridinium) treatment	miR-141-3p was upregulated in MPP+-treated PC12 cells.	33204711
859	Rat	rno-miR-141-3p	miRNA	letrozole	polycystic ovarian syndrome (PCOS)	Ovary?tissues	letrozole treatment	dysregulated	26745201
860	Rat	rno-miR-141-3p	miRNA	phthalate mixture	prostate development	Pregnant females filial generation rat prostate	Pregnant females were divided into 4 groups and orally dosed daily from GD10 to PND21 with corn oil (Control:C) or the phthalate mixture at three doses (20?¦Ìg/kg/d:T1; 200?¦Ìg/kg/d:T2; 200?mg/kg/d:T3). treatment	upregulated	31199487
861	Rat	rno-miR-141-3p	miRNA	bleomycin (BLM)	lung fibrosis	rat lung tissues	bleomycin (BLM) treatment	downregulated	30755599
862	Rat	rno-miR-141-3p	miRNA	TGF-¦Â1	lung fibrosis	RLE-6TN cells	TGF-¦Â1 treatment	downregulated	30755599
863	Rat	rno-miR-141-3p	miRNA	high glucose (HG)	pyroptosis	H9c2 cells	high glucose (HG) treatment	"MALAT1 mRNA expression levels were significantly increased, whereas miR-141-3p expression levels were significantly decreased in HG-treated H9C2 cells compared with the NG group."	33576445
864	Rat	rno-miR-142	miRNA	electroacupuncture (EA)	hyperactivity of the HPA axis induced by hepatectomy	rats	electroacupuncture (EA) treatment	upregulated	29021740
865	Rat	rno-miR-142	miRNA	hepatectomy	hyperactivity of the HPA axis induced by hepatectomy	rats hypothalamic	hepatectomy	downregulated	29021740
866	Rat	rno-miR-142-3p	miRNA	TGF-¦Â3	blood-testis barrier (BTB) impairment	Primary Sertoli cell	TGF-¦Â3 treatment	downregulated	29590647
867	Rat	rno-miR-142-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	cultured neonatal rat cardiomyocytes	angiotensin II (Ang II) treatment	downregulated	30372837
868	Rat	rno-miR-142-3p	miRNA	citrate	cardiomyocyte autophagy	cardiomyocytes	citrate treatment	"The level of miR-142-3p was downregulated in H/R model, but upregulated in cardiomyocytes following citrate treatment."	32456513
869	Rat	rno-miR-142-3p	miRNA	isoproterenol	drug-induced cardiac injury (DICI)	heart tissues	isoproterenol treatment	upregulated	29355689
870	Rat	rno-miR-142-3p	miRNA	TGF-¦Â	liver cirrhosis	rat primary HSCs	TGF-¦Â treatment	downregulated	28823564
871	Rat	rno-miR-142-3p	miRNA	hypoxia/reoxygenation (H/R)	ischemia/reperfusion (I/R) injury	mesenchymal stem cell (MSC) exosome	hypoxia-reoxygenation (H/R) treatment	upregulated	32719674
872	Rat	rno-miR-142-3p	miRNA	phosphodiesterase 5 (PDE5) inhibitor	nonalcoholic fatty liver disease (NAFLD)	plasma exosomes	phosphodiesterase 5 (PDE5) inhibitor treatment	upregulated	33396535
873	Rat	rno-miR-142-3p	miRNA	FK506	osteogenesis	rat bone marrow stromal cells (BMSCs)	FK506 treatment	upregulated	28560399
874	Rat	rno-miR-142-3p	miRNA	X-rays	radiosensitivity	786-O and A549 cells	786-O and A549 cells treatment	dysregulated	27527863
875	Rat	rno-miR-142-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	reperfusion/ischemia brain injury	Primary cortical neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-142-3p expression was downregulated in neurons when exposed to oxygen-glucose deprivation/re-oxygenation.	32246643
876	Rat	rno-miR-142-3p	miRNA	lipopolysaccharide (LPS)	sepsis-induced acute kidney injury	rat mesangial cells (RMCs)	lipopolysaccharide (LPS) treatment	upregulated	30834562
877	Rat	rno-miR-142-5p	miRNA	acute stressor modulates	acute stress	male Fisher 344 rats	expose to an acute stressor modulates treatment	downregulated	25259839
878	Rat	rno-miR-142-5p	miRNA	oleanolic acid (OLA)	diabetic nephropathy (DN)	high glucose-induced NRK-52E cells	oleanolic acid (OLA) treatment	downregulated	31410746
879	Rat	rno-miR-142-5p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retinal tissues	streptozocin (STZ) treatment	miR-142-5p level was downregulated in retinal tissues of DR rats.	32116075
880	Rat	rno-miR-142-5p	miRNA	hypoxia	heart failure (HF)	H9c2 cells	hypoxia induce	"silence of lncRNA GAS5 attenuated hypoxia-triggered cell death, silence of lncRNA GAS5 protected H9c2 cells against hypoxia-induced injury possibly via sponging miR-142-5p."	31085811
881	Rat	rno-miR-142-5p	miRNA	Smad3 inhibitor (SIS3)	intrauterine adhesion (IUA)	endometrial stromal cells (ESCs)	Smad3 inhibitor (SIS3) treatment	upregulated	32447720
882	Rat	rno-miR-142-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemia/reperfusion (I/R) injury	rat hippocampal neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	28320085
883	Rat	rno-miR-142-5p	miRNA	hypoxia	ischemic heart disease (IHD)	H9C2 cardiomyoblasts	hypoxia treatment	downregulated	28772218
884	Rat	rno-miR-142-5p	miRNA	IL-6	osteogenesis	bone marrow stromal stem cells (BMSCs)	IL-6 treatment	"BLACAT1 expression was increased in inflammatory BMSCs, and knockdown of BLACAT1 promoted proliferation and osteogenic differentiation of BMSCs targeting miR-142-5p."	32271407
885	Rat	rno-miR-142-5p	miRNA	triclosan (TCS)	testosterone	R2C cells; testis; Leydig cells	Triclosan (TCS) treatment	"TCS treatment upregulated miR-142-5p expressions in Leydig cells, with the maximum inductive effect observed in R2C cells treated with 10 ¦ÌM of TCS"	32084696
886	Rat	rno-miR-143	miRNA	plum polyphenols	aberrant crypt foci	colon tissues	plum polyphenols treatment	upregulated	27865352
887	Rat	rno-miR-143	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	colitis	male Wistar rats inflamed colon	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	downregulated in inflamed colon	28572713
888	Rat	rno-miR-143	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	H9c2 cells	doxorubicin (Dox) treatment	Doxorubicin treatment increased the expression of miR-143.	32170053
889	Rat	rno-miR-143	miRNA	stimulation electrode	epilepsy	Adult male Sprague Dawley rats blood	A bipolar stimulation electrode (distance between tips 500 ?m) was implanted in the angular bundle treatment	dysregulated	24184920
890	Rat	rno-miR-143	miRNA	myocardin	hepatitis C virus (HCV) infection	rat primary aortic SMCs	myocardin treatment	myocardin coordinate smooth muscle differentiation by inducing transcription of microRNA-143	20489207
891	Rat	rno-miR-143	miRNA	activin A	insulin action in cardiomyocytes	primary adult rat cardiomyocytes (ARC)	activin A treatment	downregulated	23812417
892	Rat	rno-miR-143	miRNA	aerobic exercise	left ventricular hypertrophy (LVH)	left ventricular	aerobic exercise training (AET) treatment	downregulated	21709209
893	Rat	rno-miR-143	miRNA	trichostatin A (TSA)	hepatocellular carcinoma (HCC)	rat primary hepatocytes	Trichostatin A (TSA)treatment treatment	"miR-122, miR-143 and miR-379 could be related to the inhibitory effects of TSA on hepatocellular proliferation"	21513791
894	Rat	rno-miR-143	miRNA	hypoxia	myocardial infarction (MI)	neonatal rat cardiomyocytes	hypoxia induce	upregulated	30998966
895	Rat	rno-miR-143	miRNA	hypoxia/reoxygenation (H/R)	myocardial infarction (MI)	cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	lncUCA1 might protect cardiomyocyte against H/R induced apoptosis by suppressing miR-143 and modulated the following downstream MDM2/p53 signaling pathway.	30998966
896	Rat	rno-miR-143	miRNA	high fat diet (HFD)	obesity	adipose tissues	high fat diet (HFD) feed	"The obese rats in the HFD group, compared with rats in the NFD group, demonstrated a significant decrease in the expression of miR-27a (p < 0.05) and a significant increase in the expression of miR-143."	30411548
897	Rat	rno-miR-143	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	lung tissues	hypoxia treatment	upregulated	30195228
898	Rat	rno-miR-143	miRNA	single dose irradiation	radiation-induced lung injury (RILI)	male Wistar rats lung tissues	subjected to single dose irradiation with 20 Gy using 6 MV x-rays to the right lung treatment	upregulated	24886372
899	Rat	rno-miR-143	miRNA	zinc oxide nanoparticles (ZnONPs) and DPP-IV inhibitor (Vildagliptin)	type 2 diabetes mellitus (T2DM)	type 2 diabetes rats	type 2 diabetes rats treatment	downregulated	27723572
900	Rat	rno-miR-143	miRNA	high fat diet (HFD)	weight gain	end epididymal fat	high fat diet (HFD) feed	upregulated	29023027
901	Rat	rno-miR-143-3p	miRNA	atorvastatin	cardiac fibrosis	cardiac fibroblasts (CFs)	atorvastatin treatment	Atorvastatin suppressed the levels of miR-143-3p.	31758917
902	Rat	rno-miR-143-3p	miRNA	TGF-¦Â1	cardiac fibrosis	cultured?cardiac fibroblasts (CFs)	TGF-¦Â1	upregulated	31758917
903	Rat	rno-miR-143-3p	miRNA	¦Â3-adrenoceptors(¦Â3-AR) inhibitor SR 59230A	chronic heart failure (CHF)	CHF rats	1 ml SR 59230A(85 mmoL/L in 0.9% saline)twice a day for seven weeks by intraperitoneal injection treatment	upregulated	29926593
904	Rat	rno-miR-143-3p	miRNA	cisplatin and gentamicin	drug-induced acute kidney injury (DIKI)	plasma	"cisplatin (CSP, 6?mg/kg) and gentamicin (GEN, 120?mg/kg) treatment"	downregulated	30682439
905	Rat	rno-miR-143-3p	miRNA	gypenoside A (GP)	ischemia/reperfusion (I/R) injury	H9c2 cells	Gypenoside A (GP) treatment	Administration of GP decresed the expression of miR-143-3p.	31889343
906	Rat	rno-miR-143-3p	miRNA	angiotensin II (Ang II)	left ventricular hypertrophy (LVH)	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	30119211
907	Rat	rno-miR-143-3p	miRNA	atorvastatin	left ventricular hypertrophy (LVH)	angiotensin II (Ang II)-treated H9c2 cells	atorvastatin treatment	downregulated	30119211
908	Rat	rno-miR-143-3p	miRNA	H2O2	cardiac hypertrophy	H9c2 cells	H2O2 treatment	H2O2 administration increased the levels of miR-143-3p.	30203887
909	Rat	rno-miR-143-3p	miRNA	gypenoside A (GP)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	hypoxia-induced H9c2 cell line	Gypenoside A (GP) treatment	downregulated	31889343
910	Rat	rno-miR-143-3p	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cell line	hypoxia induce	upregulated	31889343
911	Rat	rno-miR-143-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
912	Rat	rno-miR-143-5p	miRNA	propofol (PPF)	neurotoxicity	primary cultured neural stem cells (NSCs)	propofol treatment	upregulated	29679758
913	Rat	rno-miR-144	miRNA	ginsenoside Rg1	apoptosis	hypoxia-induced PC12 cells	Ginsenoside Rg1 treatment	downregulated	30262824
914	Rat	rno-miR-144	miRNA	hypoxia	apoptosis	PC12 cells	OGD/R treatment	upregulated	30262824
915	Rat	rno-miR-144	miRNA	isoprenaline	cardiac hypertrophy	rat primary cardiomyocytes	isoprenaline induction	downregulated	33013286
916	Rat	rno-miR-144	miRNA	hypoxia	cardioprotective therapy	bone marrow mesenchymal stem cell (MSC)-derived exosomes	hypoxia treatment	upregulated	31973741
917	Rat	rno-miR-144	miRNA	human immunodeficiency virus (HIV)-1	chronic human immunodeficiency virus (HIV) infection	alveolar epithelial cell (AEC)	Human immunodeficiency virus (HIV)-1 infection	upregulated	31091144
918	Rat	rno-miR-144	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	H9c2 cells; Neonatal rat cardiomyocytes (NRCMs)	high glucose (HG) treatment	downregulated	31907983
919	Rat	rno-miR-144	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	downregulated	22156553
920	Rat	rno-miR-144	miRNA	high glucose (HG)	hyperglycemia-induced cardiac dysfunction	"Neonatal rat cardiomyocytes (NRCMs), rat H9c2 cells"	high glucose treatment	downregulated	31907983
921	Rat	rno-miR-144	miRNA	ginsenoside Rg1	ischemia/reperfusion (I/R) injury	OGD/R-treated PC-12 cell	Ginsenoside Rg1 (Rg1) treatment	downregulated	30262824
922	Rat	rno-miR-144	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	PC-12 cells	oxygen-glucose deprivation/reperfusion (OGD/R) treatment	upregulated	30262824
923	Rat	rno-miR-144	miRNA	swimming	left ventricular hypertrophy (LVH)	rat left ventricular	Swimming exercise training treatment	upregulated	23812090
924	Rat	rno-miR-144	miRNA	SiO2	lung injury	lung	SiO2 treatment	upregulated	27689473
925	Rat	rno-miR-144	miRNA	4-vinylcyclohexene diepoxide (VCD)	premature ovarian failure (POF)	ovarian	4-vinylcyclohexene diepoxide (VCD) tretament	downregulated	24188450
926	Rat	rno-miR-144	miRNA	botulinum neurotoxin (BoNT)	nerve sprouting	spinal cord anterior horn	botulinum neurotoxin (BoNT) treatment	downregulated	32083076
927	Rat	rno-miR-144	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	27910957
928	Rat	rno-miR-144	miRNA	4-vinylcyclohexene diepoxide (VCD)	premature ovarian failure (POF)	rat POF tissues	VCD treatment	downregulated	24188450
929	Rat	rno-miR-144	miRNA	american ginseng root's	premature ovarian failure (POF)		4-Vinylcyclohexene diepoxide (VCD) treatment	upregulated	25705687
930	Rat	rno-miR-144-3p	miRNA	high fat diet (HFD)	cardiac dysfunction	myocardium	high fat diet (HFD) feed	upregulated	32346302
931	Rat	rno-miR-144-3p	miRNA	rapamycin	cardiac fibrosis	heart tissues	rapamycin (Rap) treatment	downregulated	30647817
932	Rat	rno-miR-144-3p	miRNA	iohexol	contrast-induced acute kidney injury (CIAKI)	Renal tissue	"Animals were dehydrated for 48 h and then underwent furosemide (10 mL/kg; Harvest Pharmaceutical, Shanghai, China) injection 30 min before administration of iohexol (15 mL/kg, group CI-AKI; iodine, 350 mg/mL; GE Healthcare, Shanghai, China) or 0.9% normal saline (15 mL/kg, control group)."	miR-144-3p was downregulated in Contrast-induced acute kidney injury (CI-AKI).	31234008
933	Rat	rno-miR-144-3p	miRNA	oxyhemoglobin (OxyHb)	intracerebral hemorrhage (ICH)-induced secondary brain injury (SBI)	primary rat cortical neurons	oxyhemoglobin (OxyHb) treatment	"Following ICH induction, we found miRNA-144-3p expression to increase."	30511586
934	Rat	rno-miR-144-3p	miRNA	intracerebral hemorrhage (ICH)	secondary brain injury (SBI)	primary rat cortical neurons	oxyhemoglobin (OxyHb) treatment	"miRNA-144-3p aggravated ICH-induced SBI by targeting and downregulating FPR2, thereby contributing to neurological dysfunction and neural apoptosis via PI3K/AKT pathway activation."	30511586
935	Rat	rno-miR-144-5p	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	downregulated	32893733
936	Rat	rno-miR-145	miRNA	ethanol (EtOH)	acute gastric mucosal injury	gastric tissues?of rat	oral administration of ethanol	upregulated	23830200
937	Rat	rno-miR-145	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	lung tissues	lipopolysaccharide (LPS) treatment	The miR-145 was downregulated in the LPS-induced ARDS lung	33505551
938	Rat	rno-miR-145	miRNA	soluble ¦Â-amyloid (sA¦Â) oligomers	Alzheimer's disease (AD)	cortical neurons were isolated from E17 embryos of Sprague Dawley rats	sA¦Â treatment	upregulated	24595404
939	Rat	rno-miR-145	miRNA	reactive oxygen species (ROS)	cadmium-induced toxicity	neonatal rat cardiomyocytes	reactive oxygen species (ROS) treatment	miR-145 regulates reactive oxygen species (ROS)-induced Ca2+overload in cardiomyocytes	23702479
940	Rat	rno-miR-145	miRNA	high glucose (HG)	cardiomyocyte apoptosis	rat cardiomyocytes	high glucose concentration (25 mmol/L)	downregulated	29178342
941	Rat	rno-miR-145	miRNA	oxygen glucose deprivation (OGD)	cerebral ischemic stroke (CIS)	rats astrocytes	oxygen-glucose deprivation (OGD) treatment	downregulated	29057271
942	Rat	rno-miR-145	miRNA	hypoxia	chronic hypoxic heart disease (CHD)	H9c2 cells	hypoxia induce	"miR©\145 was repressed by hypoxia,miR©\145 overexpression caused an inhibition in viability and facilitation in apoptosis"	31190357
943	Rat	rno-miR-145	miRNA	estradiol benzoate (EB)	chronic inflammatory diseases	dorsolateral prostate	estradiol benzoate (EB) treatment	upregulated	33332750
944	Rat	rno-miR-145	miRNA	pomegranate beverage (PG)	colitis	dextran sodium sulfate (DSS) induced colitis rats	PG treatment	upregulated	28282584
945	Rat	rno-miR-145	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	H9c2 cells	high glucose (HG) treatment	"In the HG group, miR-145 expression was significantly decreased and ARF6 expression significantly increased compared with controls."	33763154
946	Rat	rno-miR-145	miRNA	lithium chloride and pilocarpine	epilepsy	hippocampus	lithium chloride-pilocarpine treatment	upregulated	30465949
947	Rat	rno-miR-145	miRNA	lithium chloride and pilocarpine	epilepsy	hippocampus	lithium chloride-pilocarpine treatment	upregulated	30465949
948	Rat	rno-miR-145	miRNA	emodin	hepatitis	LPS-treated primary hepatocyte	Emodin treatment	upregulated	31079494
949	Rat	rno-miR-145	miRNA	lipopolysaccharide (LPS)	hepatitis	primary hepatocyte	lipopolysaccharide (LPS) treatment	downregulated	31079494
950	Rat	rno-miR-145	miRNA	diethylnitrosamine (DEN)	hepatocellular carcinoma (HCC)	liver tissues	diethylnitrosamine (DEN) treatment	upregulated	30412748
951	Rat	rno-miR-145	miRNA	pomegranate fruit aqueous extract (PGE)	insulin sensitivity	Alloxan-diabetic Wistar rats plasma and homogenized suspension of liver and skeletal muscle tissues	long-term PGE treatment	downregulated in plasma and homogenized suspension of liver and skeletal muscle tissues	29105385
952	Rat	rno-miR-145	miRNA	swimming	left ventricular hypertrophy (LVH)	rat left ventricular	Swimming exercise training treatment	upregulated	23812090
953	Rat	rno-miR-145	miRNA	TGF-¦Â	liver fibrosis	rat primary HSCs	10?ng/mL TGF- treatment	upregulated	28091538
954	Rat	rno-miR-145	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia induce	upregulated	28980287
955	Rat	rno-miR-145	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia treatment	upregulated	29055960
956	Rat	rno-miR-145	miRNA	ischemia	myocardial infarction (MI)	rats heart tissues	left anterior descending artery (LAD) ligation	downregulated in heart	29218098
957	Rat	rno-miR-145	miRNA	hypoxia	myocardial ischaemic injury	rat cardiomyocytes	hypoxia treatment	The hypoxic insult led to the suppression of miR-145 expression in cultured rat cardiomyocytes in a concentration-dependent manner.	32138537
958	Rat	rno-miR-145	miRNA	Fibroblast growth factor 21 (FGF21)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	hypoxia-induced H9c2 cells	Fibroblast growth factor 21 (FGF21) treatment	upregulated	30662618
959	Rat	rno-miR-145	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia induce	downregulated	30662618
960	Rat	rno-miR-145	miRNA	geniposide (GEN)	myocarditis	H9c2 cells	geniposide (GEN) treatment	upregulated	29611016
961	Rat	rno-miR-145	miRNA	high fat diet (HFD)	obesity	rats	high fat diet (HFD) feed	dysregulated	24517225
962	Rat	rno-miR-145	miRNA	hypoxia	obstructive sleep apnea (OSA)	Sprague Dawley rats Vascular smooth muscle cells (VSMCs)	hypoxia treatment	downregulated	28465478
963	Rat	rno-miR-145	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoarthritis (OA)	experimental OA in rats	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	29072705
964	Rat	rno-miR-145	miRNA	angiotensin II (Ang II)	oxidative stress	primary cultured rat cardiomyocytes	angiotensin II (Ang II) treatment	downregulated	29178342
965	Rat	rno-miR-145	miRNA	H2O2	oxidative stress	HaCaT cells	H2O2 treatment	Anti-antioxidant impacts of circZNF609 silence in HaCaT cells through regulating miR-145	33821719
966	Rat	rno-miR-145	miRNA	high glucose (HG)	oxidative stress	primary cultured rat cardiomyocytes	Sustained high glucose concentration (25 mmol/L) treatment	downregulated	29178342
967	Rat	rno-miR-145	miRNA	pomegranate fruit aqueous extract (PGE)	oxidative stress	plasma and liver and skeletal muscle tissues	pomegranate fruit aqueous extract (PGE) treatment	upregulated	29105385
968	Rat	rno-miR-145	miRNA	streptozocin (STZ)	painful diabetic neuropathy (PDN)	L3-5 DRG neurons	streptozocin (STZ) treatment	downregulated	33185386
969	Rat	rno-miR-145	miRNA	single dose irradiation	radiation-induced lung injury (RILI)	male Wistar rats lung tissues	subjected to single dose irradiation with 20 Gy using 6 MV x-rays to the right lung treatment	upregulated	24886372
970	Rat	rno-miR-145	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
971	Rat	rno-miR-145	miRNA	TGF-¦Â	acute myocardial infarction (AMI)	mesenchymal stem cells (MSC)	TGF-¦Â(1) treatment	upregulated	21762377
972	Rat	rno-miR-145-5p	miRNA	cationic bovine serum albumin (C-BSA)	chronic glomerulonephritis (CGN)	rats renal mesangial cells	C-BSA treatment	upregulated in renal mesangial cells	29030988
973	Rat	rno-miR-145-5p	miRNA	¦Â3-adrenoceptors(¦Â3-AR) inhibitor SR 59230A	chronic heart failure (CHF)	CHF rats	1 ml SR 59230A(85 mmoL/L in 0.9% saline)twice a day for seven weeks by intraperitoneal injection treatment	upregulated	29926593
974	Rat	rno-miR-145-5p	miRNA	puerarin	diabetic nephropathy (DN)	Renal Tissue	puerarin treatment	upregulated	33122931
975	Rat	rno-miR-145-5p	miRNA	dioscin	hepatorenal damages	L-02;NRK-52E cells	dioscin treatment	Dioscin reduced the expression levels of miR-145-5p which directly targeted Sirt5	33836263
976	Rat	rno-miR-145-5p	miRNA	hypoxia/reoxygenation (H/R)	hypoxia/reoxygenation (H/R) injury	cardiac microvascular endothelial cells (CMEC)	hypoxia/reoxygenation (H/R) treatment	The injured CMECs showed significantly lower miR-145-5p expression than normal ones.	32432764
977	Rat	rno-miR-145-5p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
978	Rat	rno-miR-145-5p	miRNA	hypoxia	myocardial hypoxic/ischemic injury	H9c2 cardiac cells	hypoxia treatment	downregulated	28281187
979	Rat	rno-miR-145-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
980	Rat	rno-miR-145-5p	miRNA	geniposide (GEN)	spinal cord injury (SCI)	LPS-treated PC12 cells	Geniposide treatment	upregulated	31307231
981	Rat	rno-miR-145-5p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC12 cells	lipopolysaccharide (LPS) treatment	downregulated	31307231
982	Rat	rno-miR-146	miRNA	hypoxia	apoptosis	H9c2 rat myocardial cells	oxygen-glucose deprivation/recovery (OGD/R) treatment	downregulated	29257202
983	Rat	rno-miR-146	miRNA	carbamylated albumin	renal cell carcinoma (RCC)	rat mesangial cells (RMCs)	Carbamylated albumin treatment	upregulated	21472233
984	Rat	rno-miR-146a	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	kidney tissues; NRK-52E cells	lipopolysaccharide (LPS) treatment	downregulated	29115409
985	Rat	rno-miR-146a	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	NRK-52E cells	lipopolysaccharide (LPS) treatment	downregulated	29115409
986	Rat	rno-miR-146a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	endotoxin treatment	upregulated	26137246
987	Rat	rno-miR-146a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	MALAT1 was upregulated and mir-146a was downregulated in lps-induced ALI rat model.	29649906
988	Rat	rno-miR-146a	miRNA	sevoflurane (SEV)	acute lung injury (ALI)	lung tissues	sevoflurane treatment	downregulated	28617947
989	Rat	rno-miR-146a	miRNA	lipopolysaccharide (LPS)	acute Lung Injury (ALI)/acute respiratory distress syndrome (ARDS)	lung tissues	lipopolysaccharide (LPS) treatment	upregulated	23848342
990	Rat	rno-miR-146a	miRNA	streptozocin (STZ)	aorta inflammation	male Wistar rats diabetic aorta	streptozocin (STZ) treatment	downregulated	24824805
991	Rat	rno-miR-146a	miRNA	acupuncture	chronic atrophic gastritis (CAG)	gastric	acupuncture treatment	downregulated	27293468
992	Rat	rno-miR-146a	miRNA	dexmedetomidine (DEX)	chronic obstructive pulmonary disease (COPD)	lung	dexmedetomidine (Dex) treatment	downregulated	27677199
993	Rat	rno-miR-146a	miRNA	running	diabetes mellitus (DM)	rats kidney	exposed to 5 days of consecutive treadmill exercise for 60 min/day with the 22 m/min speed for 60 days treatment	upregulated	28858844
994	Rat	rno-miR-146a	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	rats kindey	streptozocin (STZ) treatment	downregulated	28858844
995	Rat	rno-miR-146a	miRNA	inorganic arsenic (iAs)	diabetes mellitus (DM)	rat insulinoma cells	inorganic arsenic (iAs) exposure	upregulated	31555879
996	Rat	rno-miR-146a	miRNA	streptozocin (STZ)	diabetes-related cognitive impairments	serum from STZ/CC rats	streptozotocin (STZ) treatment	downregulated	30240403
997	Rat	rno-miR-146a	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney?of rat	streptozotocin treatment	upregulated	24057185
998	Rat	rno-miR-146a	miRNA	high glucose (HG)	diabetic peripheral neuropathy (DPN)	macrophage	high glucose (HG) treatment	LncRNA HCG18 was highly expressed in DPN model and HG-induced macrophages.	32996080
999	Rat	rno-miR-146a	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	sciatic nerve	streptozotocin treatment	upregulated	25567745
1000	Rat	rno-miR-146a	miRNA	mitomycin C-polylactic acid ( MMC-PLA) film	epidural scar hyperplasia and adhesion	post-laminectomy rat scar tissues	25 mg of PLA film containing 0.01% MMC was implanted on the laminectomy area	upregulated	28617531
1001	Rat	rno-miR-146a	miRNA	lithium chloride and pilocarpine	epilepsy	brain tissues	lithium-pilocarpine treatment	dysregulated	29363732
1002	Rat	rno-miR-146a	miRNA	pilocarpine	epilepsy	adult male rats brain tissue and heart tissue	50 days of pilocarpine treatment	downregulated in the brain tissue	24530830
1003	Rat	rno-miR-146a	miRNA	sleep deprivation	epilepsy	adult male rats	total sleep deprivation (TSD 6 h) and paradoxical sleep deprivation (PSD 24 h) treatment	significant increase of miR-146a expression	24530830
1004	Rat	rno-miR-146a	miRNA	ulinastatin	hemorrhagic shock	hemorrhagic shock rats lung tissues	ulinastatin treatment	upregulated	31801723
1005	Rat	rno-miR-146a	miRNA	deoxycorticosterone acetate (DOCA) -salt (sodium chloride)	hypertension	heart tissues	deoxycorticosterone acetate (DOCA) -salt (sodium chloride) treatment	downregulated	30290168
1006	Rat	rno-miR-146a	miRNA	metformin (Met)	hypertension	deoxycorticosterone acetate (DOCA) -salt (sodium chloride)-induced hypertension rats heart tissues	metformin (MF) treatment	upregulated	30290168
1007	Rat	rno-miR-146a	miRNA	deoxycorticosterone acetate (DOCA) -salt (sodium chloride)	hypertension-induced cardiac dysfunction	heart tissues	deoxycorticosterone acetate (DOCA) -salt (sodium chloride) treatment	downregulated	30290168
1008	Rat	rno-miR-146a	miRNA	metformin (Met)	hypertension-induced cardiac dysfunction	heart tissues	Metformin treatment	upregulated	30290168
1009	Rat	rno-miR-146a	miRNA	thymosin ¦Â4 (T¦Â4)	hypoxic brain injury	Coronal cerebellar	T¦Â4 treatment	microRNA 146a expression was found to have increased in TÎ²4-treated BV-2 cells	26457369
1010	Rat	rno-miR-146a	miRNA	complete freund's adjuvant (CFA)	inflammatory pain	dorsal root ganglion (DRG)	complete Freund's adjuvant (CFA) treatment	The expression of miR-146a was decreased in CFA rats.	30129228
1011	Rat	rno-miR-146a	miRNA	fagellin (FLA)	intestinal inflammation	IEC18 cells	fagellin (FLA) treatment	upregulated	30478292
1012	Rat	rno-miR-146a	miRNA	IL-1¦Â	intestinal inflammation	IEC18 cells	IL-1¦Â treatment	upregulated	30478292
1013	Rat	rno-miR-146a	miRNA	lipopolysaccharide (LPS)	intestinal inflammation	IEC18 cells	lipopolysaccharide (LPS) treatment	upregulated	30478292
1014	Rat	rno-miR-146a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	intestinal inflammation	IEC18 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	30478292
1015	Rat	rno-miR-146a	miRNA	collagenase VII	intracerebral haemorrhage (ICH)	brain tissues	The ICH model was constructed via the stereotaxic intrastriatal injection of collagenase type VII	miR-146a was significantly downregulated in ICH rats	31656540
1016	Rat	rno-miR-146a	miRNA	cisplatin (DDP)	kidney damage	male Wistar rats	cisplatin treatment	upregulated	24880025
1017	Rat	rno-miR-146a	miRNA	spirulina diet	lactogenesis	brains	Spirulina-enriched diet treatment	upregulated	27571388
1018	Rat	rno-miR-146a	miRNA	heat stress	lung cancer	lung	Heating System 2.2 (THS2.2) treatment	downregulated	27866933
1019	Rat	rno-miR-146a	miRNA	rotenone (ROT)	mitochondrial dysfunction	brain tissues	rotenone treatment	Coordinated Action of miR-146a and Parkin Gene Regulate Rotenone-induced Neurodegeneration.	32392329
1020	Rat	rno-miR-146a	miRNA	lipopolysaccharide (LPS)	myocardial dysfunction	H9c2 cells	lipopolysaccharide (LPS) treatment	LPS Induces Oxidative Injury and miR146a Upregulation in H9C2 Cells.	30224945
1021	Rat	rno-miR-146a	miRNA	angiotensin II (Ang II)	myocardial infarction (MI)	primary neonatal rat cardiac fibroblasts (CFs) and cardiomyocytes	angiotensin II (Ang II) treatment	inhibition of miR-146a improved cardiac dysfunction and cardiac remodeling in heart failure rats.	31763669
1022	Rat	rno-miR-146a	miRNA	thymosin ¦Â4 (T¦Â4)	neurological injury	rat oligodendrocyte progenitor cells (OPCs)	"T¦Â4, ranging from 25 to 100 ng/ml for 4 days treatment"	upregulation	24828499
1023	Rat	rno-miR-146a	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	rat	high fat diet (HFD) feed	upregulated	25562147
1024	Rat	rno-miR-146a	miRNA	high fat diet (HFD)	obesity	lung tissue	high fat diet (HFD) feed	upregulated	30521085
1025	Rat	rno-miR-146a	miRNA	high fat diet (HFD)	obesity	lung tissues	OVA-sensitized with high-fat diet treatment	in the S + HFD group the mRNA expression levels of miRNA-146a increased in the lung tissues.	30521085
1026	Rat	rno-miR-146a	miRNA	ovalbumin (OVA)	obesity	lung tissue	ovalbumin (OVA) treatment	upregulated	30521085
1027	Rat	rno-miR-146a	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	rat chondrocytes	lipopolysaccharide (LPS) treatment	The levels of miR-146a in chondrocytes treated with LPS were reduced.	31472145
1028	Rat	rno-miR-146a	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	Isolated rat chondrocytes	lipopolysaccharide (LPS) treatment	"In OA cell model, the expression of miR-146a was clearly increased."	31472145
1029	Rat	rno-miR-146a	miRNA	bone morphogenetic protein 2 (BMP2)	osteogenesis	rats adipose-derived mesenchymal stem cells (ADSCs)	bone morphogenetic protein 2 (BMP2) treatment	downregulated	28205638
1030	Rat	rno-miR-146a	miRNA	resveratrol	osteonecrosis	rat bone marrow mesenchymal stem cells (BMMSCs)	resveratrol (Res) treatment	"Res application was associated with elevated microRNA-146a (miR-146a) expression, osteogenic differentiation, and suppressed osteoclastic differentiation, which were markedly reversed by miR-146a inhibitor"	33454992
1031	Rat	rno-miR-146a	miRNA	H2O2	oxidative stress	neuronal spinal cord (RN-sc) cells	H2O2 treatment	upregulated	26323253
1032	Rat	rno-miR-146a	miRNA	H2O2	oxidative stress	PC12 cells	PC12 cells were stimulated with 200 ¦ÌM of H2O2	upregulated	29484526
1033	Rat	rno-miR-146a	miRNA	high fat diet (HFD)	pulmonary inflammation	lung tissues	high fat diet (HFD) feed	upregulated	31473901
1034	Rat	rno-miR-146a	miRNA	Trans-chalcone	pulmonary inflammation	High-fat diet (HFD)-fed rats lung tissues	Trans-chalcone treatment	downregulated	31473901
1035	Rat	rno-miR-146a	miRNA	collagen	rheumatoid arthritis (RA)	synovial tissue	collagen treatment	downregulated	32662411
1036	Rat	rno-miR-146a	miRNA	iguratimod	rheumatoid arthritis (RA)	synovial tissue of collagen-induced arthritis (CIA) rat	iguratimod treatment	upregulated	32662411
1037	Rat	rno-miR-146a	miRNA	dexamethasone (DEX)	sepsis-induced acute kidney injury	renal tissues	dexamethasone (DEX) treatment	miR-146a in the renal tissues was upregulated in Dex treated group.	32415933
1038	Rat	rno-miR-146a	miRNA	lipopolysaccharide (LPS)	sepsis-induced myocardial injury	myocardial tissue	lipopolysaccharide (LPS) treatment	upregulated	31281454
1039	Rat	rno-miR-146a	miRNA	silicon dioxide (SiO2)	silicosis	fibrotic lungs	silicon dioxide (SiO2) treatment	upregulated	26239160
1040	Rat	rno-miR-146a	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	brain tissues	lithium-pilocarpine treatment	upregulated	28474544
1041	Rat	rno-miR-146a	miRNA	hypoxia	stroke	brain tissues	middle cerebral artery occlusion (MCAO) treatment	upregulation in the corpus callosum and subventricular zone (SVZ)	26738853
1042	Rat	rno-miR-146a	miRNA	SHENMAI	toxicokinetic of SHENMAI	rats serum	inject with SHENMAI treatment	upregulated	24747029
1043	Rat	rno-miR-146a	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	hippocampus and cerebral cortex	streptozocin (STZ) treatment	downregulated	29867484
1044	Rat	rno-miR-146a	miRNA	Thymoquinone (TQ)	type 2 diabetes mellitus (T2DM)	Type 2 diabetes mellitus (T2DM) rats hippocampus and cerebral cortex	Thymoquinone (TQ) treatment	upregulated	29867484
1045	Rat	rno-miR-146a	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	ulcerative colitis (UC)	rat intestinal tissues	"2,4,6-Trinitrobenzenesulfonic acid (TNBS) treatment"	upregulated	30915760
1046	Rat	rno-miR-146a	miRNA	vildagliptin (Vilda)	ulcerative colitis (UC)	colon tissues	Vildagliptin (Vilda) treatment	"Vilda hsa markedly inhibited the expression of lncRNA IFNG-AS1 and miR-146a, as well as PI3K/Akt/NF¦ÊB pathway"	33434756
1047	Rat	rno-miR-146a	miRNA	IL-4¦Â	mesial temporal lobe epilepsy (MTLE)	hippocampi of immature rats	?IL-1¦Â treatment	upregulated	22708826
1048	Rat	rno-miR-146a-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	Reduced SIRT1 and raised miR-146a-3p were found in LPS-induced BEAS-2B cells and ALI rats.	33185125
1049	Rat	rno-miR-146a-3p	miRNA	dexmedetomidine (DEX)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	dexamethasone (DEX) treatment	Dexmedetomidine upregulated expression of miR-146a-3p.	33220608
1050	Rat	rno-miR-146a-5p	miRNA	zhenbao pill	acute spinal cord injury (ASCI)	ASCI rat neuron	zhenbao pill treatment	upregulated	29187582
1051	Rat	rno-miR-146a-5p	miRNA	lithium chloride and pilocarpine	epilepsy	rat cortex and hippocampus tissues	lithium chloride-pilocarpine treatment	upregulated	31061316
1052	Rat	rno-miR-146a-5p	miRNA	intermittent hypoxia (IH)	hypoxia-induced injury	H9c2 cells	intermittent hypoxia(IH) induced	upregulated	31205587
1053	Rat	rno-miR-146a-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	rats liver	CCl4 treatment	upregulated	28739486
1054	Rat	rno-miR-146a-5p	miRNA	IL-1¦Â and TNF-¦Á	osteoarthritis (OA)	condylar chondrocytes	IL-1¦Â and TNF-¦Á treatment	upregulated	33147588
1055	Rat	rno-miR-146a-5p	miRNA	steroids	osteonecrosis	osteoblasts	steroid treatment	downregulated	27378744
1056	Rat	rno-miR-146a-5p	miRNA	letrozole	polycystic ovarian syndrome (PCOS)	ovarian tissues	letrozole treatment	downregulated	29505837
1057	Rat	rno-miR-146a-6p	miRNA	angiostrongylus cantonensis (A. cantonensis)	inflammation	healthy male SD rats	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24142286
1058	Rat	rno-miR-146b	miRNA	cisplatin (DDP)	acute kidney injury (AKI)	bone marrow MSCs (rMSCs)	cisplatin treatment	downregulated	27400799
1059	Rat	rno-miR-146b	miRNA	circadian disruption (CD)	breast cancer	mammary	circadian disruption (CD) treatment	downregulated	26097876
1060	Rat	rno-miR-146b	miRNA	angiotensin II (Ang II)	cardiac fibrosis and hypertension	cardiac fibroblasts (CFs) of rats	angiotensin II (Ang II) treatment	upregulated	23007623
1061	Rat	rno-miR-146b	miRNA	TGF-¦Â	liver fibrosis	hepatic stellate cells (HSCs)	TGF-¦Â treatment	upregulated	27740527
1062	Rat	rno-miR-146b	miRNA	aspirin-triggered resolvin D1 (AT-RvD1)	hepatic ischemia/reperfusion injury (HIRI)	liver ischemia/reperfusion (I/R) Sprague-Dawley rats liver	aspirin-triggered resolvin D1 (AT-RvD1) treatment	upregulated	28837866
1063	Rat	rno-miR-146b	miRNA	electroacupuncture (EA)	ischemic stroke (IS)	Primary stem cells	electroacupuncture (EA) treatment	EA increased miR-146b expression.	32792909
1064	Rat	rno-miR-146b	miRNA	porcine serum	liver fibrosis	rat liver tissues	porcine serum treatment	upregulation	24927615
1065	Rat	rno-miR-146b	miRNA	heat stress	lung cancer	lung	Heating System 2.2 (THS2.2) treatment	downregulated	27866933
1066	Rat	rno-miR-146b	miRNA	single dose irradiation	radiation-induced lung injury (RILI)	male Wistar rats lung tissues	subjected to single dose irradiation with 20 Gy using 6 MV x-rays to the right lung treatment	downregulated	24886372
1067	Rat	rno-miR-146b-3p	miRNA	high fat diet (HFD)	cardiac remodeling	heart tissues	high fat diet (HFD) feed	upregulated	29884823
1068	Rat	rno-miR-146b-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1069	Rat	rno-miR-146b-5p	miRNA	high fat diet (HFD)	aging-related non-alcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31899128
1070	Rat	rno-miR-146b-5p	miRNA	cadmium (Cd)	cadmium (Cd)-induced kidney injury	renal cortex	cadmium (Cd) treatment	upregulated	29543730
1071	Rat	rno-miR-146b-5p	miRNA	estradiol benzoate (EB) and testosterone (T)/E	chronic inflammatory diseases	dorsolateral prostate	estradiol benzoate (EB) and testosterone (T)/E treatment	upregulated	33332750
1072	Rat	rno-miR-146b-5p	miRNA	lipopolysaccharide (LPS)	intestinal sepsis	IEC-6 cells	lipopolysaccharide (LPS) treatment	rno-miR-146b-5p may play a vital role in the development of sepsis intestinal injury through targeting Klf4 expression and affecting promoter activity of Ccnd2.	33200654
1073	Rat	rno-miR-146b-5p	miRNA	oxygen glucose deprivation (OGD)	neonatal hypoxic-ischemic encephalopathy 	PC-12 cells	oxygen glucose deprivation (OGD) treatment	miR-146b-5p was lower in PC12 cells upon OGD insult.	32734729
1074	Rat	rno-miR-146b-5p	miRNA	oxygen glucose deprivation (OGD)	neonatal hypoxic-ischemic brain damage	oligodendrocyte precursor cells (OPCs)	oxygen/glucose deprivation (OGD) induce treatment	downregulated	31003769
1075	Rat	rno-miR-146b-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31915454
1076	Rat	rno-miR-146b-5p	miRNA	Shenling Baizhu San (SLBZS)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	Shenling Baizhu San (SLBZS) treatment	the expression levels were reversed by SLBZS administration	31915454
1077	Rat	rno-miR-146b-5p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	downregulated	26997989
1078	Rat	rno-miR-146b-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1079	Rat	rno-miR-147	miRNA	H2O2	acute myocardial infarction (AMI)	H9c2 cells	H2O2 treatment	MiR-147 expression was significantly decreased in H2O2 treated H9c2 cells.	32572895
1080	Rat	rno-miR-147	miRNA	mcyclic mechanical stretch	endoplasmic reticulum stress (ERS)	rat L6 myoblasts	mcyclic mechanical stretch treatment	downregulated	31628639
1081	Rat	rno-miR-147	miRNA	methotrexate (MTX)	rheumatoid arthritis (RA)	pristane (PS)-treated ATCC? CRL-2192TM cells (rat macrophage cells)	methotrexate treatment	upregulated	31105830
1082	Rat	rno-miR-147	miRNA	pristane (PS)	rheumatoid arthritis (RA)	ATCC? CRL-2192TM cells (rat macrophage cells)	pristane (PS) treatment	downregulated	31105830
1083	Rat	rno-mir-147	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1084	Rat	rno-miR-147b	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	MiR-147b was downregulated in lipopolysaccharide (LPS)-induced ALI rats and LPS-treated A549 cells	33660808
1085	Rat	rno-miR-147b	miRNA	H2O2	heart failure (HF)	rat H9c2 cardiomyocytes	H2O2 treatment	upregulated	29377979
1086	Rat	rno-miR-148-3p	miRNA	loureirin B	liver fibrosis	Hepatic stellate cells (HSCs)	loureirin B treatment	upregulated	30123297
1087	Rat	rno-miR-148-3p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	lung tissues	monocrotaline treatment	downregulated	28000863
1088	Rat	rno-miR-148a	miRNA	cerulein	acute pancreatitis (AP)	The rat pancreatic acinar cell line AR42J	cerulein treatment	downregulated	31122822
1089	Rat	rno-miR-148a-3p	miRNA	steroids	osteonecrosis	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	26459755
1090	Rat	rno-miR-148b	miRNA	angiotensin II (Ang II)	cardiac fibrosis	Cardiac myofibroblasts	angiotensin II (Ang II) treatment	"Ang-II downregulated the miR-148b expression, which was reversed by SRA1 siRNA, suggesting the regulation of SRA1 on miR-148b."	30694702
1091	Rat	rno-miR-148b	miRNA	hypoxia	ischemic stroke (IS)	rats subventricular zone (SVZ)	middle cerebral artery occlusion (MCAO) treatment	upregulated	29104534
1092	Rat	rno-miR-148b	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	hypoxia/reoxygenation (H/R) induce	upregulated	30820984
1093	Rat	rno-miR-148b-3p	miRNA	ginsenoside Rg1	apoptosis	hypoxia-induced male rat bone marrow mesenchymal stem cells (rBMSCs)	Ginsenoside Rg1 treatment	upregulated	29307726
1094	Rat	rno-miR-148b-3p	miRNA	hypoxia	apoptosis	Male rat bone marrow mesenchymal stem cells (rBMSCs)	hypoxia induce	downregulated	29307726
1095	Rat	rno-miR-148b-3p	miRNA	pentylenetetrazol (PTZ)	epilepsy	brain tissues	pentylenetetrazol (PTZ) treatment	downregulated	32779334
1096	Rat	rno-miR-148b-5p	miRNA	ginsenoside Rg1	apoptosis	hypoxia-induced male rat bone marrow mesenchymal stem cells (rBMSCs)	Ginsenoside Rg1 treatment	upregulated	29307726
1097	Rat	rno-miR-148b-5p	miRNA	hypoxia	apoptosis	Male rat bone marrow mesenchymal stem cells (rBMSCs)	hypoxia induce	downregulated	29307726
1098	Rat	rno-miR-149	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	hypoxia induce	upregulated	31741467
1099	Rat	rno-miR-149	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	osteogenesis	rat mesenchymal stem cells (MSCs)	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	31206187
1100	Rat	rno-miR-149-5p	miRNA	lipopolysaccharide (LPS)	intervertebral disc degeneration (IDD)	nucleus pulposus (NP) cells	lipopolysaccharide (LPS) treatment	downregulated	31263091
1101	Rat	rno-miR-149-5p	miRNA	hypoxia/reoxygenation (H/R)	ischemia/reperfusion (I/R) injury	mesenchymal stem cell (MSC) exosome	hypoxia-reoxygenation (H/R) treatment	upregulated	32719674
1102	Rat	rno-miR-149-5p	miRNA	resveratrol	ischemic stroke (IS)	rat cerebral tissue	resveratrol (RS) treatment	decreased p53 protein expression and increased miR-149-5p activity on sirtuin1 (Sirt1) activation with resveratrol after 24 h following MCAO	31866350
1103	Rat	rno-miR-149-5p	miRNA	resveratrol	ischemic stroke (IS)	brain tissues	resveratrol (RS) treatment	upregulated of Sirt1/miR-149-5p signaling may play a role in resveratrol induced protection against ischemia via p53 in rat brain	31866350
1104	Rat	rno-miR-149-5p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
1105	Rat	rno-miR-15	miRNA	cisplatin (DDP)	kidney damage	male Wistar rats	cisplatin treatment	upregulated	24880025
1106	Rat	rno-miR-15	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	H9c2 cells	Coxsackievirus B3 (CVB3) treatment	MiR-15 expression was significantly upregulated in H9c2 cells after CVB3 infection.	32099552
1107	Rat	rno-miR-150	miRNA	H2O2	acute myocardial infarction (AMI)	H9c2 cells	H2O2 treatment	FTX relieves H2O2-induced cardiomyocyte injury by increasing KLF13 expression via depletion of miR-150.	33817286
1108	Rat	rno-miR-150	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	downregulated	27649667
1109	Rat	rno-miR-150	miRNA	H2O2	cardiac injury	cardiac myocytes	?H2O2 treatment	upregulated	23824072
1110	Rat	rno-miR-150	miRNA	high glucose (HG)	cardiac hypertrophy	rat cardiac cells	high glucose treatment	downregulated	23211718
1111	Rat	rno-miR-150	miRNA	¦Â-arrestin1-biased ¦Â1-adrenergic receptor	ischemic injury	embryonic ventricular cardiomyocyte H9c2 cells	¦Â-arrestin1-biased ¦Â1-adrenergic receptor treatment	upregulated	25824147
1112	Rat	rno-miR-150	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
1113	Rat	rno-miR-150	miRNA	H2O2	oxidative stress	neuronal spinal cord (RN-sc) cells	H2O2 treatment	upregulated	26323253
1114	Rat	rno-miR-150	miRNA	tetramethylpyrazine (TMP)	parkinson's disease (PD)	hippocampu	Tetramethylpyrazine (TMP) treatment	Tetramethylpyrazine ameliorates isoflurane-induced cognitive dysfunction by inhibiting neuroinflammation via miR-150 in rats	32855738
1115	Rat	rno-miR-150	miRNA	hypoxia	pulmonary hypertension (PH)	lung tissue and plasma	hypoxia induce	downregulated	30551428
1116	Rat	rno-miR-150	miRNA	hypoxia	pulmonary hypertension (PH)	lung tissue and plasma	hypoxia treatment	miR-150 level was reduced in the lung tissue and plasma of hypoxia-treated rats.	30551428
1117	Rat	rno-miR-150	miRNA	lipopolysaccharide (LPS)	septic shock	Wistar rats serum	LPS (10 mg/kg) treatment	upregulated	24915805
1118	Rat	rno-miR-150	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
1119	Rat	rno-miR-1502	miRNA	quercetin	oxidative stress	PC-12 cells	Quercetin treatment	downregulated	33343808
1120	Rat	rno-miR-150-3p	miRNA	CP (cyclophosphamide)	cyclophosphamide (CP)-induced lung toxicity	lung tissues	CP (cyclophosphamide) treatment	Single treatment with CP caused a significant increase in the relative gene expression of miR-150-3p compared to control rats.	32747644
1121	Rat	rno-miR-150-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1122	Rat	rno-miR-150-5p	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia treatment	"XIST protects cardiomyocytes from hypoxia-induced injury by mediating miR-150-5p/Bax axis, suggesting that XIST is an important target for AMI treatment."	32096185
1123	Rat	rno-miR-150-5p	miRNA	isoproterenol	cardiac hypertrophy	Neonatal rat ventricular myocytes (NRVMs)	isoproterenol (ISO) treatment	downregulated	29786749
1124	Rat	rno-miR-150-5p	miRNA	fish oil (FO) and olive oil (OO)	cardiovascular responses	heart sissues	Fish oil (FO) and olive oil (OO) treatment	O 3-induced upregulated of miR-150-5p and miR-208a-5p were attenuated by FO and/or OO.	33091443
1125	Rat	rno-miR-150-5p	miRNA	chronic heart failure (CHF)	chronic heart failure (CHF)	myocardial tissues	aerobic exercise treatment	downregulated	33708967
1126	Rat	rno-miR-150-5p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	cardiac fibroblasts (CFs)	high glucose (HG) treatment	upregulated	31710102
1127	Rat	rno-miR-150-5p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	cardiac fibroblasts (CFs)	high-glucose (HG) treatment	upregulated	31710102
1128	Rat	rno-miR-150-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	miR-150-5p was upregulated on carbon tetrachloride (CCl4) injection for 8 weeks.	31833387
1129	Rat	rno-miR-150-5p	miRNA	uterine perfusion pressure (RUPP)	pregnancy-induced hypertension (PIH)	aortic endothelial cells (ECs)	uterine perfusion pressure (RUPP) treatment	downregulated	32800559
1130	Rat	rno-miR-150-5p	miRNA	lipopolysaccharide (LPS)	sepsis	H9c2 cells; heart tissues	lipopolysaccharide (LPS) treatment	downregulated	32908879
1131	Rat	rno-miR-150-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1132	Rat	rno-miR-151	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
1133	Rat	rno-miR-151*	miRNA	aflatoxin B1 (AFB1)	hepatocellular carcinoma (HCC)	7-week-old Fischer344 male rats liver	aflatoxin B1 (AFB5) treatment	upregulated	24472605
1134	Rat	rno-miR-151-3p	miRNA	dexamethasone (DEX)	Alzheimer's disease (AD)	PC12 cells	dexamethasone (DEX) treatment	upregulated of miRNA-151-3p enhanced the neuroprotective effect of dexmedetomidine against ¦Â-amyloid by targeting DAPK-1 and TP53.	33275947
1135	Rat	rno-miR-151-3p	miRNA	cold	cold stress	rats serum	cold conditions (4¡æ for 12h)	downregulated	28477904
1136	Rat	rno-miR-151-3p	miRNA	long-term potentiation(LTP)	long-term potentiation (LTP) persistence	Sprague-Dawley rats Dentate Gyrus Neuropil	unilaterally at perforant path-dentate gyrus synapses	upregulated in Dentate Gyrus Neuropil	28125614
1137	Rat	rno-miR-151-5p	miRNA	house dust mite (HDM) extract	allergic airway inflammation	adipose tissue and lungs	house dust mite extract treatment	upregulated	32887419
1138	Rat	rno-miR-152	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	31258681
1139	Rat	rno-miR-152	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	rat	high fat diet (HFD) feed	upregulated	25562147
1140	Rat	rno-miR-152	miRNA	astragalus polysaccharide (APS)	osteogenesis	marrow mesenchymal stem cells (MSCs)	Astragalus polysaccharide (APS) treatment	downregulated	31071509
1141	Rat	rno-miR-152	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	rheumatoid arthritis (RA)	synovium	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	upregulated	26093272
1142	Rat	rno-miR-152-3p	miRNA	pentylenetetrazol (PTZ)	epilepsy	brain tissues	pentylenetetrazol (PTZ) treatment	downregulated	32779334
1143	Rat	rno-miR-152-3p	miRNA	tanshinone IIA (Tan IIA)	heart failure (HF)	H9C2 cells	tanshinone IIA treatment	upregulated	27508033
1144	Rat	rno-miR-153	miRNA	H2O2	cardiovascular disease (CVD)	primary culture of rat ventricular cardiomyocytes	primary culture of rat ventricular cardiomyocytes treatment	upregulated	27220418
1145	Rat	rno-miR-153	miRNA	hypoxia	hypoxia-induced injury	rat pheochromocytoma (PC-12) cells	hypoxia induce	downregulated	30579328
1146	Rat	rno-miR-153	miRNA	propofol (PPF)	hypoxia-induced injury	?hypoxia-induced rat pheochromocytoma (PC-12) cells	propofol treatment	upregulated	30579328
1147	Rat	rno-miR-153	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	upregulated	27074745
1148	Rat	rno-miR-153	miRNA	lead acetate (PbAc)	lead-induced hepatotoxicity	liver tissues and primary cultured hepatocytes	lead acetate (PbAc) treatment	upregulated	29175668
1149	Rat	rno-miR-153	miRNA	grape seed proanthocyanidins (GSPs)	lepatotoxicity	lead acetate (PbAc)-treated rats liver tissues and primary cultured hepatocytes	Grape seed procyanidin extract (GSPE) treatment	downregulated	29175668
1150	Rat	rno-miR-153	miRNA	grape seed procyanidin extract (GSPE)	liver damage	rat primary hepatocytes pretreated with PbAc (100 ¦ÌM)	GSPE (100 ¦Ìg/ml)	downregulated	29175668
1151	Rat	rno-miR-153	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	primary cultured rat cardiomyocytes	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	31037501
1152	Rat	rno-miR-153	miRNA	grape seed procyanidin extract (GSPE)	nephrotoxicity	Pb induced nephrotoxicity rat	vemurafenib	downregulated	28178683
1153	Rat	rno-miR-153-3p	miRNA	hypoxia	ischemic stroke (IS)	HUVECs	pMCAO treatment	downregulated in infraction areas	28985553
1154	Rat	rno-miR-154-3p	miRNA	IL-6	skeletal muscle regeneration	rat primary skeletal muscle cells (RSkMC)	IL-6 treatment	upregulated	31820147
1155	Rat	rno-miR-154-3p	miRNA	IL-6	skeletal muscle regeneration	rat primary skeletal muscle cells (RSkMC)	IL-6 treatment	upregulated	31820147
1156	Rat	rno-miR-155	miRNA	IL-1¦Â	intervertebral disc degeneration (IDD)	nucleus pulposus (NP) cells	IL-1¦Â treatment	downregulated	29852820
1157	Rat	rno-miR-155	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	intervertebral disc degeneration (IDD)	nucleus pulposus (NP) cells	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	29852820
1158	Rat	rno-miR-155	miRNA	hypoxia/reoxygenation (H/R)	acute kidney injury (AKI)	NRK-52E cells	hypoxia-reoxygeneration (H/R) induce	upregulated	31216555
1159	Rat	rno-miR-155	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	endotoxin treatment	upregulated	26137246
1160	Rat	rno-miR-155	miRNA	sevoflurane (SEV)	acute lung injury (ALI)	lung tissues	sevoflurane treatment	downregulated	28617947
1161	Rat	rno-miR-155	miRNA	H2O2	acute myocardial infarction (AMI)	neonatal rat ventricular cardiomyocyte (NRVM)	H2O2 treatment	upregulated	31191799
1162	Rat	rno-miR-155	miRNA	galantamine	adjuvant-induced arthritis (AIA)	joint	galantamine treatment	miR-155 was downregulated in galantamine treated group when compared with AA mice.	32621912
1163	Rat	rno-miR-155	miRNA	ovalbumin (OVA)	asthma	lung tissues	ovalbumin (OVA) treatment	upregulated	29938673
1164	Rat	rno-miR-155	miRNA	gold nanoparticles (AuNPs)	AuNP-induced lung pathogenesis	lung tissues	gold nanoparticles (AuNPs) treatment	upregulated	31413563
1165	Rat	rno-miR-155	miRNA	high glucose (HG)	cardiac fibrosis	H9c2 cells	high glucose (HG) treatment	HG treatment resulted in increased miR-155 expression.	32901848
1166	Rat	rno-miR-155	miRNA	docosahexaenoic acid (DHA)	carotid restenosis	VSMCs	docosahexaenoic acid (DHA) treatment	Docosahexaenoic acid inhibits vascular smooth muscle cell migration and proliferation by decreasing microRNA-155 expression levels	32945419
1167	Rat	rno-miR-155	miRNA	valproic acid (VPA)	cerebral ischemia injury (CII)	rat cortical neuronal cells	valproic acid treatment	upregulated	22937209
1168	Rat	rno-miR-155	miRNA	acupuncture	chronic atrophic gastritis (CAG)	gastric	acupuncture treatment	downregulated	27293468
1169	Rat	rno-miR-155	miRNA	paradoxical sleep deprivation (PSD)	cognitive impairment	Hippocampal tissues	paradoxical sleep deprivation (PSD) induce treatment	upregulated	31279826
1170	Rat	rno-miR-155	miRNA	saikosaponin d (SSd)	depression	hippocampal neurons	saikosaponin d (SSd) treatment	"SSd could ameliorate depression-like behaviors in the rats treated with UCMS by downregulating NF-¦ÊB and miR-155, and upregulating FGF2"	31926302
1171	Rat	rno-miR-155	miRNA	tetrandrine	diabetes mellitus (DM)	rat pancreatic islet caused by alloxan	Tetrandrine treatment	downregulated	26064305
1172	Rat	rno-miR-155	miRNA	ibuprofen	diabetic nephropathy (DN)	spinal tissues	ibuprofen treatment	downregulated	27392937
1173	Rat	rno-miR-155	miRNA	L©\arginine	diabetic nephropathy (DN)	spinal	L-arginine treatment	downregulated	27392937
1174	Rat	rno-miR-155	miRNA	glucose	diabetic peripheral neuropathy (DPN)	rat Schwann cells (SCs)	5.5 mM glucose treatment	"miR-155 antagomir-induced inhibition increased MNCV and SNCV, strengthened angiogenesis and alleviated inflammation in DPN rats."	31404910
1175	Rat	rno-miR-155	miRNA	atorvastatin	endothelial dysfunction	erectile tissue of the aged rat	atorvastatin treatment	downregulated	29686722
1176	Rat	rno-miR-155	miRNA	Saikosaponin a (Ssa)	epilepsy	hippocampus	Ssa treatment	downregulated	28958944
1177	Rat	rno-miR-155	miRNA	light	focal retinal degeneration	right eye	light treatment	upregulated	25921151
1178	Rat	rno-miR-155	miRNA	electroacupuncture (EA)	head and neck squamous cell carcinoma (HNSCC)	rat peritoneal mast cells (RPMCs)	electro-acupuncture (EA) treatment	downregulated	29404871
1179	Rat	rno-miR-155	miRNA	perfluorooctane sulfonic acid (PFOS)	hepatomegaly	HepG2 cells	perfluorooctane sulfonate (PFOS) treatment	upregulated	26844784
1180	Rat	rno-miR-155	miRNA	asiaticoside	hyperoxia-induced bronchopulmonary dysplasia	lung tissues	asiaticoside treatment	Asiaticoside downregulated the expression of miR-155.	31948528
1181	Rat	rno-miR-155	miRNA	deoxycorticosterone acetate (DOCA) -salt (sodium chloride)	hypertension	heart tissues	deoxycorticosterone acetate (DOCA) -salt (sodium chloride) treatment	upregulated	30290168
1182	Rat	rno-miR-155	miRNA	metformin (Met)	hypertension	deoxycorticosterone acetate (DOCA) -salt (sodium chloride)-induced hypertension rats heart tissues	metformin (MF) treatment	downregulated	30290168
1183	Rat	rno-miR-155	miRNA	deoxycorticosterone acetate (DOCA) -salt (sodium chloride)	hypertension-induced cardiac dysfunction	heart tissues	deoxycorticosterone acetate (DOCA) -salt (sodium chloride) treatment	upregulated	30290168
1184	Rat	rno-miR-155	miRNA	metformin (Met)	hypertension-induced cardiac dysfunction	heart tissues	Metformin treatment	downregulated	30290168
1185	Rat	rno-miR-155	miRNA	lipopolysaccharide (LPS)	inflammation	rat alveolar macrophages NR8383	lipopolysaccharide (LPS) treatment	upregulated	30541646
1186	Rat	rno-miR-155	miRNA	gualou guizhi decoction (GLGZD)	ischemic stroke (IS)	brain tissues	Gualou Guizhi Decoction (GLGZD) treatment	"GLGZD was able to inhibit miR-155 upregulation, resulting in downregulated of miR155-targeted molecules in MCAO rats"	33081480
1187	Rat	rno-miR-155	miRNA	lipopolysaccharide (LPS)	hepatocellular carcinoma (HCC)	rat spleen myeloid cells	lipopolysaccharide (LPS) treatment	mature miR-155 is overexpressed in rat spleen myeloid cells treated with LPS	23329697
1188	Rat	rno-miR-155	miRNA	acetaminophen (APAP)	liver damage	liver tissues	acetaminophen (APAP) treatment	"miR-155 and miR-21 were evaluated as makers of inflammation and regeneration, respectively, to characterize liver status."	27051339
1189	Rat	rno-miR-155	miRNA	dexmedetomidine (DEX)	LPS-induced neuroinflammation	"adult Wistar rats brain ,plasma,"	dexmedetomidine (Dex) treatment	downregulated	28832497
1190	Rat	rno-miR-155	miRNA	lipopolysaccharide (LPS)	myocardial infarction (MI)	rat bone marrow derived macrophages (BMDMs)	lipopolysaccharide (LPS) treatment	upregulated	31207208
1191	Rat	rno-miR-155	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cell	hypoxia/reoxygenation (H/R) induce	upregulated	31807249
1192	Rat	rno-miR-155	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	miR-155 was markedly upregulated in the H/R model.	31922242
1193	Rat	rno-miR-155	miRNA	lipopolysaccharide (LPS)	neuroinflammation	adult Wistar rats brain regions	lipopolysaccharide (LPS) treatment	upregulated in both brain regions	28832497
1194	Rat	rno-miR-155	miRNA	bortezomib	neuropathic pain (NP)	L5-L6 spinal cord dorsal horn	bortezomib? treatment	Inhibition of microRNA-155 Reduces Neuropathic Pain During Chemotherapeutic Bortezomib via Engagement of Neuroinflammation.	32296644
1195	Rat	rno-miR-155	miRNA	(+)-cholesten-3-one (CN)	osteoblastic differentiation	mesenchymal stem cells (MSCs)	(+)-cholesten-3-one (CN) treatment	downregulated	30373531
1196	Rat	rno-miR-155	miRNA	myo-inositol	polycystic ovarian syndrome (PCOS)	ovaries	Myo-inositol treatment	downregulated of miR-155 was detected with myo-inositol supplementation.	32045334
1197	Rat	rno-miR-155	miRNA	N-3 polyunsaturated fatty acids (PUFA)	post-menopausal depression	brain tissues	N-3 polyunsaturated fatty acids (PUFA) treatment	"N-3 PUFA decreased blood levels of adrenocorticotropic hormone and corticosterone, and brain expressions of corticotropin-releasing factor and miRNA-218, which increased the expression of the glucocorticoid receptor. N-3 PUFA decreased the expression of tumor necrosis factor-¦Á, interleukin (IL)-6, IL-1¦Â, and prostaglandin E2, while increased the expression of miRNA-155."	33548474
1198	Rat	rno-miR-155	miRNA	nitric oxide synthase inhibitor L-NAME	pregnancy-induced hypertension (PIH)	pregnant female rats placental tissues	nitric oxide synthase inhibitor L-NAME treatment	upregulated	30402830
1199	Rat	rno-miR-155	miRNA	ischemia/reperfusion (I/R) 	renal ischemia/reperfusion (I/R) injury	kidney tissues	ischemia/reperfusion (I/R) treatment	upregulated	28006785
1200	Rat	rno-miR-155	miRNA	lipopolysaccharide (LPS)	rheumatoid arthritis (RA)	rat synoviocytes	lipopolysaccharide (LPS) treatment	upregulated	31258713
1201	Rat	rno-miR-155	miRNA	lipopolysaccharide (LPS)	sepsis-induced lung injury	NR8383 macrophages	lipopolysaccharide (LPS) treatment	upregulated	28125526
1202	Rat	rno-miR-155	miRNA	kainic acid (KA)	status epilepticus (SE)	hippocampus	kainic acidtreatment	upregulated	30006293
1203	Rat	rno-miR-155	miRNA	gualou guizhi decoction (GLGZD)	stroke	ischemic hemisphere	Gualou Guizhi Decoction (GLGZD) treatment	GLGZD was able to inhibit miR-155 upregulation.	33081480
1204	Rat	rno-miR-155	miRNA	exercise training (ET)	vascular relaxation	arteries	exercise training	downregulated	32301852
1205	Rat	rno-miR-155-3p	miRNA	puerarin	bone graft defects	bone mesenchymal stem cells (BMSCs)	puerarin treatment	miR-155-3p expression was increased by puerarin in BMScs	32377717
1206	Rat	rno-miR-155-3p	miRNA	TGF-¦Â1	lung fibrosis	lung fibroblasts	TGF-¦Â1 treatment	downregulated	32464548
1207	Rat	rno-miR-155-3p	miRNA	TGF-¦Â1	lung fibrosis	lung fibroblasts	TGF-¦Â1 treatment	upregulated	32464548
1208	Rat	rno-miR-155-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1209	Rat	rno-miR-155-3p	miRNA	diosgenin glucoside (DG)	spinal cord injury (SCI)	Spinal cord injury (SCI) rats spinal cord tissue	Diosgenin glucoside (DG) treatment	downregulated	30072674
1210	Rat	rno-miR-155-5p	miRNA	high fat diet (HFD)	aging-related non-alcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31899128
1211	Rat	rno-miR-155-5p	miRNA	alcohol	alcoholic cardiomyopathy (ACM)	heart tissues	alcohol exposure	alcohol drinking significantly upregulated miR-155-5p level	33868799
1212	Rat	rno-miR-155-5p	miRNA	rapamycin	cardiac fibrosis	heart tissues	rapamycin (Rap) treatment	upregulated	30647817
1213	Rat	rno-miR-155-5p	miRNA	valproic acid (VPA)	cell differentiation	primary cultured neural stem cells (NSCs)	valproate (VPA) treatment	upregulated	29575035
1214	Rat	rno-miR-155-5p	miRNA	geniposide and ginsenoside Rg1	cerebral ischemia injury (CII)	middle cerebral artery occlusion treated rats brain tissues	Geniposide+Ginsenoside Rg1 dual treatment	downregulated	29257264
1215	Rat	rno-miR-155-5p	miRNA	dihydromyricetin (DHM)	diabetic nephropathy (DN)	NRK-52E?cells; kidney tissues	high glucose (HG) treatment	"MiR-155-5p expression was increased, while PTEN expression was decreased in DN rat and cell model, and DHM reversed both effects."	31668144
1216	Rat	rno-miR-155-5p	miRNA	high glucose (HG)	diabetic nephropathy (DN)	NRK-52E?cells	high glucose (HG) treatment	upregulated	31668144
1217	Rat	rno-miR-155-5p	miRNA	isoproterenol	drug-induced cardiac injury (DICI)	heart tissues	isoproterenol treatment	upregulated	29355689
1218	Rat	rno-miR-155-5p	miRNA	pilocarpine	epilepsy	hippocampus	pilocarpine treatment	upregulated	29191771
1219	Rat	rno-miR-155-5p	miRNA	plasminogen activator (tPA)	neuropathy-induced blood-nerve barrier (BNB) opening	sciatic nerve from male rats	plasminogen activator (tPA) treatment	upregulated	30625382
1220	Rat	rno-miR-155-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31915454
1221	Rat	rno-miR-155-5p	miRNA	Shenling Baizhu San (SLBZS)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	Shenling Baizhu San (SLBZS) treatment	the expression levels were reversed by SLBZS administration	31915454
1222	Rat	rno-miR-155-5p	miRNA	group A streptococci	rheumatic heart disease (RHD)	valve tissues and serum exosomes	an RHD rat model was induced by inactivated Group A streptococci and complete Freund's adjuvant.	upregulated	31894293
1223	Rat	rno-miR-155-5p	miRNA	group A streptococci and complete Freund's adjuvant	rheumatic heart disease (RHD)	valve tissues; serum exosomes	group A streptococci and complete Freund's adjuvant treatment	The expression of miR-155-5p in valve tissues and serum exosomes was increased.	31894293
1224	Rat	rno-miR-155-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1225	Rat	rno-miR-155-5p	miRNA	silica	silicosis	rats lung tissues	silica treatment	upregulated	31877411
1226	Rat	rno-miR-155-5p	miRNA	silica	silicosis	lung tissues	silica treatment	upregulated	31877411
1227	Rat	rno-miR-155-5p	miRNA	geniposide and ginsenoside Rg2	stroke	middle cerebral artery occlusion rats	"geniposide (30 mg/kg, tail vein injection)+ ginsenoside Rg1 (6 mg/kg, tail vein injection)"	upregulated	29257264
1228	Rat	rno-miR-155-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	subacute thyroiditis	rat thyroid follicle FRTL-5 cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	30399324
1229	Rat	rno-miR-155-5p	miRNA	pilocarpine	temporal lobe epilepsy (TLE)	rats hippocampus	pilocarpine treatment	upregulated in hippocampus	29191771
1230	Rat	rno-miR-155-5p	miRNA	cadmium (Cd)	vascular calcification (VC)	rat vascular smooth muscle cells (rVSMCs)	CaCl2 treatment	miR-155-5p was decreased in the rat vascular smooth muscle cells (rVSMCs) undergoing calcification in vitro.	32345535
1231	Rat	rno-miR-156	miRNA	dexmedetomidine (DEX)	neuroinflammation	"adult Wistar rats brain ,plasma,"	dexmedetomidine (Dex) treatment	downregulated	28832497
1232	Rat	rno-miR-15a	miRNA	ischemia/reperfusion (I/R) 	apoptosis	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	24043355
1233	Rat	rno-miR-15a	miRNA	freund¡¯s complete adjuvant (FCA)	arthritis	Sprague-Dawley rats	injected with Freund's complete adjuvant	downregulated	28877850
1234	Rat	rno-miR-15a	miRNA	gabapentin	arthritis	Sprague-Dawley rats	administered intraperitoneally gabapentin for 8 days	upregulated	28877850
1235	Rat	rno-miR-15a	miRNA	hypoxia	glial scars	DI TNC1 cells	hypoxia treatment	upregulated	27460735
1236	Rat	rno-miR-15a	miRNA	insulin	glucose homeostasis	L6 rat skeletal muscle cells	insulin treatment	upregulated	31594761
1237	Rat	rno-miR-15a	miRNA	hypoxia	hypoxia-induced injury	PC-12 cells	hypoxia induce	upregulated	30395900
1238	Rat	rno-miR-15a	miRNA	sappanone A	hypoxia-induced injury	hypoxia-induced PC-12 cells	sappanone A treatment	downregulated	30395900
1239	Rat	rno-miR-15a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic brain injury	primary cortical neu- rons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-15a expression level in OGD/R group was increased.	31631531
1240	Rat	rno-miR-15a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic brain injury	primary cortical neurons separated from rats	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	31631531
1241	Rat	rno-miR-15a	miRNA	hypoxia	neurological injury	PC-12 cells	hypoxia induce	upregulated	30395900
1242	Rat	rno-miR-15a	miRNA	Sappanone A	neurological injury	hypoxia-induced PC-12 cells	Sappanone A treatment	downregulated	30395900
1243	Rat	rno-miR-15a	miRNA	chronic constriction injury (CCI)	neuropathic pain (NP)	Rat lumbar spinal cord tissues	chronic constriction injury (CCI) induce	downregulated	31736006
1244	Rat	rno-miR-15a	miRNA	insulin-like growth factor 1 (IGF-1)	post-stroke	brain tissues	Post-stroke ICV administration of IGF-1 to middle-aged female rats treatment	downregulated	24618563
1245	Rat	rno-miR-15a	miRNA	pilocarpine	temporal lobe epilepsy (TLE)	TLE tissues	pilocarpine treatment	mir-15a was significantly downregulated in the TLE tissues	32945401
1246	Rat	rno-miR-15a-5p	miRNA	methylprednisolone	femoral head necrosis (FHN)	femoral head tissues	methylpred-nisolone treatment	upregulated	30957181
1247	Rat	rno-miR-15a-5p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	lung tissues	monocrotaline (MCT) treatment	upregulated	31894295
1248	Rat	rno-miR-15b	miRNA	hypoxia/reoxygenation (H/R)	acute myocardial infarction (AMI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	"In H9c2 cells, hypoxia/reoxygenation induced increased miRNA-15b expression and augmented cardiomyocyte apoptosis observed at 24?hours after 24-hour hypoxia."	28814571
1249	Rat	rno-miR-15b	miRNA	ischemia/reperfusion (I/R) 	acute myocardial infarction (AMI)	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	28814571
1250	Rat	rno-miR-15b	miRNA	glycochenodeoxycholate (GCDC)	apoptosis	liver tissues	glycochenodeoxycholate (GCDC) treatment	upregulated	31152635
1251	Rat	rno-miR-15b	miRNA	hypoxia	apoptosis	Neonatal rat ventricular myocytes (NRVMs) and fibroblasts	hypoxia induce	downregulated	30876857
1252	Rat	rno-miR-15b	miRNA	ischemia/reperfusion (I/R) 	apoptosis	heart tissues	ischemia/reperfusion (I/R) treatment	upregulated	24043355
1253	Rat	rno-miR-15b	miRNA	tauroursodeoxycholate (TUDC)	apoptosis	glycochenodeoxycholate (GCDC)-induced rats liver tissues	Tauroursodeoxycholate (TUDC) treatment	downregulated	31152635
1254	Rat	rno-miR-15b	miRNA	TGF-¦Â1	apoptosis	Neonatal rat ventricular fibroblasts	TGF-¦Â1 treatment	downregulated	30876857
1255	Rat	rno-miR-15b	miRNA	allopurinol	cardiac fibrosis	fructose-treated rats heart tissues and H9c2 cells	allopurinol treatment	upregulated	31871537
1256	Rat	rno-miR-15b	miRNA	fructose	cardiac fibrosis	rats heart tissues and H9c2 cells	fructose treatment	downregulated	31871537
1257	Rat	rno-miR-15b	miRNA	Pterostilbene	cardiac fibrosis	fructose-treated rats heart tissues and H9c2 cells	Pterostilbene treatment	upregulated	31871537
1258	Rat	rno-miR-15b	miRNA	mild hypothermia	cerebral ischemia injury (CII)	brain tissues	applying ice packs around the neck and head	downregulated	30276328
1259	Rat	rno-miR-15b	miRNA	oxaliplatin	chronic neuropathic pain	rats dorsal root ganglion (DRG)	injections of oxaliplatin (2 mg¡¤kg-1 ) for five consecutive days	upregulated in the dorsal root ganglion (DRG)	28012171
1260	Rat	rno-miR-15b	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retinal capillary endothelial cells and pericytes	streptozotocin treatment	downregulated	31364104
1261	Rat	rno-miR-15b	miRNA	ionizing radiation (IR)	irradiation-induced heart damage	rat myocardium	Single irradiation of 10 Gy (4¨C5 Gy/min.) of rat¡¯s mediastinum area	downregulated	30830529
1262	Rat	rno-miR-15b	miRNA	molecular hydrogen-rich water (HRW)	irradiation-induced heart damage	irradiation-induced rat myocardium	molecular hydrogen-rich water (HRW) treatment	upregulated	30830529
1263	Rat	rno-miR-15b	miRNA	losartan	ischemia/reperfusion (I/R) injury	heart tissues	losartan treatment	upregulated	26168042
1264	Rat	rno-miR-15b	miRNA	kaempferol	ischemic heart disease (IHD)	H9c2 cells	Kaempferol (Kae) treatment	Kae exposure promoted downregulated of miR-15b.	32418959
1265	Rat	rno-miR-15b	miRNA	apigenin	myocardial ischemia/reperfusion (I/R) injury (MIRI)	hypoxia-induced H9C2 cells	apigenin treatment	downregulated	30983593
1266	Rat	rno-miR-15b	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	hypoxia induce	upregulated	30983593
1267	Rat	rno-miR-15b	miRNA	"quinacrine, erythromycin and tetracycline"	non-surgical sterilization	Wistar albino 12-14 week old female rats	"quinacrine, erythromycin , tetracycline treatment"	upregulated	25195052
1268	Rat	rno-miR-15b	miRNA	high amplitude mechanical stretching	lung fibrosis	alveolar type II (ATII) cells and lung fibroblasts	high amplitude mechanical stretching treatment	upregulated	31290711
1269	Rat	rno-miR-15b	miRNA	doxorubicin (DOX)	renal interstitial fibrosis (RIF)	kidneys	doxorubicin (ADR) induction	upregulated	32606425
1270	Rat	rno-miR-15b	miRNA	"kangxianling (KXL, anti-fibrin)"	renal interstitial fibrosis (RIF)	kidneys	"Kangxianling (KXL, anti-fibrin) treatment"	downregulated	32606425
1271	Rat	rno-miR-16	miRNA	nicotine	allergic asthma (AA)	lung tissues	nicotine injections	upregulated	28381639
1272	Rat	rno-miR-16	miRNA	amyloid-¦Â (A¦Â)	Alzheimer's disease (AD)	PC12 cells	amyloid-¦Â (A¦Â) treatment	downregulated	30142113
1273	Rat	rno-miR-16	miRNA	glycochenodeoxycholate (GCDC)	apoptosis	liver tissues	glycochenodeoxycholate (GCDC) treatment	upregulated	31152635
1274	Rat	rno-miR-16	miRNA	hypoxia	apoptosis	Bone marrow-derived mesenchymal stem cells (BM-MSCs)	hypoxia/serum deprivation (SD) induce	upregulated	29767235
1275	Rat	rno-miR-16	miRNA	partial hepatectomy (PH)	apoptosis	wistar rats liver tissues	PHS (70% PH); PHP (70% PH of an organ perfused and preserved for 24 hours) treatment	downregulated	25131054
1276	Rat	rno-miR-16	miRNA	tauroursodeoxycholate (TUDC)	apoptosis	glycochenodeoxycholate (GCDC)-induced rats liver tissues	Tauroursodeoxycholate (TUDC) treatment	downregulated	31152635
1277	Rat	rno-miR-16	miRNA	valsartan (VAL)	arrhythmogenesis	H9c2	valsartan treatment	downregulated	26654716
1278	Rat	rno-miR-16	miRNA	H2O2	cardiomyocyte oxidative injury	neonatal rat ventricular cells (NRVCs)	hydrogen peroxide	upregulated	28423616
1279	Rat	rno-miR-16	miRNA	thyroglobulin (Tg)	cell proliferation	rat FRTL-5 thyroid cells	Tg treatment	upregulated	24479877
1280	Rat	rno-miR-16	miRNA	chronic unpredictable mild stress (CUMS)	depression	cerebrospinal fluid (CSF) and raphe	chronic unpredictable mild stress (CUMS) treatment	downregulated	29957478
1281	Rat	rno-miR-16	miRNA	dingzhi Xiaowan (DZ)	depression	unpredictable mild moderate stimulation (CUMS)-induced depression rats hippocampus	Dingzhi Xiaowan (DZ) treatment	upregulated	30347920
1282	Rat	rno-miR-16	miRNA	mitomycin C-polylactic acid ( MMC-PLA) film	epidural scar hyperplasia and adhesion	post-laminectomy rat scar tissues	25 mg of PLA film containing 0.01% MMC was implanted on the laminectomy area	downregulated	28617531
1283	Rat	rno-miR-16	miRNA	hypoxia	glial scars	DI TNC1 cells	hypoxia treatment	upregulated	27460735
1284	Rat	rno-miR-16	miRNA	"acetaminophen, carbon tetrachloride, D-galactosamine and thioacetamide"	hepatotoxicity	rat liver cells	hepatotoxins treatment	"the combination of MicroRNA-16/5S Ribosomal RNA and Beta 2 Microglobulin/18S Ribosomal RNA were validated as optimal reference genes for microRNA and mRNA quantification, respectively, in rat models of acute hepatotoxicity."	22563491
1285	Rat	rno-miR-16	miRNA	lipopolysaccharide (LPS)	intervertebral disc degeneration (IDD)	NP cells	lipopolysaccharide (LPS) treatment	MiR-16 was downregulated in NP cells after LPS induction.	33747285
1286	Rat	rno-miR-16	miRNA	cisplatin (DDP)	kidney damage	male Wistar rats	cisplatin treatment	upregulated	24880025
1287	Rat	rno-miR-16	miRNA	hypoxia	myocardial hypoxia/reoxygenation (H/R) injury	H9c2(2-1) cells	hypoxia induce	upregulated	31432171
1288	Rat	rno-miR-16	miRNA	lipopolysaccharide (LPS)	myocarditis	H9c2 cells	lipopolysaccharide (LPS) treatment	downregulated	31777165
1289	Rat	rno-miR-16	miRNA	lipopolysaccharide (LPS)	myocarditis	H9C2 cells	lipopolysaccharide (LPS) treatment	upregulation of miR-16 has a protective effect on LPS-damaged H9c2 cells.	31777165
1290	Rat	rno-miR-16	miRNA	destabilization of medial meniscus (DMM)	osteoarthritis (OA)	male Sprague¨CDawley rats OA cartilage tissues	destabilization of medial meniscus (DMM) treatment	upregulated	29255591
1291	Rat	rno-miR-16	miRNA	destabilization of medial meniscus (DMM)	osteogenesis	bone marrow mesenchymal stem cells (BMSCs)	MgCl2 treatment	MgCl2 causes the decreases of miR-16 levels.	32411326
1292	Rat	rno-miR-16	miRNA	stress	post-traumatic stress disorder (PTSD)	Wistar rats HIP	controlled lighting (light on 07:00¨C19:00 hr) and temperature (25 ¡À 2¡ãC) conditions with ad libitum access to food and water treatment	upregulated	28944448
1293	Rat	rno-miR-16	miRNA	"paroxetine hydrochloride and corticotropin-releasing factor antagonist (CP-154,526)"	post-traumatic stress disorder (PTSD)	PTSD Wistar rats HIP	"CP-154,526 treatment"	downregulated	28944448
1294	Rat	rno-miR-16	miRNA	sitagliptin	renal interstitial inflammatory	type II diabetic Goto-Kakizaki (GK)	sitagliptin treatment	upregulated	28652790
1295	Rat	rno-miR-16	miRNA	cronobacter sakazakii	septicemia	amygdala	cronobacter sakazakii treatment	upregulated	26388777
1296	Rat	rno-miR-16	miRNA	perfluorooctane sulfonic acid (PFOS)	perfluorooctane sulfonate (PFOS)-induced toxic action	rat liver tissue	dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 11) treatment	different expression	24420840
1297	Rat	rno-miR-16-3p	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
1298	Rat	rno-miR-16-5p	miRNA	isoproterenol	acute cardiac injury	blood	isoproterenol treatment	upregulated	27605421
1299	Rat	rno-miR-16-5p	miRNA	"2,3,5,6-tetramethylpyrazine (TMP)"	creeclampsia (PE)	trophoblast cells of placental tissue of PE rats	"2,3,5,6-tetramethylpyrazine (TMP) treatment"	TMP inhibits trophoblast cell autophagy and promotes its viability and migration in PE rat model through regulating the miR-16-5p/IGF-2 axis.	33112793
1300	Rat	rno-miR-16-5p	miRNA	octreotide (OCT)	neuroendocrine tumors	INS-1 cells	octreotide treatment	upregulated	33045023
1301	Rat	rno-miR-17	miRNA	ethanol (EtOH)	acute gastric mucosal injury	gastric tissues?of rat	oral administration of ethanol	downregulated	23830200
1302	Rat	rno-miR-17	miRNA	butyrylated high-amylose maize starch (HAMSB)	colorectal cancer (CRC)	high-protein meat diet (HPM) fed rat colonic tissue	butyrylated high-amylose maize starch (HAMSB) feed	downregulated	31052187
1303	Rat	rno-miR-17	miRNA	high-amylose potato starch (HAPS)	colorectal cancer (CRC)	high-protein meat diet (HPM) fed rat colonic tissue	high-amylose potato starch (HAPS) feed	downregulated	31052187
1304	Rat	rno-miR-17	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	Wistar rats left ventricle (LV)	STZ treatment	upregulated	28199183
1305	Rat	rno-miR-17	miRNA	resveratrol	cardiac fibrosis	cardiac fibroblasts (CFs)	resveratrol (Res) treatment	"Resveratrol decreased the levels of miR-17,in TGF- ¦Â1-treated CFs"	30648109
1306	Rat	rno-miR-17	miRNA	high fat diet (HFD) and streptozotocin (STZ)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD); streptozotocin (STZ)  treatment	downregulated	30338914
1307	Rat	rno-miR-17	miRNA	"1,3,5-tris-4-propyl-1H-pyrazole"	spinal cord injury (SCI)	VSC4.1 motoneurons	ER agonists treatment	upregulated	24157932
1308	Rat	rno-miR-17	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	retina tissues	streptozotocin (STZ) treatment	upregulated	30170066
1309	Rat	rno-miR-17-1	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
1310	Rat	rno-miR-17-3p	miRNA	dexamethasone (DEX)	ischemia/reperfusion (I/R) injury	H9c2 cells	dexamethasone (DEX) treatment	"A concentration of 0.1-10 ?mol/l Dex attenuated H/R injury, which was accompanied by increased miR-17-3p levels."	32742334
1311	Rat	rno-miR-17-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	31730378
1312	Rat	rno-miR-17-3p	miRNA	rosuvastatin	myocardial ischemia/reperfusion (I/R) injury (MIRI)	oxygen-glucose deprivation/reoxygenation (OGD/R) induced H9C2 cells	Rosuvastatin (RS) treatment	upregulated	31730378
1313	Rat	rno-miR-17-3p	miRNA	perfluorooctane sulfonic acid (PFOS)	perfluorooctane sulfonate (PFOS)-induced toxic action	rat liver tissue	dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 9) treatment	different expression	24420840
1314	Rat	rno-miR-17-5p	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	downregulated	27535721
1315	Rat	rno-miR-17-5p	miRNA	H2O2	cardiovascular disease (CVD)	H9c2 cells	H2O2 treatment	upregulated	33350543
1316	Rat	rno-miR-17-5p	miRNA	hypoxia	glial scars	DI TNC1 cells	hypoxia treatment	upregulated	27460735
1317	Rat	rno-miR-17-5p	miRNA	H2O2	ischemia/reperfusion (I/R) injury	neonatal rat ventricular cardiomyocytes (NRVCs)	oxidative stress treatment	upregulated	25200830
1318	Rat	rno-miR-17-5p	miRNA	hypoxia	ischemic acute kidney injury	rat kidney proximal tubular cell (RPTC) line	hypoxia treatment	upregulated	27622990
1319	Rat	rno-miR-17-5p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	hepatic stellate cell (HSC)	CCl4 treatment	upregulated	25915722
1320	Rat	rno-miR-17-5p	miRNA	Salvianolic acid B (Sal B)	liver fibrosis	hepatic stellate cell (HSC)	Salvianolic acid B (Sal B) treatment	downregulated	26637809
1321	Rat	rno-miR-17-5p	miRNA	diosmin (Dios)	oxidative stress	rats	100 mg¡¤(kg body mass)-1¡¤day-1 (per oral) of Dios	downregulated	28177765
1322	Rat	rno-miR-17-5p	miRNA	ionizing radiation (IR)	oxidative stress	liver tissues	overall dose of 12 Gy on 6 fractions of 2 Gy each	upregulated	28177765
1323	Rat	rno-miR-17-5p	miRNA	X-rays	radiation-induced skin injury	rats irradiated skin	45-Gy electron beam treatment	downregulated	24447893
1324	Rat	rno-miR-17-5p	miRNA	beta-phenethyl isothiocyanate (PEITC)	sciatic nerve conditioning injury	Primary Sensory Neurons	beta-phenethyl isothiocyanate (PEITC) treatment	downregulated	29877111
1325	Rat	rno-miR-181	miRNA	"2,5-hexanedione (HD)"	"2,5-hexanedione (HD) toxicity"	spinal cord tissues	"2,5-hexanedione (HD) treatment"	upregulated	31760062
1326	Rat	rno-miR-181	miRNA	DF3016A	ischemic neuroinflammatory injury	OGD/R treated primary cultured neurons	oxygen-glucose deprivation-reoxygenation (OGD/R) treatment	downregulated	30953275
1327	Rat	rno-miR-181	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic neuroinflammatory injury	Primary Cultured neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	30953275
1328	Rat	rno-miR-181	miRNA	angiotensin II (Ang II)	renal fibrosis	NRK49F cells	angiotensin II (Ang II) treatment	downregulated	30816527
1329	Rat	rno-miR-181a	miRNA	ethanol (EtOH)	acute gastric mucosal injury	gastric tissues?of rat	oral administration of ethanol	downregulated	23830200
1330	Rat	rno-miR-181a	miRNA	adriamycin (ADR)	anthracycline-induced cardiomyocyte apoptosis	"rat myocardial cell line, H9c2, and primary cardiomyocytes"	adriamycin (ADR) treatment	upregulated	29849870
1331	Rat	rno-miR-181a	miRNA	propofol (PPF)	anthracycline-induced cardiomyocyte apoptosis	"Adriamycin? (ADM)-treated rat myocardial cell line, H9c2, and primary cardiomyocytes"	propofol treatment	downregulated	29849870
1332	Rat	rno-miR-181a	miRNA	H2O2	antiapoptotic	mesenchymal stem cells (MSCs)	H2O2 treatment	upregulated	26283227
1333	Rat	rno-miR-181a	miRNA	GW0742	astrocytic injury	rat hippocampal astrocytes	GW0742	upregulated	27789312
1334	Rat	rno-miR-181a	miRNA	sevoflurane (SEV)	cerebral ischemia/reperfusion (I/R) injury	"primary cortical neurons after OGD, rat brain after MCAO"	sevoflurane (SEVO) treatment	downregulated	31170386
1335	Rat	rno-miR-181a	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	cardiomyocytes	high glucose treatment	upregulated	27221738
1336	Rat	rno-miR-181a	miRNA	TGF-¦Â	diabetic nephropathy (DN)	Rat glomerular mesangial cells	TGF¦Â treatment	upregulated	29397070
1337	Rat	rno-miR-181a	miRNA	dapagliflozin	drug-induced acute kidney injury (DIKI)	rat kidney tissues	Dapagliflozin (DAPA) treatment	upregulated	31075409
1338	Rat	rno-miR-181a	miRNA	dapagliflozin	drug-induced acute kidney injury (DIKI)	GNT-treated rat kidney tissues	Dapagliflozin (DAPA) treatment	downregulated	31075409
1339	Rat	rno-miR-181a	miRNA	gentamicin	drug-induced acute kidney injury (DIKI)	rat kidney tissues	gentamicin (GNT) treatment	upregulated	31075409
1340	Rat	rno-miR-181a	miRNA	pentylenetetrazol (PTZ)	epilepsy	hippocampal tissues	pentylenetetrazol (PTZ) treatment	upregulated	26722477
1341	Rat	rno-miR-181a	miRNA	perinatal nicotine	health effects of E-cigarette and other novel electronic nicotine delivery systems (ENDS)	heart tissues	perinatal nicotine exposure (PNE) treatment	PNE could induce a reprogramming of cardiac miR-181a expression/DNA methylation pattern	33052248
1342	Rat	rno-miR-181a	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
1343	Rat	rno-miR-181a	miRNA	resveratrol	cardiac fibrosis	cardiac fibroblasts (CFs)	resveratrol (Res) treatment	Resveratrol decreased the levels of miR-181a in TGF- ¦Â1-treated CFs	30648109
1344	Rat	rno-miR-181a	miRNA	abdominal aortic coarctation	cardiac hypertrophy	rats cardiac tissues	abdominal aortic coarctation treatment	downregulated in cardiac tissues	29243791
1345	Rat	rno-miR-181a	miRNA	H2O2	oxidative stress	H9c2 rat cardiomyocyte cell line	H2O2 treatment	upregulated	24683439
1346	Rat	rno-miR-181a	miRNA	retinal toxicant pan-CDK inhibitors	retinal toxicity	rats in renal	a single intravitreal (IVT) injection treatment	upregulated	24114799
1347	Rat	rno-miR-181a	miRNA	hesperidin	testicular toxicity	testicular	hesperidin (HSP) treatment	upregulated	32050098
1348	Rat	rno-miR-181a/b-5p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	lung tissues	monocrotaline (MCT) treatment	downregulated	31637717
1349	Rat	rno-miR-181a/b-5p	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	pulmonary arterial hypertension (PAH)	primary rat pulmonary arterial endothelial cells (rPAECs)	tumor necrosis factor alpha (TNF-¦Á) treatment	downregulated	31637717
1350	Rat	rno-miR-181a-2-3p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	hippocampus	amyloid ¦Â1-42?(A¦Â) treatment	upregulated	29706607
1351	Rat	rno-miR-181a-5p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	33407436
1352	Rat	rno-miR-181a-5p	miRNA	methamphetamine (METH)	addiction	nucleus accumbens tissues	Methamphetamine treatment	dysregulated	28681200
1353	Rat	rno-miR-181a-5p	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	rat insulinoma (INS-1) cells	streptozotocin (STZ) treatment	Silencing of lncRNA PVT1 ameliorates streptozotocin-induced pancreatic ¦Â cell injury and enhances insulin secretory capacity by regulating miR-181a-5p	32758099
1354	Rat	rno-miR-181a-5p	miRNA	liraglutide	endothelial dysfunction	aortic endothelial in diabetic rats	liraglutide treatment	downregulated	30863684
1355	Rat	rno-miR-181a-5p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
1356	Rat	rno-miR-181a-5p	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	downregulated	27919821
1357	Rat	rno-miR-181a-5p	miRNA	high mobility group box-1 protein (HMGB1)	sepsis	rats dendritic cell (DC)	HMGB1	upregulated	28947753
1358	Rat	rno-miR-181a-5p	miRNA	CXCR4 agonist AMD3100	severe acute pancreatitis (SAP)	Severe acute pancreatitis (SAP) rats pancreas and serum	CXCR4 agonist AMD3100 treatment	downregulated	31654716
1359	Rat	rno-miR-181a-5p	miRNA	Sodium taurocholate	Severe acute pancreatitis (SAP)	pancreas and serum	Sodium taurocholate treatment	downregulated	31654716
1360	Rat	rno-miR-181a-5p	miRNA	lithium chloride and pilocarpine	temporal lobe epilepsy (TLE)	hippocampus	lithium-pilocarpine treatment	miR-181a-5p was increased in the hippocampus.	32461588
1361	Rat	rno-miR-181b	miRNA	angiotensin II (Ang II)	cardiac fibrosis and hypertension	cardiac fibroblasts (CFs) of rats	angiotensin II (Ang II) treatment	downregulated	23007623
1362	Rat	rno-miR-181b	miRNA	kainic acid (KA)	epilepsy	hippocampus of KA-induced juvenile epileptic rats	kainic acid (KA) treatment	downregulated	29808547
1363	Rat	rno-miR-181b	miRNA	magnesium-free extracellular fluid	epilepsy	hippocampal neurons	magnesium-free treatment	MiR-181b suppressed the progression of epilepsy via regulation of RASSF1A and lncRNA ZNF883.	32655808
1364	Rat	rno-miR-181b	miRNA	gleditsia sinensis extract (GSE)	hepatocellular carcinoma (HCC)	HCC liver	Gleditsia sinensis extract (GSE) treatment	upregulated	30940289
1365	Rat	rno-miR-181b	miRNA	¦Â-ionone (¦ÂI)	hepatocellular carcinoma (HCC)	rats hepatocyte	¦ÂI (16 mg/100 g body weight) treatment	"upregulated(miR-122 , miR-34a) ;downregulated (miR-181b , miR-708)"	27061051
1366	Rat	rno-miR-181b	miRNA	hypoxia	hypertensive disorders complicating pregnancy (HDCP)	primary cardiomyocytes	hypoxia treatment	downregulated	28912851
1367	Rat	rno-miR-181b	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	male Sprague¨CDawley (180¨C220 g) rats	CCl4 treatment	upregulated	25148875
1368	Rat	rno-miR-181b	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC-12 cells	1-methyl-4- phenylpyridinium iodide(MPP +) treatment	The expression of miR-181b was downregulated by the change in MPP+ concentration.	29608948
1369	Rat	rno-miR-181b	miRNA	panax notoginseng saponins (PNS)	severe acute pancreatitis (SAP)	taurocholate-induced severe acute pancreatitis (SAP) rats pancreas tissues	Panax notoginseng saponins treatment	upregulated	29402262
1370	Rat	rno-miR-181b	miRNA	taurocholate	severe acute pancreatitis (SAP)	pancreas tissues	taurocholate treatment	downregulated	29402262
1371	Rat	rno-miR-181b	miRNA	silicon dioxide (SiO2)	silicosis	fibrotic lungs	silicon dioxide (SiO2) treatment	downregulated	26239160
1372	Rat	rno-miR-181b	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	downregulated	21094214
1373	Rat	rno-miR-181b-1	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
1374	Rat	rno-miR-181b-1-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1375	Rat	rno-miR-181b-3p	miRNA	hyaluronic acid 35 (HA35)	ethanol-induced liver and intestinal injury	Kupffer cells isolated from ethanol-fed rats	HA35 for 5 h	upregulated	28257601
1376	Rat	rno-miR-181b-5p	miRNA	earle's balanced salt solution (EBSS)	autophagy	H9c2 cardiomyocytes and neonatal rat ventricular myocytes (NRVMs)	"H9c2 cardiomyocytes and neonatal rat ventricular myocytes (NRVMs) were glucose-starved in Earle's Balanced Salt Solution (EBSS) for different periods of time (0, 2, 4, 6 and 8 h)"	downregulated	30431062
1377	Rat	rno-miR-181b-5p	miRNA	glucose starvation	cardiomyocyte autophagy	H9c2 cardiomyocytes and neonatal rat ventricular myocytes (NRVMs)	glucose-starved in Earle's Balanced Salt Solution (EBSS) induce	downregulated	30431062
1378	Rat	rno-miR-181b-5p	miRNA	monocrotaline (MCT)	epithelial-mesenchymal transition (EMT)	rat pulmonary arterial	monocrotaline (MCT) treatment	downregulated	31734320
1379	Rat	rno-miR-181b-5p	miRNA	"TNF-¦Á, TGF¦Â1 and IL-1¦Â in combination"	epithelial-mesenchymal transition (EMT)	primary rat pulmonary arterial endothelial cells (rPAECs)	"TNF-¦Á, TGF¦Â1 and IL-1¦Â in combination treatment"	downregulated	31734320
1380	Rat	rno-miR-181b-5p	miRNA	hypoxia	ischemic heart disease (IHD)	H9C2 myocardial cells	hypoxia induce	upregulated	31297863
1381	Rat	rno-miR-181b-5p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	rat pulmonary arterial	monocrotaline (MCT) treatment	downregulated	31734320
1382	Rat	rno-miR-181b-5p	miRNA	"TNF-¦Á, TGF¦Â1 and IL-1¦Â in combination"	pulmonary arterial hypertension (PAH)	primary rat pulmonary arterial endothelial cells (rPAECs)	"TNF-¦Á, TGF¦Â1 and IL-1¦Â in combination treatment"	downregulated	31734320
1383	Rat	rno-miR-181b-5p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	downregulated	26997989
1384	Rat	rno-miR-181b-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1385	Rat	rno-miR-181b-5p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC-12 cells	lipopolysaccharide (LPS) treatment	?Bioinformatics prediction and luciferase reporter assay demonstrated that miR-181b-5p could directly bind to SNHG14.	33791006
1386	Rat	rno-miR-181c	miRNA	IL-6	apoptosis	INS-1 beta cells	IL-6 treatment	downregulated	30974824
1387	Rat	rno-miR-181c	miRNA	valproic acid (VPA)	autism spectrum disorder (ASD)	amygdala	valproic acid treatment	upregulated	25986729
1388	Rat	rno-miR-181c	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia injury (CII)	primary hippocampal neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-181c was significantly decreased in OGD/reoxygenation-treated hippocampal neurons.	32213240
1389	Rat	rno-miR-181c	miRNA	bilateral common carotid artery occlusion (2-VO)	chronic cerebral hypoperfusion (CCH)	rats	bilateral common carotid artery?occlusion (2VO) induce	downregulated	27933582
1390	Rat	rno-miR-181c	miRNA	ischemia/hypoxia (IH)	chronic cerebral hypoperfusion (CCH)	hippocampus	ischemia/hypoxia treatment	downregulated	27933582
1391	Rat	rno-miR-181c	miRNA	H2O2	craniofacial defect	Bone mesenchymal stem cell (BMSC)	H2O2 treatment	downregulated	33111200
1392	Rat	rno-miR-181c	miRNA	H2O2	craniofacial defect reconstruction	Bone mesenchymal stem cell (BMSC)	hydrogen peroxide (H2O2) treatment	downregulated	31578723
1393	Rat	rno-miR-181c	miRNA	hypoxia/reoxygenation (H/R)	doxorubicin (DOX)-induced cardiotoxicity	H9C2 cells	hypoxia /reoxygenation (H/R) treatment	MiR-181c protects cardiomyocyte injury by preventing cell apoptosis through PI3K/Akt signaling pathway	32968640
1394	Rat	rno-miR-181c	miRNA	methamphetamine (METH)	intestinal barrier dysfunction	IEC-6 cells (rat small intestine epithelial cells)	Methamphetamine treatment	downregulated	31862507
1395	Rat	rno-miR-181c	miRNA	H2O2	oxidative stress	Bone mesenchymal stem cells (BMSC)	H2O2 treatment	downregulated	31466503
1396	Rat	rno-miR-181c	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC12	1-methyl-4-phenylpyridinium (MPP+) treatment	upregulated	28770951
1397	Rat	rno-miR-181c	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	downregulated	21094214
1398	Rat	rno-miR-181c-3p	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	primary cortical neurons?and secreted exosomes	oxygen and glucose deprivation (OGD) treatment	downregulated	31665717
1399	Rat	rno-miR-181c-5p	miRNA	aflatoxin B1 (AFB1)	hepatocellular carcinoma (HCC)	F344 rats liver tissues	aflatoxin B1 (AFB3) treatment	upregulated	28218475
1400	Rat	rno-miR-181c-5p	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	?H9C2 cells	hypoxia induce	upregulated	31178952
1401	Rat	rno-miR-181d-5p	miRNA	Jianpi Xiaoke (JPXK)	type 2 diabetes mellitus (T2DM)	rat	Jianpi Xiaoke (JPXK) treatment	upregulated	33456489
1402	Rat	rno-miR-182	miRNA	hypoxia	acute kidney injury (AKI)	NRK-52E cells	hypoxia induce	upregulated	29733821
1403	Rat	rno-miR-182	miRNA	high fat diet (HFD)	aging-related non-alcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	downregulated	31899128
1404	Rat	rno-miR-182	miRNA	vitamin D3	arterial calcification	rat calcified arterial tissues	vitamin D3 treatment	downregulated	29196163
1405	Rat	rno-miR-182	miRNA	vitamin D3 and ¦Â-glycerophosphate	arterial calcification	Sprague Dawley (SD) rats calcified arterial tissues	vitamin D3 and ¦Â-glycerophosphate treatment	downregulated in calcified arterial tissues	29196163
1406	Rat	rno-miR-182	miRNA	¦Â-glycerophosphate (¦Â-GP)	arterial calcification	vascular smooth muscle cells (VSMCs)	¦Â-glycerophosphate treatment	downregulated	29196163
1407	Rat	rno-miR-182	miRNA	hypoxia	cyanotic congenital heart disease (CCHD)	H9c2 cells	hypoxia induce	downregulated	30107165
1408	Rat	rno-miR-182	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	upregulated	22156553
1409	Rat	rno-miR-182	miRNA	aflatoxin B1 (AFB1)	epatocarcinogenesis	serum	aflatoxin (AFB1 ) treatment	upregulated	31373075
1410	Rat	rno-miR-182	miRNA	fluorine combined with aluminum (FA)	fluorine combined with aluminum (FA)-induced developmental neurotoxicity	hippocampi	fluorine combined with aluminum (FA) treatment	upregulated	30033483
1411	Rat	rno-miR-182	miRNA	rapid ventricular pacing	heart failure (HF)	rat heart tissues	rapid ventricular pacing induce treatment	downregulated	31210325
1412	Rat	rno-miR-182	miRNA	adreno-cortico-tropic-hormone (ACTH)	hormonal regulation	adrenals?tissues	adreno-cortico-tropic-hormone (ACTH) treatment	upregulated	24205079
1413	Rat	rno-miR-182	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	upregulated	24205079
1414	Rat	rno-miR-182	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	downregulated	29262398
1415	Rat	rno-miR-182	miRNA	schistosomiasis japonica	liver fibrosis	hepatic fibrosis tissues	Schistosomiasis japonica infection treatment	upregulated	29323718
1416	Rat	rno-miR-182	miRNA	heat stress	lung cancer	lung	Heating System 2.2 (THS2.2) treatment	downregulated	27866933
1417	Rat	rno-miR-182	miRNA	ellagic acid (EA)	breast cancer	female rat mammary tissue	ellagic acid treatment	"ellagic acid, which inhibited E2-induced mammary tumorigenesis in our previous study, reversed the dysregulation of miR-375, miR-206, miR-182, miR-122, miR-127 and miR-183 detected with E2treatment"	23791885
1418	Rat	rno-miR-182	miRNA	fluorine combined with aluminum (FA)	neurotoxicity	hippocampi in the offspring of rats	fluorine combined with aluminum (FA) exposure	upregulated	30033483
1419	Rat	rno-miR-182	miRNA	oxymatrine	nonalcoholic fatty liver disease (NAFLD)	liver tissues	oxymatrine treatment	upregulated	32679144
1420	Rat	rno-miR-182	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	27910957
1421	Rat	rno-miR-182	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	downregulated	26997989
1422	Rat	rno-miR-182	miRNA	retinal toxicant pan-CDK inhibitors	retinal toxicity	rats in renal	a single intravitreal (IVT) injection treatment	upregulated	24114799
1423	Rat	rno-miR-182	miRNA	activated protein C(APC)	sepsis	rats blood and liver tissue	activated protein C treatment	aPC treatment coordinates beneficial cytoprotective effects during sepsis by modulating miRNA expression	22940033
1424	Rat	rno-miR-182	miRNA	colesevelam	zucker diabetic fatty (ZDF)	liver tissues	colesevelam treatment	upregulated	30160993
1425	Rat	rno-miR-182-5p	miRNA	ganoderic acid A (GAA)	hypoxia-induced cardiac dysfunctions	H9c2 cells	Ganoderic acid A (GAA) treatment	GAA obviously enhanced the expression level of miR-182-5p in H9c2 cells.	30415259
1426	Rat	rno-miR-182-5p	miRNA	diethylnitrosamine (DEN)	liver fibrosis	liver tissues	diethylnitrosamine (DEN) treatment	upregulated	29236317
1427	Rat	rno-miR-182-5p	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia induce	upregulated	29671338
1428	Rat	rno-miR-182-5p	miRNA	aldosterone	osteoporosis	Osteoporosis (OP) rats left femurs	alendronate treatment	downregulated	30413613
1429	Rat	rno-miR-182-5p	miRNA	palmitate	type 2 diabetes mellitus (T2DM)	INS-1 cells	palmitate (Pal) treatment	upregulated	30546417
1430	Rat	rno-miR-183	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia treatment	downregulated	28731278
1431	Rat	rno-miR-183	miRNA	hypoxia	acute myocardial infarction (AMI)	rat cardiomyocyte-drived H9c2 cells	hypoxia	downregulated	28731278
1432	Rat	rno-miR-183	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	upregulated	22156553
1433	Rat	rno-miR-183	miRNA	gleditsia sinensis extract (GSE)	hepatocellular carcinoma (HCC)	HCC liver	Gleditsia sinensis extract (GSE) treatment	upregulated	30940289
1434	Rat	rno-miR-183	miRNA	adreno-cortico-tropic-hormone (ACTH)	hormonal regulation	adrenals?tissues	adreno-cortico-tropic-hormone (ACTH) treatment	upregulated	24205079
1435	Rat	rno-miR-183	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	upregulated	24205079
1436	Rat	rno-miR-183	miRNA	ellagic acid (EA)	breast cancer	female rat mammary tissue	ellagic acid treatment	"ellagic acid, which inhibited E2-induced mammary tumorigenesis in our previous study, reversed the dysregulation of miR-375, miR-206, miR-182, miR-122, miR-127 and miR-183 detected with E2treatment"	23791885
1437	Rat	rno-miR-183	miRNA	retinal toxicant pan-CDK inhibitors	retinal toxicity	rats in renal	a single intravitreal (IVT) injection treatment	upregulated	24114799
1438	Rat	rno-miR-183	miRNA	colesevelam	zucker diabetic fatty (ZDF)	liver tissues	colesevelam treatment	upregulated	30160993
1439	Rat	rno-miR-183	miRNA	dexamethasone (DEX)	hormonal regulation	adrenals?tissues	dexamethasone (DEX) treatment	upregulated	24205079
1440	Rat	rno-miR-183-3p	miRNA	vagus nerve stimulation (VNS)	chronic systolic heart failure (CSHF)	heart tissues	vagus nerve stimulation (VNS) stimulation treatment	upregulated	31629817
1441	Rat	rno-miR-183-3p	miRNA	vagus nerve stimulation (VNS)	chronic systolic heart failure (CSHF)	heart tissues	vagus nerve stimulation (VNS) treatment	MicroRNA-183-3p upregulated by vagus nerve stimulation mitigates chronic systolic heart failure via the reduction of BNIP3L-mediated autophagy	31629817
1442	Rat	rno-miR-183-5p	miRNA	chronic unpredictable mild stress (CUMS)	depression	hippocampus tissues	chronic unpredictable mild stressed (CUMS) treatment	upregulated	28083819
1443	Rat	rno-miR-183-5p	miRNA	hronic unpredictable mild stressed (CUMS)	depression	rats hippocampal tissues	stimulated daily with randomly applied mild stressors from among 14 different mild stressors	upregulated	28083819
1444	Rat	rno-miR-183-5p	miRNA	diethylnitrosamine (DEN)	liver fibrosis	liver tissues	diethylnitrosamine (DEN) treatment	upregulated	29236317
1445	Rat	rno-miR-183-5p	miRNA	anoxia/reoxygenation (A/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	anoxia/reoxygenation (A/R) treatment	downregulated	31618500
1446	Rat	rno-miR-183-5p	miRNA	oxymatrine	nonalcoholic fatty liver disease (NAFLD)	liver tissues	oxymatrine treatment	upregulated	32679144
1447	Rat	rno-miR-183-5p	miRNA	N-methyl-N-nitrosourea (MNU)	retinal lesions	serum	N-methyl-N-nitrosourea (MNU) treatment	"MNU at 50?mg/kg induced photoreceptor cell death, with elevation in serum miR-183-5p levels."	30336191
1448	Rat	rno-miR-183-5p	miRNA	N-methyl-N-nitrosourea (MNU)	retinal toxicity	serum	N-methyl-N-nitrosourea (MNU) treatment	upregulated	30336191
1449	Rat	rno-miR-184	miRNA	palmitic acid (PA)	diabetic cardiomyopathy (DCM)	H9c2 cells	palmitic acid treatment	The expression of miR-184 was significantly decreased in H9c2 cardiomyoblast treated by palmitic acid	32229289
1450	Rat	rno-miR-184	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
1451	Rat	rno-miR-184	miRNA	cisplatin (DDP)	kidney damage	male Wistar rats	cisplatin treatment	upregulated	24880025
1452	Rat	rno-miR-184	miRNA	H2O2	myocardial infarction (MI)	H9c2 cells	H2O2 treatment	MiR-184 expression was significantly increased in H2O2-induced H9c2 cell injury model.	33215444
1453	Rat	rno-miR-184	miRNA	phthalate mixture	prostate development	Pregnant females filial generation rat prostate	Pregnant females were divided into 4 groups and orally dosed daily from GD10 to PND21 with corn oil (Control:C) or the phthalate mixture at three doses (20?¦Ìg/kg/d:T1; 200?¦Ìg/kg/d:T2; 200?mg/kg/d:T3). treatment	upregulated	31199487
1454	Rat	rno-miR-184	miRNA	angiotensin II (Ang II)	renal fibrosis	NRK49F cells	angiotensin II (Ang II) treatment	upregulated	30536131
1455	Rat	rno-mir-184	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1456	Rat	rno-miR-184	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	Sprague-Dawley (SD) rats colon tissues in the colon tissues	dextran sulfate sodium (DSS)	upregulated( miR-149-5p) downregulated (miR-184) in the colon tissues in the colon tissues	28246536
1457	Rat	rno-miR-184	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
1458	Rat	rno-miR-185	miRNA	tunicamycin (TM) or thapsigargin (TG)	cardiomyocyte apoptosis	neonatal rat ventricular myocytes (NRVMs)	neonatal rat ventricular myocytes (NRVMs) treatment	downregulated	26521941
1459	Rat	rno-miR-185	miRNA	rotenone (ROT)	parkinson's disease (PD)	rats substantia nigra (SN) and striatum (ST) tissues	rotenone treatment	downregulated	31814881
1460	Rat	rno-miR-186	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	apoptosis	rat primary cardiomyocytes	10¦Ìg/ml or 50¦Ìg/ml TNF¦Á stimulation for 24h treatment	downregulated	28233577
1461	Rat	rno-miR-186	miRNA	GYKI-52466 and MK-801	homeostatic synaptic scaling	hippocampal neurons	Blockade of AMPARs and NMDARs with 50 ¦ÌM GYKI-52466 and 10 ¦ÌM MK-801 for 24h	synaptic activity blockade persistently down-regulates miR-186-5p.	30808806
1462	Rat	rno-miR-187	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	Wistar rats left ventricle (LV)	STZ treatment	upregulated	28199183
1463	Rat	rno-miR-187	miRNA	IL-10	epilepsy	hippocampal tissues	IL-10 treatment	downregulated	26696826
1464	Rat	rno-miR-187-3p	miRNA	doxorubicin (DOX)	cardiotoxicity	H9c2 cells	Doxorubicin (DOX) treatment	miR-187-3p inhibitor significantly reduced PVT1-knockdown H9c2 cell viability and promoted apoptosis	31786333
1465	Rat	rno-miR-187-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	H9c2 cells	doxorubicin (DOX) treatment	"ncRNA PVT1 adsorbs miR-187-3p by sponge action, reducing miR-187-3p levels."	31786333
1466	Rat	rno-miR-188	miRNA	iodixanol	contrast-induced acute kidney injury (CIAKI)	rat renal tissues	iodixanol treatment	upregulated	31555692
1467	Rat	rno-miR-188	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	Wistar rats left ventricle (LV)	STZ treatment	upregulated	28199183
1468	Rat	rno-miR-188	miRNA	ethylene glycol monomethyl ether (EGME)	hyperglycemia	?testicle of rat	Ethylene glycol monomethyl ether (EGME) treatment	"miR-449a and miR-92a decreased obviously and, miR-320, miR-134 and miR-188 increased"	22008535
1469	Rat	rno-miR-188-3p	miRNA	sevoflurane (SEV)	cognitive impairment	rat brain tissues	sevoflurane treatment	upregulated	29344658
1470	Rat	rno-miR-188-5p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	primary hippocampal neuron	amyloid ¦Â1-42?(A¦Â) treatment	downregulated	27708404
1471	Rat	rno-miR-18a	miRNA	hypoxia	acute myocardial infarction (AMI)	cardiac tissues and H9c2 cells	hypoxia induce	upregulated	31168354
1472	Rat	rno-miR-18a	miRNA	(E)-1-(4'-aminophenyl)-3-phenylprop-2-en-1-one (APE)	breast cancer	plasma	(E)-1-(4'-aminophenyl)-3-phenylprop-2-en-1-one (APE) treatment	APE can decrease miR-18a and MMP-9 expressions and increase Dicer1 expression in rat mammary cancer.	32458624
1473	Rat	rno-miR-18a	miRNA	blueberry	breast cancer	estrogen-mediated rats breast cancer	blueberry-supplemented diet treatment	upregulated	24245576
1474	Rat	rno-miR-18a	miRNA	dexamethasone (DEX)	depression	prefrontal cortex and hippocampus of adolescent rats	dexamethasone (DEX) treatment	upregulated	30469088
1475	Rat	rno-miR-18a	miRNA	dexamethasone (DEX)	depression	prefrontal cortex and hippocampus of adolescent rats	dexamethasone (DEX) treatment	upregulated	30469088
1476	Rat	rno-miR-18a	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
1477	Rat	rno-miR-18a	miRNA	hypoxia	hypoxia-induced injury	neuronal pheochromocytoma (PC)-12 cells	hypoxia treatment	downregulated	319666702
1478	Rat	rno-miR-18a	miRNA	isoflurane	oxidative stress	H9c2 cells	Isoflurane treatment	downregulated	29627934
1479	Rat	rno-miR-18a	miRNA	nanosized SiO2	pulmonary injury	liver tissues	nanosized SiO2 treatment	upregulated	27689473
1480	Rat	rno-miR-18a-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia injury (CII)	PC12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	32815784
1481	Rat	rno-miR-19	miRNA	TGF-¦Â1	renal fibrosis	NRK-52E cells	TGF-¦Â1 treatment	miR-19 was significantly increased in cells treated with TGF-¦Â1	32355512
1482	Rat	rno-miR-190	miRNA	fish oil and pectin	colorectal cancer (CRC)	colon tissue of rats	corn oil ¡À fish oil with pectin ¡À cellulose	upregulated	21406606
1483	Rat	rno-miR-190	miRNA	fentanyl	fentanyl toxicity	rat primary hippocampal neuron cultures	fentanyl	downregulated	20457614
1484	Rat	rno-miR-190	miRNA	4-vinylcyclohexene diepoxide (VCD)	premature ovarian failure (POF)	ovarian	4-vinylcyclohexene diepoxide (VCD) tretament	upregulated	24188450
1485	Rat	rno-miR-190	miRNA	fentanyl	smooth muscle cell differentiation	rat hippocampal neurons	fentanyl treatment	downregulated	19854889
1486	Rat	rno-miR-190a	miRNA	dichlorodiphenyltrichloroethane (DDT)	dichlorodiphenyltrichloroethane (DDT) exposure	"liver, uterus, ovaries and mammary gland of female Wistar rats"	dichlorodiphenyltrichloroethane (DDT) exposure	upregulated	30421125
1487	Rat	rno-miR-190a	miRNA	isoflurane and sevoflurane	postoperative cognitive dysfunction (POCD)	Wistar rats hippocampus	exposed to isoflurane and sevoflurane for 2 or 4h	downregulated in the hippocampus	28669717
1488	Rat	rno-miR-190b	miRNA	dichlorodiphenyltrichloroethane (DDT)	dichlorodiphenyltrichloroethane (DDT) exposure	"liver, uterus, ovaries and mammary gland of female Wistar rats"	dichlorodiphenyltrichloroethane (DDT) exposure	upregulated	30421125
1489	Rat	rno-miR-190b	miRNA	isoflurane and sevoflurane	postoperative cognitive dysfunction (POCD)	Wistar rats hippocampus	exposed to isoflurane and sevoflurane for 2 or 4h	downregulated in the hippocampus	28669717
1490	Rat	rno-miR-1912-3p	miRNA	fluorine combined with aluminum (FA)	fluorine combined with aluminum (FA)-induced developmental neurotoxicity	hippocampi	fluorine combined with aluminum (FA) treatment	upregulated	30033483
1491	Rat	rno-miR-191a-5p	miRNA	paradoxical sleep deprivation (PSD)	cognitive impairment	Hippocampal tissues	paradoxical sleep deprivation (PSD) induce treatment	upregulated	31279826
1492	Rat	rno-miR-191b	miRNA	hypoxia	stroke	middle cerebral artery occlusion (MCAO) Sprague-Dawley rat	middle cerebral artery occlusion (MCAO) treatment	upregulated	29113076
1493	Rat	rno-miR-192	miRNA	connective tissue growth factor (CTGF)	gastric cancer (GC)	NRK-52E cells	CTGF treatment	downregulated	20393144
1494	Rat	rno-miR-192	miRNA	TGF-¦Â	gastric cancer (GC)	NRK-52E cells	TGF-¦Â treatment	downregulated	20393144
1495	Rat	rno-miR-192	miRNA	ischemia/reperfusion (I/R) 	acute kidney injury (AKI)	rats plasma	ischemia/reperfusion (I/R) treatment	upregulated by fourfold in the plasma and downregulatedd by about 40% in the kidney	28035621
1496	Rat	rno-miR-192	miRNA	carbon tetrachloride (CCl4)	acute liver failure (ALF)	rats	CCl4 treatment	upregulated	28616908
1497	Rat	rno-miR-192	miRNA	epigallocatechin-3-gallate (EGCG)	chronic renal injury	cadmium (Cd) pretreated Wistar albino rats	EGCG treatment	"decreased miR-21 and miR-192, enhanced miR-29a/b/c in kidney samples"	27474435
1498	Rat	rno-miR-192	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	colitis	male Wistar rats inflamed colon	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	downregulated in inflamed colon	28572713
1499	Rat	rno-miR-192	miRNA	exercise (Ex)	diabetes mellitus (DM)	Streptozotocin- induced diabetic rats	exercise treatment	upregulated	25789230
1500	Rat	rno-miR-192	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Rat glomerular mesangial cells	high glucose (HG) treatment	upregulated	30827272
1501	Rat	rno-miR-192	miRNA	astragaloside IV (AS-IV)	diabetic nephropathy (DN)	high glucose treated rat mesangial cells (RMCs)	astragaloside (AS-IV) treatment	downregulated	31572545
1502	Rat	rno-miR-192	miRNA	captopril	diabetic nephropathy (DN)	diabetes rats kidney tissue	captopril treatment	downregulated	31433203
1503	Rat	rno-miR-192	miRNA	high glucose (HG)	diabetic nephropathy (DN)	rat mesangial cells (RMCs)	high glucose (HG) treatment	upregulated	31572545
1504	Rat	rno-miR-192	miRNA	spironolactone	diabetic nephropathy (DN)	diabetes rats kidney tissue	spironolactone treatment	downregulated	31433203
1505	Rat	rno-miR-192	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissue	streptozotocin (STZ) treatment	upregulated	31433203
1506	Rat	rno-miR-192	miRNA	acetaminophen (APAP)	drug-induced liver injury (DILI)	serum	acetaminophen (APAP) treatment	dysregulated	22624025
1507	Rat	rno-miR-192	miRNA	dioscorea bulbifera (DB)	drug-induced liver injury (DILI)	serum	dioscorea bulbifera (DB) treatment	upregulated	22624025
1508	Rat	rno-miR-192	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	H9C2 cells	hypoxia induce	upregulated	30280798
1509	Rat	rno-miR-192	miRNA	cisplatin (DDP)	kidney damage	male Wistar rats	cisplatin treatment	upregulated	24880025
1510	Rat	rno-miR-192	miRNA	silymarin (Sm)	liver damage	thioacetamide (TAA) treated rat Blood and liver tissues	silymarin (Sm) treatment	upregulated	31811641
1511	Rat	rno-miR-192	miRNA	thioacetamide (TAA)	liver damage	blood and liver tissues	thioacetamide (TAA) treatment	downregulated	31811641
1512	Rat	rno-miR-192	miRNA	radiation	breast cancer	rat mammary cancer tissues	radiation treatment	upregulated	23273170
1513	Rat	rno-miR-192	miRNA	paclitaxel (PTX)	pancreatic cancer (PC)	renal tissue of rats	paclitaxel?treatment treatment	downregulated	21984124
1514	Rat	rno-miR-192	miRNA	streptozocin (STZ)	type 1 diabetes mellitus (T1DM)	serum	streptozotocin (STZ) treatment	upregulated	30186503
1515	Rat	rno-miR-192-5p	miRNA	isoproterenol	acute cardiac injury	urine tissues	isoproterenol treatment	upregulated	27605421
1516	Rat	rno-miR-192-5p	miRNA	gentamicin	acute kidney injury (AKI)	urine	gentamicin treatment	upregulated	33263228
1517	Rat	rno-miR-192-5p	miRNA	hypoxia/reoxygenation (H/R)	cardiomyocyte apoptosis	H9c2 cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	upregulated	27780314
1518	Rat	rno-miR-192-5p	miRNA	methane	diabetic retinopathy (DR)	Retinal?tissues	methane treatment	upregulated	26363454
1519	Rat	rno-miR-192-5p	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	rat renal artery endothelial cells (RRAECs)	angiotensin II (Ang II) treatment	upregulated	32346437
1520	Rat	rno-miR-192-5p	miRNA	hypoxia/reoxygenation (H/R)	hypoxia/reoxygenation (H/R) injury	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	upregulated	27780314
1521	Rat	rno-miR-192-5p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
1522	Rat	rno-miR-192-5p	miRNA	ischemia/reperfusion (I/R) 	kidney damage	Sprague-Dawley rats urine	ischemia/reperfusion (I/R) treatment	upregulated	28056546
1523	Rat	rno-miR-192-5p	miRNA	monocrotaline (MCT)	liver sinusoidal endothelial cells (LSEC) injury	serum	monocrotaline treatment	upregulated	30019166
1524	Rat	rno-miR-192-5p	miRNA	lipopolysaccharide (LPS)	myocardial injury	H9c2 cells	lipopolysaccharide (LPS) treatment	downregulated of KCNQ1OT1 advances cardiac injury through regulating miR-192-5p/XIAP axis during sepsis.	32102564
1525	Rat	rno-miR-192-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	Sprague Dawley rats liver	high fat diet (HFD) feed	upregulated in liver	29290651
1526	Rat	rno-miR-192-5p	miRNA	liraglutide	nonalcoholic fatty liver disease (NAFLD)	HDF rats liver	injection of liraglutide	downregulated in liver	29290651
1527	Rat	rno-miR-192-5p	miRNA	6-hydroxydopamine (6-OHDA)	parkinson's disease (PD)	rat pheochromocytoma PC12 cells	6-hydroxydopamine (6-OHDA) treatment	upregulated	30552896
1528	Rat	rno-miR-192-5p	miRNA	baicalin (BAI)	parkinson's disease (PD)	6-hydroxydopamine (6-OHDA)-treated rat pheochromocytoma PC12 cells	baicalin (BAI) treatment	downregulated	30552896
1529	Rat	rno-miR-192-5p	miRNA	baicalin (BAI)	parkinson's disease (PD)	PC-12 cells	baicalin (BAI) treatment	Baicalin alleviates 6-hydroxydopamine-induced neurotoxicity in PC12 cells by downregulated of microRNA-192-5p.	30552896
1530	Rat	rno-miR-193	miRNA	acetaminophen (APAP)	drug-induced liver injury (DILI)	serum	acetaminophen (APAP) treatment	dysregulated	22624025
1531	Rat	rno-miR-193	miRNA	dioscorea bulbifera (DB)	drug-induced liver injury (DILI)	serum	dioscorea bulbifera (DB) treatment	upregulated	22624025
1532	Rat	rno-miR-193	miRNA	pilocarpine	epilepsy	adult male rats brain tissue and heart tissue	50 days of pilocarpine treatment	downregulated in the brain tissue	24530830
1533	Rat	rno-miR-193	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
1534	Rat	rno-miR-193	miRNA	cisplatin (DDP)	kidney damage	male Wistar rats	cisplatin treatment	upregulated	24880025
1535	Rat	rno-miR-193	miRNA	cadmium (Cd)	ovary structure and function	Wistar rats	cadmium (Cd) treatment	upregulated	24462979
1536	Rat	rno-miR-193	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	lung tissues	monocrotaline treatment	downregulated	28000863
1537	Rat	rno-miR-193-3p	miRNA	high fat diet (HFD)	aging-related non-alcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	downregulated	31899128
1538	Rat	rno-miR-193-3p	miRNA	apolipoprotein A-I mimetic peptide 4F	pulmonary arterial hypertension (PAH)	monocrotaline rat lung tissue and serum	apolipoprotein A-I mimetic peptide 4F treatment	miR193 downregulated	24963038
1539	Rat	rno-miR-193a	miRNA	fish oil and pectin	colorectal cancer (CRC)	colon tissue of rats	corn oil ¡À fish oil with pectin ¡À cellulose	upregulated	21406606
1540	Rat	rno-miR-193a	miRNA	fructose	renal dysfunction	rat glomeruli and cultured differentiated podocytes	fructose treatment	upregulated	31085161
1541	Rat	rno-miR-193a	miRNA	Magnesium isoglycyrrhizinate (MgIG)	renal dysfunction	fructose-treated rat glomeruli and cultured differentiated podocytes	Magnesium isoglycyrrhizinate (MgIG) treatment	downregulated	31085161
1542	Rat	rno-miR-193a-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues; NR8383 cells	lipopolysaccharide (LPS) treatment	rats in LPS group also resulted in a decrease in ZFAS1 expression and increase in miR-193a-3p expression in lung tissues	33848686
1543	Rat	rno-miR-193a-3p	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	PC12 cells	amyloid-¦Â (A¦Â) 25-35 treatment	downregulated	31857133
1544	Rat	rno-miR-193a-3p	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	PC-12 cells	amyloid-¦Â (A¦Â) 25-35 treatment	miR-193a-3p was significantly downregulated in PC-12 cells.	31857133
1545	Rat	rno-miR-193a-3p	miRNA	¦Ä-opioid receptor (DOR)	hypoxic/ischemic injury	hearts	¦Ä-opioid receptor (DOR) activation treatment	upregulated	27576463
1546	Rat	rno-miR-193a-3p	miRNA	FK506	osteogenesis	rat bone marrow stromal cells (BMSCs)	FK506 treatment	upregulated	28560399
1547	Rat	rno-miR-193a-5p	miRNA	caerulein (Cae)	acute pancreatitis (AP)	AR42J cells	caerulein treatment	"circHIPK3 promotes pyroptosis in acinar cells through regulation of the miR-193a-5p/GSDMD axis, which eventually aggravates AP disease."	32318575
1548	Rat	rno-miR-193b-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	PC12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	MiR-193b-3p has a potentially neuroprotective effect on focal cerebral I/R-induced injury by inhibiting 5-LOX expression	32032565
1549	Rat	rno-miR-19-3p	miRNA	sevoflurane (SEV)	neuron proliferation	primary cultured neonatal rats neurons	?sevoflurane (SEVO) treatment	upregulated	30540563
1550	Rat	rno-miR-194	miRNA	caerulein (Cae)	acute pancreatitis (AP)	"AR42J, a rat pancreatic acinar cell line"	caerulein (Cae) treatment	downregulated	31518341
1551	Rat	rno-miR-194	miRNA	burn injury	burn-induced hyperglycemia	rats	serum from burn rats treatment	miR-194 expression was significantly elevated	25186839
1552	Rat	rno-miR-194	miRNA	serum	burn-induced hyperglycemia	Rat myoblast L6 cells	serum from burn rats treatment	miR-194 expression was significantly elevated	25186839
1553	Rat	rno-miR-194	miRNA	citrulline	gastrointestinal toxicity	rats	citrulline treatment	"Fecal miR-194 levels upregulated,"	27189632
1554	Rat	rno-miR-194	miRNA	palmitate and palmitate plus oleate.	insulin resistance (IR)	mouse myoblasts	palmitate and palmitate plus oleate treatment	upregulated	21183973
1555	Rat	rno-miR-194	miRNA	lipopolysaccharide (LPS)	intervertebral disc degeneration (IDD)	NP cells	lipopolysaccharide (LPS) treatment	MiR-194 expression was reduced in LPS-induced NP cells.	29745371
1556	Rat	rno-miR-194	miRNA	silymarin (Sm)	liver damage	thioacetamide (TAA) treated rat Blood and liver tissues	silymarin (Sm) treatment	upregulated	31811641
1557	Rat	rno-miR-194	miRNA	thioacetamide (TAA)	liver damage	blood and liver tissues	thioacetamide (TAA) treatment	downregulated	31811641
1558	Rat	rno-miR-194	miRNA	radiation	breast cancer	rat mammary cancer tissues	radiation treatment	upregulated	23273170
1559	Rat	rno-miR-194	miRNA	lipopolysaccharide (LPS)	myocardial injury	H9c2 cells	lipopolysaccharide (LPS) treatment	The expression level of microRNA-194 was increased in LPS-induced H9c2 cardiomyocytes injury model in a time-dependent manner.	29687865
1560	Rat	rno-miR-194	miRNA	lycium barbarum polysaccharide (LBP)	spinal cord injury (SCI)	PC-12 cells	Lycium barbarum polysaccharides (LBPs) treatment	downregulated	30308510
1561	Rat	rno-miR-194-1	miRNA	hypoxia	stroke	middle cerebral artery occlusion (MCAO) Sprague-Dawley rat	middle cerebral artery occlusion (MCAO) treatment	downregulated	29113076
1562	Rat	rno-miR-194-3p	miRNA	propofol (PPF)	neurotoxicity	primary cultured neural stem cells (NSCs)	propofol treatment	upregulated	29679758
1563	Rat	rno-miR-194-5p	miRNA	methamphetamine (METH)	addiction	nucleus accumbens tissues	Methamphetamine treatment	dysregulated	28681200
1564	Rat	rno-miR-194-5p	miRNA	hypothermia oxygen glucose deprivation	stroke	primary neuron tisssues	hypothermia oxygen glucose deprivation treatment	miR-194-5p expression was significantly downregulated in hypothermia oxygen glucose deprivation-treated neurons in vitro.	30232383
1565	Rat	rno-miR-195	miRNA	hypoxia/reoxygenation (H/R)	cardiomyocyte apoptosis	H9c2 cells	hypoxia/reoxygenation (H/R) injury treatment	upregulated	27608900
1566	Rat	rno-miR-195	miRNA	isoprenaline	cardiac hypertrophy	neonatal rat ventricular myocytes	isoprenaline treatment	upregulated	25100012
1567	Rat	rno-miR-195	miRNA	thyroglobulin (Tg)	cell proliferation	rat FRTL-5 thyroid cells	Tg treatment	upregulated	24479877
1568	Rat	rno-miR-195	miRNA	hypoxia	cerebral ischemia injury (CII)	brain tissues	middle cerebral artery occlusion (MCAO) treatment	downregulated in rat brain samples	28849133
1569	Rat	rno-miR-195	miRNA	chronic brain hypoperfusion (CBH)	dementia	neurons? cells	chronic brain hypoperfusion (CBH) treatment	downregulated	23447608
1570	Rat	rno-miR-195	miRNA	high-fat high-fructose diet (HFHFD)	diabetic cardiomyopathy (DCM)	heart tissues	high-fat high-fructose diet (HFHFD) feed	upregulated	30320520
1571	Rat	rno-miR-195	miRNA	high-intensity interval training (HIIT)	diabetic cardiomyopathy (DCM)	diabetic rats heart tissues	high-intensity interval training (HIIT) treatment	downregulated	30320520
1572	Rat	rno-miR-195	miRNA	high-intensity interval training (HIIT)	diabetic cardiomyopathy (DCM)	heart sissues	high-intensity interval training (HIIT)	HIIT effectively decreases the expression of miR-195 and increases the expression of Sirt1 and BCL-2 in diabetic rats compared with continuous endurance training (CET).	30320520
1573	Rat	rno-miR-195	miRNA	astragalus polysaccharide (APS)	diabetic retinopathy (DR)	high glucose (HG)-treated rat primary retinal pigment epithelium (RPE) cells	astragalus polysaccharide (APS) treatment	downregulated	31117931
1574	Rat	rno-miR-195	miRNA	high glucose (HG)	diabetic retinopathy (DR)	rat primary retinal pigment epithelium (RPE) cells	high glucose (HG) treatment	upregulated	31117931
1575	Rat	rno-miR-195	miRNA	L5 spinal nerve ligation (SNL)	duchenne muscular dystrophy (DMD)	spinal nerve ligation and spinal microglia	L5 spinal nerve ligation (SNL) treatment	that miR-195 levels were markedly increased in rats subjected to L5 spinal nerve ligation (SNL);Upregulated miR-195 was also found in spinal microglia of rats with SNL	23361941
1576	Rat	rno-miR-195	miRNA	hypoxia	glycolysis	cardiomyocytes	hypoxia treatment	"Meanwhile, miR-27 and miR-195 were also upregulated in hypoxia-induced cardiomyocytes."	33819184
1577	Rat	rno-miR-195	miRNA	oxymatrine	hepatic stellate cell (HSC) activation	TGF-¦Â1-treated HSC-T6 cells	Oxymatrine (OM) treatment	downregulated	31221141
1578	Rat	rno-miR-195	miRNA	TGF-¦Â1	hepatic stellate cell (HSC) activation	HSC-T6 cells	TGF-¦Â1 treatment	upregulated	31221141
1579	Rat	rno-miR-195	miRNA	diethylnitrosamine (DEN)	liver fibrosis	rats	diethyl nitrosamine (DEN) treatment	upregulated	28929107
1580	Rat	rno-miR-195	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
1581	Rat	rno-miR-195-5p	miRNA	hypoxia	acute kidney injury (AKI)	NRK-52E cells	hypoxia treatment	miR-195-5p was found to be markedly reduced under hypoxic conditions.	32492657
1582	Rat	rno-miR-195-5p	miRNA	particulate matter (PM2.5)	allergic rhinitis (AR)	nasal mucosa	particulate matter 2.5 (PM2.5) treatment	upregulated	32192351
1583	Rat	rno-miR-195-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cardiomyocytes	angiotensin II (Ang II) treatment	upregulated	31341888
1584	Rat	rno-miR-195-5p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	rat cardiomyocytes	high glucose (HG) treatment	upregulated	31729781
1585	Rat	rno-miR-195-5p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	Neonatal rat ventricular myocyte	high glucose treatment	upregulated	31729781
1586	Rat	rno-miR-195-5p	miRNA	lipopolysaccharide (LPS)	lung injury	lung tissues	Lipopolysaccharide (LPS) treatment	CASC9 was markedly downregulated while miR-195-5p was significantly upregulated in HSAECs treated by LPS and lung tissues of rats with sepsis.	32221619
1587	Rat	rno-miR-195-5p	miRNA	hypoxia	cell proliferation and migration	apoptosis-resistant pulmonary microvascular endothelial cells (PVECs/AR)	hypoxia treatment	upregulated	28862358
1588	Rat	rno-miR-195-5p	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	rats pulmonary microvascular endothelial cells (PVECs/AR)	exposure to hypoxia for 12 or 24 h	upregulated	28862358
1589	Rat	rno-miR-1956-5p	miRNA	iohexol	contrast-induced acute kidney injury (CIAKI)	Renal tissue	"Animals were dehydrated for 48 h and then underwent furosemide (10 mL/kg; Harvest Pharmaceutical, Shanghai, China) injection 30 min before administration of iohexol (15 mL/kg, group CI-AKI; iodine, 350 mg/mL; GE Healthcare, Shanghai, China) or 0.9% normal saline (15 mL/kg, control group)."	miR-1956-5p was significantly upregulated in Contrast-induced acute kidney injury (CI-AKI).	31234008
1590	Rat	rno-miR-196-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1591	Rat	rno-miR-196a	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	hippocampus tissues	amyloid-¦Â (A¦Â) 25-35 treatment	downregulated	31119777
1592	Rat	rno-miR-196a	miRNA	"3,5-diiodo-L-thyronine (T2)"	browning of white adipocytes	subcutaneous white adipose tissue (sWAT)	receiving a high fat diet for 10 weeks and being subsequently treated for four weeks with an HFD together with the administration of T?	upregulated	30889829
1593	Rat	rno-miR-196a	miRNA	high fat diet (HFD)	browning of white adipocytes	subcutaneous white adipose tissue (sWAT)	high fat diet (HFD) feed	downregulated	30889829
1594	Rat	rno-miR-196a	miRNA	¦Ä-opioid receptor (DOR)	hypoxic/ischemic injury	hearts	¦Ä-opioid receptor (DOR) activation treatment	upregulated	27576463
1595	Rat	rno-miR-196a	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	cultured neonatal rat cortical neurons	oxygen-glucose deprivation (OGD) induce treatment	upregulated	30720182
1596	Rat	rno-miR-196a-5p	miRNA	chronic constriction injury (CCI)	neuropathic pain (NP)	Schwann cells	chronic constriction injury (CCI) induce	Silencing H19 inhibited NP by suppressing CDK5/p35 and p-CREB phosphorylation via the miR-196a-5p/CDK5 axis.	32903807
1597	Rat	rno-miR-196a-5p	miRNA	steroids	osteonecrosis	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	26459755
1598	Rat	rno-miR-196b	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
1599	Rat	rno-miR-196b-5p	miRNA	pilocarpine	mesial temporal lobe epilepsy (MTLE)	hippocampi	pilocarpine treatment	upregulated	27695061
1600	Rat	rno-miR-196b-5p	miRNA	hypoxia	stroke	middle cerebral artery occlusion (MCAO) Sprague-Dawley rat	middle cerebral artery occlusion (MCAO) treatment	upregulated	29113076
1601	Rat	rno-miR-199a	miRNA	1-methyl-4-phenylpyridinium (MPP+)	autophagy	PC-12 cells	1-methyl-4-phenylpyridinium (MPP+) treatment	MPP+ decreased miR-199a expression in PC12 cells in a concentration-dependent manner.	32151238
1602	Rat	rno-miR-199a	miRNA	isoproterenol	cardiac fibrosis	cardiac fibroblasts (CFs)	isoproterenol (ISO) treatment	upregulated	31115026
1603	Rat	rno-miR-199a	miRNA	estradiol-17¦Â (E2)	embryo implantation	rat uterine horns	estradiol-17¦Â (E2) treatment	downregulated	24149516
1604	Rat	rno-miR-199a	miRNA	Safflor yellow B (SYB)	hypoxia-induced injury	rats RAECs	SYB (0.8 mM) treatment	upregulated	29212172
1605	Rat	rno-miR-199a	miRNA	hypoxia	hypoxia-induced injury	H9c2 cells	hypoxia induce	upregulated	31307244
1606	Rat	rno-miR-199a	miRNA	quercetin	hypoxia-induced injury	hypoxia-induced H9c2 cells	Quercetin treatment	downregulated	31307244
1607	Rat	rno-miR-199a	miRNA	3-nitropropionic acid	liver cirrhosis	brain tissue of rats	3-nitropropionic acid treatment	downregulated	22079324
1608	Rat	rno-miR-199a	miRNA	nicotine	nicotine intake	female rats prefrontal cortex (PFC) tissues	nicotine exposure	upregulated	30504847
1609	Rat	rno-miR-199a	miRNA	dexamethasone (DEX)	osteogenesis	bone marrow mesenchymal stem cells (BMSCs)	dexamethasone (DEX) treatment	"miR-199a was upregulated during OD of BMSCs, while DEX treatment caused a significant reduction in miR-199a."	32869899
1610	Rat	rno-miR-199a	miRNA	dexamethasone (DEX)	oxidative stress	PC-12 cells	dexamethasone (DEX) treatment	Dex attenuated H 2O2-induced oxidative damage in PC12 cells by down-regulating miR-199a expression.	32024386
1611	Rat	rno-miR-199a	miRNA	estradiol-17¦Â (E2)	pseudopregnant	rat uterine horns	estradiol-17¦Â (E2) treatment	Treatmentwith17b-estradiol or both 17b-estradiol and progesterone significantly diminished miR199a levels	24149516
1612	Rat	rno-miR-199a	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
1613	Rat	rno-miR-199a	miRNA	isoproterenol	¦Â-adrenoceptor intervention	rat heart tissues	isoproterenol (ISO)  treatment	upregulated	22847192
1614	Rat	rno-miR-199a-3p	miRNA	particulate matter (PM2.5)	allergic rhinitis (AR)	nasal mucosa	particulate matter 2.5 (PM2.5) treatment	upregulated	32192351
1615	Rat	rno-miR-199a-3p	miRNA	palmitate	diabetes mellitus (DM)	INS-1 cells	palmitate (Pal) treatment	upregulated	30131392
1616	Rat	rno-miR-199a-3p	miRNA	hepatitis B virus (HBV) and TGF-¦Â1	hepatic progenitor cells (HPCs) transformation	Hepatic stem-like epithelial cells (LE/6)	HBx and TGF-¦Â1 exposure	upregulated	31740785
1617	Rat	rno-miR-199a-3p	miRNA	hypoxia	neuronal cell injury	C6 glioma cells	hypoxia treatment	upregulated	33110474
1618	Rat	rno-miR-199a-3p	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC-12 cells	1-methyl-4-phenylpyridinium (MPP+) treatment	downregulated	33494069
1619	Rat	rno-miR-199a-3p	miRNA	mono-n-butyl phthalate (MBP)	precocious puberty and testicular tumors	testicular Sertoli cells (SCs)	mono-n-butyl phthalate (MBP) treatment	upregulated	29162477
1620	Rat	rno-miR-199a-3p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	downregulated	26997989
1621	Rat	rno-miR-199a-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	downregulated	22156553
1622	Rat	rno-miR-199a-5p	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	upregulated	27535721
1623	Rat	rno-miR-199a-5p	miRNA	high glucose (HG)	apoptosis	INS-1 rat pancreatic ¦Â-cells	high glucose (HG) treatment	upregulated	28338182
1624	Rat	rno-miR-199a-5p	miRNA	lithium chloride and pilocarpine	epilepsy	Hippocampal	lithium-pilocarpine treatment	upregulated	26945677
1625	Rat	rno-miR-199a-5p	miRNA	angiotensin II (Ang II)	heart failure (HF)	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	29703907
1626	Rat	rno-miR-199a-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	31059047
1627	Rat	rno-miR-199a-5p	miRNA	lidocaine	neurotoxicity	spinal cord of rats	Lidocaine treatment	Increased expression of miR-199a-5p in the spinal cord of rats treated with 10 % lidocaine was assessed by qRT-PCR.	33166664
1628	Rat	rno-miR-199a-5p	miRNA	activated protein C(APC)	sepsis	rats blood and liver tissue	activated protein C treatment	aPC treatment coordinates beneficial cytoprotective effects during sepsis by modulating miRNA expression	22940033
1629	Rat	rno-miR-199a-5p	miRNA	lidocaine	spinal cord neurotoxicity	spinal cord white matter	lidocaine treatment	upregulated	33166664
1630	Rat	rno-miR-199b-5p	miRNA	lipopolysaccharide (LPS)	rejection after lung transplantation	allograft tissues	lipopolysaccharide (LPS) treatment	downregulated	29779167
1631	Rat	rno-miR-19a	miRNA	hypoxia/reoxygenation (H/R)	hypoxia/reoxygenation (H/R) injury	H9C2 cells	hypoxia-reoxygeneration (H/R) treatment	downregulated	29054970
1632	Rat	rno-miR-19a	miRNA	ethanol (EtOH)	acute gastric mucosal injury	gastric tissues?of rat	oral administration of ethanol	downregulated	23830200
1633	Rat	rno-miR-19a	miRNA	hypoxia	acute myocardial infarction (AMI)	heart tissues and primary cardiomyocytes in vitro	hypoxia induce	downregulated	31633225
1634	Rat	rno-miR-19a	miRNA	propofol (PPF)	cerebral injury	PC12 cells	Propofol treatment	"propofol relieved Glu-triggered apoptosis and autophagy of PC12, and activated AMPK and mTOR pathways by suppressing miR-19a expression"	31913544
1635	Rat	rno-miR-19a	miRNA	hypoxia	coronary microvascular obstruction injury	cardiac myocytes	hypoxia treatment	miR-19a was gradually reduced as time increased in primary cardiomyocytes after hypoxia stimulation.	31633225
1636	Rat	rno-miR-19a	miRNA	dexamethasone (DEX)	hormonal regulation	adrenals?tissues	dexamethasone (DEX) treatment	downregulated	24205079
1637	Rat	rno-miR-19a	miRNA	hypoxia	hypoxia-induced injury	primary cardiomyocytes	hypoxia treatment	miR-19a was gradually reduced as time increased in primary cardiomyocytes after hypoxia stimulation.	31633225
1638	Rat	rno-miR-19a	miRNA	hypoxia	ischemic stroke (IS)	rat brain tissues	middle cerebral artery occlusion/reperfusion (MCAO/R) injury	downregulated	31170091
1639	Rat	rno-miR-19a	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	rat neuronal cells	oxygen glucose deprivation (OGD) treatment	downregulated	31170091
1640	Rat	rno-miR-19a	miRNA	hypoxia	microvascular obstruction (MO)	cardiomyocytes	hypoxia treatment	downregulated	27220268
1641	Rat	rno-miR-19a-3p	miRNA	phenylephrine (PE)	cardiac hypertrophy	primary cardiomyocytes; myocardium	phenylephrine (PE) treatment	downregulated	32096186
1642	Rat	rno-miR-19a-3p	miRNA	isoproterenol	drug-induced cardiac injury (DICI)	heart tissues	isoproterenol treatment	upregulated	29355689
1643	Rat	rno-miR-19a-3p	miRNA	Shenfu Injection (SFI)	cardiac hypertrophy	abdominal aortic constriction-induced myocardial hypertrophic rats cardiomyocytes	Shenfu Injection (SFI) treatment	upregulated	29549288
1644	Rat	rno-miR-19a-3p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	Primary neurons	oxygen-glucose deprivation (OGD) treatment	upregulated	31168302
1645	Rat	rno-miR-19b	miRNA	glucagon-like peptide-1 (GLP-1)	cholesterol-induced lipotoxicity	liver tissues	Glucagon-like peptide-1 (GLP-1) treatment	downregulated	30308521
1646	Rat	rno-miR-19b	miRNA	TGF-¦Â1	liver fibrosis	Primary hepatocytes and hepatic stellate cells (HSCs)	transforming growth factor beta 1 (TGF-¦Â1) treatment	downregulated	29281894
1647	Rat	rno-miR-19b	miRNA	hypoxia	hypoxia-induced injury	PC12 cells	hypoxia induce	downregulated	30767206
1648	Rat	rno-miR-19b	miRNA	alcohol	liver damage	hepatic stellate cell (HSC)	alcohol exposure	downregulated	27291156
1649	Rat	rno-miR-19b	miRNA	H2O2	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	H2O2 treatment	downregulated	26918829
1650	Rat	rno-miR-19b	miRNA	irisin	"myocardial remodeling,apoptosis"	embryonic rat cardiac myoblast H9c2 cell line	irisin treatment	upregulated	31966617
1651	Rat	rno-miR-19b	miRNA	angiotensin II (Ang II)	expression regulation	Cardiomyocytes isolated from 1- to 3-day-old neonatal rats	angiotensin II (Ang II) treatment	downregulated	24296617
1652	Rat	rno-miR-19b	miRNA	angiotensin II (Ang II)	expression regulation	Cardiomyocytes from neonatal rats	angiotensin II (Ang II) treatment	downregulated	23951138
1653	Rat	rno-miR-19b	miRNA	perfluorooctane sulfonic acid (PFOS)	perfluorooctane sulfonate (PFOS)-induced toxic action	rat liver tissue	dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 15) treatment	different expression	24420840
1654	Rat	rno-miR-19b	miRNA	perfluorooctane sulfonic acid (PFOS)	perfluorooctane sulfonate (PFOS)-induced toxic action	rat liver tissue	dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 7) treatment	different expression	24420840
1655	Rat	rno-miR-19b-1	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
1656	Rat	rno-miR-19b-3p	miRNA	cyclic mechanical stretch (CMS)	hypertension-induced vascular remodeling	vascular smooth muscle cells (VSMCs) were harvested from rat thoracic aorta	15% cyclic stretch induce	downregulated	30690026
1657	Rat	rno-miR-19b-3p	miRNA	rosmarinic acid (RA)	irradiation-induced pulmonary fibrosis	lung regions	rosmarinic acid (RA) treatment	"RA attenuated RhoA/Rock signaling through upregulating miR-19b-3p, leading to the inhibition of fibrosis."	33149731
1658	Rat	rno-miR-1a	miRNA	quinone compounds P3H4	renal cell carcinoma (RCC)	renal cancer tissue	P3H4 treatment	miR-1a was significantly upregulated in rat renal cancer tissue after the treatment of P3H4	30178839
1659	Rat	rno-miR-1a-3p	miRNA	H2O2	ischemia/reperfusion (I/R) injury	neonatal rat ventricular cells (NRVCs)	H2O2 treatment	upregulated	30292140
1660	Rat	rno-miR-1a-3p	miRNA	metformin (Met)	ischemia/reperfusion (I/R) injury	H2O2-treated neonatal rat ventricular cells (NRVCs)	Metformin treatment	downregulated	30292140
1661	Rat	rno-miR-1b	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	downregulated	32893733
1662	Rat	rno-miR-1b-5p	miRNA	anisakis complete extract (CE)	anisakiasis	sera	anisakis complete extract (CE) treatment	"mmu-miR-1b-5p and mmu-miR-10b-5p (a cancer-related miRNA) were significantly decreased (P?<?.05) in sera from the rats inoculated with Anisakis CE, compared with control rats inoculated with saline."	30006808
1663	Rat	rno-miR-20	miRNA	perillyle alcohol (PA)	pulmonary arterial hypertension (PAH)	lung tissues	Perillyle alcohol (PA) treatment	upregulated	32660602
1664	Rat	rno-miR-20	miRNA	quercetin	pulmonary arterial hypertension (PAH)	lung tissues	Quercetin (QS) treatment	upregulated	32660602
1665	Rat	rno-miR-200	miRNA	TGF-¦Â1	epithelial-mesenchymal transition (EMT)	Kidneys tissue	TGF-¦Â1 treatment	downregulated	22012804
1666	Rat	rno-miR-200	miRNA	mitomycin C-polylactic acid ( MMC-PLA) film	epidural scar hyperplasia and adhesion	post-laminectomy rat scar tissues	25 mg of PLA film containing 0.01% MMC was implanted on the laminectomy area	upregulated	28617531
1667	Rat	rno-miR-200	miRNA	perfluorooctane sulfonic acid (PFOS)	hepatotoxicity	liver tissues	Perfluorooctanesulfonate (PFOS) treatment	upregulated	26724606
1668	Rat	rno-miR-200	miRNA	perfluorooctane sulfonic acid (PFOS)	liver damage	liver tissues	Perfluorooctanesulfonate (PFOS) treatment	upregulated	26724606
1669	Rat	rno-miR-200	miRNA	ferulic acid (FA)	liver fibrosis	liver tissues	ferulic acid treatment	upregulated	32278740
1670	Rat	rno-miR-200	miRNA	gallic acid (GA)	liver fibrosis	liver tissues	gallic acid treatment	upregulated	32278740
1671	Rat	rno-miR-200a	miRNA	IL-22	liver fibrosis	rat liver tissues	IL-22 treatment	upregulated	27819314
1672	Rat	rno-miR-200a	miRNA	doxorubicin (DOX)	cardiotoxicity	H9c2 cells	Doxorubicin (DOX) treatment	downregulated	31781322
1673	Rat	rno-miR-200a	miRNA	TGF-¦Â1	cerebral vascular endothelial injury	proximal-tubular epithelial cells (NRK52E)	TGF-¦Â1 treatment	downregulated	20952520
1674	Rat	rno-miR-200a	miRNA	TGF-¦Â2	cerebral vascular endothelial injury	proximal-tubular epithelial cells (NRK52E)	TGF-¦Â2 treatment	downregulated	20952520
1675	Rat	rno-miR-200a	miRNA	antibiotics	dysbacteria	Sprague Dawley (SD) rats faeces	treat with a combination of antibiotics for 8 week	downregulated	29264965
1676	Rat	rno-miR-200a	miRNA	TGF-¦Â1	epithelial-mesenchymal transition (EMT)	rats pancreatic stellate cells	TGF-¦Â1 at a concentration of 10 ng/ml treatment	downregulated	28281184
1677	Rat	rno-miR-200a	miRNA	allopurinol	fructose-induced hepatic inflammation	fructose-induced rats liver tissues and Buffalo rat liver cell line (BRL-3?A)	allopurinol treatemnt	upregulated	30248460
1678	Rat	rno-miR-200a	miRNA	curcumin (Cur)	fructose-induced hepatic inflammation	fructose-induced rats liver tissues and Buffalo rat liver cell line (BRL-3?A)	curcumin treatment	upregulated	30248460
1679	Rat	rno-miR-200a	miRNA	fructose	fructose-induced hepatic inflammation	liver tissues and Buffalo rat liver cell line (BRL-3?A)	fructose treatment	downregulated	30248460
1680	Rat	rno-miR-200a	miRNA	TGF-¦Â1	liver fibrosis	HSC-T6 cells	TGF-¦Â1 treatment	downregulated	24242045
1681	Rat	rno-miR-200a	miRNA	furan	hepatotoxicity	liver	Furan treatment	upregulated	27371368
1682	Rat	rno-miR-200a	miRNA	diethylnitrosamine (DEN)	hepatocellular carcinoma (HCC)	F344 rat	diethylnitrosamine abdominal injection treatment	downregulated	25203708
1683	Rat	rno-miR-200a	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	serum	CCl4 treatment	downregulated	30254303
1684	Rat	rno-miR-200a	miRNA	carvedilol	liver fibrosis	CCl4-induced liver fibrosis rats serum	carvedilol treatment	upregulated	30254303
1685	Rat	rno-miR-200a	miRNA	phenobarbital (PB)	liver homeostasis	liver tissues	phenobarbital (PB) treatment	upregulated	24157574
1686	Rat	rno-miR-200a	miRNA	thymosin ¦Â4 (T¦Â4)	cell differentiation	brain progenitor cells	Thymosin beta 4 (T¦Â4) treatment	upregulated	26466330
1687	Rat	rno-miR-200a	miRNA	thymosin ¦Â4 (T¦Â4)	neurological injury	brain progenitor cells	Thymosin beta 4 (T¦Â4) treatment	upregulated	26466330
1688	Rat	rno-miR-200a	miRNA	CoCl2	neuron apoptosis	PC12 cells	cobalt chloride (CoCl2) treatment	downregulated	32004541
1689	Rat	rno-miR-200a	miRNA	high fructose	nonalcoholic fatty liver disease (NAFLD)	liver tissues and BRL-3A cells	high fructose treatment	downregulated	30014902
1690	Rat	rno-miR-200a	miRNA	polydatin (PD)	nonalcoholic fatty liver disease (NAFLD)	high fructose-induced rats liver tissues and BRL-3A cells	"Polydatin (3,4',5-trihydroxy-stilbene-3-¦Â-D-glucoside) treatment"	upregulated	30014902
1691	Rat	rno-miR-200a	miRNA	high fat diet (HFD)	obesity	rats	high fat diet (HFD) feed	dysregulated	24517225
1692	Rat	rno-miR-200a	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC12 cells	N-methyl-4-phenylpyridinium (MPP +) treatment	upregulated	30712312
1693	Rat	rno-miR-200a	miRNA	TGF-¦Â1	peritoneal fibrosis	peritoneal mesothelial cells	?transforming growth factor beta 1 (TGF-¦Â1) treatment	downregulated	30888602
1694	Rat	rno-miR-200a	miRNA	pegylated rat leptin antagonist (pRLA)	type 2 diabetes mellitus (T2DM)	rat muscle and liver	pegylated rat leptin antagonist (pRLA) treatment	"upregulation of rno-miR-10a at d28 and rno-miR-200a, rno-miR-409-5p, and rno-miR-125a-3p following HFD challenge"	23576026
1695	Rat	rno-miR-200a-3p	miRNA	particulate matter (PM2.5)	allergic rhinitis (AR)	nasal mucosa	particulate matter 2.5 (PM2.5) treatment	downregulated	32192351
1696	Rat	rno-miR-200a-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	31651553
1697	Rat	rno-miR-200a-3p	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	rat renal artery endothelial cells (RRAECs)	angiotensin II (Ang II) treatment	upregulated	32346437
1698	Rat	rno-miR-200a-3p	miRNA	enterococcus faecalis supernatants	migration of bone marrow mesenchymal stem cells (BMSCs)	bone marrow mesenchymal stem cells (BMSCs)	Enterococcus faecalis supernatants treatment	upregulated	32711573
1699	Rat	rno-miR-200a-3p	miRNA	H2O2	myocardial infarction (MI)	H9C2 cells	H2O2 treatment	downregulated	30841417
1700	Rat	rno-miR-200a-3p	miRNA	letrozole	polycystic ovarian syndrome (PCOS)	Ovary?tissues	letrozole treatment	dysregulated	26745201
1701	Rat	rno-miR-200a-3P	miRNA	X-rays	radiation-induced myocardial fibrosis (RIMF)	primary rat cardiac fibroblasts	X-ray irradiation treatment	downregulated	32382291
1702	Rat	rno-miR-200a-3p	miRNA	thymosin ¦Â4 (T¦Â4)	traumatic brain injury (TBI)	plasma	thymosin beta 4 (T¦Â4) treatment	T¦Â4 treatment significantly increased plasma levels of miR-200a-3p and miR-200b-3p	29873258
1703	Rat	rno-miR-200a-3p	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
1704	Rat	rno-miR-200a-5P	miRNA	X-rays	radiation-induced myocardial fibrosis (RIMF)	primary rat cardiac fibroblasts	X-ray irradiation treatment	downregulated	32382291
1705	Rat	rno-miR-200a-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1706	Rat	rno-miR-200b	miRNA	high glucose (HG)	blood-brain barrier (BBB) dysfunction	rat brain microvascular endothelial cells (RBMECs)	rat brain microvascular endothelial cells (RBMECs) treatment	downregulated	27497919
1707	Rat	rno-miR-200b	miRNA	Salvianolic acid B (Sal B)	blood-brain barrier (BBB) dysfunction	high-glucose treated rat brain microvascular endothelial cells (RBMECs)	high-glucose treated rat brain microvascular endothelial cells (RBMECs) treatment	upregulation	27497919
1708	Rat	rno-miR-200b	miRNA	comfrey	tumorigenesis	rat liver	comfrey treatment	upragulated	21370286
1709	Rat	rno-miR-200b	miRNA	hypertonic saline (HS)	cerebral edema	right-sided middle cerebral artery occlusion (MCAO) treated rat brian tissues;hypoxia-induced primary microglial cells	Hypertonic saline (HS) treatment	downregulated	29577903
1710	Rat	rno-miR-200b	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	colitis	male Wistar rats inflamed colon	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	downregulated in inflamed colon	28572713
1711	Rat	rno-miR-200b	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Rat glomerular mesangial cells	high glucose (HG) treatment	upregulated	30827272
1712	Rat	rno-miR-200b	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina	streptozocin (STZ) treatment	downregulated	33324202
1713	Rat	rno-miR-200b	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	Wistar male rats retion	STZ treatment	downregulated	28122882
1714	Rat	rno-miR-200b	miRNA	methyl-deficient diet	hepatocellular carcinoma (HCC)	liver tissues	methyl-deficient diet feed	downregulated	18942116
1715	Rat	rno-miR-200b	miRNA	furan	hepatotoxicity	liver	Furan treatment	upregulated	27371368
1716	Rat	rno-miR-200b	miRNA	dexamethasone (DEX)	hormonal regulation	adrenals?tissues	dexamethasone (DEX) treatment	downregulated	24205079
1717	Rat	rno-miR-200b	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	downregulated	24205079
1718	Rat	rno-miR-200b	miRNA	cisplatin (DDP)	kidney damage	male Wistar rats	cisplatin treatment	upregulated	24880025
1719	Rat	rno-miR-200b	miRNA	phenobarbital (PB)	liver homeostasis	liver tissues	phenobarbital (PB) treatment	upregulated	24157574
1720	Rat	rno-miR-200b	miRNA	CoCl2	neuron apoptosis	PC12 cells	cobalt chloride (CoCl2) treatment	downregulated	32004541
1721	Rat	rno-miR-200b	miRNA	nitrofen	pulmonary hypoplasia	lung tissues	nitrofen treatment	upregulated	29135495
1722	Rat	rno-miR-200b-3p	miRNA	methamphetamine (METH)	addiction	nucleus accumbens tissues	Methamphetamine treatment	dysregulated	28681200
1723	Rat	rno-miR-200b-3p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	H9c2 cell line	high glucose treatment	downregulated	30506990
1724	Rat	rno-miR-200b-3p	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	heart tissues	streptozotocin (STZ) treatment	downregulated	30506990
1725	Rat	rno-miR-200b-3p	miRNA	aflatoxin B1 (AFB1)	hepatotoxicant and genotoxicant	liver	aflatoxin B1 (AFB1) treatment	upregulated	26385312
1726	Rat	rno-miR-200b-3p	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	rat renal artery endothelial cells (RRAECs)	angiotensin II (Ang II) treatment	upregulated	32346437
1727	Rat	rno-miR-200b-3p	miRNA	hypoxic/ischemic	hypoxic/ischemic brain damage (HIBD)	brain tissues	hypoxia-ischemic treatment	miR-200b-3p was upregulated in rat brains at the early stage following hypoxia-ischemic treatment.	31964527
1728	Rat	rno-miR-200b-3p	miRNA	enterococcus faecalis supernatants	migration of bone marrow mesenchymal stem cells (BMSCs)	bone marrow mesenchymal stem cells (BMSCs)	Enterococcus faecalis supernatants treatment	upregulated	32711573
1729	Rat	rno-miR-200b-3p	miRNA	thymosin ¦Â4 (T¦Â4)	traumatic brain injury (TBI)	plasma	thymosin beta 4 (T¦Â4) treatment	T¦Â4 treatment significantly increased plasma levels of miR-200a-3p and miR-200b-3p	29873258
1730	Rat	rno-miR-200b-3p	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
1731	Rat	rno-miR-200c	miRNA	ethanol (EtOH)	acute gastric mucosal injury	gastric tissues?of rat	oral administration of ethanol	downregulated	23830200
1732	Rat	rno-miR-200c	miRNA	SZ-685C	apoptosis	"A rat prolactinoma cell line, MMQ"	SZ-685C treatment	downregulated	23317100
1733	Rat	rno-miR-200c	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal rat cardiomyocytes (NCMs)	angiotensin II (Ang II) treatment	upregulated	30680929
1734	Rat	rno-miR-200c	miRNA	H2O2	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 rat cardiomyocytes	H2O2 treatment	upregulated	28770953
1735	Rat	rno-miR-200c	miRNA	glucose fluctuations (GF)	cardiovascular complications of diabetes mellitus (DM)	heart	glucose fluctuations (GF) treatment	upregulated	26497329
1736	Rat	rno-miR-200c	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	rat neonatal cardiomyocytes	high-glucose (HG)	upregulated	27696308
1737	Rat	rno-miR-200c	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	high-fat diet cardiomyocytes	streptozotocin high-fat diet treatment	upregulated	27696308
1738	Rat	rno-miR-200c	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Rat glomerular mesangial cells	high glucose (HG) treatment	upregulated	30827272
1739	Rat	rno-miR-200c	miRNA	ethanol (EtOH)	fetal alcohol spectrum disorders (FASD)	Sprague-Dawley rats	were exposed to 5.25 g/kg/day ethanol from postnatal days (PD) 4-9 via intubation	upregulated	28433422
1740	Rat	rno-miR-200c	miRNA	(+)-cholesten-3-one (CN)	osteogenesis	Sprague-Dawley rats mesenchymal stem cells (MSCs)	(+)-cholesten-3-one treatment	upregulated	29218094
1741	Rat	rno-miR-200c	miRNA	artesunate (ART) and bromocriptine (BRC)	pituitary adenoma	rat pituitary adenoma cell lines GH3 and MMQ	artesunate (ART) and bromocriptine (BRC) treatment	downregulated	28501857
1742	Rat	rno-miR-200c	miRNA	perfluorooctane sulfonic acid (PFOS)	perfluorooctane sulfonate (PFOS)-induced toxic action	rat liver tissue	dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 14) treatment	different expression	24420840
1743	Rat	rno-miR-200c-3p	miRNA	lithium chloride and pilocarpine	epilepsy	hippocampus tissues	lithium chloride-pilocarpine treatment	upregulated	31018114
1744	Rat	rno-miR-200c-3p	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	rat renal artery endothelial cells (RRAECs)	angiotensin II (Ang II) treatment	upregulated	32346437
1745	Rat	rno-miR-200c-3p	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	rat renal artery endothelial cells (RRAECs)	angiotensin II (Ang II) treatment	upregulated	31881206
1746	Rat	rno-miR-200c-3p	miRNA	angiotensin II (Ang II)	renal vascular endothelial dysfunction	rat renal artery endothelial cells (RRAECs)	angiotensin II (Ang II) treatment	upregulated	31881206
1747	Rat	rno-miR-201-5p	miRNA	letrozole	polycystic ovarian syndrome (PCOS)	Ovary?tissues	letrozole treatment	dysregulated	26745201
1748	Rat	rno-miR-201-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1749	Rat	rno-miR-202-3p	miRNA	chronic mild unpredictable mild stimulation (CUMS)	depression	hippocampus	chronic mild unpredictable mild stimulation (CUMS) treatment	upregulated	32425535
1750	Rat	rno-miR-202-3p	miRNA	chronic unpredictable mild stress (CUMS)	depression	hippocampus tissues	chronic unpredictable mild stressed (CUMS) treatment	upregulated	28083819
1751	Rat	rno-miR-202-3p	miRNA	hronic unpredictable mild stressed (CUMS)	depression	rats hippocampal tissues	stimulated daily with randomly applied mild stressors from among 14 different mild stressors	upregulated	28083819
1752	Rat	rno-miR-202-3p	miRNA	IL-1¦Â	multiple sclerosis (MS)	oligodendrocyte precursor cells (OPCs)	IL-1¦Â treatment	IL-1¦Â markedly decreased the expression of miR-202-3p.	32582975
1753	Rat	rno-miR-202-5p	miRNA	hypoxia	apoptosis	rat embryonic ventricular cardiomyocyte-derived H9c2 cells	hypoxia induce	upregulated	31966756
1754	Rat	rno-miR-202-5p	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	downregulated	32893733
1755	Rat	rno-miR-202-5p	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	neonatal rats cardiomyocytes	hypoxia/reoxygenation-induce	downregulated	31062423
1756	Rat	rno-miR-203	miRNA	acute stressor modulates	acute stress	male Fisher 344 rats	expose to an acute stressor modulates treatment	downregulated	25259839
1757	Rat	rno-miR-203	miRNA	comfrey	tumorigenesis	rat liver	comfrey treatment	downregulated	21370286
1758	Rat	rno-miR-203	miRNA	streptozocin (STZ)	diabetic foot ulcer (DFU)	?skin tissues	streptozotocin treatment	upregulated	31707396
1759	Rat	rno-miR-203	miRNA	hypoxia	hypoxic pulmonary hypertension (HPH)	pulmonary arterial smooth muscle cells (PASMCs)	hypoxia treatment	miR-203 expression in rat PASMCs was significantly lower than that in normoxia control group at 24 h and 48 h after hypoxic treatment.	29680463
1760	Rat	rno-miR-203	miRNA	lipopolysaccharide (LPS)	myocarditis	Cardiomyocyte H9c2	lipopolysaccharide (LPS) treatment	upregulated	30484891
1761	Rat	rno-miR-203	miRNA	lipopolysaccharide (LPS)	myocarditis	H9c2 cells	lipopolysaccharide (LPS) treatment	upregulated	30484891
1762	Rat	rno-miR-203	miRNA	Riboflavin (RF)	neuroprotective effects	rat model of cerebral ischemia	RF treatment	upregulated	24884571
1763	Rat	rno-miR-203	miRNA	monosodium iodoacetate	postmenopausal osteoarthritis	cartilage tissues	A combined protocol of the bilateral ovariectomy and the intra-articular monosodium iodoacetate injection was applied to establish a postmenopausal OA model in rats.	upregulated	31711313
1764	Rat	rno-miR-203	miRNA	activated protein C(APC)	sepsis	rats blood and liver tissue	activated protein C treatment	aPC treatment coordinates beneficial cytoprotective effects during sepsis by modulating miRNA expression	22940033
1765	Rat	rno-miR-203a	miRNA	respiratory syncytial virus (RSV)	asthma	Sprague-Dawley rat	respiratory syncytial virus (RSV) infection treatment	downregulated	28510638
1766	Rat	rno-miR-203a	miRNA	hypoxia/reoxygenation (H/R)	myocardial infarction (MI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	downregulated	31725080
1767	Rat	rno-miR-203a	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
1768	Rat	rno-miR-203a-3p	miRNA	acidosis	acidosis	Walker-256 mammary carcinoma cells	incubated at pH 6.6	downregulated	28685435
1769	Rat	rno-miR-203a-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	rat retinal	streptozotocin (STZ)-induced diabetic rat treatment	differential expressions	24502381
1770	Rat	rno-miR-203a-3p	miRNA	atorvastatin	endothelial senescence	high-fat diet-induced hyperlipidemic rats plasma	atorvastatin treatment	downregulated	29248491
1771	Rat	rno-miR-203a-3p	miRNA	high fat diet (HFD)	endothelial senescence	plasma	high fat diet (HFD) feed	upregulated	29248491
1772	Rat	rno-miR-203a-3p	miRNA	high fat diet (HFD)	hyperlipidemia	rats plasma	high fat diet (HFD) feed	upregulated	29248491
1773	Rat	rno-miR-203a-3p	miRNA	hypoxia	hypoxic lung injury		hypoxia treatment	downregulated of lung miR-203a-3p expression by high-altitude hypoxia enhances VEGF/Notch signaling	32112644
1774	Rat	rno-miR-203a-3p	miRNA	astragalus polysaccharide (APS)	insulin resistance (IR)	liver tissues	astragalus polysaccharide (APS) treatment	miR-203a-3p was upregulated following APS treatment.	29257218
1775	Rat	rno-miR-203a-3p	miRNA	teriparatide (TP)	postmenopausal osteoporosis (PMOP)	serum and femoral head from ovariectomy rat	teriparatide treatment	upregulated	31683019
1776	Rat	rno-miR-203a-3p	miRNA	zoledronate	postmenopausal osteoporosis (PMOP)	serum and femoral head from ovariectomy rat	zoledronate treatment	upregulated	31683019
1777	Rat	rno-miR-203a-3p	miRNA	oxygen	proliferative diabetic retinopathy (PDR)	retina of oxygen-induced retinopathy rats	"Pups and their mothers were exposed between postnatal day (P) 0 to P11 in 80% O 2 for 21 hours/day and 20% O2 for 3 hours/day. Then, rats were placed in room air from P12 to P18. treatment"	downregulated	31408201
1778	Rat	rno-miR-203a-3p	miRNA	loureirin A	skin wound healing	hair follicle stem cells (HFSCs)	loureirin A treatment	Microarray and quantitative real time polymerase chain reaction analyses demonstrated that miR-203a-3p was upregulated in differentiated HFSCs induced by loureirin A.	32589363
1779	Rat	rno-miR-203a-3p	miRNA	astragalus polysaccharide (APS)	type 2 diabetes mellitus (T2DM)	T2DM Goto Kakizaki (GK) rats liver	astragalus polysaccharide (APS) treatment	upregulated in the liver	29257218
1780	Rat	rno-miR-203a-5p	miRNA	TGF-¦Â1	bone development and bone remodeling	rat osteoblasts	TGF-¦Â1 treatment	downregulated	30951775
1781	Rat	rno-miR-204	miRNA	lipopolysaccharide (LPS)	acute kidney injury (AKI)	rat mesangial cells (RMCs)	lipopolysaccharide (LPS) treatment	downregulated	29669307
1782	Rat	rno-miR-204	miRNA	resveratrol	breast cancer	matched tumor/normal tissues	resveratrol (RS) treatment	upregulated	24447120
1783	Rat	rno-miR-204	miRNA	aldosterone	cardiac hypertrophy	isolated neonatal rat cardiomyocytes	aldosterone treatment	upregulated	30262720
1784	Rat	rno-miR-204	miRNA	nicotine	cognitive impairment	choroid plexus and CSF	nicotine treatment	upregulated	31119189
1785	Rat	rno-miR-204	miRNA	thioredoxin-interacting protein (TXNIP)	diabetes mellitus (DM)	INS-1 beta cells	TXNIP treatment	upregulated	25391656
1786	Rat	rno-miR-204	miRNA	palmitate	diabetes mellitus (DM)	INS-1 cells	palmitate (Pal) treatment	downregulated	30131392
1787	Rat	rno-miR-204	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	upregulated	22156553
1788	Rat	rno-miR-204	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	H9c2 cells	doxorubicin (DOX) treatment	downregulated	33274007
1789	Rat	rno-miR-204	miRNA	hypoxia	hypoxic/ischemic brain damage (HIBD)	10-day-old pup rats brain tissues	hypoxia induce	downregulated	31602202
1790	Rat	rno-miR-204	miRNA	hypoxia/reoxygenation (H/R)	ischemia/reperfusion (I/R) injury	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	miR-204 was significantly downregulated after H/R treatment.	29371766
1791	Rat	rno-miR-204	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	upregulated	27074745
1792	Rat	rno-miR-204	miRNA	lead (Pb)	nervous system diseases	rats hippocampus	chronic lead exposure treatment	upregulated	24960059
1793	Rat	rno-miR-204	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC12 cells	N-methyl-4-phenylpyridinium (MPP +) treatment	upregulated	30712312
1794	Rat	rno-miR-204	miRNA	"1,25-dihydroxyvitamin D 3 (calcitriol)"	pulmonary arterial hypertension (PAH)	rat pulmonary arterial endothelial cells (PAECs)	"1,25-dihydroxyvitamin D 3 (calcitriol) treatment"	upregulated	29196166
1795	Rat	rno-miR-204	miRNA	"1,25-dihydroxyvitamin D 3 (calcitriol)"	pulmonary arterial hypertension (PAH)	rat pulmonary arterial endothelial cells (PAECs)	"1,25-dihydroxyvitamin D 3 (calcitriol) treatment"	upregulated	29196166
1796	Rat	rno-miR-204	miRNA	hypoxia	pulmonary hypertension (PH)	rat pulmonary arterial intima	hypoxia induce	downregulated	31542480
1797	Rat	rno-miR-204	miRNA	aluminum (Al)	spatial learning and memory impairment	offspring rats hippocampus	exposure to aluminium during the embryonic stage	upregulated	30172012
1798	Rat	rno-miR-204	miRNA	fluoride	spatial learning and memory impairment	offspring rats hippocampus	exposure to fluorine during the embryonic stage	upregulated	30172012
1799	Rat	rno-miR-204	miRNA	hypoxia	spinal cord ischemia/reperfusion injury (SCII)	AGE1.HN;PC12 cells	hypoxia	upregulated	28714326
1800	Rat	rno-miR-204	miRNA	magnesium-free extracellular fluid	status epilepticus (SE)	hippocampal neurons	Mg(2+)-free treatment	downregulated	26947618
1801	Rat	rno-miR-204	miRNA	phosphorus (Pi)	vascular calcification (VC)	Primary rat vascular smooth muscle cells (VSMCs)	high Pi exposure treatment	downregulated	30867423
1802	Rat	rno-miR-204	miRNA	triptolide (TPL)	vascular calcification (VC)	aorta	triptolide (TPL) treatment	MiRNA-204 expression was increased in the TP-treated groups compared with VC controls	33597871
1803	Rat	rno-miR-204*	miRNA	angiotensin II (Ang II)	cardiac fibrosis and hypertension	cardiac fibroblasts (CFs) of rats	angiotensin II (Ang II) treatment	downregulated	23007623
1804	Rat	rno-miR-204-3p	miRNA	Smad3 inhibitor (SIS3)	intrauterine adhesion (IUA)	endometrial stromal cells (ESCs)	Smad3 inhibitor (SIS3) treatment	upregulated	32447720
1805	Rat	rno-miR-204-5p	miRNA	cadmium (Cd)	cadmium-induced toxicity	rat ovarian granulosa cells (OGCs)	cadmium (Cd) treatment	MicroRNA-204-5p regulates apoptosis by targeting Bcl2 in rat ovarian granulosa cells exposed to cadmium.	32500147
1806	Rat	rno-miR-204-5p	miRNA	oxygen glucose deprivation (OGD)	cerebral ischemia injury (CII)	primary cultured cerebral microvascular endothelial cell (CMEC)	oxygen glucose deprivation (OGD) treatment	downregulated	31628679
1807	Rat	rno-miR-204-5p	miRNA	oxygen glucose deprivation (OGD)	cerebral microvascular endothelial cell (CMEC) injury	cerebral microvascular endothelial cell (CMEC)	oxygen glucose deprivation (OGD) treatment	downregulated	31628679
1808	Rat	rno-miR-204-5p	miRNA	isoflurane	cognitive impairment	hippocampal tissue of rats	isoflurane exposure	"Isoflurane could significantly induce neuroinflammation, and the expression of miR-204-5p was increased in the hippocampal tissue of rats exposed to isoflurane."	33878909
1809	Rat	rno-miR-204-5p	miRNA	fluorine combined with aluminum (FA)	fluorine combined with aluminum (FA)-induced developmental neurotoxicity	hippocampi	fluorine combined with aluminum (FA) treatment	upregulated	30033483
1810	Rat	rno-miR-205	miRNA	TGF-¦Â	adaptation of tendons to mechanical loading	rat Tendon fibroblasts	Transforming growth factor-¦Â(TGF-¦Â) treatment	upregulated	22539168
1811	Rat	rno-miR-205	miRNA	apomorphine (APO)	diabetes mellitus-induced erectile dysfunction (DMED)	diabetes mellitus (DM) rats cavernous bodies	apomorphine (APO) treatment	upregulated	30729682
1812	Rat	rno-miR-205	miRNA	short-term vagus nerve stimulation (VNS)	myocardial apoptosis	rats with chronic heart failure	VNS treatment	downregulated	28849082
1813	Rat	rno-miR-205	miRNA	high glucose (HG)	neuron protection	astrocytes	high glucose (HG) treatment	upregulated	32168096
1814	Rat	rno-miR-205	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
1815	Rat	rno-miR-205	miRNA	bleomycin (BLM)	lung fibrosis	pulmonary fibrosis tissues	bleomycin (BLM) treatment	downregulated	31820686
1816	Rat	rno-miR-205	miRNA	hypoxia	renal ischemia/reperfusion (I/R) injury	rat renal tissues	hypoxia treatment	downregulated	31934284
1817	Rat	rno-miR-205	miRNA	smoking	smoke inhalation injury (SII)	bronchoalveolar lavage fluid (BALF)	Smoke inhalation treatment	upregulated	30139538
1818	Rat	rno-miR-206	miRNA	isoproterenol and doxorubicin	cardiotoxicity	rats plasma	isoproterenol and doxorubicin treatment	upregulated after treatment with doxorubicin	25092230
1819	Rat	rno-miR-206	miRNA	dexamethasone (DEX)	cartilage injury	articular cartilage	dexamethasone (DEX) treatment	miR-206 was downregulated compared with control group.	29207029
1820	Rat	rno-miR-206	miRNA	icariin (ICA)	cartilage injury	articular chondrocytes	icariin treatment	upregulated	29207029
1821	Rat	rno-miR-206	miRNA	TGF-¦Â1	cell proliferation	primary cultured airway smooth muscle cells (ASMCs)	transforming growth factor ¦Â1 (TGF-¦Â1) treatment	downregulated	29483552
1822	Rat	rno-miR-206	miRNA	ketamine	depression	rat hippocampus	ketamine (15 mg/kg) treatment	miR-206 was downregulated in hippocampus of rats	24839168
1823	Rat	rno-miR-206	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	cardiomyocytes	high glucose (HG) treatment	upregulated	27306406
1824	Rat	rno-miR-206	miRNA	hypoxia/reoxygenation (H/R)	ischemia/reperfusion (I/R) injury	H9c2 cells	hypoxia-reoxygeneration (H/R) treatment	downregulated	29237256
1825	Rat	rno-miR-206	miRNA	ketamine	ketamine-induced neurotoxicity	neurons of the hippocampus; PC-12 cells	ketamine treatment	LncRNA KCNQ1OT1 Sponges miR-206 to Ameliorate Neural Injury Induced by Anesthesia via Up-Regulating BDNF.	33204065
1826	Rat	rno-miR-206	miRNA	4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)	lung cancer	male F344 rats	was induc systemic NNK treatment	upregulated	24553369
1827	Rat	rno-miR-206	miRNA	ellagic acid (EA)	breast cancer	female rat mammary tissue	ellagic acid treatment	"ellagic acid, which inhibited E2-induced mammary tumorigenesis in our previous study, reversed the dysregulation of miR-375, miR-206, miR-182, miR-122, miR-127 and miR-183 detected with E2treatment"	23791885
1828	Rat	rno-miR-206	miRNA	repair of exercise	muscle injury	agile male rats	agile male rats treatment	upregulation in rat skeletal muscle	277067322
1829	Rat	rno-miR-206	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	The H9c2 cardiomyocytes	hypoxia induce	downregulated	30551524
1830	Rat	rno-miR-206	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia treatment	downregulated	30551524
1831	Rat	rno-miR-206	miRNA	methylmercury (MeHg)	neuronal cell death	primary rat cortical neurons	Methylmercury (MeHg) exposure	downregulated	29522201
1832	Rat	rno-miR-206	miRNA	chronic constriction injury (CCI)	neuropathic pain (NP)	rats dorsal root ganglion (DRG)	chronic constriction injury (CCI) induce	downregulated in the dorsal root ganglion (DRG)	28130187
1833	Rat	rno-miR-206	miRNA	chronic constriction injury (CCI)	neuropathic pain (NP)	L4©\L6 dorsal spinal cord of rats	chronic constriction injury (CCI) induce	downregulated	30740678
1834	Rat	rno-miR-206	miRNA	curcumin (Cur)	podocyte injury	podocyte	curcumin treatment	upregulated	26395192
1835	Rat	rno-miR-206	miRNA	TGF-¦Â1	post-angioplasty restenosis	vascular smooth muscle cells (VSMCs) VSMCs isolated from Sprague-Dawley rats	TGF-¦Â1 treatment	downregulated	28328152
1836	Rat	rno-miR-206	miRNA	H2O2	cell senescence	Bone marrow-derived mesenchymal stem cells (MSCs)	H2O2 treatment	miR-206 was upregulated in the senescent MSCs induced by H2O2.	32148656
1837	Rat	rno-miR-206	miRNA	lipopolysaccharide (LPS)	sepsis-induced acute kidney injury	alveolar type II epithelial cells (ATII)	lipopolysaccharide treatment	downregulated	31258665
1838	Rat	rno-miR-206	miRNA	"muscle toxicant 2,3,5,6-tetramethyl-p-phenylenediamine (TMPD)"	skeletal muscle injury	serum	"muscle toxicant 2,3,5,6-tetramethyl-p-phenylenediamine (TMPD) treatment"	Serum miR-206 levels significantly increased after treatment with TMPD.	32741900
1839	Rat	rno-miR-206	miRNA	"1,3,5-tris-4-propyl-1H-pyrazole"	spinal cord injury (SCI)	VSC4.1 motoneurons	ER agonists treatment	upregulated	24157932
1840	Rat	rno-miR-206	miRNA	"high concentrations of lipid and glucose, and cytokines"	vascular hyper-reactivity	VSMC	"incubat high glucose (25mmol/L) or lipid (palmitic acid 50 ¦Ì mol/L) and 200ng/ml of TNF-¦Á,IL-1¦Â and IL-6 for 26h treatment"	downregulated	25425000
1841	Rat	rno-miR-206-3p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	hippocampus	amyloid ¦Â1-42?(A¦Â) treatment	upregulated	29706607
1842	Rat	rno-miR-206-3p	miRNA	acute eccentric exercise	exercise-induced muscle damage (EIMD)	Sprague-Dawley (SD) rats	a downhill running treatment at -16? gradient	dysregulated	28638919
1843	Rat	rno-miR-206-3p	miRNA	steroids	osteonecrosis	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	26459755
1844	Rat	rno-miR-206-3p	miRNA	notexin	skeletal muscle atrophy	plasma	notexin treatment	upregulated	26952641
1845	Rat	rno-miR-206-3p	miRNA	Jianpi Xiaoke (JPXK)	type 2 diabetes mellitus (T2DM)	rat	Jianpi Xiaoke (JPXK) treatment	upregulated	33456489
1846	Rat	rno-miR-207	miRNA	light	focal retinal degeneration	right eye	light treatment	upregulated	25921151
1847	Rat	rno-miR-207	miRNA	nerve growth factor (Ngf)	neurodegenerative diseases	PC12 cells	100 ng/ml Ngf treatment	different regulation	24492999
1848	Rat	rno-miR-207	miRNA	FK506	osteogenesis	rat bone marrow stromal cells (BMSCs)	FK506 treatment	downregulated	28560399
1849	Rat	rno-miR-207	miRNA	ischemia	periodontitis	Serum	Ligation around teeth treatment	upregulated	26910654
1850	Rat	rno-miR-208	miRNA	angiotensin II (Ang II)	apoptosis	H9c2 cells	angiotensin II (Ang II) treatment	downregulated	30244257
1851	Rat	rno-miR-208	miRNA	ghrelin	apoptosis	angiotensin II (Ang II)-induced H9c2 cells	ghrelin treatment	upregulated	30244257
1852	Rat	rno-miR-208	miRNA	daunorubicin	cardiomyopathy	rats	"daunorubicin (DAU-A, 3 mg/kg, every 48 h)"	downregulated	28303410
1853	Rat	rno-miR-208	miRNA	insulin	cell proliferation	vascular smooth muscle cell	Insulin?treatment	insulin increased VSMC proliferation and miR-208 expression	21720271
1854	Rat	rno-miR-208	miRNA	isoproterenol	myocardial injury	Plasma	isoproterenol treatment	upregulated	19696117
1855	Rat	rno-miR-208	miRNA	nanosized SiO2	pulmonary injury	liver tissues	nanosized SiO2 treatment	upregulated	27689473
1856	Rat	rno-miR-208a	miRNA	ischemia	acute myocardial infarction (AMI)	heart tissues	Ligation of the proximal left anterior descending artery to induce AMI treatment	upregulated	25936493
1857	Rat	rno-miR-208a	miRNA	H2O2	apoptosis	primary cultured neonatal rat cardiomyocyte	H2O2 treatment	downregulated	29877301
1858	Rat	rno-miR-208a	miRNA	exercise training (ET)	cardiac hypertrophy	heart tissues	Exercise training (ET)	downregulated	29746886
1859	Rat	rno-miR-208a	miRNA	thyroid hormone	cardiac hypertrophy	rat cardiac tissue	thyroid hormone treatment	"AT1R mediates the hyperthyroidism-induced increase on cardiac miRNA-208a/a-MHC levels, while does not influence on the reduction of miRNA-208b/b-MHC levels."	23623871
1860	Rat	rno-miR-208a	miRNA	doxorubicin (DOX)	cardiotoxicity	Wistar rats left atrium (LA)/ventricle (LV)	doxorubicin (DOX) and liposomal doxorubicin (L-DOX) administration	downregulated in left atrium (LA)/ventricle (LV)	27990619
1861	Rat	rno-miR-208a	miRNA	aorta-caval shunt	cardiovascular disease (CVD)	adult Sprague-Dawley rats	AV shunt from 3 to 14 days treatment	upregulated	24392114
1862	Rat	rno-miR-208a	miRNA	conditioned media (CM)	diabetes-related heart disease	primary adult rat cardiomyocytes	CM-EAT-T2D	upregulated	27864612
1863	Rat	rno-miR-208a	miRNA	mechanical stress	hypertrophy	Neonatal rat cardiomyocytes	Mechanical stretch treatment	upregulated	24120154
1864	Rat	rno-miR-208a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemia/reperfusion (I/R) injury	H9c2 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"in H9c2 cells after simulated I/R injury, miR-208a was upregulated"	29681568
1865	Rat	rno-miR-208a	miRNA	ketamine	ketamine-induced cardiotoxicity	heart tissues	Ketamine treatment	upregulated	30923228
1866	Rat	rno-miR-208a	miRNA	ketamine	ketamine-induced cardiotoxicity	heart tissues	ketamine treatment	upregulated	30923228
1867	Rat	rno-miR-208a	miRNA	H2O2	myocardial injury	H9C2 cardiomyocytes	H2O2 treatment	"miR-208a mimic aggravated H2O2-induced apoptosis and oxidative injury in cardiomyocytes, while miR-208a inhibitor hadan inverse effect."	31545986
1868	Rat	rno-miR-208a	miRNA	Calhex-231 (Cal)	traumatic hemorrhagic shock (THS)	vascular smooth muscle cells (VSMCs)	Calhex-231 (Cal) treatment	The Calcilytic Drug Calhex-231 Ameliorates Vascular Hyporesponsiveness in Traumatic Hemorrhagic Shock by Inhibiting Oxidative Stress and miR-208a-Mediated Mitochondrial Fission.	33343806
1869	Rat	rno-miR-208a-3p	miRNA	isoproterenol	acute cardiac injury	heart tissues	isoproterenol treatment	upregulated	27605421
1870	Rat	rno-miR-208a-3p	miRNA	allylamine (AAM)	drug-induced cardiac injury (DICI)	plasma	allylamine (AAM) treatment	upregulated	26454886
1871	Rat	rno-miR-208a-3p	miRNA	isoproterenol	drug-induced cardiac injury (DICI)	"Heart tissues, plasma"	isoproterenol (ISO) treatment	upregulated	26454886
1872	Rat	rno-miR-208a-5p	miRNA	fish oil (FO) and olive oil (OO)	cardiovascular responses	heart sissues	Fish oil (FO) and olive oil (OO) treatment	O 3-induced upregulated of miR-150-5p and miR-208a-5p were attenuated by FO and/or OO.	33091443
1873	Rat	rno-miR-208b	miRNA	thyroid hormone	cardiac hypertrophy	rat cardiac tissue	thyroid hormone treatment	"AT1R mediates the hyperthyroidism-induced increase on cardiac miRNA-208a/a-MHC levels, while does not influence on the reduction of miRNA-208b/b-MHC levels."	23623871
1874	Rat	rno-miR-208b	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia induce	upregulated	30119250
1875	Rat	rno-miR-208b	miRNA	doxorubicin (DOX)	cardiac injury	?rat heart	doxorubicin treatment	upregulated	22859947
1876	Rat	rno-miR-208b-3p	miRNA	isoproterenol	drug-induced cardiac injury (DICI)	heart tissues	isoproterenol treatment	upregulated	29355689
1877	Rat	rno-miR-208b-3p	miRNA	notexin	skeletal muscle atrophy	plasma	notexin treatment	upregulated	26952641
1878	Rat	rno-miR-20a	miRNA	HspB1	breast cancer	cortical neurons of rats	HspB1 treatment	upregulated	24141048
1879	Rat	rno-miR-20a	miRNA	ischemia/reperfusion (I/R) 	cardiomyocyte apoptosis	neonatal rat cardiomyocytes (NRCM)	ischemia/reperfusion (I/R) treatment	upregulated	22182733
1880	Rat	rno-miR-20a	miRNA	resveratrol	liver fibrosis	HSC-T6 cells	Resveratrol (RSV) treatment	RSV induces autophagy and activates the miR-20a-mediated PTEN/PI3K/AKT signaling pathway to attenuate LF	33125088
1881	Rat	rno-miR-20a	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia induce	downregulated	31444671
1882	Rat	rno-miR-20a	miRNA	high fat diet (HFD) and streptozotocin (STZ)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD); streptozotocin (STZ)  treatment	downregulated	30338914
1883	Rat	rno-miR-20a	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
1884	Rat	rno-miR-20a-5p	miRNA	pentylenetetrazol (PTZ)	epilepsy	brain tissues	pentylenetetrazol (PTZ) treatment	upregulated	32779334
1885	Rat	rno-miR-20a-5p	miRNA	diosgenin (DIO)	osteoprotective effect of diosgenin (DIO)	tibias	diosgenin (DIO) treatment	DIO might exert an anti-osteoclastogenic effect on OVX rats by upregulating the expression of miR-20a-5p in circulation and bone tissue.	32210807
1886	Rat	rno-miR-20b	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal rat ventricular cells (NRVCs)	angiotensin II (Ang II) treatment	"miR©\20b participates in cardiac hypertrophy, PTEN/AKT as a mediator of miR-20b action. CHAR regulates cardiac hypertrophy via the miR©\20b/PTEN/AKT pathway."	31465630
1887	Rat	rno-miR-20b	miRNA	resveratrol	cardiomyocyte apoptosis	Cardiomyocytes	resveratrol treatment	downregulated	22050707
1888	Rat	rno-miR-20b	miRNA	¦Ã-tocotrienol	cardiomyocyte apoptosis	Cardiomyocytes	¦Ã-tocotrienol treatment	downregulated	22050707
1889	Rat	rno-miR-20b	miRNA	methylprednisolone	steroid-induced necrosis of femoral head (SNFH)	bone tissues	methylprednisolone treatment	upregulated	31210286
1890	Rat	rno-miR-20b-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
1891	Rat	rno-miR-20b-5p	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	PC12 cells	amyloid-¦Â (A¦Â) 25-35 treatment	Inhibition of miR-20b-5p attenuates apoptosis induced by A¦Â25-35 in PC12 cells through targeting RhoC.	33278507
1892	Rat	rno-miR-20b-5p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retinas tissues	streptozotocin treatment	upregulated	31636010
1893	Rat	rno-miR-20b-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cardiomyocytes	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31823095
1894	Rat	rno-miR-20b-5p	miRNA	Chronic constriction injury (CCI)	neuropathic pain (NP)	spinal dorsal horm and isolated primary microglia	chronic constriction injury (CCI) induce	downregulated	31381191
1895	Rat	rno-miR-21	miRNA	molidustat	anemia	plasma samples	Molidustat treatment	upregulated	30657053
1896	Rat	rno-miR-21	miRNA	ethanol (EtOH)	acute gastric mucosal injury	gastric tissues?of rat	oral administration of ethanol	downregulated	23830200
1897	Rat	rno-miR-21	miRNA	hyperoxia	acute lung injury (ALI)	Sprague-Dawley (SD) rats left lung tissues	hyperoxia	downregulated	28627345
1898	Rat	rno-miR-21	miRNA	infusion of oleic acid (OA)	acute lung injury (ALI)	lung tissues	OA (200 ?l/kg) suspended in 20% ethyl alcohol was injected through the tail vein for 20 min treatment	dysregulated	24736893
1899	Rat	rno-miR-21	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lungs of LPS-induced ALI rats and NR8383 alveolar macrophages (AMs)	lipopolysaccharide (LPS) treatment	upregulated	30542412
1900	Rat	rno-miR-21	miRNA	isoproterenol	acute myocardial infarction (AMI)	rat myocardial tissues	subcutaneous injection of isoproterenol (ISO)	"SiRNA GAS5 can enhance the cardiac function of AMI model rats, relieve pathological damage, reduce myocardial cell apoptosis, and inhibit the occurrence of myocardial fibrosis. The possible underlying mechanism may be associated with upregulated of miR-21."	31646590
1901	Rat	rno-miR-21	miRNA	curcumin (Cur)	acute pulmonary embolism (APE)	acute pulmonary embolism (APE) rats lung tissues	curcumin?treatment	Curcumin decreased miR-21 expression by downregulating Sp1 to upregulate PTEN.	33730297
1902	Rat	rno-miR-21	miRNA	TGF-¦Â	adaptation of tendons to mechanical loading	rat Tendon fibroblasts	Transforming growth factor-¦Â(TGF-¦Â) treatment	upregulated	22539168
1903	Rat	rno-miR-21	miRNA	berberine (BBR)	allergic contact dermatitis (ACD)	ear tissues; Rat Peritoneal Mast Cells (RPMCs)	berberine (BBR) treatment	Berberine treatment inhibited miR-21 expression.	29282578
1904	Rat	rno-miR-21	miRNA	trimetazidine (TMZ)	angina	rat RV myocardial cells (RVMCs)	Trimetazidine treatment	downregulated	22842854
1905	Rat	rno-miR-21	miRNA	H2O2	apoptosis	C-kit(+) cardiac stem cells isolated from SD rats	H2O2 treatment	downregulated	29166725
1906	Rat	rno-miR-21	miRNA	hypoxia	apoptosis	Rat cardiomyocyte line H9c2 and primary cardiomyocytes	oxygen-glucose deprivation (OGD) treatment	downregulated	30552708
1907	Rat	rno-miR-21	miRNA	hypoxia- and serum deprivation	apoptosis	bone marrow mesenchymal stem cell- (MSC)	Hypoxia- and Serum Deprivation treatment	downregulated	21698002
1908	Rat	rno-miR-21	miRNA	hypoxia/reoxygenation (H/R)	apoptosis	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	downregulated	27680680
1909	Rat	rno-miR-21	miRNA	IL-6	apoptosis	rats DRG neurons	IL-6 treatment	upregulated	24279830
1910	Rat	rno-miR-21	miRNA	notoginsenoside R1 (NGR1)	apoptosis	oxygen-glucose deprivation (OGD) treated rat cardiomyocyte line H9c2 and primary cardiomyocytes	Notoginsenoside R1 (NG-R1) treatment	upregulated	30552708
1911	Rat	rno-miR-21	miRNA	TGF-¦Â1	asthma	rat airway smooth muscle cell (ASMC)	transforming growth factor-¦Â1 (TGF-¦Â1) treatment	upregulated	30132829
1912	Rat	rno-miR-21	miRNA	oxidized low density lipoprotein (ox-LDL)	atherosclerosis (AS)	rat vascular endothelial cells (VECs)	oxidized low-density lipoprotein (ox-LDL) treatment	upregulated	24562307
1913	Rat	rno-miR-21	miRNA	ursodeoxycholic acid (UDCA)	atherosclerosis and restenosis	vascular smooth muscle cells (VSMCs)	ursodeoxycholic acid (UDCA) treatment	UDCA inhibited intimal hyperplasia and VSMCs excessive migration and proliferation via blocking miR-21/PTEN/AKT/mTOR signaling pathway	32202193
1914	Rat	rno-miR-21	miRNA	doxycycline	atrial fibrillation (AF)	heart tissues	doxycycline treatment	"Doxycycline treatment attenuated CIH-induced atrial fibrosis, reduced microRNA-21 and PI3K."	30098136
1915	Rat	rno-miR-21	miRNA	doxycycline	atrial fibrillation (AF)	heart tissues	doxycycline treatment	downregulated	30470910
1916	Rat	rno-miR-21	miRNA	doxycycline	atrial fibrillation (AF)	heart sissues	doxycycline treatment	upregulated	30470910
1917	Rat	rno-miR-21	miRNA	hypoxia	atrial fibrillation (AF)	atrial interstitial	chronic intermittent hypoxia (CIH) treatment	upregulated	30203914
1918	Rat	rno-miR-21	miRNA	tolvaptan	atrial fibrillation (AF)	chronic intermittent hypoxia (CIH) treated rats atrial interstitial	tolvaptan treatment	downregulated	30203914
1919	Rat	rno-miR-21	miRNA	hypoxia	atrial remodeling	atrial interstitial	chronic intermittent hypoxia (CIH)-induce	upregulated	31434432
1920	Rat	rno-miR-21	miRNA	tolvaptan	atrial remodeling	chronic intermittent hypoxia (CIH)-induced atrial interstitial	tolvaptan treatment	downregulated	31434432
1921	Rat	rno-miR-21	miRNA	glucose	autophagy	mesangial cells	glucose treatment	"Ursolic acid inhibits the glucose-induced upregulated of mesangial cell miRNA-21 expression, up-regulates PTEN expression,"	25689721
1922	Rat	rno-miR-21	miRNA	axotomy	peripheral nerve injury (PNI)	adult rat DRG neurons	axotomy treatment	upregulated	21853131
1923	Rat	rno-miR-21	miRNA	N-methyl-N-nitrosourea (MNU)	breast cancer	rats with experimental breast cancer Thoracic Duct Lymph	N-Methyl-N-Nitrosourea	dysregulatedin Thoracic Duct Lymph	28091921
1924	Rat	rno-miR-21	miRNA	resveratrol	breast cancer	matched tumor/normal tissues	resveratrol (RS) treatment	upregulated	24447120
1925	Rat	rno-miR-21	miRNA	high glucose (HG)	cardiac fibrosis	rat cardiac fibroblasts	high glucose treatment	upregulated	25418215
1926	Rat	rno-miR-21	miRNA	hydrogen sulfide (H2S)	cardiac fibrosis	thyroxine-induced rats myocardial tissues	Hydrogen sulfide (H2S) treatment	downregulated	29743447
1927	Rat	rno-miR-21	miRNA	radix angelica sinensis and radix hedysari ultrafiltration extract (RAS-RH)	cardiac fibrosis	primary rat cardiac fibroblasts	Radix Angelica Sinensis and Radix Hedysari ultrafiltration extract (RAS-RH) treatment	"TBI resulted in an increase in the expression of miRNA-21 in primary rat cardiac fibroblasts, and RAS-RH mitigated the TBI-induced increased expression of miRNA-21."	30780109
1928	Rat	rno-miR-21	miRNA	thyroxine	cardiac fibrosis	myocardial tissues	thyroxine treatment	upregulated	29743447
1929	Rat	rno-miR-21	miRNA	total-body irradiation (TBI)	cardiac fibrosis	primary rat cardiac fibroblasts	a single dose of total body irradiation (TBI) at 8?Gy treatment	"TBI resulted in an increase in the expression of miRNA-21 in primary rat cardiac fibroblasts, and RAS-RH mitigated the TBI-induced increased expression of miRNA-21"	30780109
1930	Rat	rno-miR-21	miRNA	human growth hormone (hGH)	cardiac hypertrophy	ventricular muscle	recombinant human growth hormone (r-hGH) treatment	upregulated	30842884
1931	Rat	rno-miR-21	miRNA	human growth hormone (hGH)	cardiac hypertrophy	heart tissues	swimming exercise plus r-hGH treatment	upregulated	30842884
1932	Rat	rno-miR-21	miRNA	swimming	cardiac hypertrophy	ventricular muscle	swimming induce treatment	upregulated	30842884
1933	Rat	rno-miR-21	miRNA	swimming	cardiac hypertrophy	heart tissues	The exercise groups completed a 1-h swimming exercise 5 times a week for 8 weeks. treatment	upregulated	30842884
1934	Rat	rno-miR-21	miRNA	aldosterone	cardiac injury	Sprague-Dawley rats	alendronate treatment	upregulated	28368454
1935	Rat	rno-miR-21	miRNA	H2O2	cardiac injury	eonatal rat cardiac ventricular myocytes	H2O2 treatment	upregulated	19336275
1936	Rat	rno-miR-21	miRNA	hypoxia/reoxygenation (H/R)	cardiomyocyte apoptosis	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	"LncRNA-GAS5 regulates PDCD4 expression to mediate MI-induced cardiomyocyte apoptosis via targeting miR-21, suggesting that GAS5 could be a therapeutic target for MI."	32308118
1937	Rat	rno-miR-21	miRNA	palmitate	cardiomyocyte apoptosis	H9c2 cells	palmitate exposure treatment	Palmitate exposure greatly reduced miR-21 expression in cardiomyocytes	30504734
1938	Rat	rno-miR-21	miRNA	SN50 (a selective cell permeable peptide inhibitor of NF- ¦Ê B)	cardiomyocyte apoptosis	rats neonatal cardiomyocytes	SN50 treatment	downregulated	24237305
1939	Rat	rno-miR-21	miRNA	hypoxia	cardiomyocytes injury	Rat cardiomyocyte line H9c2 and primary cardiomyocytes	oxygen-glucose deprivation (OGD) treatment	downregulated	30552708
1940	Rat	rno-miR-21	miRNA	notoginsenoside R1 (NGR1)	cardiomyocytes injury	oxygen-glucose deprivation (OGD) treated rat cardiomyocyte line H9c2 and primary cardiomyocytes	Notoginsenoside R1 (NG-R1) treatment	upregulated	30552708
1941	Rat	rno-miR-21	miRNA	fish oil (FO) and olive oil (OO)	cardiovascular responses	heart sissues	Fish oil (FO) and olive oil (OO) treatment	miR-21 was upregulated by both FO and OO after O 3 exposure.	33091443
1942	Rat	rno-miR-21	miRNA	amlodipine	cell differentiation	plasma and aortic vessels	?amlodipine?treatment treatment	upregulated	30927374
1943	Rat	rno-miR-21	miRNA	hypoxia	cerebral ischemia injury (CII)	rats neural stem/progenitor cells (NSPCs)	hypoxia treatment	upregulated	28939387
1944	Rat	rno-miR-21	miRNA	rosuvastatin	cholestatic liver injury	cholestatic liver injury rat liver tissues	rosuvastatin (Rvs) treatment	downregulated	30203151
1945	Rat	rno-miR-21	miRNA	acupuncture	chronic atrophic gastritis (CAG)	gastric	acupuncture treatment	downregulated	27293468
1946	Rat	rno-miR-21	miRNA	ischemia	chronic constriction injury	rat spinal cord	ligation of the sciatic nerve treatment	"The expression levels of a large number of miRNAs in the dorsal horn of the spinal cord in CCI rats changed (miR-500, -221 and -21)"	23124577
1947	Rat	rno-miR-21	miRNA	doxycycline	chronic intermittent hypoxia (CIH)-induced atrial fibrosis	heart tissues	doxycycline treatment	downregulated	29380561
1948	Rat	rno-miR-21	miRNA	ochratoxin A (OTA)	chronic nephropathy	rat renal proximal tubule cells (NRK-52E) co-cultured with renal fibroblasts (NRK-49F)	Ochratoxin A (OTA) treatment	upregulated	31415839
1949	Rat	rno-miR-21	miRNA	epigallocatechin-3-gallate (EGCG)	chronic renal injury	cadmium (Cd) pretreated Wistar albino rats	EGCG treatment	"decreased miR-21 and miR-192, enhanced miR-29a/b/c in kidney samples"	27474435
1950	Rat	rno-miR-21	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	Wistar rats left ventricle (LV)	STZ treatment	upregulated	28199183
1951	Rat	rno-miR-21	miRNA	chaihuang Yishen granule (CHYS)	diabetic nephropathy (DN)	type 1 DN Wistar rats	CHYS at a dose of 0.56 g/kg body weight treatment	upregulated	24646636
1952	Rat	rno-miR-21	miRNA	geraniol	diabetic nephropathy (DN)	kidney tissues	Geraniol treatment	downregulated	32666288
1953	Rat	rno-miR-21	miRNA	high glucose (HG)	diabetic nephropathy (DN)	human kidney glomerular mesangial cells	high glucose treatment	"In renal mesangial cells, high glucose increased the expression of miR-21"	21613227
1954	Rat	rno-miR-21	miRNA	high glucose (HG)	diabetic nephropathy (DN)	NRK-52E cells	high glucose (HG) treatment	upregulated	30847937
1955	Rat	rno-miR-21	miRNA	high glucose (HG)	diabetic nephropathy (DN)	NRK-52E cells	high glucose treatment	upregulated	31655195
1956	Rat	rno-miR-21	miRNA	high glucose (HG)	diabetic nephropathy (DN)	NRK-52E cells	high glucose treatment	upregulated	31933879
1957	Rat	rno-miR-21	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retinal tissues of DR rats	"rats were fed with a high-sugar and high-fat diet for 8 weeks, during which, the rats were rendered diabetic with an intraperitoneal injection of 2% streptozotocin (STZ) at a concentration of 60 mg/kg. treatment"	upregulated	31759996
1958	Rat	rno-miR-21	miRNA	nucleolin	doxorubicin (DOX)-induced cardiotoxicity	H9c2 cells	nucleolin treatment	Nucleolin upregulates microRNA(miRNA)-21 expression in vivo and in vitro.	29968904
1959	Rat	rno-miR-21	miRNA	dapagliflozin	drug-induced acute kidney injury (DIKI)	rat kidney tissues	Dapagliflozin (DAPA) treatment	downregulated	31075409
1960	Rat	rno-miR-21	miRNA	dapagliflozin	drug-induced acute kidney injury (DIKI)	GNT-treated rat kidney tissues	Dapagliflozin (DAPA) treatment	upregulated	31075409
1961	Rat	rno-miR-21	miRNA	gentamicin	drug-induced acute kidney injury (DIKI)	rat kidney tissues	gentamicin (GNT) treatment	downregulated	31075409
1962	Rat	rno-miR-21	miRNA	pilocarpine	epilepsy	hippocampi	pilocarpine treatment	upregulated	27725160
1963	Rat	rno-miR-21	miRNA	stimulation electrode	epilepsy	Adult male Sprague Dawley rats blood	A bipolar stimulation electrode (distance between tips 500 ?m) was implanted in the angular bundle treatment	dysregulated	24184920
1964	Rat	rno-miR-21	miRNA	aldosterone	fibrotic remodeling of the atrial myocardium	rat cardiomyocytes of 5-day-old neonatal Sprague-Dawley rat hearts	aldosterone treatment	upregulated	24469458
1965	Rat	rno-miR-21	miRNA	formaldehyde	formaldehyde inducted immune/inflammation	rats	were exposed to formaldehyde treatment	downregulated	24304932
1966	Rat	rno-miR-21	miRNA	aristolochic acid	genotoxic and carcinogenic	tissues from transgenic Big Blue rats liver and kidney	aristolochic acid (AA) treatment	"dysregulated in the kidney, miR-34a was dysregulated in the liver"	25106556
1967	Rat	rno-miR-21	miRNA	quercetin	liver damage	liver tissues	quercetin (QUR) treatment	QUR significantly lowered levels of miR-21 and increased the protein levels and activity of Nrf2	33733575
1968	Rat	rno-miR-21	miRNA	methyl helicterate (MH)	liver fibrosis	liver tissues	methyl helicterate (MH) treatment	MH treatment significantly decreased miR-21 expression.	30419452
1969	Rat	rno-miR-21	miRNA	diethylnitrosamine (DEN)	hepatocellular carcinoma (HCC)	liver tissues	diethylnitrosamine (DEN) treatment	downregulated	30412748
1970	Rat	rno-miR-21	miRNA	gleditsia sinensis extract (GSE)	hepatocellular carcinoma (HCC)	HCC liver	Gleditsia sinensis extract (GSE) treatment	upregulated	30940289
1971	Rat	rno-miR-21	miRNA	high glucose (HG)	hyperglycemia	Rat kidney glomerular mesangial cells	high glucose treatment	"In renal mesangial cells, high glucose increased the expression of miR-21"	21613227
1972	Rat	rno-miR-21	miRNA	hypoxia	hypoxia-induced injury	H9c2 rat cardiomyocytes	hypoxia induce	downregulated	30680008
1973	Rat	rno-miR-21	miRNA	loperamide	hypoxia-induced injury	hypoxia-induced H9c2 rat cardiomyocytes	loperamide treatment	upregulated	30680008
1974	Rat	rno-miR-21	miRNA	puerarin	hypoxia-induced injury	H/R-treated H9c2 cells	Puerarin treatment	upregulated	31115556
1975	Rat	rno-miR-21	miRNA	hyperoxia	hypoxic/ischemic brain damage (HIBD)	PC12 cells	hypoxia treatment	Silencing MEG3 protects PC12 cells from hypoxic injury by targeting miR-21.	32050796
1976	Rat	rno-miR-21	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	inflammation	rat kidney IMCD cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	28214900
1977	Rat	rno-miR-21	miRNA	hypoxia	intestinal ischemia/reperfusion (I/R) injury	IEC-6 cells	hypoxia treatment	upregulated	29170412
1978	Rat	rno-miR-21	miRNA	radiation	ionizing radiation (IR) injury	cardiac fibroblasts (CFs)	radiation treatment	"Upregulation of miR-21 in irradiated CFs, which persistently increased up to 7 days after 85 Gy irradiation"	33354435
1979	Rat	rno-miR-21	miRNA	ionizing radiation (IR)	irradiation-induced heart damage	rat myocardium	Single irradiation of 10 Gy (4¨C5 Gy/min.) of rat¡¯s mediastinum area	upregulated	30830529
1980	Rat	rno-miR-21	miRNA	molecular hydrogen-rich water (HRW)	irradiation-induced heart damage	irradiation-induced rat myocardium	molecular hydrogen-rich water (HRW) treatment	downregulated	30830529
1981	Rat	rno-miR-21	miRNA	ischemia	ischemic heart disease (IHD)	?rat hearts	ischaemic preconditioning (IP) treatment	upregulated	20219857
1982	Rat	rno-miR-21	miRNA	isoflurane	ischemia/reperfusion (I/R) injury	cardiomyocytes	isoflurane treatment	upregulated	25536091
1983	Rat	rno-miR-21	miRNA	kaempferol	ischemia/reperfusion (I/R) injury	H9c2 cells	Kaempferol treatment	Kaempferol enhanced miR-21 level in H9c2 cells exposed to H/R.	33151961
1984	Rat	rno-miR-21	miRNA	sodium hydrosulfide (NaHS)	ischemia/reperfusion (I/R) injury	?rat liver (BRL) cells	sodium hydrosulfide (NaHS) treatment	upregulated	29187695
1985	Rat	rno-miR-21	miRNA	trimetazidine (TMZ)	ischemia/reperfusion (I/R) injury	rat heart	Trimetazidine treatment	upregulated	27666568
1986	Rat	rno-miR-21	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	upregulated	27074745
1987	Rat	rno-miR-21	miRNA	H2O2	ischemic cerebrovascular disease (ICVD)	PC-12 cells	H2O2 treatment	downregulated	30802826
1988	Rat	rno-miR-21	miRNA	luteolin	ischemic cerebrovascular disease (ICVD)	H2O2 treated PC-12 cells	luteolin treatment	upregulated	30802826
1989	Rat	rno-miR-21	miRNA	sodium sulfide (Na2S)	ischemic injury	adult primary rat cardiomyocytes	Na2S treatment	upregulated	24825878
1990	Rat	rno-miR-21	miRNA	cecal ligation and puncture (CLP)	kidney damage	Wistar rats	cecal ligation and puncture (CLP) treatment	upregulated	28821165
1991	Rat	rno-miR-21	miRNA	cisplatin (DDP)	kidney damage	male Wistar rats	cisplatin treatment	upregulated	24880025
1992	Rat	rno-miR-21	miRNA	vitamin D3 (Vit D) and erythropoietin (EPO)	kidney ischemia reperfusion (IR) injury	renal cells	vitamin D3 (Vit D) and erythropoietin (EPO) treatment	upregulated	33262439
1993	Rat	rno-miR-21	miRNA	swimming	left ventricular hypertrophy (LVH)	rat left ventricular	Swimming exercise training treatment	upregulated	23812090
1994	Rat	rno-miR-21	miRNA	atorvastatin	liver fibrosis	liver tissues	atorvastatin treatment	downregulated	32822716
1995	Rat	rno-miR-21	miRNA	corilagin	liver fibrosis	CCl4-induced liver fibrosis rats liver tissues	Corilagin treatment	downregulated	31752524
1996	Rat	rno-miR-21	miRNA	curcumin (Cur)	liver fibrosis	liver tissues	curcumin treatment	downregulated	32822714
1997	Rat	rno-miR-21	miRNA	"DDT (2,2-dichlorodiphenyl-1,1,1-trichloroethane)"	liver fibrosis	liver tissues	"DDT (2,2-dichlorodiphenyl-1,1,1-trichloroethane) treatment"	Long-term DDT exposure increased micro RNA-21 (miR-21) level.	32508177
1998	Rat	rno-miR-21	miRNA	ferulic acid (FA)	liver fibrosis	liver tissues	ferulic acid treatment	downregulated	32278740
1999	Rat	rno-miR-21	miRNA	gallic acid (GA)	liver fibrosis	liver tissues	gallic acid treatment	downregulated	32278740
2000	Rat	rno-miR-21	miRNA	methyl helicterate (MH)	liver fibrosis	HSC-T6 cells	Methyl helicterate (MH) treatment	downregulated	30419452
2001	Rat	rno-miR-21	miRNA	quercetin	liver fibrosis	liver tissues	quercetin treatment	downregulated	32822715
2002	Rat	rno-miR-21	miRNA	acetaminophen (APAP)	liver damage	liver tissues	acetaminophen (APAP) treatment	"miR-155 and miR-21 were evaluated as makers of inflammation and regeneration, respectively, to characterize liver status."	27051339
2003	Rat	rno-miR-21	miRNA	methotrexate (MTX)	liver damage	liver tissues	methotrexate (MTX) treatment	upregulated	33349067
2004	Rat	rno-miR-21	miRNA	GYY4137	hepatic ischemia/reperfusion injury (HIRI)	Wistar rats liver	"undergoing hepatic I/R for 30 min, followed by a 3-h reperfusion"	upregulated	29187695
2005	Rat	rno-miR-21	miRNA	partial hepatectomy (PH)	liver regeneration	primary rat hepatocytes	?partial hepatectomy (PH) treatment	upregulated	20689055
2006	Rat	rno-miR-21	miRNA	"DDT (2,2-dichlorodiphenyl-1,1,1-trichloroethane), benzo[a]pyrene (BP), and 3-methylcholanthrene (MC)"	post-transcriptional regulation	?the livers and ovaries of chemically induced rats	"DDT, benzo[a]pyrene (BP), and 3-methylcholanthrene (MC) treatment"	downregulated	24727239
2007	Rat	rno-miR-21	miRNA	angiotensin II (Ang II)	lung fibrosis	rats	angiotensin II (Ang II) treatment	upregulated	29084974
2008	Rat	rno-miR-21	miRNA	angiotensin-(1-7)	lung fibrosis	rats	angiotensin-(1-7) treatment	downregulated	29084974
2009	Rat	rno-miR-21	miRNA	TGF-¦Â1	cardiac fibrosis	primary rat cardiomyocytes	TGF-¦Â1 treatment	microRNA-21 were Upregulated in Fibrotic Primary Rat Cardiomyocytes Induced by TGF-¦Â1	30058694
2010	Rat	rno-miR-21	miRNA	ginsenoside Rb1	myocardial infarction (MI)	hypoxia-induced neonatal rat cardiomyocytes	Ginsenoside Rb1 (GS-Rb1) treatment	upregulated	30988756
2011	Rat	rno-miR-21	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia induce	downregulated	30861181
2012	Rat	rno-miR-21	miRNA	hypoxia	myocardial infarction (MI)	neonatal rat cardiomyocytes	hypoxia induce	downregulated	30988756
2013	Rat	rno-miR-21	miRNA	indoxyl sulfate (IS)	myocardial infarction (MI)	cardiac fibroblasts	indoxyl sulfate (IS) treatment	upregulated	25896982
2014	Rat	rno-miR-21	miRNA	oxygen glucose deprivation (OGD)	myocardial infarction (MI)	"cardiomyocytes, cardiac fibroblasts, and conditioned medium (CM) derived from cardiomyocytes"	Oxygen-glucose-deprivation (OGD) treatment	upregulated	31430983
2015	Rat	rno-miR-21	miRNA	TGF-¦Â1	myocardial infarction (MI)	primary cardiac fibroblasts (CFs) isolated from 1 to 3-day-old Sprague-Dawley rats	TGF-¦Â1 treatment	upregulated	28817807
2016	Rat	rno-miR-21	miRNA	gastrodin (GAS)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	hypoxia-treated H9c2 cells	gastrodin (GSTD) treatment	upregulated	30684569
2017	Rat	rno-miR-21	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia induce	upregulated	30684569
2018	Rat	rno-miR-21	miRNA	extracellular superoxide dismutase (SOD3)	myocardial reperfusion injury	hind limb of rats	Extracellular superoxide dismutase (SOD3) treatment	upregulated	21909393
2019	Rat	rno-miR-21	miRNA	baicalin (BAI)	myocarditis	H9c2 cells	baicalin (BAI) treatment	The enhanced expression of miR-21 triggered by LPS was further elevated by Baicalin.	31984561
2020	Rat	rno-miR-21	miRNA	xenon (Xe)	nephrotoxicity	kidney tissues	Xenon (Xe)? treatment	upregulated	23737979
2021	Rat	rno-miR-21	miRNA	nerve growth factor (Ngf)	neurodegenerative diseases	PC12 cells	100 ng/ml Ngf treatment	different regulation	24492999
2022	Rat	rno-miR-21	miRNA	hypoxic/ischemic	neuronal cell death	Primary microglial cells	Hypoxia/Ischemia treatment	downregulated	22907769
2023	Rat	rno-miR-21	miRNA	apocynin	nonalcoholic fatty liver disease (NAFLD)	Immortalized rat Kupffer cell line (SV40)	apocynin treatment	downregulated	31393787
2024	Rat	rno-miR-21	miRNA	microcystin (MC)	nonalcoholic fatty liver disease (NAFLD)	Immortalized rat Kupffer cell line (SV40)	microcystin (MC) treatment	upregulated	31393787
2025	Rat	rno-miR-21	miRNA	"nitrone spin trap 5,5 dimethyl-1- pyrroline N-oxide (DMPO)"	nonalcoholic fatty liver disease (NAFLD)	Immortalized rat Kupffer cell line (SV40)	"nitrone spin trap 5,5 dimethyl-1- pyrroline N-oxide (DMPO) treatment"	downregulated	31393787
2026	Rat	rno-miR-21	miRNA	"quinacrine, erythromycin and tetracycline"	non-surgical sterilization	Wistar albino 12-14 week old female rats	"quinacrine, erythromycin , tetracycline treatment"	upregulated	25195052
2027	Rat	rno-miR-21	miRNA	"3,6-dihydroxyflavone (3,6-DHF)"	obesity	breast?of rats	"3,6-dihydroxyflavone (3,6-DHF) treatment"	"the global upregulation of miR-21 and downregulated of miR-34a in breast carcinogenesis could be reversed by 3,6-DHF"	22616882
2028	Rat	rno-miR-21	miRNA	H2O2	oxidative stress	neuronal spinal cord (RN-sc) cells	H2O2 treatment	upregulated	26323253
2029	Rat	rno-miR-21	miRNA	H2O2	oxidative stress	exosomes derived from bone marrow mesenchymal stem cells (MSCs)	H2O2 treatment	upregulated	29444190
2030	Rat	rno-miR-21	miRNA	glucagon-like peptide-1 (GLP-1)	pancreatic ¦Â-cell dysfunction	INS-1 832/3 cells	glucagon-like peptide 1 (GLP-1) treatment	upregulated	26218441
2031	Rat	rno-miR-21	miRNA	penetrating ballistic-like brain injury	penetrating ballistic-like brain injury (PBBI)	male Sprague-Dawley rats brain tissue	a unilateral frontal 10% PBBI treatment	upregulated in brain tissue	28452880
2032	Rat	rno-miR-21	miRNA	high glucose (HG)	peritoneal fibrosis	"Peritoneal tissues in fibrosis rats, peritoneal mesothelial cells"	high glucose treatment	upregulated	30515805
2033	Rat	rno-miR-21	miRNA	high glucose (HG)	peritoneal fibrosis	peritoneal mesothelial cells	high glucose (HG) treatment	upregulated	30515805
2034	Rat	rno-miR-21	miRNA	angiotensin II type I receptor agonistic autoantibodies (AT1-AA)	preeclampsia (PE)	neonatal rat cardiomyocytes	Angiotensin II type I receptor agonistic autoantibodies (AT1-AA) treatment	downregulated	31105840
2035	Rat	rno-miR-21	miRNA	amniotic fluid mesenchymal stem cells (AFMSCs)	premature ovarian dysfunction (POD)	ovarian lysate	amniotic fluid mesenchymal stem cells (AFMSCs) treatment	miRNA-21 allowed regeneration by modulating PTEN and caspase 3 apoptotic pathways.	33049041
2036	Rat	rno-miR-21	miRNA	propofol (PPF)	prostate cancer	vascular smooth muscle cells	?propofol treatment	upregulated	21263323
2037	Rat	rno-miR-21	miRNA	osthole	pulmonary arterial hypertension (PAH)	blood	osthole treatment	osthole hsa a role of metabolic regulator to potentially treat PAH by targeting inhibition of Sphk1/S1P via microRNA-21-PI3K/Akt/mTOR signal pathway.	32402408
2038	Rat	rno-miR-21	miRNA	platelet-derived growth factor (PDGF)	pulmonary arterial hypertension (PAH)	pulmonary arterial smooth muscle cell (PASMC)	platelet-derived growth factor (PDGF) treatment	upregulated	30453304
2039	Rat	rno-miR-21	miRNA	exercise training (ET)	pulmonary arterial stenosis (PAS)	PAS rats	PAS rats treatment	miR-1 downregulated and miR-21 upregulation	27994552
2040	Rat	rno-miR-21	miRNA	baicalin (BAI)	lung fibrosis	lung tissue of rats	baicalin (BAI) treatment	downregulated	23523661
2041	Rat	rno-miR-21	miRNA	bleomycin (BLM)	lung fibrosis	lung tissues	?bleomycin (BLM)?treatment treatment	upregulated	29843043
2042	Rat	rno-miR-21	miRNA	resveratrol	lung fibrosis	?bleomycin (BLM)-induced pulmonary fibrosis (PF) rats lung tissues	resveratrol (Res) treatment	downregulated	29843043
2043	Rat	rno-miR-21	miRNA	IFN-¦Ã	lung fibrosis	lung tissues	interferon gamma (IFN-¦Ã) treatment	downregulated	25704671
2044	Rat	rno-miR-21	miRNA	antigen	pulmonary inflammation	plasma and lavaged lung	antigen treatment	upregulated	27075111
2045	Rat	rno-miR-21	miRNA	aspirin	radiation-induced heart disease (RIHD)	left ventricle (LV)	male Wistar rats were subjected to a single sub-lethal dose of chest radiation at 25 Gy and treated with aspirin (3 mg/day) for six weeks.	downregulated	29642568
2046	Rat	rno-miR-21	miRNA	atorvastatin	radiation-induced heart disease (RIHD)	left ventricle (LV)	male Wistar rats were subjected to a single sub-lethal dose of chest radiation at 25 Gy and treated with atorvastatin (0.25 mg/day) for six weeks.	upregulated	29642568
2047	Rat	rno-miR-21	miRNA	X rays	radiation-induced heart disease (RIHD)	left ventricle (LV)	male Wistar rats were subjected to a single sub-lethal dose of chest radiation at 25 Gy treatment	upregulated	29642568
2048	Rat	rno-miR-21	miRNA	single dose irradiation	radiation-induced lung injury (RILI)	male Wistar rats lung tissues	subjected to single dose irradiation with 20 Gy using 6 MV x-rays to the right lung treatment	downregulated	24886372
2049	Rat	rno-miR-21	miRNA	X-rays	radiation-induced skin injury	rats irradiated skin	45-Gy electron beam treatment	upregulated	24447893
2050	Rat	rno-miR-21	miRNA	TGF-¦Â1	renal fibrosis	NRK-49F cells	TGF-¦Â1 treatment	upregulated	29361523
2051	Rat	rno-miR-21	miRNA	TGF-¦Â	renal injury	rat tubular epithelial cells (NRK52E)	Transforming growth factor (TGF)-¦Â? treatment	upregulated	21704009
2052	Rat	rno-miR-21	miRNA	doxorubicin (DOX)	renal interstitial fibrosis (RIF)	kidneys	doxorubicin (ADR) induction	upregulated	32606425
2053	Rat	rno-miR-21	miRNA	fuzheng huayu recipe (FZHY)	renal interstitial fibrosis (RIF)	kidney tissues	Fuzheng Huayu recipe (FZHY) treatment	miR-21 is the key fibrosis-related miRNA regulated by FZHY	32912827
2054	Rat	rno-miR-21	miRNA	"kangxianling (KXL, anti-fibrin)"	renal interstitial fibrosis (RIF)	kidneys	"Kangxianling (KXL, anti-fibrin) treatment"	downregulated	32606425
2055	Rat	rno-miR-21	miRNA	norepinephrine (NE)	rheumatoid arthritis (RA)	rats primary granulosa cells	norepinephrine treatment	downregulated	28473352
2056	Rat	rno-miR-21	miRNA	astragalus polysaccharide (APS)	rheumatoid arthritis (RA)	adjuvant arthritis (AA) rats cardiac tissues	astragalus polysaccharides (APS) treatment	downregulated	31495827
2057	Rat	rno-miR-21	miRNA	methotrexate (MTX)	rheumatoid arthritis (RA)	adjuvant arthritis (AA) rats cardiac tissues	methotrexate (MTX) treatment	downregulated	31495827
2058	Rat	rno-miR-21	miRNA	triptolide (TPL)	rheumatoid arthritis (RA)	adjuvant arthritis (AA) rats cardiac tissues	triptolide (TPL) treatment	downregulated	31495827
2059	Rat	rno-miR-21	miRNA	xinfeng capsules (XFC)	rheumatoid arthritis (RA)	cardiac tissues	xinfeng capsules (XFC) treatment	upregulated	31495827
2060	Rat	rno-miR-21	miRNA	Xinfeng capsules (XFC)	rheumatoid arthritis (RA)	adjuvant arthritis (AA) rats cardiac tissues	Xinfeng capsules (XFC) treatment	downregulated	31495827
2061	Rat	rno-miR-21	miRNA	morphine	spinal cord injury (SCI)	rats brain tissues	morphine at either 2 or 15 days post-SCI treatment	upregulated	24867772
2062	Rat	rno-miR-21	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	downregulated	21094214
2063	Rat	rno-miR-21	miRNA	"1,1-trichloro-2,2-di(4-chlorophenyl)ethane (DDT)"	toxic effects of DDT	Wistar rats livers	"1,1-trichloro-2,2-di(4-chlorophenyl)ethane (DDT) treatment"	downregulated	28900085
2064	Rat	rno-miR-21	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	transplant vasculopathy	VSMCs isolated from rat aorta	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	28415796
2065	Rat	rno-miR-21	miRNA	hydrogen gas (H2)	traumatic brain injury (TBI)	traumatic brain injury (TBI) rats brain tissues	H2 treatment was given by exposure to 2% H2 from 30 min to 5?h after TBI operation	upregulated	29028768
2066	Rat	rno-miR-21	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	blood	streptozotocin (STZ) treatment	upregulated	32233625
2067	Rat	rno-miR-21	miRNA	isoproterenol	¦Â-adrenoceptor intervention	rat heart tissues	isoproterenol (ISO)  treatment	downregulated	22847192
2068	Rat	rno-miR-21	miRNA	high salt (HS)	hypertension	aorta of? rats	high salt (HS) treatment	downregulated	24161401
2069	Rat	rno-miR-21?	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	Streptozotocin (STZ) treatment	miR-21 expression was upregulated in kidney tissues of STZ-induced DN rats	30212710
2070	Rat	rno-miR-21*	miRNA	perfluorooctane sulfonic acid (PFOS)	perfluorooctane sulfonate (PFOS)-induced toxic action	rat liver tissue	dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 8) treatment	different expression	24420840
2071	Rat	rno-miR-210	miRNA	soluble ¦Â-amyloid (sA¦Â) oligomers	Alzheimer's disease (AD)	cortical neurons were isolated from E17 embryos of Sprague Dawley rats	sA¦Â treatment	upregulated	24595404
2072	Rat	rno-miR-210	miRNA	hypoxia- and serum deprivation	apoptosis	bone marrow mesenchymal stem cell- (MSC)	Hypoxia- and Serum Deprivation treatment	downregulated	21698002
2073	Rat	rno-miR-210	miRNA	hypobaric hypoxia (HH)	brain injury	hippocampus tissues	hypobaric hypoxia (HH) induce	downregulated	30878546
2074	Rat	rno-miR-210	miRNA	Rhodiola crenulata aqueous extract (RCAE)	brain injury	hippocampus tissues	Rhodiola crenulata aqueous extract (RCAE) treatment	upregulated	30878546
2075	Rat	rno-miR-210	miRNA	H2O2	cardiomyocyte apoptosis	Rat cardiomyoblast H9c2 cells	H2O2 treatment	upregulated	25968948
2076	Rat	rno-miR-210	miRNA	crocin	cardiovascular disease (CVD)	Wistar rats heart tissue	crocin treatment	upregulated	28678929
2077	Rat	rno-miR-210	miRNA	immunoregulatory molecule soluble HLA-G (sHLA-G)	CD4+ T cells proliferation	CD4+ T cells	immunoregulatory molecule soluble HLA-G (sHLA-G) treatment	"sHLA-G triggered a modulation of miRNA expression that may in turn modulate downstream gene expression, thus affecting CD4+ T -cell function."	23220581
2078	Rat	rno-miR-210	miRNA	hypoxia	cytoprotective effects	H9c2 cells (ATTC)	Hypoxia treatment	upregulated	21841015
2079	Rat	rno-miR-210	miRNA	garlic	diabetes mellitus (DM)	myocardium	garlic feed	downregulated	30570073
2080	Rat	rno-miR-210	miRNA	garlic	diabetes mellitus (DM)	diabetic rats heart tissues	Garlic treatment	downregulated	30570073
2081	Rat	rno-miR-210	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	heart tissues	streptozotocin (STZ) treatment	upregulated	30570073
2082	Rat	rno-miR-210	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	myocardium	streptozotocin treatment	upregulated	30570073
2083	Rat	rno-miR-210	miRNA	voluntary exercise	diabetes mellitus (DM)	myocardium	voluntary exercise treatment	downregulated	30570073
2084	Rat	rno-miR-210	miRNA	voluntary exercise	diabetes mellitus (DM)	diabetic rats heart tissues	voluntary exercise treatment	downregulated	30570073
2085	Rat	rno-miR-210	miRNA	paraquat (PQ)	epithelial-mesenchymal transition (EMT)	rat alveolar type II cells (RLE-6TN)	paraquat (PQ) treatment	upregulated	28699704
2086	Rat	rno-miR-210	miRNA	hypoxia	fetal hypoxia	cardiomyocytes	hypoxia treatment	upregulated	29113299
2087	Rat	rno-miR-210	miRNA	hypoxia	hypoxia-induced injury	cardiac stem cells (CSCs) were isolated from rat ventricular wall and cultured until passage 4	hypoxia induce	upregulated	30668175
2088	Rat	rno-miR-210	miRNA	hypoxia	hypoxia-induced renal tubular cell apoptosis	rats renal tubular cells	hypoxia treatment	upregulated in renal tubular cells	29387863
2089	Rat	rno-miR-210	miRNA	hypoxia	hypoxia-induced injury	PC-12 cells	hypoxia treatment	upregulated	29018330
2090	Rat	rno-miR-210	miRNA	nicotine	hypoxic/ischemic injury	hypoxic-ischemic (HI) injury neonates brain	nicotine exposure in perinatal rats	upregulated in brain	28123348
2091	Rat	rno-miR-210	miRNA	hypoxia	hypoxic/ischemic brain damage (HIBD)	microglia in the neonatal brain	hypoxia induce	upregulated	31300734
2092	Rat	rno-miR-210	miRNA	hypoxic/ischemic	hypoxic-ischemic brain edema	left brain	hypoxia-ischemia (HI) treatment	downregulated	27530798
2093	Rat	rno-miR-210	miRNA	hypoxic/ischemic	hypoxic-ischemic encephalopathy (HIE)	brain tissues	hypoxic-ischemic? treatment	downregulated	24089674
2094	Rat	rno-miR-210	miRNA	oxygen glucose deprivation (OGD)	hypoxic-ischemic encephalopathy (HIE)	PC12 cells	oxygen and glucose deprivation-induced treatment	upregulated	25323830
2095	Rat	rno-miR-210	miRNA	losartan	ischemia/reperfusion (I/R) injury	heart tissues	losartan treatment	upregulated	26168042
2096	Rat	rno-miR-210	miRNA	Vagus nerve stimulation (VNS)	ischemia/reperfusion (I/R) injury	brain matrix	Vagus nerve stimulation (VNS) treatment	upregulated	25783636
2097	Rat	rno-miR-210	miRNA	oxygen glucose deprivation (OGD)	ischemic hypoxia (IH)	PC12 rat pheochromocytoma cells	OGD treatment	upregulated	25323830
2098	Rat	rno-miR-210	miRNA	4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)	lung cancer	male F344 rats	was induc systemic NNK treatment	downregulated	24553369
2099	Rat	rno-miR-210	miRNA	Hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia induce	upregulated	29710553
2100	Rat	rno-miR-210	miRNA	CoCl2	myocardial injury	H9c2 cells	CoCl2 treatment	MiR-210 suppressed autophagy by upregulating p62 and downregulating LC3II/I in hypoxic H9C2 cells.	33234216
2101	Rat	rno-miR-210	miRNA	cardiac shock wave therapy (SWT)	myocardial ischaemic injury	HL-1 cells	Cardiac shock wave therapy (SWT) treatment	Cardiac shock wave therapy protects cardiomyocytes from hypoxia-induced injury by modulating miR-210	31974607
2102	Rat	rno-miR-210	miRNA	hypoxia	neonatal brain hypoxia	neural stem cells (NSCs) derived from embryo 14 Sprague-Dawley rats	hypoxia induce	downregulated	29864934
2103	Rat	rno-miR-210	miRNA	salidroside (SAL)	neonatal brain hypoxia	hypoxia-induced neural stem cells (NSCs)	Salidroside treatment	upregulated	29864934
2104	Rat	rno-miR-210	miRNA	hypoxic/ischemic	neonatal hypoxic-ischemic brain damage	brain tissues	hypoxic/ischemic treatment	upregulated in the neonatal rat brain	28672801
2105	Rat	rno-miR-210	miRNA	hypoxia	neurilemmoma	schwannoma RT4-D6P2T cells	1% O2 tri-gas incubator	upregulated	28440459
2106	Rat	rno-miR-210	miRNA	lipopolysaccharide (LPS)	osteoarthritis (OA)	chondrocytes	lipopolysaccharide (LPS) treatment	downregulated	26244598
2107	Rat	rno-miR-210	miRNA	H2O2	oxidative stress	H9c2 cells	H2O2 for 48 h	upregulated	28661226
2108	Rat	rno-miR-210-3p	miRNA	docosahexaenoic Acid (DHA)	apoptosis	H9C2 cardiomyocyte	Docosahexaenoic Acid (DHA) treatment	upregulated	33791918
2109	Rat	rno-miR-210-3p	miRNA	valproic acid (VPA)	cell differentiation	primary cultured neural stem cells (NSCs)	valproate (VPA) treatment	upregulated	29575035
2110	Rat	rno-miR-210-3p	miRNA	cold	cold stress	rats serum	cold conditions (4¡æ for 12h)	downregulated	28477904
2111	Rat	rno-miR-210-3p	miRNA	melamine and cyanuric acid (MEL&CYA)	kidney damage	serum	melamine and cyanuric acid (MEL&CYA) treatment	downregulated	27621052
2112	Rat	rno-miR-210-3p	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia treatment	downregulated	32187165
2113	Rat	rno-miR-210-3p	miRNA	CoCl2	neural stem cells (NSCs) injury	neural stem cells (NSCs)	Cobalt chloride treatment	miR-210-3p was significantly higher in the cobalt chloride-induced hypoxia group.	33000190
2114	Rat	rno-miR-210-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2115	Rat	rno-miR-211	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	bronchoalveolar lavage fluid (BALF)-derived macrophages	lipopolysaccharide (LPS) treatment	upregulated	29402831
2116	Rat	rno-miR-211	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	PC-12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-211 expression was significantly downregulated in PC12 cells in response to OGD/R	32050841
2117	Rat	rno-miR-211	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	upregulated	22156553
2118	Rat	rno-miR-211	miRNA	hypoxia	hypoxic/ischemic injury	striatal tissues	hypoxia treatment	miR-211 was upregulated in striatal tissues of HI group.	30563429
2119	Rat	rno-miR-211	miRNA	radiation	breast cancer	rat mammary cancer tissues	radiation treatment	upregulated	23273170
2120	Rat	rno-miR-211	miRNA	hypoxic/ischemic	neonatal cerebral palsy	striatal tissues	hypoxic-ischemic (HI) treatment	"MIAT overexpression reduced apoptosis of Neuro2A cells through miR-211/GDNF, which relieved HI injury of neonatal rats."	30563429
2121	Rat	rno-miR-211	miRNA	lead (Pb)	nervous system diseases	rats hippocampus	chronic lead exposure treatment	upregulated	24960059
2122	Rat	rno-miR-211	miRNA	tougu xiaotong capsule (TXC)	osteoarthritis (OA)	chondrocyte cells	Tougu Xiaotong capsule (TXC) treatment	upregulated	30342192
2123	Rat	rno-miR-211	miRNA	tougu xiaotong capsule (TXC)	osteoarthritis (OA)	tunicamycin-treated primary chondrocytes	Tougu Xiaotong capsule (TXC) treatment	upregulated	30342192
2124	Rat	rno-miR-211	miRNA	tunicamycin (TM)	osteoarthritis (OA)	primary chondrocytes	tunicamycin (TM) treatment	downregulated	30342192
2125	Rat	rno-miR-211	miRNA	activated protein C(APC)	sepsis	rats blood and liver tissue	activated protein C treatment	aPC treatment coordinates beneficial cytoprotective effects during sepsis by modulating miRNA expression	22940033
2126	Rat	rno-miR-211	miRNA	H2O2	spinal cord injury (SCI)	PC-12 cells	hydrogen peroxide (H2O2 ) treatment	downregulated	30145837
2127	Rat	rno-miR-211	miRNA	high inorganic phosphate (Pi)	vascular calcification (VC)	vascular smooth muscle	high-phosphorous treatment	downregulated	26187577
2128	Rat	rno-miR-211	miRNA	high inorganic phosphate (Pi)	vascular calcification (VC)	vascular smooth muscle	high-phosphorous treatment	lower levels of miR-133b and miR-211 and higher levels of miR-29b	26187577
2129	Rat	rno-miR-211-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	PC-12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-211-5p expression significantly increased in OGD-treated PC12 cells and peaked at 24 h.	32311346
2130	Rat	rno-miR-211-5p	miRNA	dexmedetomidine (DEX)	chronic inflammatory visceral pain (CIVP)	trinitrobenzene sulfonic acid (TNBS)-induced chronic inflammatory visceral pain (CIVP) rats spinal cord	dexamethasone (DEX) treatment	upregulated	30874971
2131	Rat	rno-miR-211-5p	miRNA	trinitrobenzene sulfonic acid (TNBS)	chronic inflammatory visceral pain (CIVP)	spinal cord	trinitrobenzene sulfonic acid (TNBS) treatment	downregulated	30874971
2132	Rat	rno-miR-212	miRNA	cocaine hydrochloride	cocaine addiction	rats brain structures	cocaine hydrochloride was dissolved in sterile 0.9 % NaCl and administered intravenously	upregulated	26944283
2133	Rat	rno-miR-212	miRNA	electroconvulsive stimulation (ECS)	depression	rat brain tissue cells and whole blood cells	electroconvulsive stimulation (ECS) treatment	upregulated	23721784
2134	Rat	rno-miR-212	miRNA	formaldehyde	formaldehyde inducted immune/inflammation	rats	were exposed to formaldehyde treatment	upregulated	24304932
2135	Rat	rno-miR-212	miRNA	adreno-cortico-tropic-hormone (ACTH)	hormonal regulation	adrenals?tissues	adreno-cortico-tropic-hormone (ACTH) treatment	upregulated	24205079
2136	Rat	rno-miR-212	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	upregulated	24205079
2137	Rat	rno-miR-212	miRNA	angiotensin II (Ang II)	hypertension	heart tissues	angiotensin II (Ang II) treatment	upregulated	23712358
2138	Rat	rno-miR-212	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic brain injury	Primary cerebral cortical neuronal cultures	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31651707
2139	Rat	rno-miR-212	miRNA	SiO2	lung injury	lung	SiO2 treatment	upregulated	27689473
2140	Rat	rno-miR-212	miRNA	nanosized SiO2	pulmonary injury	liver tissues	nanosized SiO2 treatment	upregulated	27689473
2141	Rat	rno-miR-212	miRNA	ionizing radiation (IR)	radiation-induced heart disease (RIHD)	heart tissues	ionizing radiation (IR) treatment	upregulated	31380269
2142	Rat	rno-miR-212	miRNA	angiotensin II (Ang II)	renal interstitial fibrosis (RIF)	NRK49F cells	angiotensin II (Ang II) treatment	upregulated	33495813
2143	Rat	rno-miR-212	miRNA	TGF-¦Â1	renal interstitial fibrosis (RIF)	NRK49F cells	TGF-¦Â1 treatment	upregulated	33495813
2144	Rat	rno-miR-212	miRNA	isoproterenol	¦Â-adrenoceptor intervention	rat heart tissues	isoproterenol (ISO)  treatment	upregulated	22847192
2145	Rat	rno-miR-212	miRNA	propranolol (PRO)	¦Â-adrenoceptor intervention	rat heart	propranolol (PRO) treatment	downregulated	22847192
2146	Rat	rno-miR-212-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	rat retinal	streptozotocin (STZ)-induced diabetic rat treatment	differential expressions	24502381
2147	Rat	rno-miR-212-3p	miRNA	angiostrongylus cantonensis (A. cantonensis)	inflammation	healthy male SD rats	angiostrongylus cantonensis (A. cantonensis) infection	upregulated	24142286
2148	Rat	rno-miR-212-3p	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia treatment	upregulated	32196615
2149	Rat	rno-miR-212-3p	miRNA	di(2-ethylhexyl) phthalate (DEHP)	neurotoxicity	female Long Evans rats hippocampal	di(2-ethylhexyl) phthalate (DEHP) treatment	upregulated	28192093
2150	Rat	rno-miR-212-3p	miRNA	di(2-ethylhexyl) phthalate (DEHP)	neurotoxicity	male Long Evans rats hippocampal	di(2-ethylhexyl) phthalate (DEHP) treatment	downregulated	28192093
2151	Rat	rno-miR-212-5p	miRNA	di(2-ethylhexyl) phthalate (DEHP)	neurotoxicity	female Long Evans rats hippocampal	di(2-ethylhexyl) phthalate (DEHP) treatment	upregulated	28192093
2152	Rat	rno-miR-212-5p	miRNA	di(2-ethylhexyl) phthalate (DEHP)	neurotoxicity	male Long Evans rats hippocampal	di(2-ethylhexyl) phthalate (DEHP) treatment	downregulated	28192093
2153	Rat	rno-miR-212-5p	miRNA	lipopolysaccharide (LPS)	sepsis	?H9c2 cells	?lipopolysaccharide (LPS) treatment	downregulated	31806569
2154	Rat	rno-miR-213	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
2155	Rat	rno-miR-21-3p	miRNA	aristolochic acid	acute kidney injury (AKI)	rats kidney	aristolochic acid (AA) treatment	upregulated	27422293
2156	Rat	rno-miR-21-3p	miRNA	aristolochic acid	acute kidney injury (AKI)	kidney	aristolochic acid (AA) treatment	upregulated	27422293
2157	Rat	rno-miR-21-3p	miRNA	gentamicin	acute kidney injury (AKI)	urine	gentamicin treatment	upregulated	33263228
2158	Rat	rno-miR-21-3p	miRNA	Yiqifumai Injection (YQFM)	chronic heart failure (CHF)	H9c2 cells	Yiqifumai Injection (YQFM) treatment	upregulated	29467665
2159	Rat	rno-miR-21-3p	miRNA	high glucose (HG)	diabetic cardiac fibrosis	cardiac fibroblasts	high glucose (HG) treatment	miR-21-3p level was upregulated in high glucose-induced cardiac fibroblasts.	33385416
2160	Rat	rno-miR-21-3p	miRNA	streptozocin (STZ)	diabetic cardiac fibrosis	heart sissues	streptozocin (STZ) treatment	miR-21-3p level was upregulated in STZ-induced diabetic cardiac fibrosis tissues.	33385416
2161	Rat	rno-miR-21-3p	miRNA	steroids	osteonecrosis	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	26459755
2162	Rat	rno-miR-21-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2163	Rat	rno-miR-21-3p	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	downregulated	30595983
2164	Rat	rno-miR-214	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	acute ischemic stroke (AIS)	PC12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	32827544
2165	Rat	rno-miR-214	miRNA	D-galactosamine/lipopolysaccharide (D-GalN/LPS)	acute liver injury (ALI)	hepatic tissues of ALF rats	D©\galactose+LPS treatment	upregulated	30938885
2166	Rat	rno-miR-214	miRNA	zhenbao pill	acute spinal cord injury (ASCI)	cultured CD4+ T cells	Zhenbao Pill treatment	downregulated	30287503
2167	Rat	rno-miR-214	miRNA	isoproterenol	agonism	heart tissues	isoproterenol treatment	upregulated	25925428
2168	Rat	rno-miR-214	miRNA	isoflurane	Alzheimer's disease (AD)	primary cultured rat hippocampal neurons	Isoflurane treatment	downregulated	23408966
2169	Rat	rno-miR-214	miRNA	hydrogen sulfide (H2S)	cardiac fibrosis	thyroxine-induced rats myocardial tissues	Hydrogen sulfide (H2S) treatment	downregulated	29743447
2170	Rat	rno-miR-214	miRNA	isoproterenol	cardiac fibrosis	cardiac fibroblast (CF)	"isoproterenol (ISO, a ¦Â-AR agonist) treatment"	upregulated	26692091
2171	Rat	rno-miR-214	miRNA	thyroxine	cardiac fibrosis	myocardial tissues	thyroxine treatment	upregulated	29743447
2172	Rat	rno-miR-214	miRNA	fish oil and pectin	colorectal cancer (CRC)	colon tissue of rats	corn oil ¡À fish oil with pectin ¡À cellulose	upregulated	21406606
2173	Rat	rno-miR-214	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	Wistar rats left ventricle (LV)	STZ treatment	downregulated	28199183
2174	Rat	rno-miR-214	miRNA	streptozocin (STZ)	diabetic corneal endothelial keratopathy	corneal endothelial cells	streptozotocin (STZ) treatment	downregulated	31693400
2175	Rat	rno-miR-214	miRNA	Xuesaitong (XST)	diabetic nephropathy (DN)	glomeruli	Xuesaitong (XST) treatment	XST significantly reduced the miR-214 mRNA expression in diabetic glomeruli	32051833
2176	Rat	rno-miR-214	miRNA	high glucose (HG)	diabetic nephropathy (DN)	rat glomerular MCs	25 mM glucose for 24 h	upregulated	28701356
2177	Rat	rno-miR-214	miRNA	desflurane	cell differentiation	primary rat hippocampal neurons	desflurane treatment	downregulated	24021802
2178	Rat	rno-miR-214	miRNA	adreno-cortico-tropic-hormone (ACTH)	hormonal regulation	adrenals?tissues	adreno-cortico-tropic-hormone (ACTH) treatment	downregulated	24205079
2179	Rat	rno-miR-214	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	downregulated	24205079
2180	Rat	rno-miR-214	miRNA	hypoxia	hypoxia-induced injury	neural stem cells (NSCs)	hypoxia induce	upregulated	31282213
2181	Rat	rno-miR-214	miRNA	puerarin	hypoxia-induced injury	hypoxia-induced neural stem cells (NSCs)	Puerarin treatment	further upregulated	31282213
2182	Rat	rno-miR-214	miRNA	hypoxia	ischemic heart disease (IHD)	H9c2 cells	hypoxia induce	downregulated	31220945
2183	Rat	rno-miR-214	miRNA	oridonin	ischemic heart disease (IHD)	hypoxia-induced H9c2 cells	Oridonin (Orid) treatment	upregulated	31220945
2184	Rat	rno-miR-214	miRNA	H2O2	apoptosis	L6 SKM cells	H2O2 treatment	H2O2 could significantly increase miR-214 gene expression in L6 SKM.	32131653
2185	Rat	rno-miR-214	miRNA	ketamine	learning and memory impairment and neurodegeneration	brain tissues	ketamine administered at a dose of 80 mg/kg treatment	downregulated	24914689
2186	Rat	rno-miR-214	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	upregulated	29915227
2187	Rat	rno-miR-214	miRNA	sevoflurane (SEV)	liver damage	BRL-3a cells	sevoflurane treatment	Exposure to sevoflurane upregulated the expression level of miR-214	29226348
2188	Rat	rno-miR-214	miRNA	massive small bowel resection	lung cancer	rat jejunum and IEC-6 cells	massive small bowel resection treatment	upregulated	22418008
2189	Rat	rno-miR-214	miRNA	nicotine	nicotine intake	female rats prefrontal cortex (PFC) tissues	nicotine exposure	upregulated	30504847
2190	Rat	rno-miR-214	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
2191	Rat	rno-miR-214	miRNA	propofol (PPF)	propofol-induced neuroapoptosis	serum	propofol treatment	The serum level of miR-214 expression was observed to be significantly upregulated in propofol-induced neuroapoptosis rats	30106086
2192	Rat	rno-miR-214	miRNA	X-rays	radiation-induced skin injury	rats irradiated skin	45-Gy electron beam treatment	upregulated	24447893
2193	Rat	rno-miR-214	miRNA	H2O2	reactive oxygen species (ROS)-induced cardiac myocyte injury	Sprague¨CDawley rats cardiac myocytes	H2O2 treatment	upregulated	23904244
2194	Rat	rno-miR-214	miRNA	TGF-¦Â	renal injury	rat tubular epithelial cells (NRK52E)	Transforming growth factor (TGF)-¦Â? treatment	upregulated	21704009
2195	Rat	rno-miR-214	miRNA	electroacupuncture (EA)	spinal cord injury (SCI)	SCI rats	electroacupuncture (EA) treatment	upregulated	28298073
2196	Rat	rno-miR-214	miRNA	hypoxia/reoxygenation (H/R)	spinal cord ischemia/reperfusion injury (SCII)	PC12 cells	hypoxia/reoxygenation (H/R) treatment	Foxd3 induces spinal cord ischemia-reperfusion injury by potentiating microRNA-214-dependent inhibition of Kcnk2	31959866
2197	Rat	rno-miR-214	miRNA	CoCl2	vascular senescence	Rat aortic vascular smooth muscle cell (A7r5)	CoCl2 treatment	miR-214 level was elevated in both intracellular and exosome samples of VSMCs after CoCl2 treatment.	32410577
2198	Rat	rno-miR-214	miRNA	exercise training (ET)	ventricular contractile dysfunction	cardiac	exercise training treatment	exercise training restores microRNA-1 and -214 expression levels	26646371
2199	Rat	rno-miR-214	miRNA	isoproterenol	¦Â-adrenoceptor intervention	rat heart tissues	isoproterenol (ISO)  treatment	upregulated	22847192
2200	Rat	rno-miR-214-3p	miRNA	particulate matter (PM2.5)	allergic rhinitis (AR)	nasal mucosa	particulate matter 2.5 (PM2.5) treatment	upregulated	32192351
2201	Rat	rno-miR-214-3p	miRNA	estradiol benzoate (EB)	chronic inflammatory diseases	dorsolateral prostate	estradiol benzoate (EB) treatment	upregulated	33332750
2202	Rat	rno-miR-214-3p	miRNA	testosterone	chronic inflammatory diseases	dorsolateral prostate	estradiol benzoate (EB) treatment	downregulated	33332750
2203	Rat	rno-miR-214-3p	miRNA	high glucose (HG)	diabetic corneal endothelial keratopathy	rat corneal endothelial cells	high glucose treatment	downregulated	31693400
2204	Rat	rno-miR-214-3p	miRNA	high fat diet (HFD)	hyperlipidemic pancreatitis (HP)	"kidney, pancreas and serum"	high fat diet (HFD) feed	upregulated	31790686
2205	Rat	rno-miR-214-3p	miRNA	Sodium taurocholate	hyperlipidemic pancreatitis (HP)	"kidney, pancreas and serum"	long-term high-fat diet and sodium taurocholic injection treatment	upregulated	31790686
2206	Rat	rno-miR-214-3p	miRNA	salt	hypertension	renal outer medulla	salt treatment	miR-214-3p in the renal outer medulla was significantly more abundant in SS rats on the 4% NaCl diet compared with SS13BN26 rats	30049682
2207	Rat	rno-miR-214-3p	miRNA	hypoxia	pulmonary hypertension (PH)	pulmonary artery smooth muscle cells (PASMCs)	hypoxia induce	upregulated	31373336
2208	Rat	rno-miR-214-3p	miRNA	tetramethylpyrazine (TMP)	spinal cord injury (SCI)	SCI Sprague-Dawley rats spinal cord	TMP treatment	downregulated	28802236
2209	Rat	rno-miR-214-3p	miRNA	escitalopram	stress-induced depression	nucleus accumbens (NAc) tissues	Escitalopram treatment	dysregulated	31856805
2210	Rat	rno-miR-214-5p	miRNA	hypoxia	myocardial injury	H9c2 cells	hypoxia exposure	LncRNA RMRP accelerates hypoxia-induced injury by targeting miR-214-5p in H9c2 cells.	31839421
2211	Rat	rno-miR-214-5p	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia induce	downregulated	32864001
2212	Rat	rno-miR-215	miRNA	doxorubicin (DOX)	cardiac injury	?rat heart	doxorubicin treatment	upregulated	22859947
2213	Rat	rno-miR-215	miRNA	connective tissue growth factor (CTGF)	gastric cancer (GC)	NRK-52E cells	CTGF treatment	downregulated	20393144
2214	Rat	rno-miR-215	miRNA	TGF-¦Â	gastric cancer (GC)	NRK-52E cells	TGF-¦Â treatment	downregulated	20393144
2215	Rat	rno-miR-215	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	downregulated	27535721
2216	Rat	rno-miR-215	miRNA	fish oil and pectin	colorectal cancer (CRC)	colon tissue of rats	corn oil ¡À fish oil with pectin ¡À cellulose	upregulated	21406606
2217	Rat	rno-miR-215	miRNA	citrulline	gastrointestinal toxicity	rats	citrulline treatment	"Fecal miR-215 levels upregulated, and plasma miR-215 downregulatedd"	27189632
2218	Rat	rno-miR-215	miRNA	high fat diet (HFD)	hepatic insulin resistance	liver tissues	high fat diet (HFD) feed	upregulated	30896868
2219	Rat	rno-miR-215	miRNA	ethanol (EtOH)	oxidative stress	rat normal hepatocyte (BRL)	ethanol treatment	upregulated	23905774
2220	Rat	rno-miR-215	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	downregulated	21094214
2221	Rat	rno-miR-215	miRNA	Jianpi Xiaoke (JPXK)	type 2 diabetes mellitus (T2DM)	rat	Jianpi Xiaoke (JPXK) treatment	downregulated	33456489
2222	Rat	rno-miR-215-5p	miRNA	lipopolysaccharide (LPS)	sepsis-induced myocardial injury	H9c2 cells	lipopolysaccharide (LPS) treatment	MiR-215-5p was overtly downregulated in LPS-treated H9c2 cells.	31806569
2223	Rat	rno-miR-21-5p	miRNA	cadmium (Cd)	cadmium (Cd)-induced kidney injury	renal cortex	cadmium (Cd) treatment	upregulated	29543730
2224	Rat	rno-miR-21-5p	miRNA	rapamycin	cardiac fibrosis	heart tissues	rapamycin (Rap) treatment	upregulated	30647817
2225	Rat	rno-miR-21-5p	miRNA	hypoxia	cardiac injury	Rat H9C2 cells and isolated primary cardiomyocytes	hypoxia induce	downregulated	31782491
2226	Rat	rno-miR-21-5p	miRNA	prostaglandin E1 (PGE1)	cardiac injury	hypoxia/reoxygenation (H/R)-induced?rat H9C2 cells and isolated primary cardiomyocytes	Prostaglandin-E1 (PGE1) treatment	upregulated	31782491
2227	Rat	rno-miR-21-5p	miRNA	high glucose (HG)	diabetes mellitus-induced erectile dysfunction (DMED)	corpus cavernosum smooth muscle cells (CCSMCs)	high glucose (HG) treatment	downregulated	32808325
2228	Rat	rno-miR-21-5p	miRNA	allylamine (AAM)	drug-induced cardiac injury (DICI)	heart tissues	allylamine treatment	upregulated	29355689
2229	Rat	rno-miR-21-5p	miRNA	isoproterenol	drug-induced cardiac injury (DICI)	heart tissues	isoproterenol treatment	upregulated	29355689
2230	Rat	rno-miR-21-5p	miRNA	atorvastatin	endothelial senescence	high-fat diet-induced hyperlipidemic rats plasma	atorvastatin treatment	downregulated	29248491
2231	Rat	rno-miR-21-5p	miRNA	high fat diet (HFD)	endothelial senescence	plasma	high fat diet (HFD) feed	upregulated	29248491
2232	Rat	rno-miR-21-5p	miRNA	kainic acid (KA)	epilepsy	hippocampus	kainic acid treatment	upregulated	29751355
2233	Rat	rno-miR-21-5p	miRNA	lithium chloride and pilocarpine	epilepsy	hippocampal neuron	lithium chloride and pilocarpine induce	"?FTX is notably reduced in the hippocampus of SE rat model. Moreover, the in?vivo overexpression of FTX inhibited SE-induced hippocampus neuron apoptosis."	30871773
2234	Rat	rno-miR-21-5p	miRNA	melatonin	fibroblast-myofibroblast transdifferentiation (FMT)	NRK-49F cells	Melatonin treatment	Melatonin remarkably attenuated the expression of miR-21-5p.	32243691
2235	Rat	rno-miR-21-5p	miRNA	perfluorooctane sulfonic acid (PFOS)	hepatotoxicity	liver tissues	Perfluorooctanesulfonate (PFOS) treatment	downregulated	26724606
2236	Rat	rno-miR-21-5p	miRNA	high fat diet (HFD)	hyperlipidemia	rats plasma	high fat diet (HFD) feed	upregulated	29248491
2237	Rat	rno-miR-21-5p	miRNA	H2O2	hyperoxia-induced acute lung injury (HALI)	rat type II alveolar epithelial cells (AECII)	hydrogen peroxide (H2O2) treatment	downregulated	29436647
2238	Rat	rno-miR-21-5p	miRNA	perfluorooctane sulfonic acid (PFOS)	liver damage	liver tissues	Perfluorooctanesulfonate (PFOS) treatment	downregulated	26724606
2239	Rat	rno-miR-21-5p	miRNA	steroids	osteonecrosis of femoral head (ONFH)	serum	steroid treatment	upregulated	29887962
2240	Rat	rno-miR-21-5p	miRNA	bortezomib	peripheral neuropathy	PC12 cells	bortezomib treatment	downregulated	31979371
2241	Rat	rno-miR-21-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2242	Rat	rno-miR-21-5p	miRNA	glucocorticoid (GC)	steroid-induced osteonecrosis of femoral head (ONFH)	bone marrow-derived mesenchymal stem cells (BMSCs)	Glucocorticoid (GC)? treatment	"We found that CircPVT1 was decreased in the femoral head of SIONFH rats and GC-treated BMSCs, while miR-21-5p was markedly upregulated."	33733589
2243	Rat	rno-miR-216a	miRNA	TGF-¦Â	acute pancreatitis (AP)	AR42J cells	TGF-¦Â treatment	upregulated	25501921
2244	Rat	rno-miR-216a	miRNA	cerulein or cyanohydroxybutene (CHB)	exocrine pancreatic injury (EPIJ)	serum	cerulein or cyanohydroxybutene (CHB) treatment	upregulated	24285669
2245	Rat	rno-miR-216a	miRNA	cerulein or cyanohydroxybutene (CHB)	exocrine pancreatic injury (EPIJ)	serum	rats were administered cerulein or CHB to induce EPIJ treatment	upregulated	24285669
2246	Rat	rno-miR-216a	miRNA	TGF-¦Â	liver cirrhosis	Rat pluripotent LPC-like WB-F344 cells	Hepatic transforming growth factor beta?treatment treatment	TGF-¦Â-induced Akt activation and LPC transformation was mediated by microRNA-216a-modulated phosphatase and tensin homolog deleted on chromosome 10 (PTEN) suppression	22898879
2247	Rat	rno-miR-216a	miRNA	TGF-¦Â1	renal interstitial fibrosis (RIF)	NRK-52E cells	Transforming growth factor-¦Â1 (TGF-¦Â1) treatment	upregulated	31378905
2248	Rat	rno-miR-216a	miRNA	yttrium aluminium garnet (YAG) laser	retinal injury	retinal tissue	yttrium aluminium garnet (YAG) laser treatment	downregulated	30541958
2249	Rat	rno-miR-216a-5p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	rat retinal	streptozotocin (STZ)-induced diabetic rat treatment	differential expressions	24502381
2250	Rat	rno-miR-216a-5p	miRNA	ginsenoside Rg1	spinal cord injury (SCI)	H2O2-treated PC-12 cell	Ginsenoside Rg1 treatment	upregulated	31605711
2251	Rat	rno-miR-216a-5p	miRNA	H2O2	spinal cord injury (SCI)	PC-12 cell	H2O2 treatment	downregulated	31605711
2252	Rat	rno-miR-216b	miRNA	doxorubicin (DOX)	cardiac injury	?rat heart	doxorubicin treatment	upregulated	22859947
2253	Rat	rno-miR-216b-5p	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	upregulated	32893733
2254	Rat	rno-miR-217	miRNA	streptozocin (STZ)	atherosclerosis (AS)	aortic	streptozocin (STZ) treatment	downregulated	33283391
2255	Rat	rno-miR-217	miRNA	silk ascending aorta proximal	cardiac hypertrophy	Sprague Dawley rats cardiomyocytes	silk suture was tightened around the ascending aorta proximal to the brachiocephalic trunk treatment	downregulated in cardiomyocytes	27893464
2256	Rat	rno-miR-217	miRNA	lipopolysaccharide (LPS)	cell differentiation	differentiated BM-MSCs	lipopolysaccharide (LPS) treatment	"In hepatocytes differentiated from BM-MSCs, miR-217 was downregulated and lncRNA MALAT1 was upregulated. RIP analysis showed MALAT1 was physically associated with miR-217 and might function in the regulation of ZEB-1, further enhancing the expression of TERT so as to augment telomerase activity."	30658864
2257	Rat	rno-miR-217	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	Primary rat cerebral cortical neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	upregulated	31173187
2258	Rat	rno-miR-217	miRNA	streptozocin (STZ)	diabetic foot ulcer (DFU)	serum	streptozotocin (STZ) treatment	upregulated	31079353
2259	Rat	rno-miR-217	miRNA	carbon tetrachloride (CCl4)	liver damage	hepatocytes	carbon tetrachloride (CCl4) treatment	upregulated	30417525
2260	Rat	rno-miR-217	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia induce	The expression of miR-217 was significantly decreased after hypoxia treatment.	30843674
2261	Rat	rno-miR-217-5p	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	upregulated	32893733
2262	Rat	rno-miR-218	miRNA	bleomycin and IgG IC	acute lung injury (ALI)	lung tissues	bleomycin and IgG IC treatment	MicroRNA-218 was significantly downregulated in bleomycin and IgG IC-induced lung injury rat model.	30556885
2263	Rat	rno-miR-218	miRNA	homocysteine (Hcy)	coronary artery disease (CAD)	cardiac microvascular endothelial cells (CMECs)	homocysteine (HCY) treatment	downregulated	31566720
2264	Rat	rno-miR-218	miRNA	high glucose (HG)	diabetic nephropathy (DN)	NRK-52E cells	high glucose (HG) treatment	downregulated	33615661
2265	Rat	rno-miR-218	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin treatment	downregulated	31549412
2266	Rat	rno-miR-218	miRNA	mixture of oleate and palmitate	nonalcoholic steatohepatitis (NASH)	BRL-3A cells	mixture of oleate and palmitate treatment	downregulated	31850710
2267	Rat	rno-miR-218	miRNA	high fat diet (HFD)	obesity	rats	high fat diet (HFD) feed	dysregulated	24517225
2268	Rat	rno-miR-218	miRNA	N-3 polyunsaturated fatty acids (PUFA)	post-menopausal depression	brain tissues	N-3 polyunsaturated fatty acids (PUFA) treatment	"N-3 PUFA decreased blood levels of adrenocorticotropic hormone and corticosterone, and brain expressions of corticotropin-releasing factor and miRNA-218, which increased the expression of the glucocorticoid receptor. N-3 PUFA decreased the expression of tumor necrosis factor-¦Á, interleukin (IL)-6, IL-1¦Â, and prostaglandin E2, while increased the expression of miRNA-155."	33548474
2269	Rat	rno-miR-218	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	spinal cord injury (SCI)	astrocytes	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	CCAT1 Protects Astrocytes Against OGD/R-Induced Damage by Targeting the miR-218/NFAT5-Signaling Axis	32239388
2270	Rat	rno-miR-218-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	acute ischemic stroke (AIS)	PC-12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	MiR-218-5p level was notably increased in OGD/R injured PC12 cells	32048632
2271	Rat	rno-miR-218a-2-3p	miRNA	FK506	osteogenesis	rat bone marrow stromal cells (BMSCs)	FK506 treatment	downregulated	28560399
2272	Rat	rno-miR-218a-5p	miRNA	emodin	intestinal dysfunction	intestinal tract	Emodin treatment	emodin reduced the expression of miR-218a-5p in the intestinal tract.	32664763
2273	Rat	rno-miR-218a-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2274	Rat	rno-miR-218b	miRNA	ochratoxin A (OTA)	ochratoxin A (OTA) nephrotoxicity	kidney?tissues	OTA nephrotoxicity treatment	suppressed in mid dose but then elevated in high dose	24885635
2275	Rat	rno-mir-218b	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2276	Rat	rno-miR-219	miRNA	angiotensin II (Ang II)	liver fibrosis	Hepatic stellate cells (HSCs)	angiotensin II (Ang II) treatment	downregulated	30592264
2277	Rat	rno-miR-219-2-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	downregulated	22156553
2278	Rat	rno-miR-219-5p	miRNA	hypoxia	congenital heart disease (CHD)	H9C2 cells	hypoxia induce	The data showed that miR-219-5p expression was higher in patients with cyanotic CHD compared with patients with acyanotic CHD gradually increased in H9C2 cells with prolonged hypoxia time.	33262822
2279	Rat	rno-miR-219-5p	miRNA	morphine	morphine tolerance	spinal cord of rats	10 ¦Ìg morphine sulfate (in a volume of 10 ¦ÌL) was delivered via an intrathecal catheter twice daily for 7 d	downregulated in spinal cord of rats	28423675
2280	Rat	rno-miR-219-5p	miRNA	pulsed electromagnetic field (PEMF)	spinal cord injury (SCI)	primary oligodendrocyte precursor cells (OPCs)	?low frequency pulsed electromagnetic field (PEMF)?treatment treatment	upregulated	30885522
2281	Rat	rno-miR-219-5p	miRNA	acute stress (AS) and chronic stress (CS)	stress-induced myocardial injury	rat	Rats were bound and suspended treatment	upregulated	24669248
2282	Rat	rno-miR-219a-1-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2283	Rat	rno-miR-219a-2-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	inflammation	primary brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"?In particular, the expression levels of rno-miR-666-3p, rno-miR-92a-2-5p, and rno-miR-219a-2-3p decreased in OGD/R-exposed cells compared with those in the control"	33745435
2284	Rat	rno-miR-219a-2-3p	miRNA	insulin-like growth factor 1 (IGF-1)	spinal cord injury (SCI)	Neural stem cells were obtained from E15 fetal rat cerebral cortex cultured supernatant exosomes	insulin growth factor-1 (IFG-1) treatment	upregulated	31848325
2285	Rat	rno-miR-219a-5p	miRNA	ethanol (EtOH)	chronic alcoholic liver disease (ALD)	liver tissues	Ethanol exposure	downregulated	31428222
2286	Rat	rno-miR-219a-5p	miRNA	protocatechuic acid (PCA)	chronic alcoholic liver disease (ALD)	liver tissues	Protocatechuic acid (PCA) treatment	upregulated	31428222
2287	Rat	rno-miR-219a-5p	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	nucleus accumbens (NAc) was isolated from rat whole brain	methamphetamine (METH) self-administration (SA)	upregulated	30867225
2288	Rat	rno-miR-219a-5p	miRNA	electroacupuncture (EA)	spinal cord injury (SCI)	spinal cords	electroacupuncture (EA) treatment	downregulated	32468009
2289	Rat	rno-miR-22	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	hippocampus	amyloid ¦Â1-42?(A¦Â) treatment	downregulated	30672441
2290	Rat	rno-miR-22	miRNA	caerulein (Cae)	apoptosis	AR42J cells	caerulein (Cae) treatment	upregulated	30568389
2291	Rat	rno-miR-22	miRNA	angiotensin II (Ang II)	cardiac fibrosis	neonatal rat cardiac fibroblasts (CFs)	angiotensin II (Ang II) treatment	upregulated	29486470
2292	Rat	rno-miR-22	miRNA	2-acetylaminofluorene	hepatocellular carcinoma (HCC)	liver tissue of rats	2-acetylaminofluorene treatment	downregulated	22213190
2293	Rat	rno-miR-22	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
2294	Rat	rno-miR-22	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	hypoxic-ischemic encephalopathy (HIE)	neural stem cells (NSCs)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	32052645
2295	Rat	rno-miR-22	miRNA	ionizing radiation (IR)	ionizing radiation (IR) injury	Bone marrow mesenchymal stromal cells (BMSCs)	"The cells were subjected to IR (electrons) using 6 MeV (Precise Treatment System, Elekta, Sweden) at a dosage of 6 Gy and a dose rate of 600 Mu."	upregulated	30846680
2296	Rat	rno-miR-22	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemia/reperfusion (I/R) injury	PC-12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-22 expression was significantly downregulated in the PC12 cells subjected to I/R.	32065044
2297	Rat	rno-miR-22	miRNA	ischemia/reperfusion (I/R) 	ischemia/reperfusion (I/R) injury	myocardial in rats	ischemia/reperfusion (I/R) treatment	upregulated	24338162
2298	Rat	rno-miR-22	miRNA	hypoxia/reoxygenation (H/R)	ischemic heart disease (IHD)	Neonatal rat ventricular cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	downregulated	26707060
2299	Rat	rno-miR-22	miRNA	starvation	ischemic heart disease (IHD)	cardiomyocytes (NRCMs)	starvation treatment	downregulated	27544030
2300	Rat	rno-miR-22	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	PC12 cells (a rat pheochromocytoma cell line)	oxygen glucose deprivation (OGD) treatment	downregulated	31115561
2301	Rat	rno-miR-22	miRNA	angelica polysaccharide (AP)	myocardial infarction (MI)	H9c2 cells	angelica polysaccharide (AP) treatment	ASP pretreatment attenuated hypoxia-induced H9c2 cell injury.	29960169
2302	Rat	rno-miR-22	miRNA	hypoxia	myocardial infarction (MI)	Primary neonatal rat ventricular cardiomyocytes (PNCM) and H9C2 cells	hypoxia induce	upregulated	31581847
2303	Rat	rno-miR-22	miRNA	lentinan (LNT)	myocardial infarction (MI)	hypoxia-induced primary neonatal rat ventricular cardiomyocytes (PNCM) and H9C2 cells	Lentinan (LEN) treatment	downregulated	31581847
2304	Rat	rno-miR-22	miRNA	curcumin (Cur)	neointimal hyperplasia	vascular smooth muscle cells (VSMC)	curcumin treatment	Curcumin increased the expression of miR-22.	32631202
2305	Rat	rno-miR-22	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
2306	Rat	rno-miR-22	miRNA	6-hydroxydopamine (6-OHDA)	parkinson's disease (PD)	PC12 cells	6-hydroxydopamine (6-OHDA) treatment	downregulated	27631550
2307	Rat	rno-miR-22	miRNA	insulin-like growth factor 1 (IGF-1)	post-stroke	brain tissues	Post-stroke ICV administration of IGF-1 to middle-aged female rats treatment	downregulated	24618563
2308	Rat	rno-miR-22	miRNA	high glucose (HG)	renal tubulointerstitial fibrosis (TIF)	NRK-52E cells	high glucose (HG) treatment	upregulated	29850604
2309	Rat	rno-miR-22	miRNA	streptozocin (STZ)	renal tubulointerstitial fibrosis (TIF)	renal Tissues	streptozocin (STZ) treatment	upregulated	29850604
2310	Rat	rno-mir-22	miRNA	hypoxia/reoxygenation (H/R)	reperfusion injury	rat cardiomyocytes;	hypoxia and hypoxia-reoxygenation treatment	upregulated	32826883
2311	Rat	rno-miR-22	miRNA	escherichia coli (E.coli)	sepsis-induced acute kidney injury	kidney tissues	Escherichia coli infection	"TapSAKI was elevated in urine derived sepsis-induced kidney injury, and promoted HK-2 cell apoptosis and inflammatory response through miR-22/PTEN/TLR4/NF-¦ÊB pathway."	30666657
2312	Rat	rno-miR-22	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
2313	Rat	rno-miR-22	miRNA	scratch	traumatic brain injury (TBI)	neuronal cell	scratch treatment	downregulated	27186313
2314	Rat	rno-miR-22	miRNA	isoproterenol	¦Â-adrenoceptor intervention	rat heart tissues	isoproterenol (ISO)  treatment	upregulated	22847192
2315	Rat	rno-miR-221	miRNA	TGF-¦Â	adaptation of tendons to mechanical loading	rat Tendon fibroblasts	Transforming growth factor-¦Â(TGF-¦Â) treatment	upregulated	22539168
2316	Rat	rno-miR-221	miRNA	nicotine	allergic asthma (AA)	lung tissues	nicotine injections	upregulated	28381639
2317	Rat	rno-miR-221	miRNA	L©\arginine	atherosclerosis (AS)	endothelial cells	L-Arginine treatment	L-Arginine Ameliorates High-Fat Diet-Induced Atherosclerosis by Downregulating miR-221.	32090093
2318	Rat	rno-miR-221	miRNA	TGF-¦Â1	bladder cancer	Human bladder cancer cell lines (RT4 and T24)	TGF-¦Â1 treatment	upregulated	25928257
2319	Rat	rno-miR-221	miRNA	N-methyl-N-nitrosourea (MNU)	breast cancer	rats with experimental breast cancer Thoracic Duct Lymph	N-Methyl-N-Nitrosourea	dysregulatedin Thoracic Duct Lymph	28091921
2320	Rat	rno-miR-221	miRNA	hydrogen sulfide (H2S)	cardiac fibrosis	thyroxine-induced rats myocardial tissues	Hydrogen sulfide (H2S) treatment	upregulated	29743447
2321	Rat	rno-miR-221	miRNA	thyroxine	cardiac fibrosis	myocardial tissues	thyroxine treatment	downregulated	29743447
2322	Rat	rno-miR-221	miRNA	ischemia	chronic constriction injury	rat spinal cord	ligation of the sciatic nerve treatment	"The expression levels of a large number of miRNAs in the dorsal horn of the spinal cord in CCI rats changed (miR-500, -221 and -21)"	23124577
2323	Rat	rno-miR-221	miRNA	mitomycin C-polylactic acid ( MMC-PLA) film	epidural scar hyperplasia and adhesion	post-laminectomy rat scar tissues	25 mg of PLA film containing 0.01% MMC was implanted on the laminectomy area	downregulated	28617531
2324	Rat	rno-miR-221	miRNA	high glucose (HG)	gestational diabetes mellitus (GDM)	rat INS-1?cell	high glucose (HG) treatment	downregulated	31587871
2325	Rat	rno-miR-221	miRNA	diethylnitrosamine (DEN)	hepatocellular carcinoma (HCC)	liver tissues and HepG2 cells	diethylnitrosamine (DEN) treatment	upregulated	31801250
2326	Rat	rno-miR-221	miRNA	oroxin B (OB)	hepatocellular carcinoma (HCC)	DEN-treated liver tissues and HepG2 cells	Oroxin B (OB) treatment	downregulated	31801250
2327	Rat	rno-miR-221	miRNA	overfeeding	insulin resistance (IR)	liver tissues	overfeeding treatment	Overfeeding induces hepatic miR-221 expression.	32305038
2328	Rat	rno-miR-221	miRNA	"DDT (2,2-dichlorodiphenyl-1,1,1-trichloroethane), benzo[a]pyrene (BP), and 3-methylcholanthrene (MC)"	post-transcriptional regulation	?the livers and ovaries of chemically induced rats	"DDT, benzo[a]pyrene (BP), and 3-methylcholanthrene (MC) treatment"	downregulated	24727239
2329	Rat	rno-miR-221	miRNA	propofol (PPF)	mast cell degranulation	RBL-2H3 cells	Propofol treatment	Propofol inhibited miR-221 expression in a dose-dependent manner	30116391
2330	Rat	rno-miR-221	miRNA	hypoxia/reoxygenation (H/R)	myocardial infarction (MI)	H9c2 and rat cardiac fibroblast (cFB)	hypoxia and reoxygenation (H/R) induce	downregulated	31261033
2331	Rat	rno-miR-221	miRNA	lipopolysaccharide (LPS)	myocarditis	H9c2 cells	lipopolysaccharide (LPS) treatment	"?miR-221 was negatively regulated by lncRNA CHRF. LncRNA CHRF silence did not protect H9c2 cells against LPS when miR-221 was suppressed. Also, the inhibitory effects of lncRNA CHRF silence on the activation of NF-¦ÊB and JNK pathways were flattened by miR-221 suppression."	30695715
2332	Rat	rno-miR-221	miRNA	chronic constriction injury (CCI)	neuropathic pain (NP)	spinal cord and the isolated microglia	chronic constrictive injury (CCI) treatment	upregulated	27059231
2333	Rat	rno-miR-221	miRNA	estradiol	obesity	high fat (HF) diet-induced obesity rats liver tissues	estradiol treatment	upregulated	29957877
2334	Rat	rno-miR-221	miRNA	postnatal overfeeding	obesity	rat liver tissue	postnatal overfeeding treatment	We first report postnatal overfeeding induces hepatic miR-221 expression	32305038
2335	Rat	rno-miR-221	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
2336	Rat	rno-miR-221	miRNA	cadmium (Cd)	ovary structure and function	Wistar rats	cadmium (Cd) treatment	upregulated	24462979
2337	Rat	rno-miR-221	miRNA	estradiol-17¦Â (E2)	oxidative stress	liver tissues	estradiol-17¦Â (E2) treatment	downregulated	30574741
2338	Rat	rno-miR-221	miRNA	6-hydroxydopamine (6-OHDA)	parkinson's disease (PD)	PC12 cells	6-hydroxydopamine (6-OHDA) treatment	miRNA-221 is significantly lower in 6-OHDA treated PC12 pheochromocytoma cells compared to the normal cells.	29405726
2339	Rat	rno-miR-221	miRNA	crocin	parkinson's disease (PD)	striatal tissueS	crocin treatment	Crocin upregulated the expression of miRNA-221.	31811872
2340	Rat	rno-miR-221	miRNA	rotenone (ROT)	parkinson's disease (PD)	striatal tissueS	rotenone (ROT) treatment	miRNA-221 was significantly repressed upon ROT treatment	31811872
2341	Rat	rno-miR-221	miRNA	rotenone (ROT)	parkinson's disease (PD)	striatal tissueS	rotenone (ROT) treatment	miRNA-7 was significantly repressed upon ROT treatment	31811872
2342	Rat	rno-miR-221	miRNA	angiotensin II (Ang II)	renal fibrosis	rat kidney interstitial fibroblast (NRK-49F) cells	angiotensin II (Ang II) treatment	upregulated	25228106
2343	Rat	rno-miR-221	miRNA	hypoxia	stroke	rat brain tissues	Transient focal ischemia was induced by intraluminal occlusion of the right Middle cerebral artery occlusion (MCAO)	"GAS5 was upregulated in MCAO rats and in vitro hypoxia cell model while miR-221 expression was decreased in vitro hypoxia cell model. GAS5 promoted cells apoptosis, while miR-221 inhibited cell apoptosis through regulation of PUMA and downstream JNK/H2AX signaling."	31878844
2344	Rat	rno-miR-221-3p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	myocardium	high glucose (HG) treatment	upregulated	33313941
2345	Rat	rno-miR-221-3p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	H9c2 cells	high glucose (HG) treatment	"GAS5 downregulated high blood glucose concentrations in STZ-induced diabetic rats, however its expression levels decreased in both HG-processed H9C2 cells and the myocardium of DM model rats."	33313941
2346	Rat	rno-miR-221-3p	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	myocardium	streptozotocin (STZ) treatment	upregulated	33313941
2347	Rat	rno-miR-221-3p	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	H9c2 cells	streptozotocin (STZ) treatment	"GAS5 downregulated high blood glucose concentrations in STZ-induced diabetic rats, however its expression levels decreased in both HG-processed H9C2 cells and the myocardium of DM model rats"	33313941
2348	Rat	rno-miR-221-3p	miRNA	H2O2	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	H2O2 treatment	The expression of miR-221-3p was elevated in H2O2-incubated cells.	29693157
2349	Rat	rno-miR-2218	miRNA	quercetin	oxidative stress	PC-12 cells	Quercetin treatment	downregulated	33343808
2350	Rat	rno-miR-222	miRNA	TGF-¦Â	adaptation of tendons to mechanical loading	rat Tendon fibroblasts	Transforming growth factor-¦Â(TGF-¦Â) treatment	upregulated	22539168
2351	Rat	rno-miR-222	miRNA	N-methyl-N-nitrosourea (MNU)	breast cancer	rats with experimental breast cancer Thoracic Duct Lymph	N-Methyl-N-Nitrosourea	dysregulatedin Thoracic Duct Lymph	28091921
2352	Rat	rno-miR-222	miRNA	"DDT (2,2-dichlorodiphenyl-1,1,1-trichloroethane), benzo[a]pyrene (BP), and 3-methylcholanthrene (MC)"	post-transcriptional regulation	?the livers and ovaries of chemically induced rats	"DDT, benzo[a]pyrene (BP), and 3-methylcholanthrene (MC) treatment"	downregulated	24727239
2353	Rat	rno-miR-222	miRNA	nickel	muscle tumor	rat muscle tumor tissue	nickel treatment	upregulated	23447020
2354	Rat	rno-miR-222	miRNA	cadmium (Cd)	ovary structure and function	Wistar rats	cadmium (Cd) treatment	upregulated	24462979
2355	Rat	rno-miR-222	miRNA	activated protein C(APC)	sepsis	rats blood and liver tissue	activated protein C treatment	aPC treatment coordinates beneficial cytoprotective effects during sepsis by modulating miRNA expression	22940033
2356	Rat	rno-miR-222	miRNA	"high concentrations of lipid and glucose, and cytokines"	vascular hyper-reactivity	VSMC	"incubat high glucose (25mmol/L) or lipid (palmitic acid 50 ¦Ì mol/L) and 200ng/ml of TNF-¦Á,IL-1¦Â and IL-6 for 27h treatment"	downregulated	25425000
2357	Rat	rno-miR-222-5p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	primary microglial cells	lipopolysaccharide (LPS) treatment	"We revealed that LncRNA LEF1-AS1 was distinctly upregulated, whereas miR-222-5p was significantly downregulated in LPS-treated SCI and microglial cells."	33407665
2358	Rat	rno-miR-223	miRNA	TGF-¦Â1	asthma	airway smooth muscle cells (ASMCs)	TGF-¦Â1 treatment	TGF-¦Â1 stimulation lowers the expression of miR-223.	29636864
2359	Rat	rno-miR-223	miRNA	paeonol (PAE)	atherosclerosis (AS)	plasma-derived exosome	Paeonol (Pae) treatment	Pae-exo successfully increased the expression of exosomal miR-223 and relieved inflammatory secretion	32800809
2360	Rat	rno-miR-223	miRNA	phenylephrine (PE)	cardiac hypertrophy	neonatal rat cardiomyocytes (NRCs)	phenylephrine (PE) treatment	downregulated	29110214
2361	Rat	rno-miR-223	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia injury (CII)	cortical neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-223 was significantly over-expressed after OGD/R treatment	29663740
2362	Rat	rno-miR-223	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	rat colon Epithelial cells	azoxymethane (AOM) treatment	"Of the 27 miRNAs expressed at higher (P < 0.05) levels in tumors, miR-34a, 132, 223 and 224 were overexpressed at >10-fold. In contrast, the expression levels of miR-192, 194, 215 and 375 were dramatically reduced (?0.32-fold) in adenocarcinomas."	19825969
2363	Rat	rno-miR-223	miRNA	heat stress	febrile seizure (FS)	hippocampus tissues	hot water-bath induce	downregulated	30947016
2364	Rat	rno-mir-223	miRNA	phenylephrine (PE)	hypertrophy	neonatal rat cardiomyocytes (HNRCs)	phenylephrine (PE) treatment	downregulated	29110214
2365	Rat	rno-miR-223	miRNA	lipopolysaccharide (LPS)	inflammation	Isolated rat nucleus pulposus (NP) cells	lipopolysaccharide (LPS) treatment	downregulated	29707878
2366	Rat	rno-miR-223	miRNA	ischemic brain extract (IBE)	ischemic injury	"C6 rat astrocytoma cells, and primary rat MSCc (rMSCs)"	IBE treatment	upregulated	24999035
2367	Rat	rno-miR-223	miRNA	electroacupuncture (EA)	ischemic stroke (IS)	subventricular zone (SVZ) and hippocampus tissues	electroacupuncture (EA) treatment	upregulated	31883264
2368	Rat	rno-miR-223	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	primary cortical neuron culture	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	FGD5-AS1 may protect the neuron against OGD/R injury via acting as a ceRNA for miR-223 to mediate IGF1R expression	32337949
2369	Rat	rno-miR-223	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia treatment	upregulated	29608885
2370	Rat	rno-miR-223	miRNA	TGF-¦Â1	myocardial infarction (MI)	Cultured cardiac fibroblasts (CFs)	TGF-¦Â1 treatment	upregulated	29689569
2371	Rat	rno-miR-223	miRNA	emodin	myocarditis	LPS-treated H9c2 cells	Emodin treatment	downregulated	30745529
2372	Rat	rno-miR-223	miRNA	lipopolysaccharide (LPS)	myocarditis	H9c2 cells	lipopolysaccharide (LPS) treatment	upregulated	30745529
2373	Rat	rno-miR-223	miRNA	2-methoxyestradiol (2-Me)	obstructive sleep apnea (OSA)	pulmonary artery smooth muscle cells (PASMCs); lung tissues	2-methoxyestradiol (2-Me) treatment	"Chronic intermittent hypoxia (CIH) decreased the expression of miR-223, whereas 2-Me reversed the downregulated of miR-223 both in vivo and in vitro."	30246291
2374	Rat	rno-miR-223	miRNA	2-methoxyestradiol (2-Me)	pulmonary hypertension (PH)	Chronic intermittent hypoxia (CIH) model rat lung tissues	2-methoxyestradiol (2-Me) treatment	upregulated	30246291
2375	Rat	rno-miR-223	miRNA	hypoxia	pulmonary hypertension (PH)	lung tissues	Chronic intermittent hypoxia (CIH) induce	downregulated	30246291
2376	Rat	rno-miR-223	miRNA	X-rays	radiation-induced skin injury	rats irradiated skin	45-Gy electron beam treatment	upregulated	24447893
2377	Rat	rno-miR-223	miRNA	lipopolysaccharide (LPS)	septic shock	Wistar rats serum	LPS (10 mg/kg) treatment	upregulated	24915805
2378	Rat	rno-miR-223	miRNA	angelica polysaccharide (AP)	spinal cord injury (SCI)	PC-12 cells	angelica polysaccharide (AP) treatment	AP pre-treatment attenuated LPS-induced miR-223 expression level increase in PC-12 cells.	30372834
2379	Rat	rno-miR-223	miRNA	electroacupuncture (EA)	stroke	cortex tissues	Electroacupuncture (EA) treatment	upregulated	31237865
2380	Rat	rno-miR-223	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	colon tissues	dextran sulfate sodium (DSS) treatment	upregulated	31210320
2381	Rat	rno-miR-223	miRNA	methylglyoxal (MGO)	vascular tones	A10 cells	methylglyoxal (MGO) treatment	miR-223 expression in the cultured SMCs after 300 ¦ÌM MGO exposure by 5-6 folds.	32151743
2382	Rat	rno-miR-223	miRNA	naringenin	spinal cord injury (SCI)	spinal cords	Naringenin (NR)treatment	downregulated	27432064
2383	Rat	rno-miR-223-3p	miRNA	high fat diet (HFD)	aging-related non-alcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31899128
2384	Rat	rno-miR-223-3p	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	rat renal artery endothelial cells (RRAECs)	angiotensin II (Ang II) treatment	upregulated	32346437
2385	Rat	rno-miR-223-3p	miRNA	hypoxia	ischemic heart disease (IHD)	H9c2 cells	hypoxia induce	upregulated	30336138
2386	Rat	rno-miR-223-3p	miRNA	sevoflurane (SEV)	learning and memory deficits	rat neuron cells	sevoflurane (SEVO) treatment	upregulated	31450504
2387	Rat	rno-miR-223-3p	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	pulmonary arterial smooth muscle cells (PASMCs)	hypoxia induce	downregulated	30507047
2388	Rat	rno-miR-223-3p	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	primary rat pulmonary arterial smooth muscle cells (PASMCs)	hypoxia induce	downregulated	30507047
2389	Rat	rno-miR-223-3p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	pulmonary artery;right ventricle	monocrotaline (MCT) treatment	downregulated	30507047
2390	Rat	rno-miR-223-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2391	Rat	rno-miR-223-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2392	Rat	rno-miR-22-3p	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	upregulated	27535721
2393	Rat	rno-miR-22-3p	miRNA	gastrodin (GAS)	cerebral ischemia/reperfusion (I/R) injury	OGD/R-treated rat primary cortical neurons	gastrodin (GAS) treatment	upregulated	33839999
2394	Rat	rno-miR-22-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	Rat primary cortical neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	33839999
2395	Rat	rno-miR-22-3p	miRNA	berberine (BBR)	hepatocellular carcinoma (HCC)	HepG2 cells	berberine (BBR) treatment	upregulated	27904693
2396	Rat	rno-miR-22-3p	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	downregulated	27919821
2397	Rat	rno-miR-22-3p	miRNA	resveratrol	pulmonary embolism	pulmonary embolism (PE) induced heart tissues	resveratrol (Res) treatment	upregulated	31573048
2398	Rat	rno-miR-22-3p	miRNA	angiotensin II (Ang II)	thoracic aortic aneurysm (TAA)	thoracic aorta	angiotensin II (Ang II) treatment	The expression of miR-22-3p in Ang II group was significantly lower than that in the normal group.	32633388
2399	Rat	rno-miR-224	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	rat colon Epithelial cells	azoxymethane (AOM) treatment	"Of the 27 miRNAs expressed at higher (P < 0.05) levels in tumors, miR-34a, 132, 223 and 224 were overexpressed at >10-fold. In contrast, the expression levels of miR-192, 194, 215 and 375 were dramatically reduced (?0.32-fold) in adenocarcinomas."	19825969
2400	Rat	rno-miR-224	miRNA	furan	hepatotoxicity	liver	Furan treatment	upregulated	27371368
2401	Rat	rno-miR-224	miRNA	lead acetate (PbAc)	lead (Pb) acetate-induced thyrotoxicity	thyroid tissues	lead (Pb) exposure	upregulated	29665650
2402	Rat	rno-miR-224	miRNA	selenium nanoparticles (SeNPs)	lead (Pb) acetate-induced thyrotoxicity	lead (Pb) acetate-exposured rats thyroid tissues	Selenium nanoparticles (Se-NPs) treatment	downregulated	29665650
2403	Rat	rno-miR-224-5p	miRNA	cadmium (Cd)	cadmium (Cd)-induced kidney injury	renal cortex	cadmium (Cd) treatment	upregulated	29543730
2404	Rat	rno-miR-224-5p	miRNA	"2,2',4,4'-tetrabromodiphenyl ether (BDE47)"	hypothyroidism	liver tissues and H4-II-E cells	"2,2',4,4'-tetrabromodiphenyl ether (BDE47) treatment"	downregulated	31901531
2405	Rat	rno-miR-224-5p	miRNA	"2,2',4,4'-tetrabromodiphenyl ether (BDE47)"	hypothyroidism	H4-II-E cells	"2,2',4,4'-tetrabromodiphenyl ether (BDE47) treatment"	rno-miR-224-5p level was decreased by BDE47 in a dose-dependent manner.	31901531
2406	Rat	rno-miR-224-5p	miRNA	glucocorticoid (GC)	osteonecrosis of femoral head (ONFH)	rat bone marrow stromal stem cells (BMSCs)	glucocorticoids (GCs) treatment	"In the present study, we demonstrated that miR-224-5p was upregulated in GC-treated BMSCs"	33453444
2407	Rat	rno-miR-224-5p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
2408	Rat	rno-miR-22-5p	miRNA	pirarubicin (THP)	cardiomyocytes injury	rat cardiomyocytes	pirarubicin (THP) treatment	"In this study, we developed an microRNA (miRNA) chip by replicating the rat model of THP-induced myocardial injury and identified miR-22-5p and the RAP1-member of RAS oncogene family/extracellular regulated protein kinases (RAP1/ERK) signaling pathway as an object of study"	32864822
2409	Rat	rno-miR-22-5p	miRNA	rutin (RUT)	cardiomyocytes injury	rat cardiomyocytes	rutin (RUT) treatment	"In this study, we developed an microRNA (miRNA) chip by replicating the rat model of THP-induced myocardial injury and identified miR-22-5p and the RAP1-member of RAS oncogene family/extracellular regulated protein kinases (RAP1/ERK) signaling pathway as an object of study"	32864822
2410	Rat	rno-miR-22-5p	miRNA	rutin (RUT)	pirarubicin (THP)-induced myocardial damage	myocardial tissues	rutin (RUT) treatment	"RUT significantly improved THP-induced myocardial damage , increased the expression of miR-22-5p"	32864822
2411	Rat	rno-miR-22a-3p	miRNA	"3,5-diiodo-L-thyronine (T2)"	glucose homeostasis	serum from high fat diet fed rats	"3,5-diiodo-L-thyronine (T2) treatment"	downregulated	31719576
2412	Rat	rno-miR-23	miRNA	isoflurane	oxidative stress	H9c2 cells	Isoflurane treatment	downregulated	29627934
2413	Rat	rno-miR-23a	miRNA	lipopolysaccharide (LPS)	sepsis	myocardial and kidney tissues	lipopolysaccharide (LPS) treatment	downregulated	33538509
2414	Rat	rno-miR-23a	miRNA	streptozocin (STZ)	acute diabete	rats gastrocnemius	streptozotocin treatment	downregulated	24336651
2415	Rat	rno-miR-23a	miRNA	H2O2	acute myocardial infarction (AMI)	H9c2 cells	H2O2 treatment	upregulated	29488607
2416	Rat	rno-miR-23a	miRNA	bone marrow mesenchymal stem cells (BMSCs)	apoptosis	infarcted rats myocardium	bone marrow mesenchymal stem cells (BMSCs) treatment	downregulated	28662151
2417	Rat	rno-miR-23a	miRNA	hypoxia- and serum deprivation	apoptosis	bone marrow mesenchymal stem cell- (MSC)	Hypoxia- and Serum Deprivation treatment	downregulated	21698002
2418	Rat	rno-miR-23a	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	apoptosis	mesenchymal stem cells	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	24269648
2419	Rat	rno-miR-23a	miRNA	ovalbumin (OVA)	asthma	lung tissues	OVA treatment	upregulated	31020662
2420	Rat	rno-miR-23a	miRNA	isoproterenol and aldosterone	cardiac hypertrophy	Neonatal rat cardiomyocytes	isoproterenol and aldosterone treatment	upregulated	19574461
2421	Rat	rno-miR-23a	miRNA	doxorubicin (DOX)	cardiotoxicity	primary neonatal rat ventricular myocytes (NRVMs)	Doxorubicin (DOX) treatment	upregulated	30831132
2422	Rat	rno-miR-23a	miRNA	deep hypothermic circulatory arrest	cerebral injury	rat hippocampal tissues	deep hypothermic circulatory arrest treatment	downregulated	30824348
2423	Rat	rno-miR-23a	miRNA	ginsenoside Rg1	diabetic foot ulcer (DFU)	diabetic rats?incision area and tissue	Ginsenoside Rg1 treatment	downregulated	31158376
2424	Rat	rno-miR-23a	miRNA	stimulation electrode	epilepsy	Adult male Sprague Dawley rats blood	A bipolar stimulation electrode (distance between tips 500 ?m) was implanted in the angular bundle treatment	dysregulated	24184920
2425	Rat	rno-miR-23a	miRNA	formaldehyde	formaldehyde inducted immune/inflammation	rats	were exposed to formaldehyde treatment	downregulated	24304932
2426	Rat	rno-miR-23a	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	Liver tissues	carbon tetrachloride (CCl4) treatment	miR-23a expression increased significantly in hepatic fibrosis tissues.	30735452
2427	Rat	rno-miR-23a	miRNA	berberine (BBR)	inflammation	LPS-treated adjuvant-induced arthritic synovial macrophages (AA-SM)	berberine (BBR) treatment	upregulated	30240693
2428	Rat	rno-miR-23a	miRNA	NQDI1 (apoptosis signal-regulating kinase 1 (ASK1) inhibitor)	inflammation	LPS-treated adjuvant-induced arthritic synovial macrophages (AA-SM)	NQDI1 treatment	upregulated	30240693
2429	Rat	rno-miR-23a	miRNA	TNF-¦Á and lipopolysaccharide (LPS)	inflammation	adjuvant-induced arthritic synovial macrophages (AA-SM)	TNF-¦Á and lipopolysaccharide (LPS) treatment	downregulated	30240693
2430	Rat	rno-miR-23a	miRNA	H2O2	ischemia/reperfusion (I/R) injury	H9c2 rat myocardial cell	H2O2	downregulated	29272015
2431	Rat	rno-miR-23a	miRNA	hypoxia	neuron apoptosis	SH-SY5Y cells	1% O2 hypoxia	upregulated	28529459
2432	Rat	rno-miR-23a	miRNA	hypoxia	neuron apoptosis	brain tissues	chronic hypobaric hypoxia rat model as well as a tissue culture model where were exposed to	upregulated	28529459
2433	Rat	rno-miR-23a	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
2434	Rat	rno-miR-23a-3p	miRNA	acupuncture	intracerebral haemorrhage (ICH)	brain tissues	acupuncture?treatment	Acupuncture also alleviated ferroptosis and decreased miR-23a-3p expression	33403590
2435	Rat	rno-miR-23a-3p	miRNA	long-term potentiation(LTP)	long-term potentiation (LTP) persistence	Sprague-Dawley rats Dentate Gyrus Neuropil	unilaterally at perforant path-dentate gyrus synapses	upregulated in Dentate Gyrus Neuropil	28125614
2436	Rat	rno-miR-23a-3p	miRNA	high glucose (HG)	maternal hyperglycemia	H9c2 cells	high glucose (HG) treatment	Upregulation of miRNA-23a-3p rescues high glucose-induced cell apoptosis and proliferation inhibition in cardiomyocytes	33197036
2437	Rat	rno-miR-23a-3p	miRNA	ionizing radiation (IR)	radiation-induced central nervous system toxicity	Primary cortical neurons	ionizing radiation (IR) treatment	miR-23a-3p is rapidly decreased after neuronal irradiation.	32456284
2438	Rat	rno-miR-23a-5p	miRNA	platelet-derived growth factor (PDGF)	liver fibrosis	hepatic stellate cells (HSCs)	platelet-derived growth factor (PDGF) treatment	upregulated	32306379
2439	Rat	rno-miR-23b	miRNA	lipopolysaccharide (LPS)	cardiomyopathy induced by sepsis	H9C2 cardiomyoblasts	lipopolysaccharide (LPS) treatment	upregulated	30734878
2440	Rat	rno-miR-23b	miRNA	hypoxia	congenital heart disease (CHD)	H9C2 cells	prolonged hypoxia	upregulated	29078258
2441	Rat	rno-miR-23b	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
2442	Rat	rno-miR-23b	miRNA	lipopolysaccharide (LPS)	sepsis	vascular endothelial cells (VECs)	lipopolysaccharide (LPS) treatment	Endothelial microvesicles (EMVs) play an important role in pulmonary vascular leakage and lung injury during sepsis by transferring functional miR-23b.	32766250
2443	Rat	rno-miR-23b-3p	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	hippocampus tissues	streptozocin (STZ) treatment	miRNA-23b-3p expression was upregulated in cognitive impairment of diabetic rats	30282005
2444	Rat	rno-miR-23b-3p	miRNA	hypoxia/reoxygenation (H/R)	ischemia/reperfusion (I/R)-mediated acute myocardial infarction (AMI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	upregulated	32558131
2445	Rat	rno-miR-23b-3p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	upregulated	26997989
2446	Rat	rno-miR-23b-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9C2 cells	angiotensin II (Ang II) treatment	upregulated	31103821
2447	Rat	rno-miR-23c	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	rats renal tubular epithelial cells	streptozotocin treatment	downregulated	27964927
2448	Rat	rno-miR-24	miRNA	hypoxia	cardiomyocyte apoptosis	acute myocardial infarction (AMI) rat myocardium	hypoxia induce	upregulated	31378912
2449	Rat	rno-miR-24	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	LPS-induced lung injury in neonatal rats and resulted in significant downregulated of miR-24 expression.	30600184
2450	Rat	rno-miR-24	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	30600184
2451	Rat	rno-miR-24	miRNA	taurolithocholic acid-3 sulfate	acute pancreatitis (AP)	rat pancreatic acinar AR42J cells	taurolithocholic acid-3 sulfate treatment	dysregulated	28849189
2452	Rat	rno-miR-24	miRNA	thyroglobulin (Tg)	cell proliferation	rat FRTL-5 thyroid cells	Tg treatment	upregulated	24479877
2453	Rat	rno-miR-24	miRNA	high-salt/low-potassium diet	cerebral and renal vascular injuries	stroke-prone spontaneously hypertensive rats	high-salt/low-potassium diet treatment	downregulated	23297375
2454	Rat	rno-miR-24	miRNA	alloxan	diabetes mellitus (DM)	plasma	alloxan treatment	downregulated	31508175
2455	Rat	rno-miR-24	miRNA	gambogic acid (GA)	diabetes mellitus (DM)	plasma	Gallic acid (GA) treatment	upregulated	31508175
2456	Rat	rno-miR-24	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	vascular smooth muscle cells (VSMCs)	high glucose (HG) treatment	downregulated	31005375
2457	Rat	rno-miR-24	miRNA	trimetazidine (TMZ)	endothelial dysfunction	plasma	Trimetazidine (TMZ) treatment	"Trimetazidine Increases Plasma MicroRNA-24 and MicroRNA-126 Levels and Improves Dyslipidemia, Inflammation and Hypotension in Diabetic Rats"	33680027
2458	Rat	rno-miR-24	miRNA	stimulation electrode	epilepsy	Adult male Sprague Dawley rats blood	A bipolar stimulation electrode (distance between tips 500 ?m) was implanted in the angular bundle treatment	dysregulated	24184920
2459	Rat	rno-miR-24	miRNA	lingguizhugan decoction (LGZG)	heart failure (HF)	heart tissues	doxorubicin (DOX)-treated rats	downregulated	31829159
2460	Rat	rno-miR-24	miRNA	hypoxia/reoxygenation (H/R)	hypoxia/reoxygenation (H/R) injury	cardiomyocytes	hypoxia/reoxygenation (H/R) treatment	H/R exposure decreased the expression of miR-24 in rat cardiomyocytes.	32728001
2461	Rat	rno-miR-24	miRNA	lycium barbarum polysaccharide (LBP)	hypoxia-induced injury	oxygen and glucose deprivation (OGD)-treated PC-12 cells	Lycium barbarum polysaccharides (LBPs) treatment	upregulated	31588805
2462	Rat	rno-miR-24	miRNA	oxygen glucose deprivation (OGD)	hypoxia-induced injury	PC-12 cells	oxygen and glucose deprivation (OGD) treatment	downregulated	31588805
2463	Rat	rno-miR-24	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	bleomycin-injured rats lung tissues	bleomycin (BLM) treatment	downregulated	30446578
2464	Rat	rno-miR-24	miRNA	bleomycin (BLM)	idiopathic pulmonary fibrosis (IPF)	lung tissues	bleomycin (BLM) treatment	downregulated	30446578
2465	Rat	rno-miR-24	miRNA	isoflurane	isoflurane-induced neurotoxicity	hippocampus	isoflurane treatment	downregulated	31533001
2466	Rat	rno-miR-24	miRNA	lipopolysaccharide (LPS)	myocardial injury	H9c2 cells	lipopolysaccharide (LPS) treatment	downregulated	32181504
2467	Rat	rno-miR-24	miRNA	high glucose (HG)	oxidative stress	vascular smooth muscle cells (VSMCs) isolated from the thoracic aorta	high glucose (HG) treatment	downregulated	31539718
2468	Rat	rno-miR-24	miRNA	isoflurane	oxidative stress	H9c2 cells	Isoflurane treatment	downregulated	29627934
2469	Rat	rno-miR-24	miRNA	thrombin	post-intracerebral hemorrhage (ICH)	endothelial cells	thrombin injection treatment	thrombin reduces HIF-1¦Á degradation and initiates angiogenesis by increasing miR-24	32413855
2470	Rat	rno-miR-24	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
2471	Rat	rno-miR-24	miRNA	isoproterenol	¦Â-adrenoceptor intervention	rat heart tissues	isoproterenol (ISO)  treatment	upregulated	22847192
2472	Rat	rno-miR-24	miRNA	hypoxia-inducible factor 1¦Á (HIF-1¦Á)	cancer and inflammation	rat cardiomyocytes	HIF-1 treatment	upregulated	23098654
2473	Rat	rno-miR-24-1	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
2474	Rat	rno-miR-24-1-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2475	Rat	rno-miR-24-1-5p	miRNA	hypoxia	stroke	middle cerebral artery occlusion (MCAO) Sprague-Dawley rat	middle cerebral artery occlusion (MCAO) treatment	upregulated	29113076
2476	Rat	rno-miR-2424	miRNA	bleomycin (BLM)	lung fibrosis	lung tissues	bleomycin (BLM) treatment	upregulated	33193637
2477	Rat	rno-miR-24-2-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2478	Rat	rno-miR-24-3p	miRNA	estradiol benzoate (EB)	chronic inflammatory diseases	dorsolateral prostate	estradiol benzoate (EB) treatment	upregulated	33332750
2479	Rat	rno-miR-24-3p	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	downregulated	27919821
2480	Rat	rno-miR-24-3p	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	H9C2 cardiomyocyte cell line	hypoxia induce	downregulated	30622671
2481	Rat	rno-miR-24-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2482	Rat	rno-miR-2467-3p	miRNA	streptozocin (STZ)	type 1 diabetes mellitus (T1DM)	Urinary; blood; kidney tissues	streptozotocin (STZ) treatment	STZ-induced type 1 diabetic rat exhibit the reduction both of urinary and circulating miR-2467-3p	32050151
2483	Rat	rno-miR-24a	miRNA	dexamethasone (DEX)	acute diabete	C2C12 myotubes	dexamethasone (DEX) treatment	downregulated	24336651
2484	Rat	rno-miR-25	miRNA	hypoxia	cardiomyocytes proliferation and migration	heart tissues; primary neonatal;adult cardiomyocytes	hypoxia induce	downregulated	31058341
2485	Rat	rno-miR-25	miRNA	repetitive transcranial magnetic stimulation (rTMS)	focal cerebral ischemia	Sprague-Dawley rats ischemic cortex	rTMS treatment	upregulated	25302788
2486	Rat	rno-miR-25	miRNA	emodin	hypoxic brain injury	hypoxia-induced PC-12 cells	Emodin (EMO) treatment	upregulated	31257935
2487	Rat	rno-miR-25	miRNA	hypoxia	hypoxic brain injury	PC-12 cells	hypoxia induce	downregulated	31257935
2488	Rat	rno-miR-25	miRNA	estradiol-17¦Â (E2)	osteogenesis	primary bone marrow mesenchymal stem cells from rats (rBMSCs)	estradiol-17¦Â (E2) treatment	upregulated	31089333
2489	Rat	rno-miR-25	miRNA	cholesterol-enriched diet	oxidative stress	Serum and tissue of rat	cholesterol-enriched diet treatment	upregulated	23722270
2490	Rat	rno-miR-25	miRNA	high amplitude mechanical stretching	lung fibrosis	alveolar type II (ATII) cells and lung fibroblasts	high amplitude mechanical stretching treatment	upregulated	31290711
2491	Rat	rno-miR-25	miRNA	lipopolysaccharide (LPS)	sepsis-induced myocardial injury	cardiac H9C2 cell line	lipopolysaccharide (LPS) treatment	downregulated	29440462
2492	Rat	rno-miR-25	miRNA	H2O2	spinal cord injury (SCI)	PC-12 cells	?H2O2 treatment	downregulated	28605990
2493	Rat	rno-miR-25	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	downregulated	21094214
2494	Rat	rno-miR-25-3p	miRNA	hypoxia	cyanotic congenital heart disease (CCHD)	H9c2 cells	hypoxia induce	"SNHG14 and KLF4 were upregulated, whereas miR-25-3p was downregulated in hypoxia-induced H9c2 cells and cardiac tissues of patients with CCHD compared with their controls."	33278191
2495	Rat	rno-miR-25-3p	miRNA	kainic acid (KA)	epilepsy	rats hippocampi; hippocampal neurons	Kainic acid (KA) induction	downregulated	31954517
2496	Rat	rno-miR-25-3p	miRNA	magnesium-free extracellular fluid	epilepsy	rats hippocampi; hippocampal neurons	Mg2+-free solution	downregulated	31954517
2497	Rat	rno-miR-25-3p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
2498	Rat	rno-miR-25-5p	miRNA	serotonin	smooth muscle cell differentiation	brown Norway rat BMSCs	serotonin treatment	downregulated	24595007
2499	Rat	rno-miR-25-5p	miRNA	insulin-like growth factor 1 (IGF-1)	spinal cord injury (SCI)	Neural stem cells were obtained from E15 fetal rat cerebral cortex cultured supernatant exosomes	insulin growth factor-1 (IFG-1) treatment	upregulated	31848325
2500	Rat	rno-miR-26-3p	miRNA	gentamicin	acute kidney injury (AKI)	urine	gentamicin treatment	upregulated	33263228
2501	Rat	rno-miR-26a	miRNA	methotrexate (MTX)	arthritis	rat macrophage line NR8383 cells	methotrexate treatment	downregulated	24423102
2502	Rat	rno-miR-26a	miRNA	pristane (PS)	arthritis	NR8383 cells	pristane treatment	downregulated	24423102
2503	Rat	rno-miR-26a	miRNA	CoCl2	cardiac arrest-induced brain damage	Neural stem cells (NSCs)	CoCl2 treatment to induce hypoxia injury model	downregulated	30992390
2504	Rat	rno-miR-26a	miRNA	H2O2	cytotoxicity	RGC-5 cells	H2O2 treatment	downregulated	25757910
2505	Rat	rno-miR-26a	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	rat heart tissues	streptozotocin (STZ) treatment	downregulated	31389595
2506	Rat	rno-miR-26a	miRNA	high glucose (HG)	diabetic nephropathy (DN)	Rat glomerular mesangial cells	High glucose treatment	upregulated	25797045
2507	Rat	rno-miR-26a	miRNA	repeated binge-EtOH exposure	ethanol addiction	dorsal and ventral hippocampus of male Wistar rats	repeated binge-EtOH exposure treatment	different regulation	24416161
2508	Rat	rno-miR-26a	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	vascular tissues	abdominal incision induce	downregulated	30132885
2509	Rat	rno-miR-26a	miRNA	oxygen glucose deprivation (OGD)	myocardial infarction (MI)	H9c2 cells	oxygen glucose deprivation (OGD) treatment	miR-26a was downregulated in oxygen-glucose deprivation (OGD)-treated H9c2 cells.	31990056
2510	Rat	rno-miR-26a	miRNA	rotenone (ROT)	parkinson's disease (PD)	striatum of parkinsonian rats	rotenone exposure treatment	upregulated	30267378
2511	Rat	rno-miR-26a	miRNA	antigen	pulmonary inflammation	plasma and lavaged lung	antigen treatment	upregulated	27075111
2512	Rat	rno-miR-26a	miRNA	TGF-¦Â1	renal fibrosis	renal tubular epithelial cells (NRK-52E)	TGF-¦Â1 treatment	downregulated	27874055
2513	Rat	rno-miR-26a	miRNA	type II collagen	rheumatoid arthritis (RA)	cartilage tissues and inflammatory articular chondrocytes of RA rats	type II collagen treatment	downregulated	31267533
2514	Rat	rno-miR-26a	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
2515	Rat	rno-miR-26a	miRNA	perfluorooctane sulfonic acid (PFOS)	perfluorooctane sulfonate (PFOS)-induced toxic action	rat liver tissue	dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 12) treatment	different expression	24420840
2516	Rat	rno-miR-26a-1-5p	miRNA	H2O2	abdominal aortic aneurysm (AAA)	primary vascular smooth muscle cells (VSMCs)	H2O2 treatment	downregulated	29956734
2517	Rat	rno-miR-26a-5p	miRNA	¦Â3-adrenoceptors(¦Â3-AR) inhibitor SR 59230A	chronic heart failure (CHF)	CHF rats	1 ml SR 59230A(85 mmoL/L in 0.9% saline)twice a day for seven weeks by intraperitoneal injection treatment	upregulated	29926593
2518	Rat	rno-miR-26a-5p	miRNA	liraglutide	endothelial dysfunction	aortic endothelial in diabetic rats	liraglutide treatment	upregulated	30863684
2519	Rat	rno-miR-26a-5p	miRNA	hemin	intracerebral haemorrhage (ICH)	PC-12 cells	hemin treatment	downregulated	33000559
2520	Rat	rno-miR-26b	miRNA	cisplatin (DDP)	cisplatin (DDP)-induced nephrotoxicity	renal tissue homogenate	cisplatin treatment	downregulated	32777238
2521	Rat	rno-miR-26b	miRNA	pentoxifylline (PTX)	cisplatin (DDP)-induced nephrotoxicity	renal tissue homogenate	pentoxifylline (PTX) treatment	downregulated	32777238
2522	Rat	rno-miR-26b	miRNA	intermittent hypoxia (IH)	cognitive impairment	rats hippocampus	intermittent hypoxia (IH) treatment	downregulated in hippocampus	28647595
2523	Rat	rno-miR-26b	miRNA	high salt (HS)	hypertension	aorta of? rats	high salt (HS) treatment	downregulated	24161401
2524	Rat	rno-miR-26b	miRNA	osteoactivin (OA)	osteogenesis	bone marrow-derived mesenchymal stem cells (BMSCs)	Osteoactivin (OA) treatment	upregulated	30768922
2525	Rat	rno-miR-26b	miRNA	hypoxia	pulmonary hypertension (PH)	pulmonary arterial smooth muscle cells (PASMCs)	hypoxia treatment	Hypoxia-induced microRNA-26b inhibition contributes to hypoxic pulmonary hypertension via CTGF.	28816418
2526	Rat	rno-miR-26b	miRNA	glycine	subarachnoid hemorrhage (SAH)	Cultured cortical neurons and microglia	Glycine treatment	upregulated	31612303
2527	Rat	rno-miR-26b	miRNA	metformin (Met)	type 2 diabetes mellitus (T2DM)	brain tissues	"orally and daily administrated 2.0 ml NSO, 100 mg metformin (MT)"	downregulated in the brain	28505155
2528	Rat	rno-miR-26b-3p	miRNA	rapamycin	cardiac fibrosis	heart tissues	rapamycin (Rap) treatment	upregulated	30647817
2529	Rat	rno-miR-26b-3p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
2530	Rat	rno-miR-26b-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	PC12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	Our results showed that miR-26b-5p was downregulated in OGD/R-induced PC12 cells	33559506
2531	Rat	rno-miR-26b-5p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
2532	Rat	rno-miR-27	miRNA	hypoxia	glycolysis	cardiomyocytes	hypoxia treatment	"Meanwhile, miR-27 and miR-195 were also upregulated in hypoxia-induced cardiomyocytes."	33819184
2533	Rat	rno-miR-27	miRNA	lipopolysaccharide (LPS)	myocarditis	H9c2 cells	lipopolysaccharide (LPS) treatment	downregulated	31576518
2534	Rat	rno-miR-27	miRNA	isoflurane	oxidative stress	H9c2 cells	Isoflurane treatment	upregulated	29627934
2535	Rat	rno-miR-27a	miRNA	chronic brain hypoperfusion (CBH)	apoptosis	rats	chronic brain hypoperfusion (CBH) treatment	upregulated	26993299
2536	Rat	rno-miR-27a	miRNA	nimodipine	cognitive impairment	brain tissues	nimodipine treatment	Nimodipine can improve CI after SAH in rats through the lncRNA NEAT1/miR-27a/MAPT axis.	32606599
2537	Rat	rno-miR-27a	miRNA	high glucose (HG)	diabetic nephropathy (DN)	rat MC line (HBZY-1)	rat MC line (HBZY-1) treatment	upregulated	27184517
2538	Rat	rno-miR-27a	miRNA	high glucose (HG)	diabetic nephropathy (DN)	NRK-52E cells	high glucose (HG) treatment	upregulated	32484208
2539	Rat	rno-miR-27a	miRNA	omentin-1	diabetic nephropathy (DN)	HBZY-1 cells	omentin-1 treatment	downregulated	30103116
2540	Rat	rno-miR-27a	miRNA	cyclic mechanical stretch (CMS)	cell proliferation	primary rat aortic ECs	15% cyclic stretch	upregulated in vascular smooth muscle cells -derived microparticles (VSMC-MPs)	28106155
2541	Rat	rno-miR-27a	miRNA	stimulation electrode	epilepsy	Adult male Sprague Dawley rats blood	A bipolar stimulation electrode (distance between tips 500 ?m) was implanted in the angular bundle treatment	dysregulated	24184920
2542	Rat	rno-miR-27a	miRNA	adreno-cortico-tropic-hormone (ACTH)	hormonal regulation	adrenals?tissues	adreno-cortico-tropic-hormone (ACTH) treatment	downregulated	24205079
2543	Rat	rno-miR-27a	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	downregulated	24205079
2544	Rat	rno-miR-27a	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	renal tissues	"rats were anesthetized following the inhalation of 2% isoflurane. Subsequently, an abdominal incision was created, and the renal pedicle was clamped for 45 min with a microaneurysm clamp."	downregulated	31173204
2545	Rat	rno-miR-27a	miRNA	aerobic exercise	left ventricular hypertrophy (LVH)	left ventricular	aerobic exercise training (AET) treatment	upregulated	21709209
2546	Rat	rno-miR-27a	miRNA	glucagon-like peptide-1 (GLP-1)	lipotoxicity	INS-1 pancreatic ¦Â-cell line derived from rat insulinoma	10 nmol/L GLP-1 for 24 h	downregulated	29032333
2547	Rat	rno-miR-27a	miRNA	porcine serum	liver fibrosis	rat liver tissues	porcine serum treatment	upregulation	24927615
2548	Rat	rno-miR-27a	miRNA	lipopolysaccharide (LPS)	microglial neuroinflammation	primary microglial cells	lipopolysaccharide (LPS) treatment	downregulated	26971344
2549	Rat	rno-miR-27a	miRNA	bilobalide (BB)	myocardial infarction (MI)	hypoxia-induced H9C2 cells	bilobalide treatment	upregulated	31322008
2550	Rat	rno-miR-27a	miRNA	oxygen glucose deprivation (OGD)	myocardial infarction (MI)	H9C2 cells	oxygen-glucose deprivation (OGD)-induce treatment	downregulated	31322008
2551	Rat	rno-miR-27a	miRNA	high fat diet (HFD)	obesity	adipose tissues	high fat diet (HFD) feed	"The obese rats in the HFD group, compared with rats in the NFD group, demonstrated a significant decrease in the expression of miR-27a (p < 0.05) and a significant increase in the expression of miR-143."	30411548
2552	Rat	rno-miR-27a	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
2553	Rat	rno-miR-27a	miRNA	endothelin-1 (ET-1)	pulmonary hypertension (PH)	primary cultured rat PASMC	endothelin-1 (ET-1) treatment	upregulated	28484848
2554	Rat	rno-miR-27a	miRNA	H2O2	spinal cord injury (SCI)	primary rat neurons	H2O2 treatment	downregulated	32679145
2555	Rat	rno-miR-27a	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	microglial cells	lipopolysaccharide (LPS) treatment	miR-27a was lowly expressed in LPS-induced microglial cells.	31778769
2556	Rat	rno-miR-27a	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	mouse primary microglial cells	lipopolysaccharide (LPS) treatment	"higher level of XIST and Smurf1, but lower level of miR-27a in SCI rats and lipopolysaccharide (LPS)-induced primary microglial cells."	31778769
2557	Rat	rno-miR-27a	miRNA	dexamethasone (DEX)	steroid-induced osteonecrosis of femoral head (ONFH)	serum	dexamethasone (DEX) treatment	downregulated	30535438
2558	Rat	rno-miR-27a	miRNA	dexamethasone (DEX)	steroid-induced osteonecrosis of femoral head (ONFH)	ONFH rats serum	dexamethasone (DEX) treatment	downregulated	30535438
2559	Rat	rno-miR-27a	miRNA	high fat diet (HFD)	weight gain	end epididymal fat	high fat diet (HFD) feed	downregulated	29023027
2560	Rat	rno-miR-27a	miRNA	dexamethasone (DEX)	hormonal regulation	adrenals?tissues	dexamethasone (DEX) treatment	downregulated	24205079
2561	Rat	rno-miR-27a-3p	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia treatment	downregulated	31923741
2562	Rat	rno-miR-27a-3p	miRNA	kainic acid (KA)	epilepsy	rat neuronal cells	kainic acid (KA) treatment	upregulated	31710596
2563	Rat	rno-miR-27a-3p	miRNA	hypoxia	hypoxia-induced injury	H9c2 cell	hypoxia induce	downregulated	31923741
2564	Rat	rno-miR-27a-3p	miRNA	FK506	osteogenesis	rat bone marrow stromal cells (BMSCs)	FK506 treatment	downregulated	28560399
2565	Rat	rno-miR-27a-3p	miRNA	bleomycin (BLM)	lung fibrosis	lung tissues	bleomycin A5 treatment	downregulated	32538751
2566	Rat	rno-miR-27a-3p	miRNA	bleomycin (BLM)	renal ischemia/reperfusion (I/R) injury	NRK-52E cells	hypoxia/reoxygenation (H/R) treatment	upregulated	32084559
2567	Rat	rno-miR-27a-3p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	upregulated	26997989
2568	Rat	rno-miR-27a-3p	miRNA	phosphorus (Pi)	vascular calcification (VC)	A10 cells	Pi treatment	downregulated	33230462
2569	Rat	rno-miR-27a-5p	miRNA	hypoxia	acute myocardial infarction (AMI)	rat cardiomyoblast cells (H9c2)	hypoxia induce	downregulated	31100777
2570	Rat	rno-miR-27a-5p	miRNA	caerulein (Cae)	acute pancreatitis (AP)	Rat pancreatic acinar cell line AR42J	caerulein (Cae) treatment	downregulated	31106896
2571	Rat	rno-miR-27a-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2572	Rat	rno-miR-27ab	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	neurotoxicity	brain tissues of rats	RDX at a dose(47 mg/kg) for 48 h treatment	upregulated	25559034
2573	Rat	rno-miR-27b	miRNA	angiotensin II (Ang II)	cardiac fibrosis	rat neonatal cardiac fibroblasts (CFs)	angiotensin II (Ang II) treatment	upregulated	31881012
2574	Rat	rno-miR-27b	miRNA	collagenase	intracerebral haemorrhage (ICH)	rats striatum	collagenase treatment	downregulated	29050310
2575	Rat	rno-miR-27b	miRNA	ischemic brain extract (IBE)	ischemic injury	"C6 rat astrocytoma cells, and primary rat MSCc (rMSCs)"	IBE treatment	downregulated	24999035
2576	Rat	rno-miR-27b	miRNA	sevoflurane (SEV)	learning deficits and abnormal social behaviors	brain	sevoflurane treatment	upregulated	27973945
2577	Rat	rno-miR-27b	miRNA	aerobic exercise	left ventricular hypertrophy (LVH)	left ventricular	aerobic exercise training (AET) treatment	upregulated	21709209
2578	Rat	rno-miR-27b	miRNA	4-vinylcyclohexene diepoxide (VCD)	premature ovarian failure (POF)	ovarian	4-vinylcyclohexene diepoxide (VCD) tretament	upregulated	24188450
2579	Rat	rno-miR-27b	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
2580	Rat	rno-miR-27b	miRNA	puromycin aminonucleoside (PAN)	podocyte protection	non-human primates (NHPs)	puromycin aminonucleoside (PAN) treatment	"In NHP primary podocyte culture, significant downregulated of miR-27b was observed during treatment of puromycin aminonucleoside (PAN), a classic nephrotoxin"	30429458
2581	Rat	rno-miR-27b	miRNA	endothelin-1 (ET-1)	pulmonary hypertension (PH)	primary cultured rat PASMC	endothelin-1 (ET-1) treatment	upregulated	28484848
2582	Rat	rno-miR-27b	miRNA	sitagliptin	renal interstitial inflammatory	type II diabetic Goto-Kakizaki (GK)	sitagliptin treatment	upregulated	28652790
2583	Rat	rno-miR-27b	miRNA	isoproterenol	¦Â-adrenoceptor intervention	rat heart tissues	isoproterenol (ISO)  treatment	downregulated	22847192
2584	Rat	rno-miR-27b-3p	miRNA	guarana	adipogenesis	3T3L1 cells	guarana	downregulated	28632199
2585	Rat	rno-miR-27b-3p	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozocin (STZ) treatment	miR-27b-3p was decreased in DN rats and high-glucose-induced mice mesangial cells	30549040
2586	Rat	rno-miR-27b-3p	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	rat kidney tissues	streptozotocin (STZ) treatment	downregulated	30549040
2587	Rat	rno-miR-28	miRNA	hypoxia	cerebral ischemia injury (CII)	Rat pheochomocytoma PC-12?cells	hypoxia induce	upregulated	31002779
2588	Rat	rno-miR-28	miRNA	tanshinone IIA (Tan IIA)	cerebral ischemia injury (CII)	hypoxia induced Rat pheochomocytoma PC-12?cells	Tanshinone IIA treatment	downregulated	31002779
2589	Rat	rno-miR-28	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
2590	Rat	rno-miR-28	miRNA	hypoxia	hypoxic brain injury	PC-12 cell	hypoxia induce	"lncRNA H19 downregulated miR-28 expression, which in turn preventing SP1 from degradation by miR-28, and ultimately deactivated PDK/AKT and JAK/STAT signaling pathways."	30312698
2591	Rat	rno-miR-28*	miRNA	aflatoxin B1 (AFB1)	hepatocellular carcinoma (HCC)	7-week-old Fischer344 male rats liver	aflatoxin B1 (AFB7) treatment	upregulated	24472605
2592	Rat	rno-miR-28-3p	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	upregulated	32893733
2593	Rat	rno-miR-28-5p	miRNA	phosgene	acute lung injury (ALI)	Lung-derived exosomes	phosgene induce treatment	upregulated	31707339
2594	Rat	rno-miR-28-5p	miRNA	dexamethasone (DEX)	cartilage injury	articular cartilage	dexamethasone (DEX) treatment	miR-28-5p was downregulated compared with control group.	29207029
2595	Rat	rno-miR-29	miRNA	cigarette/nicotine	cardiac dysfunction	primary neonatal rat cardiac fibroblasts	cigarette/nicotine exposure	downregulated	32795172
2596	Rat	rno-miR-29	miRNA	aerobic exercise	cardiac hypertrophy	rat cardiac muscle tissues	aerobic exercise training (AET) treatment	aerobic training increase miR-29 expression in the heart	21447748
2597	Rat	rno-miR-29	miRNA	combined resistance-endurance (RE) training	cardiovascular disease risk in women during menopause	ovariectomy (OVX) rats heart tissues	combined resistance-endurance (RE) training treatment	upregulated	30766462
2598	Rat	rno-miR-29	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	rat isolated dorsal root ganglion (DRG) neurons	STZ treatment	downregulated	24819309
2599	Rat	rno-miR-29	miRNA	TGF-¦Â	erythroid cell differentiation	Rat tubular epithelial cells (NRK52E)	TGF-¦Â treatment	downregulated	24103556
2600	Rat	rno-miR-29	miRNA	dexamethasone (DEX)	excess of glucocorticoids (GCs)	pregnant rats	dexamethasone (DEX) treatment	upregulated	24253049
2601	Rat	rno-miR-29	miRNA	hepatocyte growth factor (HGF)	hepatic stellate cells (HSC) transdifferentiate into myofibroblasts	rat hepatic stellate cells (HSC)	Hepatocyte growth factor (HGF) treatment	upregulated	21931759
2602	Rat	rno-miR-29	miRNA	TGF-¦Â	hepatic stellate cells (HSC) transdifferentiate into myofibroblasts	rat hepatic stellate cells (HSC)	transforming growth factor-¦Â (TGF-¦Â) treatment	downregulated	21931759
2603	Rat	rno-miR-29	miRNA	dexamethasone (DEX)	maternal undernutrition (MUN) during pregnancy	fetal rat lung fibroblasts	dexamethasone (DEX) treatment	Dexamethasone treatment of cultured fetal rat lung fibroblasts significantly induced miR-29 expression.	30088984
2604	Rat	rno-miR-29	miRNA	ginkgolide B (GB)	myocardial infarction (MI)	H9c2 cells	Ginkgolide B treatment	Hypoxia-induced apoptosis of cardiomyocytes is restricted by ginkgolide B-downregulated microRNA-29.	32295500
2605	Rat	rno-miR-29	miRNA	PPAR-¦Ãagonist	myocardial ischemia/reperfusion (I/R) injury (MIRI)	rat left ventricl tissue	PPAR-¦Ãagonist treatment	downregulated	20164119
2606	Rat	rno-miR-29	miRNA	cisplatin (DDP)	nephrotoxicity	male Sprague-Dawley (SD) rats urine	cisplatin treatment	upregulated	24863737
2607	Rat	rno-miR-29	miRNA	dexamethasone (DEX)	vascular smooth muscle cell proliferation	Blood samples	dexamethasone (Dex) treatment	upregulated	24253049
2608	Rat	rno-miR-29	miRNA	hepatitis C virus (HCV)	hepatitis C virus (HCV) infection	primary rat hepatocytes	hepatitis C virus (HCV) infection	downregulated	21606534
2609	Rat	rno-miR-291a-3p	miRNA	"2,5-hexanedione (HD)"	"2,5-hexanedione (HD) toxicity"	spinal cord tissues	"2,5-hexanedione (HD) treatment"	upregulated	31760062
2610	Rat	rno-miR-291a-3p	miRNA	dexamethasone (DEX)	osteoporosis	bone marrow-derived mesenchymal stem cells (BMSCs)	dexamethasone (Dex) treatment	DEX (DEX) inhibited cell viability and decreased the expression of miR-291a-3p in BMSCs.	31729834
2611	Rat	rno-miR-291a-3p	miRNA	dexamethasone (DEX)	osteoporosis	Primary rat bone marrow-derived mesenchymal stem cells (BMSCs)	dexamethasone (DEX) treatment	"miRNA-291a-3p could improve the cell viability, osteogenic differentiation, and ALP activity, which are suppressed by DEX in BMSCs."	31729834
2612	Rat	rno-miR-291b	miRNA	ethanol (EtOH)	alcoholic liver disease (ALD)	male Wistar rats Kupffer cells	ethanol treatment	upregulated in Kupffer cells	29142263
2613	Rat	rno-miR-29-3p	miRNA	hypoxia-inducible factor 1¦Á (HIF-1¦Á)	hypoxic pulmonary hypertension (HPH)	pulmonary adventitial fibroblasts	hypoxia-inducible factor-1 ¦Á treatment	downregulated	25421979
2614	Rat	rno-miR-294	miRNA	hypoxia/reoxygenation (H/R)	ischemia/reperfusion (I/R) injury	mesenchymal stem cell (MSC) exosome	hypoxia-reoxygenation (H/R) treatment	upregulated	32719674
2615	Rat	rno-miR-296	miRNA	(+)-cholesten-3-one (CN)	osteoblastic differentiation	mesenchymal stem cells (MSCs)	(+)-cholesten-3-one (CN) treatment	downregulated	30373531
2616	Rat	rno-miR-296	miRNA	acute stress (AS) and chronic stress (CS)	stress-induced myocardial injury	rat	Rats were bound and suspended treatment	upregulated	24669248
2617	Rat	rno-miR-296-5p	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	colonic tissue of rat	azoxymethane (AOM) treatment	downregulated	23049818
2618	Rat	rno-miR-297	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal rat cardiomyocytes (NCMs)	angiotensin II (Ang II) treatment	upregulated	28286226
2619	Rat	rno-miR-297	miRNA	perfluorooctane sulfonic acid (PFOS)	neural dysfunctions	rat brains	perfluorooctane sulfonic acid (PFOS) treatment	downregulated	22594572
2620	Rat	rno-miR-297	miRNA	lipopolysaccharide (LPS)	septic shock	Wistar rats serum	LPS (10 mg/kg) treatment	upregulated	24915805
2621	Rat	rno-miR-297a	miRNA	valproic acid (VPA)	cerebral ischemia injury (CII)	rat cortical neuronal cells	valproic acid treatment	upregulated	22937209
2622	Rat	rno-miR-298	miRNA	hypoxia	cortical injury	rat cortex tisssues	hypoxia treatment	downregulated	23272113
2623	Rat	rno-miR-298	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cardiomyocytes	hypoxia induce	upregulated	31138376
2624	Rat	rno-miR-298	miRNA	(+)-cholesten-3-one (CN)	osteoblastic differentiation	mesenchymal stem cells (MSCs)	(+)-cholesten-3-one (CN) treatment	downregulated	30373531
2625	Rat	rno-miR-298	miRNA	quercetin	oxidative stress	PC-12 cells	Quercetin treatment	downregulated	33343808
2626	Rat	rno-miR-29a	miRNA	L©\arginine	acute edematous pancreatitis (AEP)	AR42J cell	L-arginine treatment	upregulated	27239114
2627	Rat	rno-miR-29a	miRNA	NOX inhibitor VAS2870	acute ischemic stroke (AIS)	tMCAO rats	intravenous treatment with NOX inhibitor VAS2870	upregulated	27325364
2628	Rat	rno-miR-29a	miRNA	deoxycholic acid (DCA)	acute pancreatitis (AP)	AR42J cells	deoxycholic acid (DCA) treatment	upregulated	30554587
2629	Rat	rno-miR-29a	miRNA	VEGF-A	cardiac fibrosis	rat cardiac fibroblasts	VEGF-A treatment	downregulated	27060017
2630	Rat	rno-miR-29a	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	31162869
2631	Rat	rno-miR-29a	miRNA	angiotensin II (Ang II)	cell proliferation and collagen synthesis	cardiac fibroblasts of Sprague-Dawley rats	angiotensin II (Ang II) treatment	downregulated	28615545
2632	Rat	rno-miR-29a	miRNA	infrasound	cell proliferation and collagen synthesis	cardiac fibroblasts of Sprague-Dawley rats pre-treat with Ang II	infrasound treatment	upregulated	28615545
2633	Rat	rno-miR-29a	miRNA	epigallocatechin-3-gallate (EGCG)	chronic renal injury	cadmium (Cd) pretreated Wistar albino rats	EGCG treatment	"decreased miR-21 and miR-192, enhanced miR-29a/b/c in kidney samples"	27474435
2634	Rat	rno-miR-29a	miRNA	follicle stimulating hormone (FSH)	colorectal cancer (CRC)	rat granulosa cells	Follicle-stimulating hormone (FSH)treatment	downregulated	20734245
2635	Rat	rno-miR-29a	miRNA	streptozocin (STZ)	diabetic cataract (DC)	lens epithelial cells (LECs)	Streptozotocin (STZ) treatment	downregulated	28003969
2636	Rat	rno-miR-29a	miRNA	captopril	diabetic nephropathy (DN)	diabetes rats kidney tissue	captopril treatment	upregulated	31433203
2637	Rat	rno-miR-29a	miRNA	spironolactone	diabetic nephropathy (DN)	diabetes rats kidney tissue	spironolactone treatment	upregulated	31433203
2638	Rat	rno-miR-29a	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissue	streptozotocin (STZ) treatment	downregulated	31433203
2639	Rat	rno-miR-29a	miRNA	high glucose (HG)	diabetic retinopathy (DR)	rat retinal M¨¹ller cells	high glucose treatment	downregulated	29409329
2640	Rat	rno-miR-29a	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	rat retinal tissues	streptozotocin (STZ) treatment	downregulated	29409329
2641	Rat	rno-miR-29a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	hypothermic Circulatory Arrest (DHCA)-associated neural injury	HT-22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	29623838
2642	Rat	rno-miR-29a	miRNA	hypoxic/ischemic	hypoxic/ischemic injury	rat kidneys tissue cells	Hypoxia/Ischemia treatment	upregulated	23596515
2643	Rat	rno-miR-29a	miRNA	clamping both renal arteries	ischemia/reperfusion (I/R) injury	male rats	clamping both renal arteries for 45 min	upregulated	28129785
2644	Rat	rno-miR-29a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	primary astrocyte cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	30628716
2645	Rat	rno-miR-29a	miRNA	corticotrophin releasing factor (CRF) receptor I antagonist (BMS-764459)	hepatocellular carcinoma (HCC)	rat liver cells	"The corticotrophin releasing factor (CRF) receptor I antagonist, BMS-764459 treatment"	"MiR-680 and miR-29a were identified as potential regulators and biomarkers of atypical CYP1A1 induction by regulating Abcc3, CYP3A and CYP2B as well as a number of AhR targeted genes"	23831372
2646	Rat	rno-miR-29a	miRNA	4-vinylcyclohexene diepoxide (VCD)	premature ovarian failure (POF)	ovarian	4-vinylcyclohexene diepoxide (VCD) tretament	downregulated	24188450
2647	Rat	rno-miR-29a	miRNA	swimming	myocardial infarction (MI)	myocardial-Infarcted Rats BR and RM	ST consisted of 60 min/day/10 weeks and began four weeks after MI treatment	upregulated	24642957
2648	Rat	rno-miR-29a	miRNA	lipopolysaccharide (LPS)	myocardial injury	H9c2 cells	lipopolysaccharide (LPS) treatment	CRNDE/miR-29a/SIRT1 network regulated sepsis-induced myocardial injury.	32473249
2649	Rat	rno-miR-29a	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"Oip5-as1 suppresses miR-29a leading to activation of the SIRT1/AMPK/PGC1¦Á pathway, which attenuates mitochondria-mediated apoptosis during MI/R injury"	32468629
2650	Rat	rno-miR-29a	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 myocardial cells	hypoxia induce	upregulated	31481517
2651	Rat	rno-miR-29a	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	upregulated	31481517
2652	Rat	rno-miR-29a	miRNA	arbutin (ARB)	optic nerve injury	H2O2 treated rat primary retinal ganglion cells (RGCs)	arbutin (ARB) treatment	upregulated	30970524
2653	Rat	rno-miR-29a	miRNA	H2O2	optic nerve injury	rat primary retinal ganglion cells (RGCs)	H2O2 treatment	downregulated	30970524
2654	Rat	rno-miR-29a	miRNA	"5,7,3',4'-tetramethoxyflavone (TMF)"	osteoarthritis (OA)	chondrocytes isolated from the rat cartilages	"5,7,3',4'-tetramethoxyflavone (TMF) treatment"	downregulated	31354246
2655	Rat	rno-miR-29a	miRNA	4-vinylcyclohexene diepoxide (VCD)	premature ovarian failure (POF)	rat POF tissues	VCD treatment	downregulated	24188450
2656	Rat	rno-miR-29a	miRNA	american ginseng root's	premature ovarian failure (POF)		4-Vinylcyclohexene diepoxide (VCD) treatment	upregulated	25705687
2657	Rat	rno-miR-29a	miRNA	sepsis	renal injury	?kidney tissues	cecal ligation puncture induced sepsis treatment	the expression of miR-29a was prominently decreased in the sepsis-induced kidney injury model	31858562
2658	Rat	rno-miR-29a	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC-12 cells	lipopolysaccharides (LPS) treatment	High NEAT1 levels can increase LPS-induced injury in PC-12 cells through the miR-29a/BCL2L11 pathway.	32776916
2659	Rat	rno-miR-29a	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	downregulated	21094214
2660	Rat	rno-miR-29a-3p	miRNA	endothelin-1 (ET-1)	cardiac hypertrophy	H9c2	endothelin-1 (ET-1) treatment	downregulated	26992639
2661	Rat	rno-miR-29a-3p	miRNA	Neuropeptide Y (NPY)	cardiac hypertrophy	Neonatal Rat Cardiomyocytes	Neuropeptide Y (NPY) treatment	NPY leads to downregulated of miR-29a-3p expression.	32297569
2662	Rat	rno-miR-29a-3p	miRNA	muscle contraction	diabetes mellitus (DM)	muscle tissues	"stimulated to contract in vitro for twitch tension analysis (0.5 Hz), 30 min later for tetanic analysis (100 Hz)"	upregulated	28000044
2663	Rat	rno-miR-29a-3p	miRNA	hypoxia	hypoxic pulmonary hypertension (HPH)	pulmonary adventitial fibroblast	hypoxia treatment	downregulated	25421979
2664	Rat	rno-miR-29a-3p	miRNA	dexamethasone (DEX)	hypoxic/ischemic brain damage (HIBD)	hippocampus	dexamethasone (DEX) treatment	Dex treatment increased miR-29a-3p expression and decreased HDAC4 expression.	33232741
2665	Rat	rno-miR-29a-3p	miRNA	high fat diet (HFD)	osteogenesis	rat bone marrow mesenchymal stem cells (BMSCs)	high fat diet (HFD) feed	downregulated	31168988
2666	Rat	rno-miR-29a-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	oxygen-glucose deprivation/reoxygenation (OGD/R) injury	PC-12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	MiR-29a-3p Enhances the Viability of Rat Neuronal Cells that Injured by Oxygen-Glucose Deprivation/Reoxygenation Treatment Through Targeting TNFRSF1A and Regulating NF-¦ÊB Signaling Pathway	33066952
2667	Rat	rno-miR-29a-3p	miRNA	angiotensin II (Ang II)	renal glomerular and tubulo-interstitial fibrosis	renal tubules	angiotensin II (Ang II) treatment	downregulated	26700017
2668	Rat	rno-miR-29a-3p	miRNA	yunpiheluo (YPHL) decoction	type 2 diabetes mellitus (T2DM)	Zucker diabetic fatty (ZDF) rats liver tissues	Yunpiheluo (YPHL) decoction treatment	"YPHL decoction attenuated IR in T2DM probably by down-regulating or maintaining the miR-29a-3p level, increasing the expression of IRS1 mRNA and its phosphorylated proteins, and regulating the expression of insulin receptor signaling-related proteins"	31128151
2669	Rat	rno-miR-29a-3p	miRNA	cyclic mechanical stretch (CMS)	vein graft restenosis	Venous vascular smooth muscle cells	Venous VSMCs exposed to 10%-1.25Hz cyclic stretch by using the Flexcell system were used to simulate arterial mechanical conditions in vitro.	upregulated	31513704
2670	Rat	rno-miR-29a-5p	miRNA	valproic acid (VPA)	cell differentiation	primary cultured neural stem cells (NSCs)	valproate (VPA) treatment	upregulated	29575035
2671	Rat	rno-miR-29a-5p	miRNA	dehydroepiandrosterone (DHEA)	polycystic ovarian syndrome (PCOS)	rats' ovarian tissues	DHEA treatment	downregulated in rats' ovarian tissues	28673204
2672	Rat	rno-miR-29b	miRNA	chitosan	achilles tendon injury	rats fibroblasts	chitosan treatment	upregulated	25674210
2673	Rat	rno-miR-29b	miRNA	carvedilol	alcohol addiction	LV myocardium of rat	carvedilol treatment	upregulated	24086569
2674	Rat	rno-miR-29b	miRNA	warfarin plus vitamin K	calcific aortic valve disease (CAVD)	aorta; plasma	warfarin plus vitamin K treatment	upregulated	32845082
2675	Rat	rno-miR-29b	miRNA	tanshinone IIA (Tan IIA)	cardiac fibrosis	cardiac fibroblast (CF)	Tanshinone IIA (TSN) treatment	upregulated	25636075
2676	Rat	rno-miR-29b	miRNA	complete freund's adjuvant (CFA)	chronic pain	L4-6 dorsal root ganglions (DRGs)	complete Freund's adjuvant (CFA) treatment	CFA leads to the upregulation of miR-29b level.	31980031
2677	Rat	rno-miR-29b	miRNA	vitamin D receptor activators (VDRAs)	chronic renal failure (CRF)	nephrectomized Wistar rats	equivalent doses of two VDRAs: calcitriol and paricalcitol treatment	upregulated	28460073
2678	Rat	rno-miR-29b	miRNA	epigallocatechin-3-gallate (EGCG)	chronic renal injury	cadmium (Cd) pretreated Wistar albino rats	EGCG treatment	"decreased miR-21 and miR-192, enhanced miR-29a/b/c in kidney samples"	27474435
2679	Rat	rno-miR-29b	miRNA	hypoxia	cortical injury	rat cortex tisssues	hypoxia treatment	downregulated	23272113
2680	Rat	rno-miR-29b	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	the retinal ganglion cells (RGCs) ;the cells of the inner nuclear layer (INL)	streptozotocin (STZ) injection treatment	upregulated	21897745
2681	Rat	rno-miR-29b	miRNA	captopril	diabetic nephropathy (DN)	diabetes rats kidney tissue	captopril treatment	upregulated	31433203
2682	Rat	rno-miR-29b	miRNA	spironolactone	diabetic nephropathy (DN)	diabetes rats kidney tissue	spironolactone treatment	upregulated	31433203
2683	Rat	rno-miR-29b	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissue	streptozotocin (STZ) treatment	downregulated	31433203
2684	Rat	rno-miR-29b	miRNA	high glucose (HG)	diabetic retinopathy (DR)	rat retinal M¨¹ller cells	high glucose treatment	downregulated	29409329
2685	Rat	rno-miR-29b	miRNA	resveratrol	diabetic retinopathy (DR)	diabetic rats retina	RSV (5 and 10 mg/kg/day)s at 1-7 months treatment	upregulated	27311771
2686	Rat	rno-miR-29b	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	rat retinal tissues	streptozotocin (STZ) treatment	downregulated	29409329
2687	Rat	rno-miR-29b	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	Cardiomyocytes	doxorubicin (Dox) treatment	upregulated	30025410
2688	Rat	rno-miR-29b	miRNA	angiotensin II (Ang II)	epithelial-mesenchymal transition (EMT)	spontaneously hypertensive rats (SHRs) and age-matched Wistar-Kyoto (WKY) rats	angiotensin II (Ang II) treatment	downregulated	25231273
2689	Rat	rno-miR-29b	miRNA	cyclosporine A (CsA)	gingival overgrowth	gingival fibroblasts	cyclosporine A treatment	downregulated	26738448
2690	Rat	rno-miR-29b	miRNA	2-acetylaminofluorene	hepatocellular carcinoma (HCC)	liver tissue of rats	2-acetylaminofluorene treatment	downregulated	22213190
2691	Rat	rno-miR-29b	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	hypothermic Circulatory Arrest (DHCA)-associated neural injury	HT-22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	29623838
2692	Rat	rno-miR-29b	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	upregulated	27074745
2693	Rat	rno-miR-29b	miRNA	curcumin (Cur)	liver fibrosis	HSC-T6 cells	curcumin treatment	upregulated	24138392
2694	Rat	rno-miR-29b	miRNA	phenobarbital (PB)	liver homeostasis	liver tissues	phenobarbital (PB) treatment	upregulated	24157574
2695	Rat	rno-miR-29b	miRNA	hypoxia/reoxygenation (H/R)	myocardial dysfunction	H9c2 cells	hypoxia-reoxygenation (H/R) treatment	hypoxia-reoxygenation (H/R) reduced the expression of miRNA-29b in cardiomyoblasts cultures.	30362585
2696	Rat	rno-miR-29b	miRNA	indoxyl sulfate (IS)	myocardial infarction (MI)	cardiac fibroblasts	indoxyl sulfate (IS) treatment	downregulated	25896982
2697	Rat	rno-miR-29b	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	hypoxia induce	downregulated	30362585
2698	Rat	rno-miR-29b	miRNA	lipopolysaccharide (LPS)	myocarditis	H9c2 cells	lipopolysaccharide (LPS) treatment	upregulated	29518613
2699	Rat	rno-miR-29b	miRNA	oxygen glucose deprivation (OGD)	neuron apoptosis	rat primary hippocampal microglial cells	oxygen-glucose deprivation (OGD) induce treatment	downregulated	30742923
2700	Rat	rno-miR-29b	miRNA	isoflurane	oxidative stress	H9c2 cells	Isoflurane treatment	upregulated	29627934
2701	Rat	rno-miR-29b	miRNA	insulin-like growth factor 1 (IGF-1)	post-stroke	brain tissues	Post-stroke ICV administration of IGF-1 to middle-aged female rats treatment	downregulated	24618563
2702	Rat	rno-miR-29b	miRNA	angiotensin II (Ang II)	renal interstitial fibrosis (RIF)	NRK-52E cells	angiotensin II (Ang II) treatment	downregulated	29568897
2703	Rat	rno-miR-29b	miRNA	activated protein C(APC)	sepsis	rats blood and liver tissue	activated protein C treatment	aPC treatment coordinates beneficial cytoprotective effects during sepsis by modulating miRNA expression	22940033
2704	Rat	rno-miR-29b	miRNA	silica	silicosis	RLE-6TN cells (rat type II alveolar epithelial cell line)	supernatant of RAW264.7 cells stimulated by 50 mg/mL silica treatment	downregulated	30529807
2705	Rat	rno-miR-29b	miRNA	silica	silicosis	RLE-6TN cells	treatment treatment	Exposure of RLE-6TN cells to silica for 48 hr also resulted in EMT and a decrease in miR-29b gene expression	30529807
2706	Rat	rno-miR-29b	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
2707	Rat	rno-miR-29b	miRNA	angiotensin II (Ang II)	unilateral ureteral obstruction (UUO)	NRK-52E cells	angiotensin II (Ang II) treatment	"?In this study, loss of miR-29b accompanied with increased epithelial-mesenchymal transition (EMT) was observed in renal tubules of mice after UUO and cultured NRK-52E cells exposed to AngII."	33742315
2708	Rat	rno-miR-29b	miRNA	high inorganic phosphate (Pi)	vascular calcification (VC)	vascular smooth muscle	high-phosphorous treatment	upregulated	26187577
2709	Rat	rno-miR-29b	miRNA	high inorganic phosphate (Pi)	vascular calcification (VC)	vascular smooth muscle	high-phosphorous treatment	lower levels of miR-133b and miR-211 and higher levels of miR-29b	26187577
2710	Rat	rno-miR-29b-3p	miRNA	cholecalciferol	arterial calcification	Sprague Dawley rats calcified arterial tissues	subcutaneous injection of a toxic dose of cholecalciferol	downregulated in calcified arterial tissues	28164126
2711	Rat	rno-miR-29b-3p	miRNA	"1,2-dichloroethane (1,2-DCE)"	brain edema	brain parenchyma and around the vessels of the cerebral cortex	"1,2-dichloroethane (1,2-DCE) treatment"	upregulated	31734271
2712	Rat	rno-miR-29b-3p	miRNA	"1,2-dichloroethane (1,2-DCE)"	brain edema	brain cortex	"1,2-dichloroethane (1,2-DCE) treatment"	upregulated	31734271
2713	Rat	rno-miR-29b-3p	miRNA	TGF-¦Â1	cardiac fibrosis	Cardiac fibrosis	TGF-¦Â1 treatment	TGF-¦Â1 treatment dose-dependently curbed miR-29b-3p expression in CFs	32812641
2714	Rat	rno-miR-29b-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	TUG1 functioned as a positive modulator of cardiac hypertrophy via sponging miR-29b-3p	31183682
2715	Rat	rno-miR-29b-3p	miRNA	Na/K-ATPase	chronic kidney disease (CKD)	cardiac fibroblasts	Na/K-ATPase treatment	"a specific Na/K-ATPase signaling antagonist, pNaKtide, prevented ouabain-induced increases in collagen synthesis and decreases in miR-29b-3p expression in these cells"	26702050
2716	Rat	rno-miR-29b-3p	miRNA	ketamine	depression	prefrontal cortex of the normal rats	Ketamine treatment	upregulated	30369596
2717	Rat	rno-miR-29b-3p	miRNA	muscle contraction	diabetes mellitus (DM)	muscle tissues	"stimulated to contract in vitro for twitch tension analysis (0.5 Hz), 30 min later for tetanic analysis (100 Hz)"	downregulated	28000044
2718	Rat	rno-miR-29b-3p	miRNA	fluorine combined with aluminum (FA)	fluorine combined with aluminum (FA)-induced developmental neurotoxicity	hippocampi	fluorine combined with aluminum (FA) treatment	upregulated	30033483
2719	Rat	rno-miR-29b-3p	miRNA	hypoxia	heart failure (HF)	H9c2 cells	hypoxia induce	downregulated	30560317
2720	Rat	rno-miR-29b-3p	miRNA	hypoxia	heart failure (HF)	H9c2 cells	hypoxia induce	downregulated	30560317
2721	Rat	rno-miR-29b-3p	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	rat renal artery endothelial cells (RRAECs)	angiotensin II (Ang II) treatment	upregulated	32346437
2722	Rat	rno-miR-29b-3p	miRNA	hypoxia	intestinal ischemia/reperfusion (I/R) injury	IEC-6 cells	hypoxia induce	downregulated	31167039
2723	Rat	rno-miR-29b-3p	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	upregulated	27919821
2724	Rat	rno-miR-29b-3p	miRNA	particulate matter (PM2.5)	ischemia/reperfusion (I/R) injury	H9c2 cells	PM2.5 exposure treatment	LncRNA NR_136400 Suppresses Cell Proliferation and Invasion by Acting as a ceRNA of TUSC5 That Is Modulated by miR-8081 in Osteosarcoma	32100595
2725	Rat	rno-miR-29b-3p	miRNA	metformin (Met)	polycystic ovarian syndrome (PCOS)	ovary tissues	Metformin (Met) treatment	upregulated	30989649
2726	Rat	rno-miR-29c	miRNA	NOX inhibitor VAS2870	acute ischemic stroke (AIS)	tMCAO rats	intravenous treatment with NOX inhibitor VAS2870	upregulated	27325364
2727	Rat	rno-miR-29c	miRNA	fastigial nucleus stimulation (FNS)	brain injury	left intracerebroventricular	fastigial nucleus stimulation (FNS)treatment	downregulated	25678279
2728	Rat	rno-miR-29c	miRNA	exercise training (ET)	cardiac remodeling and cardiac dysfunction	obese Zucker rats carsiac	"exercise training (AET) consisted of 10 weeks of 60-min swimming sessions, and 5 days/week"	downregulated and miR-1 was upregulated compared with the control lean rats in carsiac	29138674
2729	Rat	rno-miR-29c	miRNA	epigallocatechin-3-gallate (EGCG)	chronic renal injury	cadmium (Cd) pretreated Wistar albino rats	EGCG treatment	"decreased miR-21 and miR-192, enhanced miR-29a/b/c in kidney samples"	27474435
2730	Rat	rno-miR-29c	miRNA	streptozocin (STZ)	diabetic cataract (DC)	lens epithelial cells (LECs)	Streptozotocin (STZ) treatment	downregulated	28003969
2731	Rat	rno-miR-29c	miRNA	captopril	diabetic nephropathy (DN)	diabetes rats kidney tissue	captopril treatment	upregulated	31433203
2732	Rat	rno-miR-29c	miRNA	spironolactone	diabetic nephropathy (DN)	diabetes rats kidney tissue	spironolactone treatment	upregulated	31433203
2733	Rat	rno-miR-29c	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin (STZ) treatment	upregulated	31364127
2734	Rat	rno-miR-29c	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissue	streptozotocin (STZ) treatment	downregulated	31433203
2735	Rat	rno-miR-29c	miRNA	mithramycin A and decitabine	glucocorticoids effects	rat aortic smooth muscle cells	mithramycin A and decitabine treatment	upregulated	28801263
2736	Rat	rno-miR-29c	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	hypothermic Circulatory Arrest (DHCA)-associated neural injury	HT-22 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	29623838
2737	Rat	rno-miR-29c	miRNA	nerve growth factor (Ngf)	neurodegenerative diseases	PC12 cells	100 ng/ml Ngf treatment	different regulation	24492999
2738	Rat	rno-miR-29c	miRNA	insulin-like growth factor 1 (IGF-1)	post-stroke	brain tissues	Post-stroke ICV administration of IGF-1 to middle-aged female rats treatment	downregulated	24618563
2739	Rat	rno-miR-29c	miRNA	Specificity protein 1 (Sp1)	renal fibrosis	Rat proximal tubular epithelial cell (NRK-52E)	Specificity protein 1 (Sp1) treatment	downregulated	23806282
2740	Rat	rno-miR-29c	miRNA	TGF-¦Â1	renal interstitial fibrosis (RIF)	NRK-49F cells	TGF-¦Â1 treatment	MiR-29c expression was downregulated in TGF-¦Â1-treated NRK-49F cells	32346368
2741	Rat	rno-miR-29c	miRNA	SiO2	trans-differentiation of pulmonary fibroblasts into myofibroblasts	Fibroblasts which were co-cultured with pulmonary macrophages (NR8383)	SiO2 treatment	downregulated	31177707
2742	Rat	rno-miR-29c-3p	miRNA	lipopolysaccharide (LPS)	epilepsy	CTX-TNA2 (CRL-2006) astrocyte cell line	lipopolysaccharide (LPS) treatment	downregulated	33776905
2743	Rat	rno-miR-29c-3p	miRNA	pentylenetetrazol (PTZ)	epilepsy	dorsal hippocampus	pentylenetetrazol treatment	downregulated	33776905
2744	Rat	rno-miR-29c-3p	miRNA	high glucose (HG)	functions of cardiac fibroblasts	primary cardiac fibroblasts	high glucose (HG) treatment	"MiR-29c-3p was downregulated, and STAT3 was upregulated in HG-induced cardiac fibroblasts."	32720796
2745	Rat	rno-miR-29c-3p	miRNA	fish oil	nonalcoholic fatty liver disease (NAFLD)	high-fat high-cholesterol diet rats	supplemented with fish oil (FOH)	dysregulated	28691019
2746	Rat	rno-miR-30	miRNA	doxorubicin (DOX)	cardiomyopathy	Adult rat ventricular cardiomyocytes (ARVCM)	doxorubicin treatment	downregulated	25950484
2747	Rat	rno-miR-30	miRNA	angiotensin II (Ang II)	chronic kidney disease (CKD)	neonatal rat ventricular myocytes (NRVMs)	angiotensin II (Ang II) treatment	"?Furthermore, CKD-related detrimental factors, such as fibroblast growth factor-23 (FGF-23), uraemic toxin, angiotensin-II (Ang-II) and transforming growth factor-¦Â (TGF-¦Â), suppress cardiac miRNA-30 expression"	33848263
2748	Rat	rno-miR-30	miRNA	fibroblast growth factor 23 (FGF23)	chronic kidney disease (CKD)	neonatal rat ventricular myocytes (NRVMs)	fibroblast growth factor-23 (FGF-23) treatment	"?Furthermore, CKD-related detrimental factors, such as fibroblast growth factor-23 (FGF-23), uraemic toxin, angiotensin-II (Ang-II) and transforming growth factor-¦Â (TGF-¦Â), suppress cardiac miRNA-30 expression"	33848263
2749	Rat	rno-miR-30	miRNA	indoxyl sulfate (IS)	chronic kidney disease (CKD)	neonatal rat ventricular myocytes (NRVMs)	indoxyl sulfate (IS) treatment	"?Furthermore, CKD-related detrimental factors, such as fibroblast growth factor-23 (FGF-23), uraemic toxin, angiotensin-II (Ang-II) and transforming growth factor-¦Â (TGF-¦Â), suppress cardiac miRNA-30 expression"	33848263
2750	Rat	rno-miR-30	miRNA	TGF-¦Â	chronic kidney disease (CKD)	neonatal rat ventricular myocytes (NRVMs)	TGF-¦Â treatment	"?Furthermore, CKD-related detrimental factors, such as fibroblast growth factor-23 (FGF-23), uraemic toxin, angiotensin-II (Ang-II) and transforming growth factor-¦Â (TGF-¦Â), suppress cardiac miRNA-30 expression"	33848263
2751	Rat	rno-miR-30	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	glomeruli	streptozotocin (STZ) treatment	downregulated	33490186
2752	Rat	rno-miR-30	miRNA	angiotensin-converting enzyme 2 (ACE2)	doxorubicin (DOX)-induced cardiotoxicity	Primary cardiomyocytes and H9C2 cell line	ACE2 (angiotensin-converting enzyme 2) treatment	upregulated	27633839
2753	Rat	rno-miR-30	miRNA	ferulic acid (FA)	liver fibrosis	liver tissues	ferulic acid treatment	upregulated	32278740
2754	Rat	rno-miR-30	miRNA	gallic acid (GA)	liver fibrosis	liver tissues	gallic acid treatment	upregulated	32278740
2755	Rat	rno-miR-30	miRNA	folic acid	renal fibrosis	kidney tissues	folic acid treatment	downregulated	29158184
2756	Rat	rno-miR-30	miRNA	TGF-¦Â1	renal fibrosis	rat kidney fibroblast cell NRK-49F and renal tubular epithelial cell NRK-52E	TGF-¦Â1 treatment	downregulated	29158184
2757	Rat	rno-miR-30	miRNA	TGF-¦Â1	renal fibrosis	Rat kidney fibroblast cell NRK-49F and renal tubular epithelial cell NRK-52E	TGF-¦Â1 treatment	downregulated	29158184
2758	Rat	rno-miR-30	miRNA	angiotensin II (Ang II)	WC-Co-induced carcinogenesis	Cardiomyocyte	angiotensin II (Ang II) treatment	Angiotensin II induces downregulated of miR-30 in cardiomyocytes	23326547
2759	Rat	rno-miR-300-3p	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
2760	Rat	rno-miR-300-5p	miRNA	angiotensin II (Ang II)	cardiac fibrosis and hypertension	cardiac fibroblasts (CFs) of rats	angiotensin II (Ang II) treatment	downregulated	23007623
2761	Rat	rno-miR-301a	miRNA	glycine	neuronal cell injury	cortical neurons	Glycine treatment	upregulated	27230112
2762	Rat	rno-miR-301a	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
2763	Rat	rno-miR-301b-3p	miRNA	mono-n-butyl phthalate (MBP)	cell proliferation	rat juvenile Sertoli cells (SCs)	treat with 0.1mM MBP	upregulated	29162477
2764	Rat	rno-miR-302	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	31845077
2765	Rat	rno-miR-302a	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	31845077
2766	Rat	rno-miR-302b	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	31845077
2767	Rat	rno-miR-302b-3p	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin (STZ) treatment	upregulated	32432759
2768	Rat	rno-miR-302b-3p	miRNA	isoflurane	neuronal cell injury	primary hippocampal neurons	Isoflurane (ISO) treatment	ISO stimulation led to miR-302b-3p upregulation and neuronal injury.	33370590
2769	Rat	rno-miR-302b-3p	miRNA	isoflurane	neuronal cell injury	rat hippocampal neurons	Isoflurane (ISO) treatment	?We discovered that ISO stimulation led to miR-302b-3p upregulation and neuronal injury.	33370590
2770	Rat	rno-miR-302c	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	31845077
2771	Rat	rno-miR-302c	miRNA	high glucose (HG)	mesothelial/epithelial-mesenchymal transition (MMT/EMT)	mouse peritoneum	high glucose peritoneal dialysate induce	downregulated	30693641
2772	Rat	rno-miR-302d	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	31845077
2773	Rat	rno-miR-302e	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	31222747
2774	Rat	rno-miR-302e	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	MAGI1-IT1 functioned as a negative regulator in CH through inactivating Wnt/beta-catenin pathway via targeting miR-302e/DKK1 axis	31222747
2775	Rat	rno-miR-30-3p	miRNA	hypoxia	myocardial infarction (MI)	H9C2 cells	"cobalt chloride solution as 1000 ?mol/L, hypoxia for 12 hours"	miRNA-30-3p had the effect of improving cell apoptosis induced by myocardial ischemia in vitro and in vivo studies by the regulation of the PTEN/PI3K/AKT pathway.	31131466
2776	Rat	rno-miR-3068-3p	miRNA	glutamate	ischemic stroke (IS)	rat primary cortical neurons	glutamate treatment	upregulated	31792968
2777	Rat	rno-mir-3074	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2778	Rat	rno-miR-3074-5p	miRNA	palmitate	pancreatic ¦Â-cell dysfunction	INS-1E cells	palmitate treatment	lncEif4g2 is able to indirectly regulate the expression of CREB via targeting miR-3074-5p in INS-1E cells and mouse islets	32956705
2779	Rat	rno-miR-3084a-3p	miRNA	cadmium (Cd)	cadmium (Cd)-induced kidney injury	renal cortex	cadmium (Cd) treatment	upregulated	29543730
2780	Rat	rno-miR-3084c-3p	miRNA	cadmium (Cd)	cadmium (Cd)-induced kidney injury	renal cortex	cadmium (Cd) treatment	upregulated	29543730
2781	Rat	rno-miR-30a	miRNA	paeonol (PAE)	atherosclerosis (AS)	vascular endothelial cells (VECs)	paeonol treatment	"ox-LDL decreased miR-30a and increased Beclin-1 expression, pretreatment with paeonol could reverse the process of regulation in dose-dependent manners"	29472864
2782	Rat	rno-miR-30a	miRNA	triiodo-l-thyronine (T3)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	primary cardiomyocyte of neonatal rats with hypoxia	T3 treatment	upregulated	25137026
2783	Rat	rno-miR-30a	miRNA	phenylephrine (PE)	cardiac hypertrophy	H9c2 cells	phenylephrine treatment	downregulated	23660952
2784	Rat	rno-miR-30a	miRNA	rapamycin	cell senescence	vascular smooth muscle cells (VSMCs)	rapamycin treatment	downregulated	30747228
2785	Rat	rno-miR-30a	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	colitis	male Wistar rats inflamed colon	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	downregulated in inflamed colon	28572713
2786	Rat	rno-miR-30a	miRNA	caffeic acid	diabetic nephropathy (DN)	high-fat diet and streptozotocin-induced (HFD-STZ) diabetic rats	caffeic acid (CA) treatment	downregulated	28536471
2787	Rat	rno-miR-30a	miRNA	S100A12	diabetic retinopathy (DR)	Retinal microglia	S100A12 treatment	downregulated	31199706
2788	Rat	rno-miR-30a	miRNA	TGF-¦Â1	insulin resistance (IR)	peritoneal tissue in a rat	TGF-¦Â1 treatment	downregulated	24378208
2789	Rat	rno-miR-30a	miRNA	cisplatin (DDP)	hepatocellular carcinoma (HCC)	HepS cells	cis-dichloro-diamine platinum (cis-DDP) treatment	upregulated	22157765
2790	Rat	rno-miR-30a	miRNA	taxol	hepatocellular carcinoma (HCC)	HepS cells	Taxol treatment	upregulated	22157765
2791	Rat	rno-miR-30a	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	downregulated	29587268
2792	Rat	rno-miR-30a	miRNA	melatonin	malignant arrhythmias	older obese female rat hearts	melatonin treatment	downregulated	30446908
2793	Rat	rno-miR-30a	miRNA	melatonin	malignant arrhythmias	high-sucrose-induced left ventricles of female rat hearts	Melatonin treatment	downregulated	30446908
2794	Rat	rno-miR-30a	miRNA	omega-3 polyunsaturated fatty acids (¦Ø-3 PUFA)	malignant arrhythmias	older obese female rat hearts	omega-3 polyunsaturated fatty acids treatment	downregulated	30446908
2795	Rat	rno-miR-30a	miRNA	omega-3 polyunsaturated fatty acids (¦Ø-3 PUFA)	malignant arrhythmias	high-sucrose-induced left ventricles of female rat hearts	omega-3 polyunsaturated fatty acids treatment	downregulated	30446908
2796	Rat	rno-miR-30a	miRNA	substance P (SP)	malignant arrhythmias	left ventricles of female rat hearts	sucrose treatment	upregulated	30446908
2797	Rat	rno-miR-30a	miRNA	sucrose	malignant arrhythmias	older obese female rat hearts	sucrose treatment	upregulated	30446908
2798	Rat	rno-miR-30a	miRNA	angiotensin II (Ang II)	myocardial injury	rats primary cardiomyocytes	angiotensin II (Ang II) treatment	downregulated	25501305
2799	Rat	rno-miR-30a	miRNA	epigallocatechin-3-gallate (EGCG)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	hypoxia-induced H9c2 cardiomyocytes	EGCG treatment	upregulated	31029907
2800	Rat	rno-miR-30a	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cardiomyocytes	hypoxia induce	downregulated	31029907
2801	Rat	rno-miR-30a	miRNA	osthole	myocardial ischemia/reperfusion (I/R) injury (MIRI)	I/R in rat heart tissues and hypoxia/reoxygenation (H/R) in myocardial cells in vitro	osthole treatment	downregulated	31017665
2802	Rat	rno-miR-30a	miRNA	H2O2	oxidative stress	cardiovascular cells NRVCs and RAVSMCs	H2O2 treatment	downregulated	24612558
2803	Rat	rno-miR-30a	miRNA	isoflurane and sevoflurane	postoperative cognitive dysfunction (POCD)	Wistar rats hippocampus	exposed to isoflurane and sevoflurane for 2 or 4h	downregulated in the hippocampus	28669717
2804	Rat	rno-miR-30a	miRNA	insulin-like growth factor 1 (IGF-1)	post-stroke	brain tissues	Post-stroke ICV administration of IGF-1 to middle-aged female rats treatment	downregulated	24618563
2805	Rat	rno-miR-30a	miRNA	grape seed proanthocyanidins (GSPs)	prostatic deficits	prostate	orally given for 20 weeks	upregulated	28499242
2806	Rat	rno-miR-30a*	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
2807	Rat	rno-miR-30a-3p	miRNA	compound 21 (C21)	cardiac hypertrophy	Zucker diabetic fatty (ZDF) rats heart tissues	Compound 21 (C21) treatment	downregulated	30187136
2808	Rat	rno-miR-30a-3p	miRNA	losartan	cardiac hypertrophy	Zucker diabetic fatty (ZDF) rats heart tissues	losartan treatment	downregulated	30187136
2809	Rat	rno-miR-30a-3p	miRNA	compound 21 (C21)	cardiac hypertrophy	heart tissues	Compound 21 (C21) treatment	downregulated	30187136
2810	Rat	rno-miR-30a-3p	miRNA	losartan	cardiac hypertrophy	heart tissues	losartan treatment	downregulated	30187136
2811	Rat	rno-miR-30a-5p	miRNA	¦Â3-adrenoceptors(¦Â3-AR) inhibitor SR 59230A	chronic heart failure (CHF)	CHF rats	1 ml SR 59230A(85 mmoL/L in 0.9% saline)twice a day for seven weeks by intraperitoneal injection treatment	upregulated	29926593
2812	Rat	rno-miR-30a-5p	miRNA	glucose	glucotoxicity	rat islets and INS-1 cells	glucose treatment	upregulated	23338554
2813	Rat	rno-miR-30a-5p	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	Hypoxia/reoxygenation (H/R) remarkably raised the level of miR-30a-5p in H9c2 cardiomyocytes.	33058540
2814	Rat	rno-miR-30a-5p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC-12 cells	lipopolysaccharide (LPS) treatment	LINC00707 alleviates LPS-induced inflammation and apoptosis in PC-12 cells by targeting miR-30a-5p/Neurod 1	31272297
2815	Rat	rno-miR-30b	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	PC12; C6 cells	amyloid-¦Â (A¦Â) 25-35 treatment	MALAT1 could promote neuronal recovery following AD through the miR-30b/CNR1 network and the PI3K/AKT signaling activation.	32976819
2816	Rat	rno-miR-30b	miRNA	angiotensin II (Ang II)	cardiomyocytes cell death	rat neonatal cardiomyocytes	angiotensin II (Ang II) treatment	dysregulated	24178239
2817	Rat	rno-miR-30b	miRNA	hypoxia/reoxygenation (H/R)	cardiomyopathy	H9C2 cell line	hypoxia/re-oxygenation treatment	downregulated	27294099
2818	Rat	rno-miR-30b	miRNA	high glucose (HG)	diabetic retinopathy (DR)	rat retinal M¨¹ller cells (rMC-1) cells	high glucose	downregulated	28246353
2819	Rat	rno-miR-30b	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	30721562
2820	Rat	rno-miR-30b	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
2821	Rat	rno-miR-30b	miRNA	H2O2	oxidative stress	cardiovascular cells NRVCs and RAVSMCs	H2O2 treatment	downregulated	24612558
2822	Rat	rno-miR-30b	miRNA	grape seed proanthocyanidins (GSPs)	prostatic deficits	prostate	orally given for 20 weeks	upregulated	28499242
2823	Rat	rno-miR-30b-3p	miRNA	triptolide (TPL)	nephropathy	blood and renal tissues	rats with adriamycin-induced nephropathy treatment	triptolide treatment reversed the increase in the expression of these two miRNAs	26078766
2824	Rat	rno-miR-30b-5p	miRNA	estradiol-17¦Â (E2)	osteogenesis	primary bone marrow mesenchymal stem cells from rats (rBMSCs)	estradiol-17¦Â (E2) treatment	downregulated	31089333
2825	Rat	rno-miR-30b-5p	miRNA	oxaliplatin	peripheral neuropathic pain	dorsal root ganglion (DRG) tissues	oxaliplatin treatment	downregulated	31054938
2826	Rat	rno-miR-30b-5p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	upregulated	26997989
2827	Rat	rno-miR-30c	miRNA	TGF-¦Â1	atrial fibrosis	primary cultured neonatal cardiac fibroblasts (CFs)	transforming growth factor-¦Â1 (TGF-¦Â1) treatment	downregulated	29532993
2828	Rat	rno-miR-30c	miRNA	vitamin D receptor activators (VDRAs)	chronic renal failure (CRF)	nephrectomized Wistar rats	equivalent doses of two VDRAs: calcitriol and paricalcitol treatment	upregulated	28460073
2829	Rat	rno-miR-30c	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	cardiomyocytes	high glucose treatment	upregulated	27221738
2830	Rat	rno-miR-30c	miRNA	palmitate	diabetic cardiomyopathy (DCM)	H9c2 cells and primary neonatal rat cardiomyocytes	palmitate treatment	downregulated	30635067
2831	Rat	rno-miR-30c	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	cardiomyocytes	low-dose streptozotocin-high-fat diet treatment	downregulated	25781190
2832	Rat	rno-miR-30c	miRNA	pilocarpine	epilepsy	adult male rats brain tissue and heart tissue	50 days of pilocarpine treatment	downregulated in heart tissue	24530830
2833	Rat	rno-miR-30c	miRNA	hydrogen sulfide (H2S)	ischemia/reperfusion (I/R) injury	spinal cord infarct zone	Hydrogen sulfide (H2S) treatment	downregulated	26149869
2834	Rat	rno-miR-30c	miRNA	angiotensin II (Ang II)	liver fibrosis/cirrhosis	hepatic stellate cells (HSCs)	angiotensin II (Ang II) treatment	downregulated	27142827
2835	Rat	rno-miR-30c	miRNA	cisplatin (DDP)	nephrotoxicity	rats renal tubules and epithelial cell	cisplatin treatment	downregulated	28796263
2836	Rat	rno-miR-30c	miRNA	nerve growth factor (Ngf)	neurodegenerative diseases	PC12 cells	100 ng/ml Ngf treatment	different regulation	24492999
2837	Rat	rno-miR-30c	miRNA	grape seed proanthocyanidins (GSPs)	prostatic deficits	prostate	orally given for 20 weeks	upregulated	28499242
2838	Rat	rno-miR-30c	miRNA	TGF-¦Â1	renal fibrosis	renal tubular epithelial cells (NRK-52E)	TGF-¦Â1 treatment	downregulated	27874055
2839	Rat	rno-miR-30c	miRNA	oxygen glucose deprivation (OGD)	spinal cord ischemia/reperfusion injury (SCII)	PC12 cells	oxygen-glucose deprivation (OGD) treatment	upregulated	30776367
2840	Rat	rno-miR-30c	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
2841	Rat	rno-miR-30c	miRNA	propranolol (PRO)	¦Â-adrenoceptor intervention	rat heart	propranolol (PRO) treatment	upregulated	22847192
2842	Rat	rno-miR-30c-1*	miRNA	grape seed procyanidin extract (GSPE)	pancreatic islet injury	rat islets	grape seed procyanidin extract (GSPE)treatment	"GSPE altered significantly the expression of miR-1249, miR-483, miR-30c-1*, and miR-3544."	23215023
2843	Rat	rno-miR-30c-2*	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
2844	Rat	rno-miR-30c-5p	miRNA	ischemia/reperfusion (I/R) 	kidney damage	Sprague-Dawley rats urine	ischemia/reperfusion (I/R) treatment	upregulated	28056546
2845	Rat	rno-miR-30c-5p	miRNA	tert-butyl hydroperoxide (TBHP)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	tert- butyl hydroperoxide tBHP treatment	MiR-30c-5p mediates the effects of panax notoginseng saponins in myocardial ischemia reperfusion injury by inhibiting oxidative stress-induced cell damage.	32036220
2846	Rat	rno-miR-30c-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2847	Rat	rno-miR-30d	miRNA	valproic acid (VPA)	autism spectrum disorder (ASD)	amygdala	valproic acid treatment	upregulated	25986729
2848	Rat	rno-miR-30d	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	neonatal cardiomyocytes	angiotensin II (Ang II) treatment	upregulated	33860820
2849	Rat	rno-miR-30d	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	rats heart	STZ treatment	upregulated	25341033
2850	Rat	rno-miR-30d	miRNA	SGLT-2 inhibitors	diabetic cardiomyopathy (DCM)	heart tissues	SGLT-2 inhibitors treatment	SGLT-2 inhibitors prevented heart function decline in diabetic rats by inhibiting miR-30d	32572932
2851	Rat	rno-miR-30d	miRNA	TianMai Xiaoke tablet(TM)	type 2 diabetes mellitus (T2DM)	diabetic rats islet	TM treatment	upregulated	24812635
2852	Rat	rno-miR-30d	miRNA	follicle stimulating hormone (FSH)	colorectal cancer (CRC)	rat granulosa cells	Follicle-stimulating hormone (FSH)treatment	downregulated	20734245
2853	Rat	rno-miR-30d-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2854	Rat	rno-miR-30d-5p	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	upregulated	27919821
2855	Rat	rno-miR-30d-5p	miRNA	fish oil	nonalcoholic fatty liver disease (NAFLD)	high-fat high-cholesterol diet rats	supplemented with fish oil (FOH)	dysregulated	28691019
2856	Rat	rno-miR-30d-5p	miRNA	follicle stimulating hormone (FSH)	polycystic ovarian syndrome (PCOS)	rat cultured granulosa cells	follicle stimulating hormone (FSH) treatment	upregulated	31853272
2857	Rat	rno-miR-30e	miRNA	isoproterenol	cardiac fibrosis	Sprague Dawley rats hearts	ISO treatment	downregulated in the hearts	28777253
2858	Rat	rno-miR-30e	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	upregulated	27074745
2859	Rat	rno-miR-30e	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	rat myocardial tissues	hypoxia/reoxygenation injury (H/R)? treatment	Decreased miR-30e and increased SOX9 were found in myocardial tissues of MI/RI rats and H/R-treated cardiomyocytes.	33293097
2860	Rat	rno-miR-30e	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation injury (H/R) treatment	downregulated	33293097
2861	Rat	rno-miR-30e	miRNA	high fat diet (HFD)	obesity	rats	high fat diet (HFD) feed	dysregulated	24517225
2862	Rat	rno-miR-30e	miRNA	serum	cell proliferation	VSMCs isolated from normal aorta of adult male rats	were stimulated with 10% serum treatment	downregulated	28123167
2863	Rat	rno-miR-30e	miRNA	schisandrin B (Sch B)	tubulointerstitial fibrosis (TIF)	TGF-¦Â1-treated NRK-52e cells	Schisandrin B (Sch B) treatment	upregulated	31697999
2864	Rat	rno-miR-30e	miRNA	TGF-¦Â1	tubulointerstitial fibrosis (TIF)	NRK-52e cells	TGF-¦Â1 treatment	downregulated	31697999
2865	Rat	rno-miR-30e-3p	miRNA	rapamycin	cardiac fibrosis	heart tissues	rapamycin (Rap) treatment	upregulated	30647817
2866	Rat	rno-miR-31	miRNA	atorvastatin	cardiac hypertrophy	chronic intermittent hypoxia (CIH)-treated H9c2 cells	atorvastatin treatment	downregulated	30074205
2867	Rat	rno-miR-31	miRNA	hypoxia	cardiac hypertrophy	H9c2 cells	chronic intermittent hypoxia (CIH) induce	upregulated	30074205
2868	Rat	rno-miR-31	miRNA	hypoxia	myocardial infarction (MI)	heart tissues	MI was induced by ligation of the left anterior descending coronary artery (LAD)	upregulated	28865712
2869	Rat	rno-miR-31	miRNA	isoflurane and sevoflurane	postoperative cognitive dysfunction (POCD)	Wistar rats hippocampus	exposed to isoflurane and sevoflurane for 2 or 4h	downregulated in the hippocampus	28669717
2870	Rat	rno-miR-31-5p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	H9c2 cells	doxorubicin (Dox) treatment	downregulated	32135167
2871	Rat	rno-miR-31a-5p	miRNA	high fat diet (HFD)	aging-related non-alcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	downregulated	31899128
2872	Rat	rno-miR-31a-5p	miRNA	angiotensin II (Ang II)	heart failure (HF)	cardiac H9C2 cell line	angiotensin II (Ang II) treatment	downregulated	29286111
2873	Rat	rno-miR-31a-5p	miRNA	angiotensin II (Ang II)	heart failure (HF)	H9C2 cell line	angiotensin II (Ang II) treatment	downregulated	29286111
2874	Rat	rno-miR-31a-5p	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	upregulated	32893733
2875	Rat	rno-miR-31b	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	upregulated	32893733
2876	Rat	rno-miR-31c	miRNA	H2O2	oxidative stress	cardiovascular cells NRVCs and RAVSMCs	H2O2 treatment	downregulated	24612558
2877	Rat	rno-miR-32	miRNA	streptozocin (STZ)	liver fibrosis	liver tissue	streptozotocin (STZ) treatment	upregulated	30816482
2878	Rat	rno-miR-320	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	Wistar rats left ventricle (LV)	STZ treatment	downregulated	28199183
2879	Rat	rno-miR-320	miRNA	high glucose (HG)	diabetic retinopathy (DR)	M¨¹ller cells	high glucose (HG) treatment	DR patients exhibited significantly increased expression of serum LncRNA-OGRU compared with normal individuals. Streptozotocin (STZ)-challenged rats with DR also had higher OGRU expression in retinas	33762162
2880	Rat	rno-miR-320	miRNA	ethylene glycol monomethyl ether (EGME)	hyperglycemia	?testicle of rat	Ethylene glycol monomethyl ether (EGME) treatment	"miR-449a and miR-92a decreased obviously and, miR-320, miR-134 and miR-188 increased"	22008535
2881	Rat	rno-miR-320	miRNA	high salt (HS)	hypertension	aorta of? rats	high salt (HS) treatment	upregulated	24161401
2882	Rat	rno-miR-320	miRNA	edaravone (ED)	intestinal mucosa barrier dysfunction after burn injury	intestinal mucosal tissue injury in burned rats	edaravone (ED) treatment	upregulated	31829167
2883	Rat	rno-miR-320	miRNA	oxygen glucose deprivation (OGD)	ischemic heart disease (IHD)	H9c2 cells	oxygen and glucose deprivation (OGD) treatment	Overexpressed circRNA-DENND4C in H9c2 cells attenuated OGD/R-induced injuries by the downregulated of miR-320 through the ERK and mTOR activation	33090893
2884	Rat	rno-miR-320	miRNA	verapamil	male fertility	testis	verapamil treatment	downregulated	32725937
2885	Rat	rno-miR-320	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cardiac myocytes	hypoxia induce	upregulated	29521436
2886	Rat	rno-miR-320	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia induce	upregulated	30181740
2887	Rat	rno-miR-320	miRNA	insulin	myocardial ischemia/reperfusion (I/R) injury (MIRI)	hypoxia-induced H9C2 cardiac myocytes	insulin treatment	downregulated	29521436
2888	Rat	rno-miR-320	miRNA	luteolin	renal ischemia/reperfusion (I/R) injury	ischemia-reperfusion (I/R) injury rats kidney tissues	luteolin treatment	downregulated	31089916
2889	Rat	rno-miR-3202	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	rats bronchia	cigarette smoke (CS) treatment	downregulated in bronchia	29208459
2890	Rat	rno-miR-320-3p	miRNA	morphine	myocardial hypoxia/reoxygenation (H/R) injury	H9c2 cells	Morphine pre-conditioning (MPC)	The expression of miR-320-3p in the MPC+H/R group was significantly lower than that in the H/R group.	32468068
2891	Rat	rno-miR-320-5p	miRNA	¦Â3-adrenoceptors(¦Â3-AR) inhibitor SR 59230A	chronic heart failure (CHF)	CHF rats	1 ml SR 59230A(85 mmoL/L in 0.9% saline)twice a day for seven weeks by intraperitoneal injection treatment	upregulated	29926593
2892	Rat	rno-miR-320a	miRNA	insulin	polycystic ovarian syndrome (PCOS)	KGN cells	insulin treatment	upregulated	28849208
2893	Rat	rno-miR-320b	miRNA	insulin-like growth factor 1 (IGF-1)	post-stroke	brain tissues	Post-stroke ICV administration of IGF-1 to middle-aged female rats treatment	downregulated	24618563
2894	Rat	rno-miR-320c	miRNA	streptozocin (STZ)	type 1 diabetes mellitus (T1DM)	INS-1 cells	streptozocin (STZ) treatment	Secretions of miR-320c was significantly increased in streptozotocin-treated INS-1 cells	29370422
2895	Rat	rno-miR-322	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	Wistar rats left ventricle (LV)	STZ treatment	upregulated	28199183
2896	Rat	rno-miR-322	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	upregulated	33333053
2897	Rat	rno-miR-322	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	rat liver tissue	CCl4 treatment	"miR-322/424 level in liver cirrhosis patients, mouse liver fibrosis induced by CCl4?and BDL, and rat liver fibrosis induced by CCl4?and dimethylnitrosamine was increased."	33333053
2898	Rat	rno-miR-322-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	downregulated	32436661
2899	Rat	rno-miR-322-5p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	rat vascular smooth muscle cells (VSMCs)	high glucose	downregulated	28536423
2900	Rat	rno-miR-322-5p	miRNA	bortezomib	peripheral neuropathy	PC12 cells	bortezomib treatment	downregulated	31979371
2901	Rat	rno-miR-322-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2902	Rat	rno-miR-323	miRNA	hypoxia	cerebral infarction (CI)	PC12 cells	hypoxia induce	upregulated	30535466
2903	Rat	rno-miR-323	miRNA	oxygen glucose deprivation (OGD)	neuronal cell death	primary hippocampal neuron	oxygen-glucose deprivation (OGD) treatment	upregulated	26617783
2904	Rat	rno-miR-323-3p	miRNA	H2O2	myocardial infarction (MI)	H9c2 cells	H2O2 treatment	downregulated	32633390
2905	Rat	rno-miR-323a-3p	miRNA	angiotensin II (Ang II)	cardiac fibrosis	rat cardiac fibroblasts (CFs)	angiotensin II (Ang II) treatment	MiR-323a-3p was found upregulated in CFs cultured with Angiotensin ¢ò (Ang ¢ò).	30551487
2906	Rat	rno-miR-324	miRNA	aerobic exercise	parkinson's disease (PD)	brain tissues	aerobic exercise training (AET) treatment	downregulated	31309116
2907	Rat	rno-miR-324-3p	miRNA	2-imidazolidinethione	anorectal malformations (ARM)	Intestinal epithelial cells; IECs and anorectal tissues	2-imidazolidinethione treatment	"Rno_circ_0005139 influences cell proliferation and apoptosis by acting as a miR-324-3p sponge, thereby downregulating Wnt5a in ARM."	32848333
2908	Rat	rno-miR-324-3p	miRNA	high fat diet (HFD)	cardiac remodeling	heart tissues	high fat diet (HFD) feed	upregulated	29884823
2909	Rat	rno-miR-324-3p	miRNA	hypoxia	cortical injury	rat cortex tisssues	hypoxia treatment	downregulated	23272113
2910	Rat	rno-miR-324-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retinas tissues	streptozotocin treatment	downregulated	31430717
2911	Rat	rno-miR-324-3p	miRNA	¦Ä-opioid receptor (DOR)	hypoxic/ischemic injury	hearts	¦Ä-opioid receptor (DOR) activation treatment	upregulated	27576463
2912	Rat	rno-miR-324-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	acute myocardial infarction (AMI)	rat ventricular cardiomyocytes (NRCMs)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31622017
2913	Rat	rno-miR-324-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	primary rat neurons	oxygen-glucose deprivation (OGD) induce treatment	downregulated	31885705
2914	Rat	rno-miR-324-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	primary rat neurons	oxygen-glucose deprivation (OGD) treatment	Downregulated miRNA-324-5p aggravates neuronal injury induced by oxygen-glucose deprivation via modulating RAN	31885705
2915	Rat	rno-miR-324-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	Neonatal rat ventricular cardiomyocytes (NRCMs)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	Inhibition of the LncRNA Gpr19 attenuates ischemia-reperfusion injury after acute myocardial infarction by inhibiting apoptosis and oxidative stress via the miR-324-5p/Mtfr1 axis.	31622017
2916	Rat	rno-miR-325-3p	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia induce	"The expression levels of MEG3 and TRPV4 were significantly increased, whereas miR-325-3p expression levels were significantly decreased in hypoxic H9c2 cells compared with normoxic H9c2 cells."	33179099
2917	Rat	rno-miR-325-5p	miRNA	neonatal colonic inflammation (NCI)	chronic visceral hypersensitivity	colon-related dorsal root ganglia (DRGs)	neonatal colonic inflammation (NCI) induce	downregulated	30980241
2918	Rat	rno-miR-326	miRNA	alcohol	fetal alcohol exposure (FAE)	pregnant Fisher 344 rats pituitary	liquid diet containing 6.7% alcohol between gestational days 7-21 (AF)	upregulated	28710248
2919	Rat	rno-miR-326	miRNA	formaldehyde	formaldehyde inducted immune/inflammation	rats	were exposed to formaldehyde treatment	upregulated	24304932
2920	Rat	rno-miR-326	miRNA	oxygen glucose deprivation (OGD)	hypoxic/ischemic brain damage (HIBD)	PC-12 cells	oxygen glucose deprivation (OGD) treatment	The expression levels of miR-326 was significantly lower in the HIBD group.	32228617
2921	Rat	rno-miR-326-3p	miRNA	cadmium (Cd)	kidney damage	NRK-52E cells	cadmium (Cd) treatment	miR-122-5p and miR-326-3p might enhance cadmium-induced NRK-52E cell apoptosis through downregulating PLD1 expression.	32697411
2922	Rat	rno-miR-326-3p	miRNA	cadmium (Cd)	renal toxic	"NRK-52E cells, rat kidney, serum and urine samples"	cadmium (Cd) treatment	upregulated	31626960
2923	Rat	rno-miR-326-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	primary rat cortical neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"Mfn2 and miR-326-5p were reduced, and STAT3 was elevated in OGD-treated neurons and brain tissues of MCAO rats"	33877455
2924	Rat	rno-miR-327	miRNA	angiotensin II (Ang II)	cardiac hypertrophy and fibrosis	rat cardiac fibroblasts	angiotensin II (Ang II) treatment	miR-327 levels in fibroblasts were increased.	29393356
2925	Rat	rno-miR-327	miRNA	oxygen	lung injury	pregnant rats lung tissue	inspired oxygen of 10.5 or 23% for two days treatment	downregulated	25120593
2926	Rat	rno-miR-327	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	H9c2 cells were exposed to hypoxia for 4?hr and reoxygenation for 12?hr to mimic I/R injury	upregulated	31587299
2927	Rat	rno-miR-327	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H92c cells	hypoxia/reoxygenation (H/R) treatment	Inhibition of microRNA-327 ameliorates ischemia/reperfusion injury-induced cardiomyocytes apoptosis through targeting apoptosis repressor with caspase recruitment domain	31587299
2928	Rat	rno-miR-328	miRNA	doxycycline	atrial fibrillation (AF)	heart tissues	doxycycline treatment	downregulated	30470910
2929	Rat	rno-miR-328	miRNA	doxycycline	atrial fibrillation (AF)	heart sissues	doxycycline treatment	upregulated	30470910
2930	Rat	rno-miR-328	miRNA	60 mmHg of pressure	renal fibrosis	rat renal tubular cells (NRK-52E)	culture under 60 mmHg of pressure treatment	downregulated	24919189
2931	Rat	rno-miR-328a	miRNA	high fat diet (HFD)	erectile dysfunction (ED)	rats	high fat diet (HFD) feed	corpus cavernosum (CC)	28970082
2932	Rat	rno-miR-328a-3p	miRNA	cold	cold stress	rats serum	cold conditions (4¡æ for 12h)	downregulated	28477904
2933	Rat	rno-miR-328a-3p	miRNA	fish oil	nonalcoholic fatty liver disease (NAFLD)	high-fat high-cholesterol diet rats	supplemented with fish oil (FOH)	dysregulated	28691019
2934	Rat	rno-miR-328a-5	miRNA	cadmium (Cd)	cadmium (Cd)-induced reproductive toxicity	testes	cadmium (Cd) treatment	"miR-328a-5p was significantly increased only in the 2.0 mg/kg Cd treatment group at PND 21. at PND 56, the expression of miR-328a-5p decreased in all of the Cd treatment groups (P < 0.05 and P < 0.01) and decreased to 0.4 in the 2.0 mg/kg Cd treatment group."	31654709
2935	Rat	rno-miR-329	miRNA	comfrey	tumorigenesis	rat liver	comfrey treatment	downregulated	21370286
2936	Rat	rno-miR-329-3p	miRNA	estradiol benzoate (EB) and testosterone (T)/E	chronic inflammatory diseases	dorsolateral prostate	estradiol benzoate (EB) and testosterone (T)/E treatment	downregulated	33332750
2937	Rat	rno-miR-32d	miRNA	H2O2	oxidative stress	cardiovascular cells NRVCs and RAVSMCs	H2O2 treatment	downregulated	24612558
2938	Rat	rno-miR-33	miRNA	grape seed proanthocyandin extract (GSPE)	dysregulated fatty acid and cholesterol metabolism	rat liver cells	grape seed proanthocyanidins extracts (GSPE) treatment	downregulated	22965541
2939	Rat	rno-miR-33	miRNA	icariside II (ICA II)	erectile dysfunction (ED)	Adipose derived stem cells (ADSCs)	Icariside II (ICA II) treatment	ICA II promoted the differentiation of ADSCs to SCs through downregulating miR-33.	32066039
2940	Rat	rno-miR-33	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
2941	Rat	rno-miR-33	miRNA	estradiol	metabolic effects of estrogen	liver tissues	estradiol treatment	upregulated	32045601
2942	Rat	rno-miR-33	miRNA	arterial mechanical stretch	neointimal hyperplasia	Sprague-Dawley rats venous smooth muscle cells (SMCs)	exposed to a 10%-1.25 Hz cyclic arterial stretch	downregulated	28137944
2943	Rat	rno-miR-330	miRNA	lipopolysaccharide (LPS)	disseminated intravascular coagulation (DIC)	liver tissues	lipopolysaccharide (LPS) treatment	upregulated	24806323
2944	Rat	rno-miR-330	miRNA	fructose	kidney damage	rats kidney cortex	fructose treatment	downregulated in kidney cortex	28205387
2945	Rat	rno-miR-330	miRNA	(+)-cholesten-3-one (CN)	osteoblastic differentiation	mesenchymal stem cells (MSCs)	(+)-cholesten-3-one (CN) treatment	upregulated	30373531
2946	Rat	rno-miR-330-3p	miRNA	high glucose (HG)	gestational diabetes mellitus (GDM)	INS-1 cells	high glucose (HG) treatment	The miR-330-3p expression level positively correlated with blood glucoseand and it was highly expressed in glucose-treated INS-1 cells.	32202040
2947	Rat	rno-miR-330-5p	miRNA	H2O2	adipogenesis	mesenchymal stem cells (MSCs)	H2O2 treatment	downregulated	30015907
2948	Rat	rno-miR-330-5p	miRNA	high fat diet (HFD)	cardiac remodeling	heart tissues	high fat diet (HFD) feed	upregulated	29884823
2949	Rat	rno-miR-330-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2950	Rat	rno-miR-331-3p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC-12 cells	lipopolysaccharide (LPS) treatment	SOX2OT was elevated in SCI rat and cell models.	33340723
2951	Rat	rno-miR-331-5p	miRNA	ketamine	drug addiction	hippocampus tissues	ketamine treatment	downregulated	29476799
2952	Rat	rno-miR-331-5p	miRNA	rhynchophylline	drug addiction	ketamine-addicted rats hippocampus tissues	rhynchophylline treatment	downregulated	29476799
2953	Rat	rno-miR-335	miRNA	hypoxia	acute ischemic stroke (AIS)	brain tissues	Middle cerebral artery occlusion (MCAO) treatment	downregulated	30747210
2954	Rat	rno-miR-335	miRNA	high fat diet (HFD)	aging-related non-alcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31899128
2955	Rat	rno-miR-335	miRNA	methane	diabetic retinopathy (DR)	Retinal?tissues	methane treatment	upregulated	26363454
2956	Rat	rno-miR-335	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	miR-335 was significantly downregulat- ed in H/R-exposed cardiomyocytes.	30662652
2957	Rat	rno-miR-335	miRNA	glucocorticoid (GC)	osteonecrosis of femoral head (ONFH)	rat femoral head bone microvascular endothelial cells (BMECs)	glucocorticoids treatment	ICA could regulate the overexpression of miRNA-335 induced by glucocorticoids.	32911026
2958	Rat	rno-miR-335	miRNA	icariin (ICA)	osteonecrosis of femoral head (ONFH)	rat femoral head bone microvascular endothelial cells (BMECs)	Icariin (ICA) treatment	ICA could regulate the overexpression of miRNA-335 induced by glucocorticoids.	32911026
2959	Rat	rno-mir-335	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2960	Rat	rno-miR-335	miRNA	methylprednisolone	steroid-induced osteonecrosis of femoral head (ONFH)	bone microvascular endothelial cells (BMECs)	methylprednisolone treatment	upregulated	29408208
2961	Rat	rno-miR-335-3p	miRNA	chronic normobaric hypoxia (CNH)	pulmonary arterial hypertension (PAH)	lung tissues	chronic normobaric hypoxia (CNH) treatment	MiR-335-3p was significantly increased in lung tissue of CNH-induced PAH mice.	32015687
2962	Rat	rno-miR-33-5p	miRNA	fish oil	nonalcoholic fatty liver disease (NAFLD)	high-fat high-cholesterol diet rats	supplemented with fish oil (FOH)	dysregulated	28691019
2963	Rat	rno-miR-336-5p	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	upregulated	27535721
2964	Rat	rno-miR-337	miRNA	"bone matrix gelatin ,collagen,and pristane"	chondrogenesis	rat cartilage	"bone matrix gelatin ,collagen,and pristane treatment"	downregulated	22425884
2965	Rat	rno-miR-337	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	neonatal rat ventricular cardiomyocytes	hypoxia induce	upregulated	31220137
2966	Rat	rno-miR-337	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	primary cultured astrocytes (AST)	lipopolysaccharide (LPS) treatment	upregulated	30257365
2967	Rat	rno-miR-337	miRNA	mulberrin (Mul)	spinal cord injury (SCI)	Spinal cord injury (SCI) rats spinal cord tissue	Mulberrin (Mul) treatment	downregulated	30257365
2968	Rat	rno-miR-337	miRNA	mulberrin (Mul)	spinal cord injury (SCI)	LPS-treated primary cultured astrocytes (AST)	Mulberrin (Mul) treatment	downregulated	30257365
2969	Rat	rno-miR-337-3p	miRNA	CoCl2	hypoxia-induced injury	PC12 cells	CoCl2 treatment	upregulated	31264277
2970	Rat	rno-miR-337-3p	miRNA	palmitate and palmitate plus oleate.	insulin resistance (IR)	mouse myoblasts	palmitate and palmitate plus oleate treatment	upregulated	21183973
2971	Rat	rno-miR-337-5p	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
2972	Rat	rno-miR-338	miRNA	Tectorigenin	cell proliferation	rat pulmonary fibroblasts	Tectorigenin treatment	"Tectorigenin inhibits the proliferation of pulmonary fibroblasts in vitro and enhances miR-338* expression, which might in turn downregulate LPA1"	20600766
2973	Rat	rno-miR-338	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
2974	Rat	rno-miR-338	miRNA	¦Ä-opioid receptor (DOR)	hypoxic/ischemic injury	hearts	¦Ä-opioid receptor (DOR) activation treatment	upregulated	27576463
2975	Rat	rno-miR-338	miRNA	oxygen	lung injury	pregnant rats lung tissue	inspired oxygen of 10.5 or 24% for two days treatment	downregulated	25120593
2976	Rat	rno-miR-338	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	downregulated	22156553
2977	Rat	rno-miR-338-3p	miRNA	particulate matter (PM2.5)	allergic rhinitis (AR)	nasal mucosa	particulate matter 2.5 (PM2.5) treatment	upregulated	32192351
2978	Rat	rno-miR-338-3p	miRNA	particulate matter (PM2.5)	allergic rhinitis (AR)	nasal mucosa tissues	fine particulate matter (PM2.5) exposure treatment	The results showed that miR-338-3p was downregulated in both nasal mucosa of PM25-exacerbated AR rat models and PM25-treated RPMI-2650 cells	33770685
2979	Rat	rno-miR-338-3p	miRNA	IL-6	skeletal muscle regeneration	rat primary skeletal muscle cells (RSkMC)	IL-6 treatment	upregulated	31820147
2980	Rat	rno-miR-338-3p	miRNA	IL-6	skeletal muscle regeneration	rat primary skeletal muscle cells (RSkMC)	IL-6 treatment	upregulated	31820147
2981	Rat	rno-miR-339	miRNA	adenosine	effect of acupuncture	nerve growth factor-induced differentiated PC12 cells	adenosine treatment	downregulated	25199539
2982	Rat	rno-miR-339-3p	miRNA	sevoflurane (SEV)	neural function	left cortex of the brain	Sevoflurane treatment	significantly increased	26021509
2983	Rat	rno-miR-339-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
2984	Rat	rno-miR-339-5p	miRNA	loureirin A	follicle stem cell (HFSC) differentiation	primary rat follicle stem cell (HFSC)	loureirin A treatment	downregulated	29901112
2985	Rat	rno-miR-33a	miRNA	grape seed proanthocyanidins (GSPs)	cardiovascular disease (CVD)	healthy rats liver	chronic (3 weeks) of grape seed proanthocyanidins (GSPE) treatment	downregulated	24445039
2986	Rat	rno-miR-33a	miRNA	cafeteria diet	dyslipidemia	liver of rat	cafeteria diet feed	upregulated	23922812
2987	Rat	rno-miR-33a	miRNA	proanthocyanidins or docosahexaenoic acid	dyslipidemia	liver of rat	proanthocyanidins or docosahexaenoic acid?treatment treatment	downregulated	23922812
2988	Rat	rno-miR-33a	miRNA	tanshinone IIA (Tan IIA)	hyperlipidemia	liver tissues	Tanshinone IIA treatment	downregulated	27082100
2989	Rat	rno-miR-33a	miRNA	proanthocyanidin	obesity	livers of obese rats	proanthocyanidin treatment	3 weeks of supplementation with grape seed proanthocyanidin extract normalized the overexpression of miR-33a and miR-122 in obese rats' liver for all doses studied	25769350
2990	Rat	rno-miR-33a	miRNA	grape seed proanthocyandin extract (GSPE)	obesity and metabolic syndrome	rat hepatoma Fao cells	grape seed proanthocyanidins extracts (GSPE) treatment	"although GSPE reduced both miR-122 and miR-33a levels, GPE reduced miR-122 but upregulated miR-33a expression. The expression of miR-122 and miR-33a was not altered by the DF fraction in either Fao or HepG2 cells"	24165878
2991	Rat	rno-miR-33a	miRNA	insulin-like growth factor 1 (IGF-1)	post-stroke	brain tissues	Post-stroke ICV administration of IGF-1 to middle-aged female rats treatment	downregulated	24618563
2992	Rat	rno-miR-33a	miRNA	grape seed proanthocyanidins (GSPs)	reduced postprandial lipemia	rat liver tissues and lipid extraction	grape seed proanthocyanidins (GSPE) treatment	GSPE repressed miR-33a and miR-122 liver expression and reduced postprandial lipemia in a dose-dependent manner.	24445039
2993	Rat	rno-miR-33a	miRNA	ghrelin	type 2 diabetes mellitus (T2DM)	diabetes rat liver tissues	ghrelin treatment	downregulated	31468622
2994	Rat	rno-miR-33a	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	rat liver tissues	streptozotocin treatment	upregulated	31468622
2995	Rat	rno-miR-33a-3p	miRNA	"3,5-diiodo-L-thyronine (T2)"	glucose homeostasis	serum from high fat diet fed rats	"3,5-diiodo-L-thyronine (T2) treatment"	downregulated	31719576
2996	Rat	rno-miR-33a-5p	miRNA	homocysteine (Hcy)	cell damage	primary cardiac microvascular endothelial cells (CMECs)	homocysteine (HCY) treatment	upregulated	30825202
2997	Rat	rno-miR-33a-5p	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	brain microvascular endothelial cell (BMEC)	oxygen glucose deprivation (OGD) treatment	miR-33a-5p expression was the lowest at 4 h and the highest at 10 h after OGD treatment.	31986122
2998	Rat	rno-miR-33b	miRNA	lovastatin	medulloblastoma	c-Myc-null rat fibroblast Rat1 cells (clone HO15.19)	lovastatin? treatment	upregulated	22887866
2999	Rat	rno-miR-33e	miRNA	H2O2	oxidative stress	cardiovascular cells NRVCs and RAVSMCs	H2O2 treatment	downregulated	24612558
3000	Rat	rno-miR-34	miRNA	dimethylnitrosamine (DMN)	liver fibrosis	rat hepatic fibrosis tissue	dimethylnitrosamine (DMN) treatment	upregulated	21366874
3001	Rat	rno-miR-34	miRNA	tamoxifen (TAM)	hepatocellular carcinoma (HCC)	rat liver	tamoxifen? treatment	upregulated	17343880
3002	Rat	rno-miR-340-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3003	Rat	rno-miR-340-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	acute ischemic stroke (AIS)	PC-12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	The expression levels of miR-340-5p were decreased in PC12 cells following OGD/R induction.	32468054
3004	Rat	rno-miR-340-5p	miRNA	sevoflurane (SEV)	acute lung injury (ALI)	lung tissues	sevoflurane treatment	downregulated	28617947
3005	Rat	rno-miR-340-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	acute myocardial infarction (AMI)	H9C2 cardiomyocytes	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	30989715
3006	Rat	rno-miR-340-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	rat hippocampal neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	31870893
3007	Rat	rno-miR-340-5p	miRNA	oxygen glucose deprivation (OGD)	depression	primary hippocampal neurons	oxygen glucose deprivation (OGD) treatment	miR-340-5p was poorly expressed in these neurons after OGDR stimulation.	31870893
3008	Rat	rno-miR-340-5p	miRNA	collagenase VII	intracerebral haemorrhage (ICH)	brain tissues	collagenase VII treatment	downregulated	33176298
3009	Rat	rno-miR-340-5p	miRNA	chronic constriction injury (CCI)	neuropathic pain (NP)	spinal cord tissues and isolated microglial cells	chronic constriction injury (CCI) induce	downregulated	30848438
3010	Rat	rno-miR-341	miRNA	huoxue jiedu formula (HXJDF)	diabetic retinopathy (DR)	retinal tissues	HuoXue JieDu Formula (HXJDF) treatment	miR-341 was downregulated in HuoXue JieDu Formula (HXJDF) treated group when compared with diabetic mice.	33271246
3011	Rat	rno-miR-341	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
3012	Rat	rno-miR-342	miRNA	caffeic acid	diabetic nephropathy (DN)	high-fat diet and streptozotocin-induced (HFD-STZ) diabetic rats	caffeic acid (CA) treatment	downregulated	28536471
3013	Rat	rno-miR-342-5p	miRNA	cisplatin (DDP)	nasopharyngeal carcinoma (NPC)	HNE1cells; CNE2 cells	cisplatin treatment	LINC00346 regulates the cisplatin resistance of NPC cells by inhibiting miR-342-5p.	32397872
3014	Rat	rno-miR-344b-1-3p	miRNA	aspergillus fumigatus (A. fumigatus)	autophagy	"A rat alveolar macrophage cell line, NR8383"	aspergillus fumigatus infection	downregulated	31258647
3015	Rat	rno-miR-344b-1-3p	miRNA	smoking	chronic obstructive pulmonary disease (COPD)	rats alveolar macrophages (AMs)	smoke inhalation treatment	upregulated in alveolar macrophages (AMs)	28243080
3016	Rat	rno-miR-344b-3p	miRNA	triptolide (TPL)	nephropathy	blood and renal tissues	rats with adriamycin-induced nephropathy treatment	triptolide treatment reversed the increase in the expression of these two miRNAs	26078766
3017	Rat	rno-miR-345	miRNA	quercetin	oxidative stress	PC-12 cells	Quercetin treatment	downregulated	33343808
3018	Rat	rno-miR-346	miRNA	H2O2	acute myocardial infarction (AMI)	H9c2 cells	H2O2 treatment	MiR-346 was significantly upregulated in H2O2-treated H9c2 cells.	33275244
3019	Rat	rno-miR-346-3p	miRNA	dexmedetomidine (DEX)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	rat cardiomyocytes	dexamethasone (DEX) treatment	DEX promoted miR-346-3p expression in MI/R rats	33731281
3020	Rat	rno-miR-347	miRNA	hypoxia	cortical injury	rat cortex tisssues	hypoxia treatment	downregulated	23272113
3021	Rat	rno-miR-347	miRNA	light	focal retinal degeneration	right eye	light treatment	upregulated	25921151
3022	Rat	rno-miR-3473	miRNA	cisplatin and gentamicin	drug-induced acute kidney injury (DIKI)	plasma	"cisplatin (CSP, 6?mg/kg) and gentamicin (GEN, 120?mg/kg) treatment"	miR-3473 was specifically upregulated in the glomerular injury models.	30682439
3023	Rat	rno-mir-3473	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3024	Rat	rno-miR-3473	miRNA	Jianpi Xiaoke (JPXK)	type 2 diabetes mellitus (T2DM)	rat	Jianpi Xiaoke (JPXK) treatment	upregulated	33456489
3025	Rat	rno-miR-34a	miRNA	betanin (BET)	liver damage	cisplatin (DDP)-induced liver injury rats liver tissues	betanin (BET) treatment	downregulated	33661552
3026	Rat	rno-miR-34a	miRNA	cisplatin (DDP)	liver damage	liver tissues	cisplatin treatment	upregulated	33661552
3027	Rat	rno-miR-34a	miRNA	sepsis	acute kidney injury (AKI)	?kidney tissues	cecal ligation puncture induced sepsis treatment	MiR-34a level in kidney tissues was upregulated in the sepsis-induced AKI model	31081107
3028	Rat	rno-miR-34a	miRNA	diclofenac (Diclo)	acute kidney injury (AKI)	kidney tissues	diclofenac (Diclo) treatment	Diclo administration caused a significant reduction of mitofusin-2 (Mfn2) and increase of microRNA-34a (miR-34a) mRNA expressions.	33165700
3029	Rat	rno-miR-34a	miRNA	Thymoquinone (TQ)	acute kidney injury (AKI)	kidney tissues	thymoquinone treatment	downregulated	33165700
3030	Rat	rno-miR-34a	miRNA	D-galactosamine (D-GalN)	aging	hippocampus	D-gal treatment	upregulated	27780933
3031	Rat	rno-miR-34a	miRNA	alcohol	alcoholic liver disease (ALD)	liver tissues	alcohol exposure	upregulated	29873178
3032	Rat	rno-miR-34a	miRNA	valproic acid (VPA)	autism spectrum disorder (ASD)	ASD rats cerebellar cortex and primary cerebellar cortical neuronal cells	VPA treatment	upregulated in cerebellar cortex and primary cerebellar cortical neuronal cells	28803955
3033	Rat	rno-miR-34a	miRNA	low temperature	breast cancer	neural stem cells (NSCs)	low temperatures treatment	downregulated	23354401
3034	Rat	rno-miR-34a	miRNA	comfrey	tumorigenesis	rat liver	comfrey treatment	upragulated	21370286
3035	Rat	rno-miR-34a	miRNA	doxorubicin (DOX)	cardiac injury	cardiac cells	doxorubicin (DOXO) treatment	upregulated	27694688
3036	Rat	rno-miR-34a	miRNA	hydrogen sulfide (H2S)	cardiac fibrosis	thyroxine-induced rats myocardial tissues	Hydrogen sulfide (H2S) treatment	downregulated	29743447
3037	Rat	rno-miR-34a	miRNA	TGF-¦Â1	cardiac fibrosis	primary rat cardiac fibroblasts	TGF-¦Â1 treatment	upregulated	29551367
3038	Rat	rno-miR-34a	miRNA	thyroxine	cardiac fibrosis	myocardial tissues	thyroxine treatment	upregulated	29743447
3039	Rat	rno-miR-34a	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	rat cardiomyocytes	angiotensin II (Ang II) treatment	downregulated	24728149
3040	Rat	rno-miR-34a	miRNA	high glucose (HG)	cardiomyocyte apoptosis	H9c2 tissues	High Glucose treatment	miR-34a contributes to high glucose-induced decreases in Bcl-2 expression and subsequent cardiomyocyte apoptosis	24339958
3041	Rat	rno-miR-34a	miRNA	paraquat (PQ)	apoptosis	PC 12 cells	paraquat (PQ) treatment	upregulated	25174400
3042	Rat	rno-miR-34a	miRNA	X-rays	cell cycle arrest	rats	X-ray exposure treatment	upregulated	25594002
3043	Rat	rno-miR-34a	miRNA	high-salt/low-potassium diet	cerebral and renal vascular injuries	stroke-prone spontaneously hypertensive rats	high-salt/low-potassium diet treatment	downregulated	23297375
3044	Rat	rno-miR-34a	miRNA	typhae pollen polysaccharides (TPP)	cerebral ischemia injury (CII)	PC12 cells	typhae pollen polysaccharides (TPP) treatment	TPP downregulated miR-34a expression	32635836
3045	Rat	rno-miR-34a	miRNA	furan	cholangiocarcinoma and hepatocellular tumors	liver	furan treatment	upregulated	26194646
3046	Rat	rno-miR-34a	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	chronic inflammatory visceral pain (CIVP)	spinal cord tissues of rats	"2,4,6-Trinitrobenzenesulfonic acid (TNBS) treatment"	downregulated	31324142
3047	Rat	rno-miR-34a	miRNA	dexmedetomidine (DEX)	chronic inflammatory visceral pain (CIVP)	spinal cord tissues of (TNBS)-induced chronic inflammatory visceral pain (CIVP) rats	dexamethasone (DEX) treatment	upregulated	31324142
3048	Rat	rno-miR-34a	miRNA	cisplatin (DDP)	cisplatin (DDP)-induced nephrotoxicity	renal tissue homogenate	cisplatin treatment	upregulated	32777238
3049	Rat	rno-miR-34a	miRNA	pentoxifylline (PTX)	cisplatin (DDP)-induced nephrotoxicity	renal tissue homogenate	pentoxifylline (PTX) treatment	downregulated	32777238
3050	Rat	rno-miR-34a	miRNA	urolithin A (UA)	cognitive impairment	H2O2-induced PC12 cell	?urolithin A treatment	downregulated	31420820
3051	Rat	rno-miR-34a	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	rat colon Epithelial cells	azoxymethane (AOM) treatment	"Of the 27 miRNAs expressed at higher (P < 0.05) levels in tumors, miR-34a, 132, 223 and 224 were overexpressed at >10-fold. In contrast, the expression levels of miR-192, 194, 215 and 375 were dramatically reduced (?0.32-fold) in adenocarcinomas."	19825969
3052	Rat	rno-miR-34a	miRNA	fish oil and pectin	colorectal cancer (CRC)	colon tissue of rats	corn oil ¡À fish oil with pectin ¡À cellulose	upregulated	21406606
3053	Rat	rno-miR-34a	miRNA	palmitate	diabetes mellitus (DM)	INS-1 cells	palmitate (Pal) treatment	upregulated	30131392
3054	Rat	rno-miR-34a	miRNA	astragaloside IV (AS-IV)	diabetic cardiomyopathy (DCM)	High glucose (HG)-treated rat cardiomyocytes (H9C2(2-1))	astragaloside IV (AS-IV) treatment	downregulated	31713440
3055	Rat	rno-miR-34a	miRNA	granulocyte-colony stimulating factor (G-CSF)	diabetic cardiomyopathy (DCM)	H9c2 cells	Granulocyte colony-stimulating factor?treatment	G-CSF treatment significantly decreased apoptosis and reduced miR-34a expression in diabetic myocardium and H9c2 cells under the HG condition.	31237127
3056	Rat	rno-miR-34a	miRNA	granulocyte-colony stimulating factor (G-CSF)	diabetic cardiomyopathy (DCM)	high glucose (HG)-induced H9c2 cells	Granulocyte colony-stimulating factor?treatment	downregulated	31237127
3057	Rat	rno-miR-34a	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	H9c2 cells	?high glucose (HG) induce	HOTAIR protected against DCM via activation of the SIRT1 expression by sponging miR-34a.	30216438
3058	Rat	rno-miR-34a	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	rat cardiomyocytes (H9C2(2-1))	high glucose (HG) treatment	upregulated	31713440
3059	Rat	rno-miR-34a	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	H9c2 cells	high glucose treatment	OIP5-AS1 overexpression promotes viability and inhibits high glucose-induced oxidative stress of cardiomyocytes by targeting microRNA-34a/SIRT1 axis in diabetic cardiomyopathy.	33380310
3060	Rat	rno-miR-34a	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	Wistar rats left ventricle (LV)	STZ treatment	upregulated	28199183
3061	Rat	rno-miR-34a	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	heart tissues	streptozotocin (STZ) treatment	miR-34a was upregulated in the diabetic hearts	30216438
3062	Rat	rno-miR-34a	miRNA	high glucose (HG)	diabetic retinopathy (DR)	Rat retinal vascular endothelial cells (RVECs)	high glucose (HG) treatment	MicroRNA-34a promotes apoptosis of retinal vascular endothelial cells by targeting SIRT1 in rats with diabetic retinopathy.	31863767
3063	Rat	rno-miR-34a	miRNA	mitomycin C-polylactic acid ( MMC-PLA) film	epidural scar hyperplasia and adhesion	post-laminectomy rat scar tissues	25 mg of PLA film containing 0.01% MMC was implanted on the laminectomy area	upregulated	28617531
3064	Rat	rno-miR-34a	miRNA	magnesium (Mg2+ )	epilepsy	rat hippocampal neuronal cells	"To induce the hippocampal neuronal spontaneous recurrent epileptiform discharges (SREDs) pattern, the neuronal cultures had been treated with a solution containing no added MgCl2 (Mg2+-free) for 3?h on the 14th day"	SREDs Induces Increase of?miR-34a Expression and?Decrease of?Notch Pathway Expression	30877521
3065	Rat	rno-miR-34a	miRNA	pterostilbene	fructose-induced hepatic lipid accumulation	BRL-3A cells	Pterostilbene treatment	Pterostilbene recovered the fructose-disturbed miR-34a expression	31927917
3066	Rat	rno-miR-34a	miRNA	N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)	gastric cancer (GC)	rat gastric tissue	N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) treatment	downregulated	31648165
3067	Rat	rno-miR-34a	miRNA	Weipixiao (WPX) decoction	gastric cancer (GC)	N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) treated rat gastric tissue	N-methyl-N'-nitro-N-nitrosoguanidine (MNNG) treatment	upregulated	31648165
3068	Rat	rno-miR-34a	miRNA	aristolochic acid	genotoxic and carcinogenic	tissues from transgenic Big Blue rats liver and kidney	aristolochic acid (AA) treatment	"dysregulated in the kidney, miR-34a was dysregulated in the liver"	25106556
3069	Rat	rno-miR-34a	miRNA	chromium (Cr)	hepatic ischemia/reperfusion injury (HIRI)	serum	Cr treatment	downregulated	28963950
3070	Rat	rno-miR-34a	miRNA	zinc sulfate (ZnSO4)	hepatic ischemia/reperfusion injury (HIRI)	ischemia-reperfusion (IR) injuried rats liver tissues	zinc sulfate (ZnSO4) treatment	downregulated	30014282
3071	Rat	rno-miR-34a	miRNA	zinc sulfate (ZnSO4)	hepatic ischemia/reperfusion injury (HIRI)	ischemia-reperfusion (IR) rats serum	zinc sulfate (ZnSO4) treatment	downregulated	30014282
3072	Rat	rno-miR-34a	miRNA	zinc sulfate (ZnSO4)	hepatic ischemia/reperfusion injury (HIRI)	serum	ZnSO4 treatment	downregulated	28963950
3073	Rat	rno-miR-34a	miRNA	methyl-deficient diet	hepatocellular carcinoma (HCC)	liver tissues	methyl-deficient diet feed	downregulated	18942116
3074	Rat	rno-miR-34a	miRNA	¦Â-ionone (¦ÂI)	hepatocellular carcinoma (HCC)	rats hepatocyte	¦ÂI (16 mg/100 g body weight) treatment	"upregulated(miR-122 , miR-34a) ;downregulated (miR-181b , miR-708)"	27061051
3075	Rat	rno-miR-34a	miRNA	furan	hepatotoxicity	liver	Furan treatment	upregulated	27371368
3076	Rat	rno-miR-34a	miRNA	streptozocin (STZ)	hyperglycemia-induced vascular endothelial cell damage	thoracic aorta tissues	streptozotocin (STZ) treatment	upregulated	29529692
3077	Rat	rno-miR-34a	miRNA	clamping both renal arteries	ischemia/reperfusion (I/R) injury	male rats	clamping both renal arteries for 45 min	upregulated	28129785
3078	Rat	rno-miR-34a	miRNA	ischemia/reperfusion (I/R) 	ischemia/reperfusion (I/R) injury	cardiomyocytes (NRCMs)	ischemia/reperfusion (I/R) treatment	upregulated	28599575
3079	Rat	rno-miR-34a	miRNA	hypoxia	ischemic injury	cardiomyocytes of 1-3 day-old male Wistar rats	long-term (4 h) exposure to hypoxia followed by 6 h of reoxygenation	upregulated	28709867
3080	Rat	rno-miR-34a	miRNA	hypoxia	ischemic injury	cardiomyocytes	hypoxia treatment	upregulated	28709867
3081	Rat	rno-miR-34a	miRNA	TGF-¦Â1	kidney fibrosis	rat renal fibroblast cell line (NRK-49F)	TGF-¦Â1-ed fibroblasts treatment	miR-34a is markedly upregulated in microvesicles isolated from the cell culture medium	25107369
3082	Rat	rno-miR-34a	miRNA	fructose	liver fibrosis	rats liver tissues and BRL-3A cells	fructose treatment	upregulated	30632134
3083	Rat	rno-miR-34a	miRNA	Pterostilbene	liver fibrosis	fructose-treated rats liver tissues and BRL-3A cells	Pterostilbene treatment	downregulated	30632134
3084	Rat	rno-miR-34a	miRNA	estradiol	metabolic effects of estrogen	liver tissues	estradiol treatment	downregulated	32045601
3085	Rat	rno-miR-34a	miRNA	deoxycholic acid (DCA)	apoptosis	primary rat hepatocytes	deoxycholic acid (DCA) treatment	upregulated	24421392
3086	Rat	rno-miR-34a	miRNA	resveratrol	cardiac fibrosis	cardiac fibroblasts (CFs)	resveratrol (Res) treatment	Resveratrol decreased the levels of miR-34ain TGF- ¦Â1-treated CFs	30648109
3087	Rat	rno-miR-34a	miRNA	oxygen glucose deprivation (OGD)	myocardial infarction (MI)	rat H9c2 cells	oxygen glucose deprivation (OGD) treatment	circDENND2A negatively regulated miR-34a miR-34a overexpression weakened the protective effects of circDENND2A in OGD-injury	31878833
3088	Rat	rno-miR-34a	miRNA	oxygen glucose deprivation (OGD)	myocardial infarction (MI)	H9c2 cells	oxygen glucose deprivation (OGD) treatment	circDENND2A overexpression enhanced OGD-inhibited cell viability and migration but declined OGD-promoted apoptosis by downregulating miR-34a and via ¦Â-catenin and Ras/Raf/MEK/ERK pathways	31878833
3089	Rat	rno-miR-34a	miRNA	silymarin (Sm)	myocardial infarction (MI)	heart sissues	Silymarin (SM) treatment	miRNA-34a was downregulated in SM-treated rats	31974855
3090	Rat	rno-miR-34a	miRNA	isoproterenol	myocardial injury	heart tissues	isoproterenol (ISO) treatment	upregulated	31794687
3091	Rat	rno-miR-34a	miRNA	resveratrol	myocardial injury	isoproterenol-induced rat heart tissues	resveratrol (RS) treatment	downregulated	31794687
3092	Rat	rno-miR-34a	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	1%O	upregulated	28894025
3093	Rat	rno-miR-34a	miRNA	luteolin	neuritogenesis	PC12 cells	Luteolin treatment	upregulated	25865700
3094	Rat	rno-miR-34a	miRNA	nerve growth factor (NGF)	neuronal differentiation	differentiating PC12 cells	nerve growth factor (NGF) treatment	upregulated	28084588
3095	Rat	rno-miR-34a	miRNA	lidocaine	neurotoxicity	dorsal root ganglia neurons (DRGNs)	lidocaine treatment	downregulated	26455477
3096	Rat	rno-miR-34a	miRNA	fish oil	nonalcoholic fatty liver disease (NAFLD)	high-fat high-cholesterol diet rats	supplemented with fish oil (FOH)	dysregulated	28691019
3097	Rat	rno-miR-34a	miRNA	"quinacrine, erythromycin and tetracycline"	non-surgical sterilization	Wistar albino 12-14 week old female rats	"quinacrine, erythromycin , tetracycline treatment"	upregulated	25195052
3098	Rat	rno-miR-34a	miRNA	"3,6-dihydroxyflavone (3,6-DHF)"	obesity	breast?of rats	"3,6-dihydroxyflavone (3,6-DHF) treatment"	"the global upregulation of miR-21 and downregulated of miR-34a in breast carcinogenesis could be reversed by 3,6-DHF"	22616882
3099	Rat	rno-miR-34a	miRNA	IL-1¦Â	osteoarthritis (OA)	rat Articular chondrocytes	IL-1¦Â treatment	Silencing of miR-34a by LNA-modified anti-sense could effectively reduce rat chondrocyte apoptosis induced by IL-1¦Â	20675358
3100	Rat	rno-miR-34a	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
3101	Rat	rno-miR-34a	miRNA	oxygen	oxygen-induced retinopathy (OIR)	retinas tissues	oxygen induce treatment	downregulated	30571142
3102	Rat	rno-miR-34a	miRNA	rotenone (ROT)	parkinson's disease (PD)	striatum of parkinsonian rats	rotenone exposure treatment	upregulated	30267378
3103	Rat	rno-miR-34a	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC12 cells	N-methyl-4-phenylpyridinium (MPP +) treatment	"MPP+ toxicity significantly caused upregulated in miR-34a, miR-141, and miR-9."	29631008
3104	Rat	rno-miR-34a	miRNA	single dose irradiation	radiation-induced lung injury (RILI)	male Wistar rats lung tissues	subjected to single dose irradiation with 20 Gy using 6 MV x-rays to the right lung treatment	upregulated	24886372
3105	Rat	rno-miR-34a	miRNA	dioscin	renal injury	cisplatin (CDDP)-induced rats nephrotoxicity	dioscin treatment	downregulated	28514495
3106	Rat	rno-miR-34a	miRNA	TGF-¦Â1	renal interstitial fibrosis (RIF)	Rat proximal tubular epithelial cell line (NRK-52E) secreted microvesicles (MVs)	TGF-¦Â1 treatment	upregulated	30867715
3107	Rat	rno-miR-34a	miRNA	diclofenac (Diclo)	renal oxidative damage	kidney tissues	diclofenac (Diclo) treatment	Diclo administration caused a significant reduction of mitofusin-2 (Mfn2) and increase of microRNA-34a (miR-34a) mRNA expressions.	33165700
3108	Rat	rno-miR-34a	miRNA	oxygen	retinal angiogenesis	retina of oxygen-induced retinopathy rats	oxygen induce treatment	downregulated	30571142
3109	Rat	rno-miR-34a	miRNA	lipopolysaccharide (LPS)	sepsis	plasma and renal tissue	lipopolysaccharide (LPS) treatment	upregulated	29663998
3110	Rat	rno-miR-34a	miRNA	lipopolysaccharide (LPS)	sepsis	pulmonary macrophages	lipopolysaccharide (LPS) treatment	miR-34a was upregulated in Lipopolysaccharide (LPS)-induced pulmonary macrophages.	30021364
3111	Rat	rno-miR-34a	miRNA	allen's weight-drop method	spinal cord injury (SCI)	spinal neuron	allen's weight-drop method treatment	downregulated	31490756
3112	Rat	rno-miR-34a	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
3113	Rat	rno-miR-34a	miRNA	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine)"	teratogenesis	mouse and rat limb buds	"5-Aza-2'-deoxycytidine (5-Aza-dC, decitabine) treatment"	miR-34 family members are the most upregulated miRNAs	24623309
3114	Rat	rno-miR-34a	miRNA	cyclosporine A (CsA)	testicular damage	testis	cyclosporine A (CsA) treatment	Exposure to CsA increased the expression of mir-34a.	32569592
3115	Rat	rno-miR-34a	miRNA	high glucose and palmitate (HG/PA)	type 2 diabetes mellitus (T2DM)	INS-1 cells	high glucose and palmitate (HG/PA) treatment	upregulated	31737170
3116	Rat	rno-miR-34a	miRNA	metformin (Met)	type 2 diabetes mellitus (T2DM)	brain tissues	"orally and daily administrated 2.0 ml NSO, 100 mg metformin (MT)"	downregulated in the brain	28505155
3117	Rat	rno-miR-34a	miRNA	coxsackievirus B3 (CVB3)	viral myocarditis (VM)	rat primary cultured cardiomyocytes	Coxsackievirus B3 (CVB3) infection	upregulated	30968966
3118	Rat	rno-miR-34a-3p	miRNA	sevoflurane (SEV)	acute lung injury (ALI)	lung tissues	Sevoflurane (Sev) treatment	"sevoflurane reduces inflammatory factor expression, increases lung cell viability and inhibits lung cell apoptosis in ALI through upregulation of miR-34a-3p"	32147387
3119	Rat	rno-miR-34a-3p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	serum	monocrotaline (MCT) treatment	downregulated	29431643
3120	Rat	rno-miR-34a-5p	miRNA	cadmium (Cd)	cadmium (Cd)-induced kidney injury	renal cortex	cadmium (Cd) treatment	upregulated	29543730
3121	Rat	rno-miR-34a-5p	miRNA	doxorubicin (DOX)	cardiotoxicity	rat cardiomyocyte H9c2 cells	doxorubicin treatment	upregulated	28928469
3122	Rat	rno-miR-34a-5p	miRNA	liraglutide	endothelial dysfunction	aortic endothelial in diabetic rats	liraglutide treatment	downregulated	30863684
3123	Rat	rno-miR-34a-5p	miRNA	aflatoxin B1 (AFB1)	hepatocellular carcinoma (HCC)	F344 rats liver tissues	aflatoxin B1 (AFB4) treatment	upregulated	28218475
3124	Rat	rno-miR-34a-5p	miRNA	sorafenib (SOR)	hepatocellular carcinoma (HCC)	pulmonary metastatic tissue	sorafenib treatment	upregulated	26026584
3125	Rat	rno-miR-34a-5p	miRNA	aflatoxin B1 (AFB1)	hepatotoxicant and genotoxicant	liver	aflatoxin B1 (AFB1) treatment	upregulated	26385312
3126	Rat	rno-miR-34a-5p	miRNA	sevoflurane (SEV)	hypoxia-induced injury	H9c2 cells	sevoflurane treatment	downregulated	29554593
3127	Rat	rno-miR-34a-5p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	downregulated	29262398
3128	Rat	rno-miR-34a-5p	miRNA	thioacetamide (TAA)	liver toxicity	Sprague-Dawley rats livers	"treat with TAA at three doses (4.5, 15 and 45 mg/kg) and four time points (3-, 7-, 14- and 28-days) treatment"	dysregulatedin livers	28596526
3129	Rat	rno-miR-34a-5p	miRNA	N-methyl-D-aspartate receptor	long-term potentiation (LTP) persistence	rat dentate gyrus	rat dentate gyrus 20 min post-LTP induction in vivo treatment	downregulated	25538559
3130	Rat	rno-miR-34a-5p	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia induce	upregulated	30312158
3131	Rat	rno-miR-34a-5p	miRNA	high fat diet (HFD)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31915454
3132	Rat	rno-miR-34a-5p	miRNA	Shenling Baizhu San (SLBZS)	nonalcoholic fatty liver disease (NAFLD)	liver tissues	Shenling Baizhu San (SLBZS) treatment	the expression levels were reversed by SLBZS administration	31915454
3133	Rat	rno-miR-34a-5p	miRNA	H2O2	spinal cord injury (SCI)	rat PC-12 cells	H2O2 treatment	miR-34a-5p was confirmed as a target of PEG10 and miR-34a-5p inhibitor remitted PEG10-induced H2O2-injury.	31835090
3134	Rat	rno-miR-34a-5p	miRNA	H2O2	spinal cord injury (SCI)	PC-12 cells	H2O2 treatment	Knockdown PEG10 remitted H2O2-injury of PC-12 cells by targeting miR-34a-5p/TLX.	31835090
3135	Rat	rno-miR-34b	miRNA	H2O2	cerebral ischemia/reperfusion (I/R) injury	rat neuroblast B35 cells	H2O2 treatment	downregulated	30539753
3136	Rat	rno-miR-34b	miRNA	nitrate	fertility parameters	testicular	Nitrate treatment	Nitrate administration in the DN group also decreased miR-34b.	32129362
3137	Rat	rno-miR-34b	miRNA	H2O2	ischemic stroke (IS)	rat neuroblast B35 cells	H2O2 treatment	downregulated	30539753
3138	Rat	rno-miR-34b	miRNA	hypoxia	ischemic stroke (IS)	brain tissue	Middle cerebral artery occlusion (MCAO) treatment	downregulated	30539753
3139	Rat	rno-miR-34b	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	neonatal rat ventricular cardiomyocytes	hypoxia induce	upregulated	31220137
3140	Rat	rno-miR-34b	miRNA	lead (Pb)	nervous system diseases	rats hippocampus	chronic lead exposure treatment	upregulated	24960059
3141	Rat	rno-miR-34b-3p	miRNA	rapamycin	cardiac fibrosis	heart tissues	rapamycin (Rap) treatment	upregulated	30647817
3142	Rat	rno-miR-34b-3p	miRNA	steroids	osteonecrosis	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	26459755
3143	Rat	rno-miR-34b-3p	miRNA	smoking	smoke inhalation injury (SII)	bronchoalveolar lavage fluid (BALF)	Smoke inhalation treatment	upregulated	30139538
3144	Rat	rno-miR-34b-5p	miRNA	guarana	adipogenesis	3T3L1 cells	guarana	downregulated	28632199
3145	Rat	rno-miR-34b-5p	miRNA	flurothyl	brain injury	hippocampus	flurothyl treatment	upregulated	27514646
3146	Rat	rno-miR-34b-5p	miRNA	fluorine combined with aluminum (FA)	fluorine combined with aluminum (FA)-induced developmental neurotoxicity	hippocampi	fluorine combined with aluminum (FA) treatment	upregulated	30033483
3147	Rat	rno-miR-34b-5p	miRNA	fluorine combined with aluminum (FA)	neurotoxicity	hippocampi in the offspring of rats	fluorine combined with aluminum (FA) exposure	upregulated	30033483
3148	Rat	rno-miR-34b-5p	miRNA	6-hydroxydopamine (6-OHDA)	parkinson's disease (PD)	substantia nigra	6-hydroxydopamine (6-OHDA) treatment	downregulated of lncRNA BACE1-AS inhibits iNOS activation in the substantial nigra and improve oxidative stress injury in PD rats by upregulating miR-34b-5p and downregulating BACE1.	32308102
3149	Rat	rno-miR-34b-5p	miRNA	letrozole	polycystic ovarian syndrome (PCOS)	Ovary?tissues	letrozole treatment	dysregulated	26745201
3150	Rat	rno-miR-34c	miRNA	doxorubicin (DOX)	cardiac injury	?rat heart	doxorubicin treatment	upregulated	22859947
3151	Rat	rno-miR-34c	miRNA	blueberry	breast cancer	estrogen-mediated rats breast cancer	blueberry-supplemented diet treatment	upregulated	24245576
3152	Rat	rno-miR-34c	miRNA	high glucose (HG)	diabetic nephropathy (DN)	rat glomerular mesangial cell line (HBZY-1)	high glucose (HG) treatment	downregulated	32721950
3153	Rat	rno-miR-34c	miRNA	pentylenetetrazol (PTZ)	epilepsy	brain tissues	pentylenetetrazol (PTZ) treatment	upregulated	29344671
3154	Rat	rno-miR-34c	miRNA	lead (Pb)	nervous system diseases	rats hippocampus	chronic lead exposure treatment	upregulated	24960059
3155	Rat	rno-miR-34c	miRNA	lidocaine	neurotoxicity	dorsal root ganglia neurons (DRGNs)	lidocaine treatment	downregulated	26455477
3156	Rat	rno-miR-34c	miRNA	catheter injury	pathologic cardiovascular	carotid artery	catheter injury treatment	upregulated	25683915
3157	Rat	rno-miR-34c-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	primary cortical neurons	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	the expression levels of miR-34c-5p were significantly reduced in MCAO rats and OGD/RP cells	33842985
3158	Rat	rno-miR-34c-5p	miRNA	cigarette smoke (CS)	chronic obstructive pulmonary disease (COPD)	lung tissues	cigarette smoke exposure	downregulated	31032652
3159	Rat	rno-miR-34c-5p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	rat retinal	streptozotocin (STZ)-induced diabetic rat treatment	differential expressions	24502381
3160	Rat	rno-miR-34c-5p	miRNA	"3,5-diiodo-L-thyronine (T2)"	glucose homeostasis	serum from high fat diet fed rats	"3,5-diiodo-L-thyronine (T2) treatment"	downregulated	31719576
3161	Rat	rno-miR-34c-5p	miRNA	H2O2	hyperoxia-induced acute lung injury (HALI)	rat type II alveolar epithelial cells (AECII)	hydrogen peroxide (H2O2) treatment	downregulated	29436647
3162	Rat	rno-miR-34c-5p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
3163	Rat	rno-miR-34c-5p	miRNA	steroids	osteonecrosis	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	26459755
3164	Rat	rno-miR-34c-5p	miRNA	smoking	smoke inhalation injury (SII)	bronchoalveolar lavage fluid (BALF)	Smoke inhalation treatment	upregulated	30139538
3165	Rat	rno-miR-350	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	upregulated	27535721
3166	Rat	rno-miR-350	miRNA	triiodo-l-thyronine (T3)	liver fibrosis	cardiomyocytes	triiodothyronine (T?) treatment	upregulated	22525353
3167	Rat	rno-miR-351	miRNA	light	focal retinal degeneration	right eye	light treatment	upregulated	25921151
3168	Rat	rno-miR-351-5p	miRNA	dioscin	intestinal ischemia/reperfusion (I/R) injury	hypoxia-induced IEC-6 cells	dioscin treatment	downregulated	30503840
3169	Rat	rno-miR-351-5p	miRNA	hypoxia	intestinal ischemia/reperfusion (I/R) injury	IEC-6 cells	hypoxia induce	upregulated	30503840
3170	Rat	rno-miR-351-5p	miRNA	dioscin	intestinal ischemia/reperfusion (I/R) injury	hypoxia-induced IEC-6 cells	dioscin treatment	downregulated	30240824
3171	Rat	rno-miR-351-5p	miRNA	hypoxia	intestinal ischemia/reperfusion (I/R) injury	IEC-6 cells	hypoxia induce	upregulated	30240824
3172	Rat	rno-mir-351-5p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	downregulated	26997989
3173	Rat	rno-miR-351-5p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
3174	Rat	rno-miR-352	miRNA	elevated fluid shear stress (FSS)	improved collateral circulation	rat hind limbs	elevated fluid shear stress (FSS)	downregulated	28751690
3175	Rat	rno-miR-352	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	upregulated	27919821
3176	Rat	rno-miR-352	miRNA	pilocarpine	mesial temporal lobe epilepsy (MTLE)	hippocampi	pilocarpine treatment	upregulated	27695061
3177	Rat	rno-miR-3541	miRNA	alcohol	brain damage due to chronic heavy alcohol	hippocampal tissues	chronic alcohol administration	upregulated	33228793
3178	Rat	rno-miR-3544	miRNA	grape seed procyanidin extract (GSPE)	pancreatic islet injury	rat islets	grape seed procyanidin extract (GSPE)treatment	"GSPE altered significantly the expression of miR-1249, miR-483, miR-30c-1*, and miR-3544."	23215023
3179	Rat	rno-mir-3548	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3180	Rat	rno-miR-3552	miRNA	hypoxia	stroke	middle cerebral artery occlusion (MCAO) Sprague-Dawley rat	middle cerebral artery occlusion (MCAO) treatment	upregulated	29113076
3181	Rat	rno-miR-3557	miRNA	aerobic exercise	parkinson's disease (PD)	brain tissues	aerobic exercise training (AET) treatment	upregulated	31309116
3182	Rat	rno-miR-3557-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3183	Rat	rno-miR-3559-5p	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
3184	Rat	rno-miR-3559-5p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
3185	Rat	rno-miR-3562	miRNA	huoxue jiedu formula (HXJDF)	diabetic retinopathy (DR)	retinal tissues	HuoXue JieDu Formula (HXJDF) treatment	miR-3562 was downregulated in HuoXue JieDu Formula (HXJDF) treated group when compared with diabetic mice.	33271246
3186	Rat	rno-miR-3573-5p	miRNA	chronic unpredictable mild stress (CUMS)	depression	hippocampus tissues	chronic unpredictable mild stressed (CUMS) treatment	upregulated	28083819
3187	Rat	rno-miR-3573-5p	miRNA	hronic unpredictable mild stressed (CUMS)	depression	rats hippocampal tissues	stimulated daily with randomly applied mild stressors from among 14 different mild stressors	upregulated	28083819
3188	Rat	rno-miR-3574	miRNA	intermittent hypoxia (IH)	cardiac injury	H9C2 cells	intermittent hypoxia (IH) treatment	"We confirmed that IH inhibited cell viability, induced cell apoptosis and suppressed miR-3574 expression in the H9c2."	33582657
3189	Rat	rno-mir-3574	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3190	Rat	rno-miR-3578	miRNA	Smad3 inhibitor (SIS3)	intrauterine adhesion (IUA)	endometrial stromal cells (ESCs)	Smad3 inhibitor (SIS3) treatment	upregulated	32447720
3191	Rat	rno-mir-3578	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3192	Rat	rno-miR-3583-3p	miRNA	high fat diet (HFD)	cardiac remodeling	heart tissues	high fat diet (HFD) feed	upregulated	29884823
3193	Rat	rno-miR-3583-3p	miRNA	propofol (PPF)	neurotoxicity	primary cultured neural stem cells (NSCs)	propofol treatment	downregulated	29679758
3194	Rat	rno-miR-3584-5p	miRNA	propofol (PPF)	neural function	left cortex of the brain	Propofol treatment	significantly increased	26021509
3195	Rat	rno-miR-3584-5p	miRNA	mono-n-butyl phthalate (MBP)	precocious puberty and testicular tumors	testicular Sertoli cells (SCs)	mono-n-butyl phthalate (MBP) treatment	upregulated	29162477
3196	Rat	rno-miR-3584-5p	miRNA	mono-n-butyl phthalate (MBP)	cell proliferation	rat juvenile Sertoli cells (SCs)	treat with 0.1mM MBP	upregulated	29162477
3197	Rat	rno-miR-3586-3p	miRNA	Smad3 inhibitor (SIS3)	intrauterine adhesion (IUA)	endometrial stromal cells (ESCs)	Smad3 inhibitor (SIS3) treatment	downregulated	32447720
3198	Rat	rno-miR-3588	miRNA	huoxue jiedu formula (HXJDF)	diabetic retinopathy (DR)	retinal tissues	HuoXue JieDu Formula (HXJDF) treatment	miR-3588 was downregulated in HuoXue JieDu Formula (HXJDF) treated group when compared with diabetic mice.	33271246
3199	Rat	rno-miR-3588	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
3200	Rat	rno-miR-3588	miRNA	ochratoxin A (OTA)	ochratoxin A (OTA) nephrotoxicity	kidney?tissues	OTA nephrotoxicity treatment	suppressed in mid dose but then elevated in high dose	24885635
3201	Rat	rno-miR-3590-3p	miRNA	bleomycin (BLM)	lung fibrosis	lung tissues	bleomycin (BLM) treatment	upregulated	33193637
3202	Rat	rno-mir-3591	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3203	Rat	rno-miR-3595	miRNA	baicalin (BAI)	liver fibrosis	platelet-derived growth factor-BB-treated HSC-T6 cells	baicalin (BAI) treatment	upregulated	29393361
3204	Rat	rno-miR-3595	miRNA	platelet derived growth factor-BB (PDGF-BB)	liver fibrosis	HSC-T6 cells	platelet-derived growth factor-BB treatment	downregulated	29393361
3205	Rat	rno-miR-3596b	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
3206	Rat	rno-miR-361	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	PC12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	Protective Role of Astrocyte-Derived Exosomal microRNA-361 in Cerebral Ischemic-Reperfusion Injury by Regulating the AMPK/mTOR Signaling Pathway and Targeting CTSB	32801720
3207	Rat	rno-miR-361	miRNA	palmitate and palmitate plus oleate.	insulin resistance (IR)	mouse myoblasts	palmitate and palmitate plus oleate treatment	upregulated	21183973
3208	Rat	rno-miR-361	miRNA	(+)-cholesten-3-one (CN)	osteoblastic differentiation	mesenchymal stem cells (MSCs)	(+)-cholesten-3-one (CN) treatment	downregulated	30373531
3209	Rat	rno-miR-361-5p	miRNA	dexmedetomidine (DEX)	osteoporosis	human umbilical vein endothelial cells (HUVECs)	dexamethasone (DEX) treatment	"After Dex treatment, the expressions of miR-361-5p, VEGFA, BMD related indexes were increased in OP rats."	33631172
3210	Rat	rno-miR-362*	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
3211	Rat	rno-miR-362-3p	miRNA	palmitate	diabetes mellitus (DM)	INS-1 cells	palmitate (Pal) treatment	downregulated	30131392
3212	Rat	rno-miR-362-3p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC-12 cells	lipopolysaccharide (LPS) treatment	"SNHG1 regulated cell viability, apoptosis and autophagy in LPS-treated PC12 cells"	33515352
3213	Rat	rno-miR-362-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3214	Rat	rno-miR-363	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
3215	Rat	rno-miR-363	miRNA	hypoxia	myocardial infarction (MI)	rat myocardium-derived H9C2 and 293T cells	1% O2 at 37 _x0002_C for 24 h	upregulated	28402919
3216	Rat	rno-miR-363	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	Bladder Detrusor Tissues	streptozocin (STZ) treatment	miR-363 is Downregulated in STZ-Induced T2DM.	33294298
3217	Rat	rno-miR-365	miRNA	dexamethasone (DEX)	cartilage injury	articular cartilage	dexamethasone (DEX) treatment	miR-365 was downregulated compared with control group.	29207029
3218	Rat	rno-miR-365	miRNA	cyclic mechanical stretch (CMS)	cell differentiation	bone marrow-derived mesenchymal stem cells (BMSCs)	Cyclic tensile strain (CTS) treatment	upregulated	31276691
3219	Rat	rno-miR-365	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	retina tissues	streptozotocin (STZ) treatment	upregulated	29196060
3220	Rat	rno-miR-365	miRNA	H2O2	ischemic neuroinflammatory injury	primary cultured neurons	H2O2 treatment	upregulated	30977043
3221	Rat	rno-miR-365	miRNA	morphine	morphine tolerance	neurons of the spinal cord	rats treatment treatment	downregulated	27922111
3222	Rat	rno-miR-365	miRNA	(+)-cholesten-3-one (CN)	osteoblastic differentiation	mesenchymal stem cells (MSCs)	(+)-cholesten-3-one (CN) treatment	upregulated	30373531
3223	Rat	rno-miR-3657	miRNA	apatinib	advanced gastric cancers (AGCs)	BGC-823 and HGC-27	apatinib treatment	Silencing of circRACGAP1 sensitizes gastric cancer cells to apatinib via modulating autophagy by targeting miR-3657 and ATG7	32139670
3224	Rat	rno-miR-367	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	upregulated	31845077
3225	Rat	rno-miR-367	miRNA	doxorubicin (DOX)	cardiac injury	?rat heart	doxorubicin treatment	upregulated	22859947
3226	Rat	rno-miR-369	miRNA	hypoxia	myocardial infarction (MI)	rat myocardial tissues	hypoxia treatment	Our data indicated that miR-369 expression was significantly downregulated and TRPV3 was significantly upregulated in myocardial tissue after MI in rats and in hypoxic-treated neonatal rat cardiomyocytes (NRCMs).	33470394
3227	Rat	rno-miR-369-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3228	Rat	rno-miR-370	miRNA	TGF-¦Â1	hepatic fibrogenesis	hepatic stellate cells (HSCs)	TGF-¦Â1 treatment	downregulated	25686745
3229	Rat	rno-miR-370	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	upregulated	24205079
3230	Rat	rno-miR-370	miRNA	H2O2	myocardial infarction (MI)	H9C2 cells	hydrogen peroxide (H2O2) treatment	downregulated	31555385
3231	Rat	rno-miR-370	miRNA	hypoxia	myocardial infarction (MI)	Sprague-Dawley rats border area	anterior descending artery was ligated with 7¨C0 ligation line 2 mm at the lower edge of the right in the left atrial appendage	downregulated	28350072
3232	Rat	rno-miR-370-3p	miRNA	chronic unpredictable mild stress (CUMS)	depression	hippocampus tissues	chronic unpredictable mild stressed (CUMS) treatment	downregulated	28083819
3233	Rat	rno-miR-370-3p	miRNA	hronic unpredictable mild stressed (CUMS)	depression	rats hippocampal tissues	stimulated daily with randomly applied mild stressors from among 14 different mild stressors	downregulated	28083819
3234	Rat	rno-miR-370-3p	miRNA	TGF-¦Â1	lung fibrosis	lung fibroblasts	TGF-¦Â1 treatment	downregulated	32464548
3235	Rat	rno-miR-370-3p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	primary spinal neurons	lipopolysaccharide (LPS) treatment	SCI resulted in lncRNA H19 higher expression and miR-370-3p lower expression.	33708438
3236	Rat	rno-miR-371b-5p	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	lung tissues	monocrotaline treatment	miR-371b-5p was downregulated in PAH rats compared with the control group.	30387816
3237	Rat	rno-miR-372	miRNA	hypoxia	spinal cord ischemia/reperfusion injury (SCII)	PC-12 cells	hypoxia induce	upregulated	30298297
3238	Rat	rno-miR-372-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	primary neural stem cells (NSCs) were obtained from rat embryos	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	33579365
3239	Rat	rno-miR-373-3p	miRNA	lipopolysaccharide (LPS)	sepsis-induced acute hepatic injury	liver tissues	Lipopolysaccharide (LPS) treatment	downregulated	33129786
3240	Rat	rno-miR-374	miRNA	N-methyl-N'-nitro-N-nitrosoguanidine (MNNG)	gastric cancer (GC)	rats mesenchymal stem cells (MSCs) from the gastric tissues	treat with MNNG	upregulated in mesenchymal stem cells (MSCs) from the gastric tissues	28731132
3241	Rat	rno-miR-374	miRNA	sevoflurane (SEV)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	ischemia-reperfusion (I/R) injuried rats heart tissues	sevoflurane treatment	upregulated	29689553
3242	Rat	rno-miR-374-5p	miRNA	hypothermia	fatal hypothermia	iliopsoas muscle	hypothermia treatment	Mex3B expression was regulated by rno-miR-374-5p and decreased with decreasing body temperature.	32963265
3243	Rat	rno-miR-374a	miRNA	CoCl2	hypoxia-induced injury	PC-12 cells	CoCl2 treatment	downregulated	29247275
3244	Rat	rno-miR-374a	miRNA	fortunellin	inflammatory bowel disease (IBD)	rat coliti	Fortunellin treatment	Fortunellin increased mir-374a expression.	29472916
3245	Rat	rno-miR-374a	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	?hypoxia/reoxygenation (H/R) induce	downregulated	31265855
3246	Rat	rno-miR-374a-5p	miRNA	oxygen glucose deprivation (OGD)	apoptosis	PC12 cells	oxygen/glucose deprivation (OGD) induce treatment	downregulated	31127537
3247	Rat	rno-miR-375	miRNA	doxorubicin (DOX)	aoxorubicin-induced myocardial toxicity	H9c2 cells	Doxorubicin treatment	Doxorubicin significantly upregulated miR-375 expression in vitro and in vivo.	32186283
3248	Rat	rno-miR-375	miRNA	diethylnitrosamine (DEN)	carcinogen-initiated hepatocytes	resistant-hepatocyte (R-H) rat	diethyl nitrosamine (DEN) treatment	downregulated	25010260
3249	Rat	rno-miR-375	miRNA	hepatocyte growth factor (HGF)	cell migration	mesenchymal stem cells (MSCs)	hepatocyte growth factor (HGF) treatment	downregulated	29322249
3250	Rat	rno-miR-375	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	colitis	male Wistar rats inflamed colon	"2,4,6-trinitrobenzene sulfonic acid (TNBS)/ethanol treatment"	downregulated in inflamed colon	28572713
3251	Rat	rno-miR-375	miRNA	palmitate	enteric neurons and gastrointestinal motility	immorto postnatal enteric neuronal (IM-PEN) cell line	palmitate treatment	upregulated	24507550
3252	Rat	rno-miR-375	miRNA	cerulein or cyanohydroxybutene (CHB)	exocrine pancreatic injury (EPIJ)	serum	cerulein or cyanohydroxybutene (CHB) treatment	upregulated	24285669
3253	Rat	rno-miR-375	miRNA	cerulein or cyanohydroxybutene (CHB)	exocrine pancreatic injury (EPIJ)	serum	rats were administered cerulein or CHB to induce EPIJ treatment	upregulated	24285669
3254	Rat	rno-miR-375	miRNA	hypoxia	hepatocellular carcinoma (HCC)	HCCs	hypoxia treatment	"MiR-375 presented an obviously differential expression in human HCCs versus background livers (BLs) and HCCs versus normal liver tissues (NLTs). In rat models, miR-375 was gradually declined during hepatocarcinogenesis."	32215815
3255	Rat	rno-miR-375	miRNA	furan	hepatotoxicity	liver	Furan treatment	downregulated	27371368
3256	Rat	rno-miR-375	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
3257	Rat	rno-miR-375	miRNA	ellagic acid (EA)	breast cancer	female rat mammary tissue	ellagic acid treatment	"ellagic acid, which inhibited E2-induced mammary tumorigenesis in our previous study, reversed the dysregulation of miR-375, miR-206, miR-182, miR-122, miR-127 and miR-183 detected with E2treatment"	23791885
3258	Rat	rno-miR-375	miRNA	lipopolysaccharide (LPS)	neuronal cell injury	N9 cells	endotoxin treatment	upregulated	26631961
3259	Rat	rno-miR-375	miRNA	calycosin	neuroprotective effects	middle cerebral artery occlusion (MCAO) rats	calycosin treatment	upregulated	24548484
3260	Rat	rno-miR-375	miRNA	streptozocin (STZ)	pancreatic injury	acinar cells	Streptozotocin (STZ) treatment	upregulated	27521901
3261	Rat	rno-miR-375	miRNA	6-hydroxydopamine (6-OHDA)	parkinson's disease (PD)	substantia nigra	6-hydroxydopamine (6-OHDA) treatment	"Compared with the normal group, the expression of miR-375 in the substantia nigra of rats in the model group was decreased."	33245094
3262	Rat	rno-miR-375	miRNA	adjuvant	rheumatoid arthritis (RA)	fibroblast-like synoviocytes (FLS)	adjuvant treatment	downregulated	25619565
3263	Rat	rno-miR-375	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
3264	Rat	rno-miR-375	miRNA	immobilization (IMO) stress	synthesis and secretion of catecholamines	Wistar rats adrenal medulla chromaffin cells	exposed to IMO stress	downregulated in rat adrenal medulla chromaffin cells	28356269
3265	Rat	rno-miR-375	miRNA	TianMai Xiaoke tablet(TM)	type 2 diabetes mellitus (T2DM)	diabetic rats islet	TM treatment	upregulated	24812635
3266	Rat	rno-miR-375-3p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	primary cardiomyocyte	angiotensin II (Ang II) treatment	upregulated	30618075
3267	Rat	rno-miR-375-3p	miRNA	ionizing radiation (IR)	cell death	?rat pancreatic ¦Â cell line RIN-5F	7 Gy irradiation exposure	upregulated	30930975
3268	Rat	rno-miR-375-3p	miRNA	streptozocin (STZ)	cell death	?rat pancreatic ¦Â cell line RIN-5F	streptozotocin (STZ) treatment	upregulated	30930975
3269	Rat	rno-miR-375-3p	miRNA	hypoxia	congenital heart disease (CHD)	H9C2 cells	hypoxia induce	miR-375-3p was upregulated and FOXP1/Bcl2l2 was downregulated in maternal serum of women with fetal CHD and hypoxia-induced rat cardiomyocyte h9c2 cells.	33128129
3270	Rat	rno-miR-375-3p	miRNA	hypoxia	congenital heart disease (CHD)	H9c2 cells	hypoxia treatment	miR-375-3p was upregulated in hypoxia-induced rat cardiomyocyte h9c2 cells.	33128129
3271	Rat	rno-miR-375-3p	miRNA	high fructose	liver fibrosis	rat liver tissues and BRL-3A cells and/or primary rat hepatocytes	high fructose treatment	downregulated	30568253
3272	Rat	rno-miR-375-3p	miRNA	Magnesium isoglycyrrhizinate (MgIG)	liver fibrosis	high fructose-treated rat liver tissues and BRL-3A cells and/or primary rat hepatocytes	Magnesium isoglycyrrhizinate treatment	magnesium isoglycyrrhizinate increased miR-375-3p expression to suppress the JAK2/STAT3 pathway and TGF-¦Â1/Smad signaling in these animal and cell models.	30568253
3273	Rat	rno-miR-375-3p	miRNA	Magnesium isoglycyrrhizinate (MgIG)	liver fibrosis	liver tissues; BRL-3A cells; primary rat hepatocytes	magnesium isoglycyrrhizinate treatment	magnesium isoglycyrrhizinate increased miR-375-3p expression in liver fibrosis models.	30568253
3274	Rat	rno-miR-375-3p	miRNA	hypoxia	pulmonary microvascular endothelial cells (PMECs) injury	Pulmonary microvascular endothelial cells (PMECs)	hypoxia treatment	The expression of miR-375-3p and Notch1 in the PMECs was significantly downregulated and upregulated during hypoxia.	32644005
3275	Rat	rno-miR-376a	miRNA	human chorionic gonadotrophin (hCG)	expression regulation	Female 21-day-old Wistar rats	12 h after with (hCG) treatment	upregulated	25279841
3276	Rat	rno-miR-376a-3p	miRNA	fluorine combined with aluminum (FA)	fluorine combined with aluminum (FA)-induced developmental neurotoxicity	hippocampi	fluorine combined with aluminum (FA) treatment	upregulated	30033483
3277	Rat	rno-miR-376b-3p	miRNA	noradrenaline (NA)	cardiac hypertrophy	neonatal rat ventricular cells (NRVCs)	noradrenaline (NA) treatment	downregulated	29570827
3278	Rat	rno-miR-376b-3p	miRNA	ischemia	periodontitis	Serum	Ligation around teeth treatment	upregulated	26910654
3279	Rat	rno-miR-376c	miRNA	electroacupuncture (EA)	hyperactivity of the HPA axis induced by hepatectomy	rats	electroacupuncture (EA) treatment	upregulated	29021740
3280	Rat	rno-miR-376c-3p	miRNA	oxygen glucose deprivation (OGD)	neonatal hypoxic-ischemic encephalopathy 	PC-12 cells	oxygen-glucose deprivation (OGD) treatment	downregulated	31844418
3281	Rat	rno-miR-377	miRNA	hypoxia/reoxygenation (H/R)	acute myocardial infarction (AMI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	upregulated	32674625
3282	Rat	rno-miR-377	miRNA	fructose	glomerular podocyte injury	kidney cortex tissues	fructose-fed treatment	upregulated	25746774
3283	Rat	rno-miR-377	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	upregulated	24205079
3284	Rat	rno-miR-377	miRNA	hypoxia	ischemic stroke (IS)	Primary rat microglial cells and brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation (OGD) treatment	downregulated	28569430
3285	Rat	rno-miR-377	miRNA	oxygen glucose deprivation (OGD)	ischemic stroke (IS)	primary rat microglial cells and brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation (OGD) treatment	downregulated	28569430
3286	Rat	rno-miR-377*	miRNA	oxygen	lung injury	pregnant rats lung tissue	inspired oxygen of 10.5 or 22% for two days treatment	upregulated	25120593
3287	Rat	rno-miR-377-5p	miRNA	propofol (PPF)	neurotoxicity	primary cultured neural stem cells (NSCs)	propofol treatment	upregulated	29679758
3288	Rat	rno-miR-378	miRNA	TGF-¦Â	adaptation of tendons to mechanical loading	rat Tendon fibroblasts	Transforming growth factor-¦Â(TGF-¦Â) treatment	upregulated	22539168
3289	Rat	rno-miR-378	miRNA	astragaloside IV (AS-IV)	diabetic nephropathy (DN)	diabetic rats kidney tissues	astragaloside (AS-IV) treatment	upregulated	29792879
3290	Rat	rno-miR-378	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin (STZ) treatment	downregulated	29792879
3291	Rat	rno-miR-378	miRNA	TGF-¦Â1	kidney fibrosis and mesangial hypertrophy	NRK52E and mesangial cells	TGF-¦Â1 treatment	downregulated	28053239
3292	Rat	rno-miR-378	miRNA	hypoxia	vascularization	Sprague-Dawley rats mesenchymal stem cells (MSCs)	hypoxia treatment	downregulated	25418617
3293	Rat	rno-miR-378a	miRNA	mitomycin C-polylactic acid ( MMC-PLA) film	epidural scar hyperplasia and adhesion	post-laminectomy rat scar tissues	25 mg of PLA film containing 0.01% MMC was implanted on the laminectomy area	downregulated	28617531
3294	Rat	rno-miR-378a	miRNA	cisplatin (DDP)	liver damage	urine	cisplatin treatment	upregulated	27397436
3295	Rat	rno-miR-378a	miRNA	cisplatin (DDP)	nephrotoxicity	rats	cisplatin treatment	upregulated	27397436
3296	Rat	rno-miR-378a-3p	miRNA	gentamicin	acute kidney injury (AKI)	urine	gentamicin treatment	upregulated	33263228
3297	Rat	rno-miR-378a-3p	miRNA	acetaminophen (APAP)	drug-induced liver injury (DILI)	rat liver tissues	acetaminophen (APAP) treatment	downregulated	31468699
3298	Rat	rno-miR-378a-3p	miRNA	acetaminophen (APAP)	drug-induced liver injury (DILI)	liver tissues	acetaminophen (APAP) treatment	CYP2E1 and miRNA-378a-3p contribute to acetaminophen- or tripterygium glycosides-induced hepatotoxicity.	31468699
3299	Rat	rno-miR-378a-3p	miRNA	chlormethiazole (CMZ)	drug-induced liver injury (DILI)	rat liver tissues	chlormethiazole (CMZ) treatment	downregulated	31468699
3300	Rat	rno-miR-378a-3p	miRNA	Tripterygium glycosides (TGs)	drug-induced liver injury (DILI)	rat liver tissues	tripterygium glycosides (TG) treatment	downregulated	31468699
3301	Rat	rno-miR-378a-3p	miRNA	Tripterygium glycosides (TGs)	drug-induced liver injury (DILI)	liver tissues	tripterygium glycosides (TG) treatment	CYP2E1 and miRNA-378a-3p contribute to acetaminophen- or tripterygium glycosides-induced hepatotoxicity.	31468699
3302	Rat	rno-miR-378a-3p	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	upregulated	27919821
3303	Rat	rno-miR-378a-3p	miRNA	ischemia/reperfusion (I/R) 	kidney damage	Sprague-Dawley rats urine	ischemia/reperfusion (I/R) treatment	upregulated	28056546
3304	Rat	rno-miR-378a-3p	miRNA	notexin	skeletal muscle atrophy	plasma	notexin treatment	upregulated	26952641
3305	Rat	rno-miR-378a-5p	miRNA	alcohol	alcoholic cardiomyopathy (ACM)	primary rat cardiomyocytes	alcohol exposure	upregulated	28160209
3306	Rat	rno-miR-378a-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3307	Rat	rno-miR-378b	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	downregulated	27919821
3308	Rat	rno-miR-378b	miRNA	hypoxia	obesity	dietary-induced obese SD rats	hypoxia exercise training treatment	downregulated	25183036
3309	Rat	rno-mir-378b	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3310	Rat	rno-miR-379	miRNA	trichostatin A (TSA)	hepatocellular carcinoma (HCC)	rat primary hepatocytes	Trichostatin A (TSA)treatment treatment	"miR-122, miR-143 and miR-379 could be related to the inhibitory effects of TSA on hepatocellular proliferation"	21513791
3311	Rat	rno-miR-379	miRNA	SiO2	lung injury	lung	SiO2 treatment	upregulated	27689473
3312	Rat	rno-miR-379	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	27910957
3313	Rat	rno-miR-379-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3314	Rat	rno-miR-380-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3315	Rat	rno-miR-381	miRNA	dexmedetomidine (DEX)	cerebral ischemia injury (CII)	OGD/R-treated rat neuron cells	dexmedetomidine (Dex) treatment	upregulated	33314611
3316	Rat	rno-miR-381	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia injury (CII)	neuron cells were isolated from the hippocampus of rats	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	33314611
3317	Rat	rno-miR-381	miRNA	dexmedetomidine (DEX)	cerebral ischemia injury (CII)	brain tissues	dexmedetomidine (Dex) treatment	Dex was found to increase the miR-381 expression.	33314611
3318	Rat	rno-miR-381	miRNA	dexmedetomidine (DEX)	ropivacaine induced neurocyte injury	PC12 cells	dexamethasone (DEX) treatment	"Dexmedetomidine reversed role of ropivacaine (0 mM, 0.1 mM, 0.5 mM, 1 mM) by upragulating the expression of miR-381 and suppressing the expression of LRRC4 in PC12 cells."	32467829
3319	Rat	rno-miR-381-3p	miRNA	lipopolysaccharide (LPS)	acute spinal cord injury (ASCI)	Microglial BV2 cells	Lipopolysaccharide (LPS) treatment	downregulated	30229813
3320	Rat	rno-miR-382	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
3321	Rat	rno-miR-382	miRNA	alcohol	myocardial infarction (MI)	the nucleus accumbens (NAc)	alcohol exposure	upregulated	23873704
3322	Rat	rno-miR-382	miRNA	acute stress (AS) and chronic stress (CS)	stress-induced myocardial injury	rat	Rats were bound and suspended treatment	upregulated	24669248
3323	Rat	rno-miR-382	miRNA	phosphorus (Pi)	vascular calcification (VC)	rat aortic vascular smooth muscle cells	high levels of phosphate treatment	downregulated	28522697
3324	Rat	rno-miR-382*	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
3325	Rat	rno-miR-382-3p	miRNA	chronic unpredictable mild stress (CUMS)	depression	hippocampus tissues	chronic unpredictable mild stressed (CUMS) treatment	upregulated	28083819
3326	Rat	rno-miR-382-3p	miRNA	hronic unpredictable mild stressed (CUMS)	depression	rats hippocampal tissues	stimulated daily with randomly applied mild stressors from among 14 different mild stressors	upregulated	28083819
3327	Rat	rno-miR-382-5p	miRNA	chronic unpredictable mild stress (CUMS)	depression	hippocampus	chronic unpredictable mild stress (CUMS) treatment	upregulated	32982244
3328	Rat	rno-miR-383	miRNA	propofol (PPF)	anesthesia-induced cognitive impairment	hippocampus	propofol treatment	Propofol treatment significantly reduced the relative mRNA expression of miR-383	29545833
3329	Rat	rno-miR-383	miRNA	piperine	myocardial ischemia/reperfusion (I/R) injury (MIRI)	heart tissues	Piperine (PIP) treatment	MIRI-caused elevation of miR-383 and decrease of RP105/PI3K/AKT pathway were reverted by PIP treatment	33219747
3330	Rat	rno-miR-383	miRNA	piperine	myocardial ischemia/reperfusion (I/R) injury (MIRI)	rat cardiomyocytes	Piperine (PIP) treatment	?MIRI-caused elevation of miR-383 and decrease of RP105/PI3K/AKT pathway were reverted by PIP treatment	33219747
3331	Rat	rno-miR-383-3p	miRNA	high fat diet (HFD)	coronary atherosclerosis (CAS)	myocardial tissues	high fat diet (HFD) feed	MiR-383-3p was downregulated in myocardial tissues of AS rats.	29693751
3332	Rat	rno-miR-383-5p	miRNA	cold	cold stress	rats serum	cold conditions (4¡æ for 12h)	downregulated	28477904
3333	Rat	rno-miR-383-5p	miRNA	sorafenib (SOR)	hepatocellular carcinoma (HCC)	pulmonary metastatic tissue	sorafenib treatment	upregulated	26026584
3334	Rat	rno-miR-383-5p	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC-12 cells	lipopolysaccharide (LPS) treatment	The results showed that lncRNA CASC9 was downregulated and miR-383-5p was upregulated in SCI rats and LPS-induced PC12 cells.	33438067
3335	Rat	rno-miR-383-5p	miRNA	hypoxia	stroke	middle cerebral artery occlusion (MCAO) Sprague-Dawley rat	middle cerebral artery occlusion (MCAO) treatment	upregulated	29113076
3336	Rat	rno-miR-384	miRNA	epigallocatechin-3-gallate (EGCG)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	hypoxia-induced H9c2 cell lines	EGCG treatment	upregulated	31802847
3337	Rat	rno-miR-384	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cell lines	hypoxia induce	downregulated	31802847
3338	Rat	rno-miR-384	miRNA	oxygen glucose deprivation (OGD)	neonatal hypoxic-ischemic encephalopathy 	Neonatal rat primary microglia cells	oxygen-glucose deprivation (OGD) treatment	The expression of miR-384 was decreased in the serum of HIE newborns and OGD-induced activated microglia.	32621118
3339	Rat	rno-miR-384-5p	miRNA	TGF-¦Â	cardiac fibrosis	Primary cardiac fibroblasts (CFs)	TGF-¦Â treatment	downregulated	30206318
3340	Rat	rno-miR-384-5p	miRNA	TGF-¦Â	cardiac fibrosis	cardiac fibroblasts (CFs)	TGF-¦Â treatment	TGF-¦Â treatment also significantly decreased the expression of miR-384-5p in CFs	30206318
3341	Rat	rno-miR-384-5p	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	H9c2 cells	angiotensin II (Ang II) treatment	downregulated	32436661
3342	Rat	rno-miR-384-5p	miRNA	trimethyltin (TMT)	neurotoxicity	rats serum	were given a single administration of TMT treatment	upregulated	24777749
3343	Rat	rno-miR-384-5p	miRNA	ischemia	myogenic differentiation	ischemic myocardium of rats;H9c2 cells	ischemia treatment	downregulated	23315007
3344	Rat	rno-miR-39a	miRNA	high fat diet (HFD)	insulin resistance (IR)	C57BL/6 mice	high fat diet (HFD) feed	upregulated	24844433
3345	Rat	rno-miR-409	miRNA	isoflurane	isoflurane-induced neurotoxicity	hippocampal neurons; PC-12 cells	isoflurane treatment	Vitexin could significantly increase the expression of miR-409.	32011832
3346	Rat	rno-miR-409-5p	miRNA	hypoxia	myocardial hypoxic/ischemic injury	H92c cells	hypoxia treatment	USP7 expression was markedly elevated while miR-409-5p expression was significantly downregulated in H9c2 cells under hypoxic culture.	33241864
3347	Rat	rno-miR-409-5p	miRNA	pegylated rat leptin antagonist (pRLA)	type 2 diabetes mellitus (T2DM)	rat muscle and liver	pegylated rat leptin antagonist (pRLA) treatment	"upregulation of rno-miR-10a at d28 and rno-miR-200a, rno-miR-409-5p, and rno-miR-125a-3p following HFD challenge"	23576026
3348	Rat	rno-miR-409a-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3349	Rat	rno-miR-409a-5p	miRNA	TGF-¦Â1	lung fibrosis	lung fibroblasts	TGF-¦Â1 treatment	downregulated	32464548
3350	Rat	rno-mir-409b	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3351	Rat	rno-miR-410	miRNA	6-hydroxydopamine (6-OHDA)	parkinson's disease (PD)	PC12 cells	6-hydroxydopamine (6-OHDA) treatment	downregulated	31067440
3352	Rat	rno-miR-410	miRNA	bleomycin (BLM)	lung fibrosis	lung tissues	bleomycin A5 treatment	upregulated	30157485
3353	Rat	rno-miR-410	miRNA	bleomycin (BLM)	lung fibrosis	pulmonary fibrosis rats lung tissues	Prodigiosin (PG) treatment	downregulated	30157485
3354	Rat	rno-miR-410-3p	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	rat retinal	streptozotocin (STZ)-induced diabetic rat treatment	differential expressions	24502381
3355	Rat	rno-miR-410-3p	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	hypoxia/reoxygenation (H/R) treatment	FTX alleviates hypoxia/reoxygenation-induced cardiomyocyte injury via miR-410-3p/Fmr1 axis	31957854
3356	Rat	rno-miR-410-3p	miRNA	sevoflurane (SEV)	postoperative cognitive dysfunction (POCD)	hippocampal neuron	sevoflurane anesthesia-induce treatment	downregulated	31350734
3357	Rat	rno-miR-410-5p	miRNA	high fat diet (HFD)	cardiac remodeling	heart tissues	high fat diet (HFD) feed	upregulated	29884823
3358	Rat	rno-miR-410-5p	miRNA	propofol (PPF)	neurotoxicity	primary cultured neural stem cells (NSCs)	propofol treatment	downregulated	29679758
3359	Rat	rno-miR-411	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	microglia	lipopolysaccharide (LPS) treatment	MiRNA-411 increase ameliorates the inflammatory microglia-induced neurological lesion and promotes neural recovery by JNK pathway inhibition via negative targeting IL-18 in SCI.	32016950
3360	Rat	rno-miR-411-3p	miRNA	silica	lung fibrosis	lung tissues	silica treatment	downregulated	32004504
3361	Rat	rno-miR-411-3p	miRNA	TGF-¦Â1	lung fibrosis	primary fibroblasts	TGF-¦Â1 treatment	downregulated	32004504
3362	Rat	rno-miR-411-3p	miRNA	TGF-¦Â1	lung fibrosis	lung fibroblasts	TGF-¦Â1 treatment	downregulated	32464548
3363	Rat	rno-miR-411-3p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
3364	Rat	rno-miR-421	miRNA	hypoxia	hypoxia-induced injury	H9c2 cells	hypoxia induce	upregulated	31469043
3365	Rat	rno-miR-421	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H92c cells	hypoxia/reoxygenation treatment	MiR-421 inhibition protects H9c2 cells against hypoxia/reoxygenation-induced oxidative stress and apoptosis by targeting Sirt3.	31469043
3366	Rat	rno-miR-423-3p	miRNA	house dust mite (HDM) extract	allergic airway inflammation	adipose tissue and lungs	house dust mite extract treatment	upregulated	32887419
3367	Rat	rno-miR-423-5p	miRNA	ischemia/reperfusion (I/R) 	acute kidney injury (AKI)	rats kidney tissues	ischemia/reperfusion (I/R) treatment	upregulated in rat kidneys	29137244
3368	Rat	rno-miR-423-5p	miRNA	lipopolysaccharide (LPS)	acute respiratory distress syndrome (ARDS)	lung tissues	lipopolysaccharide (LPS) treatment	"The expression of H19 and FOXA1 was significantly upregulated, while the expression of miR-423-5p was downregulated in LPS-induced ARDS rats."	33629893
3369	Rat	rno-miR-423-5p	miRNA	huoxue jiedu formula (HXJDF)	diabetic retinopathy (DR)	retinal tissues	HuoXue JieDu Formula (HXJDF) treatment	miR-423-4p was downregulated in HuoXue JieDu Formula (HXJDF) treated group when compared with diabetic mice.	33271246
3370	Rat	rno-miR-423-5p	miRNA	hypoxia	hypoxia-induced injury	H9C2 cells	hypoxia induce	upregulated	31074036
3371	Rat	rno-miR-423-5p	miRNA	H2O2	spinal cord injury (SCI)	PC-12 cells	H2O2 treatment	upregulated	30977409
3372	Rat	rno-miR-424	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin treatment	downregulated	30637733
3373	Rat	rno-miR-424	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	upregulated	33333053
3374	Rat	rno-miR-424	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	rat liver tissue	CCl4 treatment	"miR-322/424 level in liver cirrhosis patients, mouse liver fibrosis induced by CCl4?and BDL, and rat liver fibrosis induced by CCl4?and dimethylnitrosamine was increased."	33333053
3375	Rat	rno-miR-425	miRNA	sevoflurane (SEV)	acute lung injury (ALI)	lung tissues	sevoflurane treatment	downregulated	28617947
3376	Rat	rno-miR-425-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3377	Rat	rno-miR-425-5p	miRNA	cold	cold stress	rats serum	cold conditions (4¡æ for 12h)	downregulated	28477904
3378	Rat	rno-miR-4262	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoarthritis (OA)	chondrocytes were separated from Sprague-Dawley rats	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	29434702
3379	Rat	rno-miR-4262	miRNA	tumor necrosis factor alpha (TNF-¦Á) 	osteoarthritis (OA)	Primary chondrocytes	tumor necrosis factor alpha (TNF-¦Á) treatment	upregulated	29434702
3380	Rat	rno-miR-429	miRNA	N-methyl-N-nitrosourea (MNU)	breast cancer	rats with experimental breast cancer Thoracic Duct Lymph	N-Methyl-N-Nitrosourea	dysregulatedin Thoracic Duct Lymph	28091921
3381	Rat	rno-miR-429	miRNA	comfrey	tumorigenesis	rat liver	comfrey treatment	upragulated	21370286
3382	Rat	rno-miR-429	miRNA	angiotensin II (Ang II)	epithelial-mesenchymal transition (EMT)	NRK-52E cells	angiotensin II (Ang II) treatment	downregulated	30132344
3383	Rat	rno-miR-429	miRNA	aflatoxin B1 (AFB1)	hepatotoxicant and genotoxicant	liver	aflatoxin B1 (AFB1) treatment	upregulated	26385312
3384	Rat	rno-miR-429	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	rat renal artery endothelial cells (RRAECs)	angiotensin II (Ang II) treatment	upregulated	32346437
3385	Rat	rno-miR-429	miRNA	"DDT (2,2-dichlorodiphenyl-1,1,1-trichloroethane), benzo[a]pyrene (BP), and 3-methylcholanthrene (MC)"	post-transcriptional regulation	?the livers and ovaries of chemically induced rats	"DDT, benzo[a]pyrene (BP), and 3-methylcholanthrene (MC) treatment"	downregulated	24727239
3386	Rat	rno-miR-429	miRNA	lipopolysaccharide (LPS)	myocarditis	H9c2 cells	lipopolysaccharide (LPS) treatment	upregulated	31876239
3387	Rat	rno-miR-429	miRNA	swainsonine (SW)	myocarditis	LPS-treated H9c2 cells	Swainsonine (SW) treatment	downregulated	31876239
3388	Rat	rno-miR-429	miRNA	CoCl2	neuron apoptosis	PC12 cells	cobalt chloride (CoCl2) treatment	downregulated	32004541
3389	Rat	rno-miR-429	miRNA	ketamine	neurotoxicity	PC12 cells	Ketamine treatment	miR-429 attenuates ketamine-induced neurotoxicity in PC12 cells by the downregulated of BAG5.	33283947
3390	Rat	rno-miR-429	miRNA	ketamine	neurotoxicity	PC12 cells	ketamine treatment	The qRT-PCR results showed that miR-429 expression was downregulated by treatment of ketamine in a dose-dependent manner.? Overexpression of miR-429 alleviated ketamine-induced neurotoxicity in PC12 cells.	33283947
3391	Rat	rno-miR-429	miRNA	swainsonine (SW)	pediatric myocarditis (PM)	H9c2 cells	swainsonine (SW) treatment	MiR-429 expression was elevated by LPS and suppressed by SW	31876239
3392	Rat	rno-miR-429	miRNA	high salt (HS)	salt-sensitive hypertension	Sprague-Dawley rats renal medullary tissues	high-salt diet (8% NaCl)	upregulated	28445205
3393	Rat	rno-miR-429	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC13 cell	lipopolysaccharide (LPS) treatment	?miR-429 was downregulated in LPS-stimulated PC12 cells. Overexpression of miR-429 contributed to LPS-induced PC12 injuries.	31309444
3394	Rat	rno-miR-429-3p	miRNA	dexmedetomidine (DEX)	chemotherapy-induced cognitive impairment (CICI)	brain tissues	dexmedetomidine (Dex) treatment	Dexmedetomidine attenuates cisplatin-induced cognitive impairment by modulating miR-429-3p expression in rats	32411568
3395	Rat	rno-miR-431	miRNA	H2O2	acute myocardial infarction (AMI)	H9c2 cells	H2O2 treatment	We revealed that miR-431 expression was decreased in H2O2-treated H9c2 cells and myocardium of MI rats.	33660818
3396	Rat	rno-miR-432-5p	miRNA	high fat diet (HFD)	insulin resistance (IR)	liver tissues	high fat diet (HFD) feed	upregulated	29802941
3397	Rat	rno-miR-432-5p	miRNA	physical exercise	insulin resistance (IR)	diet-induced obesity rats liver tissues	physical exercise treatment	downregulated	29802941
3398	Rat	rno-miR-434	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
3399	Rat	rno-miR-434-3p	miRNA	notexin	skeletal muscle atrophy	plasma	notexin treatment	upregulated	26952641
3400	Rat	rno-miR-434-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3401	Rat	rno-miR-434-5p	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
3402	Rat	rno-miR-448	miRNA	lead (Pb)	nervous system diseases	rats hippocampus	chronic lead exposure treatment	upregulated	24960059
3403	Rat	rno-miR-448	miRNA	sevoflurane (SEV)	neural function	left cortex of the brain	Sevoflurane treatment	significantly increased	26021509
3404	Rat	rno-miR-448	miRNA	isoflurane	neuron apoptosis	Sprague-Dawley rats hippocampus tissues	isoflurane treatment	upregulated in rat hippocampus tissue	29067448
3405	Rat	rno-miR-448	miRNA	freund¡¯s complete adjuvant (FCA)	rheumatoid arthritis (RA)	synovial tissues	Freund¡¯s complete adjuvant (FCA) treatment	lncRNA OIP5-AS1 may mitigate RA progression through the miR-448-PON1 axis and through the inactivation of the TLR3-NF-¦ÊB signalling pathway.	32770578
3406	Rat	rno-miR-448	miRNA	hypoxia	spinal cord ischemia/reperfusion injury (SCII)	PC12 cells	hypoxia induce	upregulated	29561961
3407	Rat	rno-miR-448-3p	miRNA	high glucose (HG)	diabetes-associated endothelial dysfunction	rat aortic endothelial cells	high glucose (HG) treatment	downregulated	32542696
3408	Rat	rno-miR-448-3p	miRNA	streptozocin (STZ)	diabetes-associated endothelial dysfunction	aorta	streptozocin (STZ) treatment	downregulated	32542696
3409	Rat	rno-miR-448-3p	miRNA	fluorine combined with aluminum (FA)	fluorine combined with aluminum (FA)-induced developmental neurotoxicity	hippocampi	fluorine combined with aluminum (FA) treatment	upregulated	30033483
3410	Rat	rno-miR-448-5p	miRNA	letrozole	polycystic ovarian syndrome (PCOS)	ovarian tissues	letrozole treatment	downregulated	29505837
3411	Rat	rno-miR-449	miRNA	cisplatin (DDP)	acute kidney injury (AKI)	NRK-52E cells	cisplatin treatment	upregulated	26968221
3412	Rat	rno-miR-449a	miRNA	hypoxia	cardiomyocytes injury	H9c2 cells	hypoxia induce	upregulated	30770559
3413	Rat	rno-miR-449a	miRNA	tetramethylpyrazine (TMP)	cardiomyocytes injury	hypoxia-induced H9c2 cells	Tetramethylpyrazine treatment	downregulated	30770559
3414	Rat	rno-miR-449a	miRNA	sodium nitrate	diabetic testicular disorder	diabetic rats testis tissues	sodium nitrate feed treatment	upregulated	30952494
3415	Rat	rno-miR-449a	miRNA	streptozocin (STZ)	diabetic testicular disorder	testis tissues	streptozotocin (STZ) treatment	downregulated	30952494
3416	Rat	rno-miR-449a	miRNA	light	focal retinal degeneration	right eye	light treatment	upregulated	25921151
3417	Rat	rno-miR-449a	miRNA	ethylene glycol monomethyl ether (EGME)	hyperglycemia	?testicle of rat	Ethylene glycol monomethyl ether (EGME) treatment	"miR-449a and miR-92a decreased obviously and, miR-320, miR-134 and miR-188 increased"	22008535
3418	Rat	rno-miR-449a	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	neonatal rat ventricular myocytes and H9C2 cells	hypoxia induce	upregulated	29758550
3419	Rat	rno-miR-449a	miRNA	lead (Pb)	nervous system diseases	rats hippocampus	chronic lead exposure treatment	upregulated	24960059
3420	Rat	rno-miR-449a	miRNA	electroacupuncture (EA)	spinal cord injury (SCI)	SCI rats	modified Allen's method	downregulated	28507480
3421	Rat	rno-miR-449a	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	spinal cord tissues; HAPI cells	lipopolysaccharide (LPS) treatment	upregulated	30119293
3422	Rat	rno-miR-449a-5p	miRNA	H2O2	hyperoxia-induced acute lung injury (HALI)	rat type II alveolar epithelial cells (AECII)	hydrogen peroxide (H2O2) treatment	downregulated	29436647
3423	Rat	rno-miR-449a-5p	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	pulmonary arterial smooth muscle cells (PASMCs)	hypoxia induce	downregulated	30715622
3424	Rat	rno-miR-450a	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
3425	Rat	rno-miR-451	miRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	vascular smooth muscle cells (VSMCs)	platelet-derived growth factor type BB (PDGF-BB) treatment	downregulated	30930138
3426	Rat	rno-miR-451	miRNA	genistein	cardiac hypertrophy	isoproterenol-treated H9C2 cells	genistein treatment	upregulated	30798118
3427	Rat	rno-miR-451	miRNA	isoproterenol	cardiac hypertrophy	H9C2 cells	isoprenaline (ISO) tteatment	downregulated	30798118
3428	Rat	rno-miR-451	miRNA	immunoregulatory molecule soluble HLA-G (sHLA-G)	CD4+ T cells proliferation	CD4+ T cells	immunoregulatory molecule soluble HLA-G (sHLA-G) treatment	"sHLA-G triggered a modulation of miRNA expression that may in turn modulate downstream gene expression, thus affecting CD4+ T -cell function."	23220581
3429	Rat	rno-miR-451	miRNA	trans-chalcone	hepatoprotective action of trans-chalcone	liver tissues	trans-chalcone treatment	Trans-chalcone increased hepatic level of miR-451 and reduced hepatic IL-8 as well as AST and ALT aft er 6 weeks	29453920
3430	Rat	rno-miR-451	miRNA	propofol (PPF)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	hypoxia treated H9C2 cells	Propofol treatment	upregulated	31188485
3431	Rat	rno-miR-451	miRNA	anoxia/reoxygenation (A/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	neonatal rat ventricular cardiomyocytes	anoxia/reoxygenation (A/R) treatment	downregulated	27121079
3432	Rat	rno-miR-451	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	downregulated	32256945
3433	Rat	rno-miR-451	miRNA	palmitic acid (PA)	obesity and diabetes	cardiac myocytes	high-fat diet (HFD) treatment	upregulated	25362209
3434	Rat	rno-miR-451	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	27910957
3435	Rat	rno-miR-451	miRNA	perfluorooctane sulfonic acid (PFOS)	perfluorooctane sulfonate (PFOS)-induced toxic action	rat liver tissue	dams received 3.2 mg/kg PFOS in their feed from gestational day 1 (GD1) to postnatal day 7 (PND 16) treatment	different expression	24420840
3436	Rat	rno-miR-451	miRNA	Silica nanoparticles (SiNPs)	vascular endothelial dysfunction	aortic arch	Silica nanoparticles (SiNPs) treatment	downregulated	30975181
3437	Rat	rno-miR-451	miRNA	heat stress	vascular permeability	lung endothelial cells	heat treatment	"MiRNA-451 was upregulated in the lung endothelial cells of the rat model, and contributed to increase lung endothelial cell permeability."	33269809
3438	Rat	rno-miR-451-5p	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	downregulated	32893733
3439	Rat	rno-miR-454	miRNA	carbon tetrachloride (CCl4)	liver cirrhosis	liver tissues	CCl4 treatment	downregulated	30535384
3440	Rat	rno-miR-454	miRNA	TGF-¦Â1	liver cirrhosis	HSC-T6 cells	transforming growth factor (TGF)-¦Â1 treatment	downregulated	30535384
3441	Rat	rno-miR-454	miRNA	pioglitazone	oxygen glucose deprivation (OGD)-induced myocardial cell injury	H9c2 cells	pioglitazone treatment	Pioglitazone significantly upregulated miR-454 expression in OGD-injured cells	30524679
3442	Rat	rno-miR-455	miRNA	hypoxia/reoxygenation (H/R)	hepatic ischemia/reperfusion injury (HIRI)	BRL-3A cells	hypoxia-reoxygenation (H/R) treatment	lncRNA Gm4419 accelerates hepatic I/R injury by targeting the miR-455-SOX6 axis.	32114773
3443	Rat	rno-miR-455-3p	miRNA	cadmium (Cd)	cadmium (Cd)-induced kidney injury	renal cortex	cadmium (Cd) treatment	downregulated	29543730
3444	Rat	rno-miR-455-3p	miRNA	bicyclol	idiopathic pulmonary fibrosis (IPF)	IPF rat lung tissues	bicyclol treatment	upregulated	31407409
3445	Rat	rno-miR-455-3p	miRNA	hypoxia/reoxygenation (H/R)	ischemia/reperfusion (I/R) injury	mesenchymal stem cell (MSC) exosome	hypoxia-reoxygenation (H/R) treatment	upregulated	32719674
3446	Rat	rno-miR-455-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	PC12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	33528807
3447	Rat	rno-miR-455-3p	miRNA	TGF-¦Â1	liver fibrosis	hepatic stellate cells (HSC-T6)	transforming growth factor ¦Â1 (TGF-¦Â1) treatment	downregulated	31150929
3448	Rat	rno-miR-455-3p	miRNA	thioacetamide (TAA)	liver toxicity	Sprague-Dawley rats livers	"treat with TAA at three doses (4.5, 15 and 45 mg/kg) and four time points (3-, 7-, 14- and 28-days) treatment"	dysregulatedin livers	28596526
3449	Rat	rno-miR-455-5p	miRNA	Smad3 inhibitor (SIS3)	intrauterine adhesion (IUA)	endometrial stromal cells (ESCs)	Smad3 inhibitor (SIS3) treatment	downregulated	32447720
3450	Rat	rno-miR-455-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	brain tissues	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	miR-455-5p expression was reduced in brain tissues of MCAO rats and OGD/R-induced PC12 cells	33309710
3451	Rat	rno-miR-465*	miRNA	oxygen	lung injury	pregnant rats lung tissue	inspired oxygen of 10.5 or 21% for two days treatment	upregulated	25120593
3452	Rat	rno-miR-466	miRNA	single dose irradiation	radiation-induced lung injury (RILI)	male Wistar rats lung tissues	subjected to single dose irradiation with 20 Gy using 6 MV x-rays to the right lung treatment	upregulated	24886372
3453	Rat	rno-miR-466b	miRNA	hypoxia	cortical injury	rat cortex tisssues	hypoxia treatment	downregulated	23272113
3454	Rat	rno-miR-466b	miRNA	adreno-cortico-tropic-hormone (ACTH)	hormonal regulation	adrenals?tissues	adreno-cortico-tropic-hormone (ACTH) treatment	downregulated	24205079
3455	Rat	rno-miR-466b	miRNA	dexamethasone (DEX)	hormonal regulation	adrenals?tissues	dexamethasone (DEX) treatment	downregulated	24205079
3456	Rat	rno-miR-466b	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	downregulated	24205079
3457	Rat	rno-miR-466b	miRNA	perfluorooctane sulfonic acid (PFOS)	neural dysfunctions	rat brains	perfluorooctane sulfonic acid (PFOS) treatment	downregulated	22594572
3458	Rat	rno-miR-466b	miRNA	acute stress (AS) and chronic stress (CS)	stress-induced myocardial injury	rat	Rats were bound and suspended treatment	downregulated	24669248
3459	Rat	rno-miR-466b-1FNx01	miRNA	propofol (PPF)	neural function	left cortex of the brain	Propofol treatment	significantly increased	26021509
3460	Rat	rno-miR-466b-1FNx01	miRNA	sevoflurane (SEV)	neural function	left cortex of the brain	Sevoflurane treatment	significantly increased	26021509
3461	Rat	rno-miR-466b-2-3p	miRNA	methylprednisolone	steroid-induced osteonecrosis of femoral head (ONFH)	bone microvascular endothelial cells (BMECs)	methylprednisolone treatment	downregulated	29408208
3462	Rat	rno-miR-466b-5p	miRNA	propofol (PPF)	neurotoxicity	primary cultured neural stem cells (NSCs)	propofol treatment	downregulated	29679758
3463	Rat	rno-miR-466b-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3464	Rat	rno-miR-466c-5p	miRNA	vitamin A	congenital scoliosis (CS)	Embryos	Vitamin A deficiency treatment	upregulated	31044535
3465	Rat	rno-miR-466f	miRNA	valproic acid (VPA)	cerebral ischemia injury (CII)	rat cortical neuronal cells	valproic acid treatment	upregulated	22937209
3466	Rat	rno-miR-466i	miRNA	palmitate and palmitate plus oleate.	insulin resistance (IR)	mouse myoblasts	palmitate and palmitate plus oleate treatment	upregulated	21183973
3467	Rat	rno-miR-466i-5p	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia treatment	"Kcnq1ot1 sponged miR-466k and miR-466i-5p to up-regulate Tead1, thus triggering cardiomyocyte injury in the process of AMI."	32422306
3468	Rat	rno-miR-466k	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia treatment	"Kcnq1ot1 sponged miR-466k and miR-466i-5p to up-regulate Tead1, thus triggering cardiomyocyte injury in the process of AMI."	32422306
3469	Rat	rno-miR-4728-5p	miRNA	H2O2	age-related cataract (ARC)	human lens epithelial cells (LECs)	oxidative stress	NONHSAT143692.2 is involved in oxidative DNA damage repair in the lens by regulating the miR-4728-5p/OGG1 axis.	33000245
3470	Rat	rno-miR-483	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
3471	Rat	rno-miR-483	miRNA	(+)-cholesten-3-one (CN)	osteoblastic differentiation	mesenchymal stem cells (MSCs)	(+)-cholesten-3-one (CN) treatment	downregulated	30373531
3472	Rat	rno-miR-483	miRNA	grape seed procyanidin extract (GSPE)	pancreatic islet injury	rat islets	grape seed procyanidin extract (GSPE)treatment	"GSPE altered significantly the expression of miR-1249, miR-483, miR-30c-1*, and miR-3544."	23215023
3473	Rat	rno-miR-483-5p	miRNA	palmitate	diabetes mellitus (DM)	INS-1 cells	palmitate (Pal) treatment	upregulated	30131392
3474	Rat	rno-miR-483-5p	miRNA	inorganic phosphate (Pi)	vascular calcification (VC)	Vascular Smooth Muscle Cells	Inorganic phosphate (Pi) treatment	upregulated	31790973
3475	Rat	rno-miR-484	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	primary cultured myocardial cells (PC); H9c2 cells	doxorubicin (DOX) treatment	downregulated	30170730
3476	Rat	rno-miR-485	miRNA	hypoxia	ischemic stroke (IS)	mouse brain tissues	middle cerebral artery occlusion (MCAO)	downregulated	31794744
3477	Rat	rno-miR-485-3p	miRNA	FK506	osteogenesis	rat bone marrow stromal cells (BMSCs)	FK506 treatment	upregulated	28560399
3478	Rat	rno-miR-485-5p	miRNA	complete freund's adjuvant (CFA)	inflammatory pain	L4-6 dorsal root ganglion (DRG)	complete Freund's adjuvant (CFA) treatment	The miRNA-485-5p expression level clearly decreased while the ASIC1 expression level was upregulated in the L4-6 dorsal root ganglion (DRG) of CFA rats.	33239909
3479	Rat	rno-miR-486	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia induce	downregulated	30121658
3480	Rat	rno-miR-486	miRNA	acute and long-term aerobic exercise	cardiorespiratory fitness	young men	acute and long-term aerobic exercise treatment	downregulated	27895662
3481	Rat	rno-miR-486	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	27910957
3482	Rat	rno-miR-486	miRNA	chronic hypoxia-hypercapnia (CHH)	skeletal muscle atrophy	gastrocnemius muscles	chronic hypoxia-hypercapnia (CHH) treatment	downregulated	30654931
3483	Rat	rno-miR-486	miRNA	neuromuscular electrical stimulation (NMES)	skeletal muscle atrophy	gastrocnemius muscles	Neuromuscular Electrical Stimulation (NMES) treatment	upregulated	30654931
3484	Rat	rno-miR-486-3p	miRNA	high glucose (HG)	diabetic retinopathy (DR)	Muller cells	high glucose (HG) treatment	Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-¦ÊB axis repression.	32979189
3485	Rat	rno-miR-486-5p	miRNA	hypoxia	cyanotic congenital heart disease (CCHD)	H9C2 cells	hypoxia induce	upregulated	31934081
3486	Rat	rno-miR-487b	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
3487	Rat	rno-miR-487b-3p	miRNA	"2,5-hexanedione (HD)"	"2,5-hexanedione (HD) toxicity"	spinal cord tissues	"2,5-hexanedione (HD) treatment"	upregulated	31760062
3488	Rat	rno-miR-488	miRNA	psoralen	osteogenesis	bone marrow mesenchymal stem cells (BMSCs)	psoralen treatment	downregulated	31485621
3489	Rat	rno-miR-489	miRNA	gentamicin	acute kidney injury (AKI)	urine	gentamicin treatment	upregulated	27074385
3490	Rat	rno-miR-489	miRNA	resveratrol	breast cancer	matched tumor/normal tissues	resveratrol (RS) treatment	upregulated	24447120
3491	Rat	rno-miR-489	miRNA	H2O2	myocardial infarction (MI)	H9c2 cells	H2O2 treatment	miR-489 expression was increased in H2O2-treated H9c2 cardiomyocytes	32880387
3492	Rat	rno-miR-489	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) induce	upregulated	31378911
3493	Rat	rno-miR-489-3p	miRNA	carbon tetrachloride (CCl4)	liver fibrosis	liver tissues	carbon tetrachloride (CCl4) treatment	miR-489-3p was significantly downregulated in liver fibrotic tissues compared with the control group.	32144602
3494	Rat	rno-miR-490-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	downregulated	33456519
3495	Rat	rno-miR-490-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	The results revealed that miR-490-3p was markedly downregulated in an LPS-induced rat ALI model	33456519
3496	Rat	rno-miR-490-5p	miRNA	sevoflurane (SEV)	brain injury	rat middle cerebral artery occlusion model rats brain tissues	Sevoflurane (SEV)??treatment treatment	Sevo raised miR-490-5p and decreased CDK1 to improve neurological deficits	33513398
3497	Rat	rno-miR-490-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3498	Rat	rno-miR-490-5p	miRNA	dextran sodium sulfate (DSS)	ulcerative colitis (UC)	Sprague-Dawley (SD) rats colon tissues in the colon tissues	dextran sulfate sodium (DSS)	upregulated( miR-149-5p) downregulated (miR-184) in the colon tissues in the colon tissues	28246536
3499	Rat	rno-miR-490-5p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	downregulated	28246536
3500	Rat	rno-miR-493	miRNA	oxygen glucose deprivation (OGD)	stroke	rat brain microvascular endothelial cells (RBMECs)	oxygen and glucose deprivation-induced treatment	downregulated	26929185
3501	Rat	rno-miR-493-3p	miRNA	chronic unpredictable mild stress (CUMS)	depression	hippocampus tissues	chronic unpredictable mild stressed (CUMS) treatment	upregulated	28083819
3502	Rat	rno-miR-493-3p	miRNA	hronic unpredictable mild stressed (CUMS)	depression	rats hippocampal tissues	stimulated daily with randomly applied mild stressors from among 14 different mild stressors	upregulated	28083819
3503	Rat	rno-miR-493-5p	miRNA	"2,5-hexanedione (HD)"	"2,5-hexanedione (HD) toxicity"	spinal cord tissues	"2,5-hexanedione (HD) treatment"	upregulated	31760062
3504	Rat	rno-miR-494	miRNA	hypoxia/reoxygenation (H/R)	acute myocardial infarction (AMI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	downregulated	33174056
3505	Rat	rno-miR-494	miRNA	ethanol (EtOH)	alcohol-induced anxiolysis	Amygdaloid	ethanol treatment	downregulated	26786313
3506	Rat	rno-miR-494	miRNA	ethanol (EtOH)	anxiolysis	amygdaloid	ethanol treatment	downregulated	26786313
3507	Rat	rno-miR-494	miRNA	lithium chloride and pilocarpine	epilepsy	hippocampus	lithium chloride-pilocarpine treatment	downregulated	32308116
3508	Rat	rno-miR-494	miRNA	propofol (PPF)	hepatic ischemia/reperfusion injury (HIRI)	myocardial cell	propofol treatment	miR-494 levels were suppressed in the propofol group compared with the I/R group	33682507
3509	Rat	rno-miR-494	miRNA	atropine sulfate	myocardial infarction (MI)	rat heart tissues	atropine sulfate treatment	downregulated	31541797
3510	Rat	rno-miR-494	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	PC-12 cells	lipopolysaccharide (LPS) treatment	downregulated	30170481
3511	Rat	rno-miR-494	miRNA	lipopolysaccharide (LPS)	spinal cord injury (SCI)	Rat pheochomocytoma PC-12?cells	lipopolysaccharide (LPS) treatment	upregulated	30816451
3512	Rat	rno-miR-494-3p	miRNA	ginsenoside Rg1	apoptosis	hypoxia-induced male rat bone marrow mesenchymal stem cells (rBMSCs)	Ginsenoside Rg1 treatment	upregulated	29307726
3513	Rat	rno-miR-494-3p	miRNA	hypoxia	apoptosis	Male rat bone marrow mesenchymal stem cells (rBMSCs)	hypoxia induce	downregulated	29307726
3514	Rat	rno-miR-494-3p	miRNA	angiotensin II (Ang II)	hypertensive nephropathy (HN)	rat renal artery endothelial cells (RRAECs)	angiotensin II (Ang II) treatment	upregulated	32346437
3515	Rat	rno-miR-494-3p	miRNA	Sera from patients with septic shock	cardiomyocytes injury	Rat cardiomyocytes (M6200)	Sera from patients with septic shock treatment	downregulated	30783439
3516	Rat	rno-miR-495	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia induce	MiR-495 expression was remarkably increased in H9c2 cells treated with hypoxia.	33506922
3517	Rat	rno-miR-495	miRNA	high glucose (HG)	diabetic retinopathy (DR)	retinal ganglion cells (RGCs)	high glucose (HG) treatment	miR-495 was significantly upregulated in HG-treated RGCs.	30119264
3518	Rat	rno-miR-495	miRNA	pilocarpine	epilepsy	hippocampus; hippocampal neurons	pilocarpine treatment	"The lncRNA UCA1 and Nrf2 were downregulated in epileptiform hippocampal tissues and neurons, while the miR-495 was upregulated"	29608952
3519	Rat	rno-miR-495	miRNA	repeated binge-EtOH exposure	ethanol addiction	dorsal and ventral hippocampus of male Wistar rats	repeated binge-EtOH exposure treatment	different regulation	24416161
3520	Rat	rno-miR-495	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
3521	Rat	rno-miR-495	miRNA	ischemia	periodontitis	Serum	Ligation around teeth treatment	upregulated	26910654
3522	Rat	rno-miR-495	miRNA	monocrotaline (MCT)	pulmonary arterial hypertension (PAH)	PAH rats right ventricular (RV) tissues	monocrotaline (MCT) treatment	upregulated	29566365
3523	Rat	rno-miR-495	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
3524	Rat	rno-miR-495-3p	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	Alveolar macrophages (NR8383)	lipopolysaccharide (LPS) treatment	"methylation of the miR-495 promoter could downregulate miR-495, whose elevation could attenuate the activation of the NLRP3 inflammasome to protect against ALI"	31734560
3525	Rat	rno-miR-495-3p	miRNA	H2O2	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9C2 cells	H2O2 treatment	downregulated	31347173
3526	Rat	rno-miR-495-3p	miRNA	H2O2	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	H2O2 treatment	NEAT1 contributed to M-I/R injury via the modulation of miR-495-3p and MAPK6.	31347173
3527	Rat	rno-miR-496	miRNA	hypoxia	cerebral ischemia/reperfusion (I/R) injury	Middle cerebral	middle cerebral artery occlusion/reperfusion (MCAO/R) induce	downregulated	30597231
3528	Rat	rno-miR-496	miRNA	hypoxia/reoxygenation (H/R)	myocardial infarction (MI)	H92c cells	hypoxia/reoxygenation (H/R) treatment	miR-496 was lowly expressed in H/R-treated H9c2 cells.	31436348
3529	Rat	rno-miR-496	miRNA	hypoxia	myocardial injury	The H9c2 rat cardiomyocyte cells	hypoxia induce	"with Hook3 functionality's aid, miR-496 upregulation defends cells from H/R-induced apoptosis and stimulates cell proliferation."	31436348
3530	Rat	rno-miR-496-3p	miRNA	methamphetamine (METH)	addiction	nucleus accumbens tissues	Methamphetamine treatment	dysregulated	28681200
3531	Rat	rno-miR-497	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	Primary cardiomyocytes	angiotensin II (Ang II) treatment	Our data indicated that TUG1 was upregulated and miR-497 was downregulated in the TAC rat model and Ang II-induced cardiomyocytes.	33817315
3532	Rat	rno-miR-497	miRNA	bone matrix gelatin	chondrogenesis	chondrocytes	bone matrix gelatin treatment	downregulated	30156864
3533	Rat	rno-miR-497	miRNA	high glucose (HG)	diabetic retinopathy (DR)	M¨¹ller cells	high glucose (HG) treatment	miR-497 was significantly increased in high glucose-treated M¨¹ller cells	29383970
3534	Rat	rno-miR-497	miRNA	exercise training (ET)	myocardial infarction (MI)	heart sissues; serum	exercise training (ET)	ET reduced the infarct size in MI rats and inhibited the levels of miR-497.	32162294
3535	Rat	rno-miR-497	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
3536	Rat	rno-miR-497-5p	miRNA	"2,5-hexanedione (HD)"	"2,5-hexanedione (HD) toxicity"	spinal cord tissues	"2,5-hexanedione (HD) treatment"	downregulated	31760062
3537	Rat	rno-miR-498	miRNA	lipopolysaccharide (LPS)	cell proliferation	chondrocytes	lipopolysaccharide (LPS) treatment	downregulated	31141496
3538	Rat	rno-miR-499	miRNA	hypoxia/reoxygenation (H/R)	acute myocardial infarction (AMI)	human umbilical vein endothelial cells (HUVECs)	hypoxia/reoxygenation (HX/R) treatment	upregulated	31270949
3539	Rat	rno-miR-499	miRNA	mechanical stress	apoptosis	rat cardiomyocytes	mechanical stress treatment	downregulated	26859150
3540	Rat	rno-miR-499	miRNA	hypoxia/reoxygenation (H/R)	cardiomyocytes injury	H9c2 cells	hypoxia/reoxygenation (H/R) induce	downregulated	31076992
3541	Rat	rno-miR-499	miRNA	daunorubicin	cardiomyopathy	rats	"daunorubicin (DAU-A, 3 mg/kg, every 48 h)"	downregulated	28303410
3542	Rat	rno-miR-499	miRNA	losartan	ischemia/reperfusion (I/R) injury	heart tissues	losartan treatment	upregulated	26168042
3543	Rat	rno-miR-499	miRNA	myricetin	myofiber type transition	soleus and gastrocnemius muscles	myricetin treatment	upregulated	31073320
3544	Rat	rno-miR-499	miRNA	lipopolysaccharide (LPS)	sepsis	cardiomyocytes	lipopolysaccharide (LPS) treatment	upregulated	26659076
3545	Rat	rno-miR-499-5p	miRNA	isoproterenol	acute cardiac injury	heart tissues	isoproterenol treatment	upregulated	27605421
3546	Rat	rno-miR-499-5p	miRNA	hyperoxia	acute myocardial infarction (AMI)	neonatal rat cardiomyocytes	hyperoxia treatment	upregulated	27231854
3547	Rat	rno-miR-499-5p	miRNA	hypoxia	hypoxic-ischemic encephalopathy (HIE)	neonatal rats brain tissues	hypoxia induce	downregulated	31812653
3548	Rat	rno-miR-499-5p	miRNA	notexin	skeletal muscle atrophy	plasma	notexin treatment	upregulated	26952641
3549	Rat	rno-miR-499a-5p	miRNA	doxorubicin (DOX)	cardiotoxicity	left ventricular samples	Doxorubicin (DOX) treatment	upregulated	31048226
3550	Rat	rno-miR-499a-5p	miRNA	high-intensity interval training (HIIT)	cardiotoxicity	DOX-induced rats left ventricular samples	high-intensity interval training (HIIT) treatment	downregulated	31048226
3551	Rat	rno-miR-499a-5p	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia induce	downregulated	31452254
3552	Rat	rno-miR-500	miRNA	ischemia	chronic constriction injury	rat spinal cord	ligation of the sciatic nerve treatment	"The expression levels of a large number of miRNAs in the dorsal horn of the spinal cord in CCI rats changed (miR-500, -221 and -21)"	23124577
3553	Rat	rno-miR-500-3p	miRNA	huoxue jiedu formula (HXJDF)	diabetic retinopathy (DR)	retinal tissues	HuoXue JieDu Formula (HXJDF) treatment	miR-500-3p was downregulated in HuoXue JieDu Formula (HXJDF) treated group when compared with diabetic mice.	33271246
3554	Rat	rno-miR-503	miRNA	hypoxia	apoptosis	H9c2 rat myocardial cells	hypoxia induce	upregulated	30404731
3555	Rat	rno-miR-503	miRNA	azoxymethane (AOM)	colorectal cancer (CRC)	colonic tissue of rat	azoxymethane (AOM) treatment	downregulated	23049818
3556	Rat	rno-miR-503	miRNA	high glucose (HG)	diabetic peripheral neuropathy (DPN)	RSC96 cells	high glucose (HG) treatment	upregulated	31581849
3557	Rat	rno-miR-503	miRNA	notoginsenoside R1 (NGR1)	diabetic peripheral neuropathy (DPN)	high glucose-treated RSC96 cells	Notoginsenoside R1 (NGR1) treatment	downregulated	31581849
3558	Rat	rno-miR-503	miRNA	adreno-cortico-tropic-hormone (ACTH)	hormonal regulation	adrenals?tissues	adreno-cortico-tropic-hormone (ACTH) treatment	downregulated	24205079
3559	Rat	rno-miR-503	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	downregulated	24205079
3560	Rat	rno-miR-503-5p	miRNA	mechanical stretch	bone formation	RBMSCs	Flexcell FX-5000TM Tension System	downregulated	27862699
3561	Rat	rno-miR-503-5p	miRNA	cyclic mechanical stretch (CMS)	orthodontic	bone mesenchymal stem cells (BMSCs)	Cyclical stretch treatment	downregulated	27862699
3562	Rat	rno-miR-503-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3563	Rat	rno-miR-506	miRNA	free fatty acids (FFA)	nonalcoholic fatty liver disease (NAFLD)	BRL3A cell	free fatty acid (FFA) treatment	downregulated	31957704
3564	Rat	rno-miR-506	miRNA	lipopolysaccharide (LPS)	pulpitis	dental pulp stem cells (DPSCs)	lipopolysaccharide (LPS) treatment	upregulated	31877121
3565	Rat	rno-miR-511	miRNA	dexamethasone (DEX)	depression	prefrontal cortex of adolescent rats	dexamethasone (DEX) treatment	downregulated	30469088
3566	Rat	rno-miR-511	miRNA	dexamethasone (DEX)	depression	prefrontal cortex of adult rats	dexamethasone (DEX) treatment	downregulated	30469088
3567	Rat	rno-miR-511-3p	miRNA	monocrotaline (MCT)	sinusoidal obstruction syndrome	plasma	monocrotaline treatment	upregulated	29353062
3568	Rat	rno-miR-519d-3p	miRNA	hypoxia	myocardial infarction (MI)	rat heart tissues	permanent ligation of the left anterior descending (LAD) coronary artery induce	upregulated	30607799
3569	Rat	rno-miR-520a	miRNA	hypoxia	cardiomyocyte apoptosis	H9c2 cardiomyocyte cell line	hypoxia induce	downregulated	31410172
3570	Rat	rno-miR-525-5p	miRNA	oxygen glucose deprivation (OGD)	brain injury	neurons	oxygen-glucose deprivation (OGD) treatment	downregulated	26770408
3571	Rat	rno-miR-525-5p	miRNA	hypoxia	myocardial infarction (MI)	myocardial cell line H9c2	hypoxia induce	downregulated	31429119
3572	Rat	rno-miR-532	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	Wistar rats left ventricle (LV)	STZ treatment	upregulated	28199183
3573	Rat	rno-miR-532-3p	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	upregulated	27535721
3574	Rat	rno-miR-532-3p	miRNA	estrogen (ES)	postmenopausal osteoporosis (PMOP)	bone tissues	estrogen treatment	downregulated	33577975
3575	Rat	rno-miR-532-5p	miRNA	parathyroid hormone (PTH)	bone remodeling	rat osteoblasts	Parathyroid hormone (PTH) treatment	downregulated	29626351
3576	Rat	rno-miR-532-5p	miRNA	hypoxia	cardiomyocytes injury	H9c2 cells	hypoxia treatment	miR-532-5p was downregulated in hypoxia-exposed H9c2 cells.	29958954
3577	Rat	rno-miR-532-5p	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
3578	Rat	rno-miR-532-5p	miRNA	anoxia/reoxygenation (A/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	anoxia/reoxygenation (A/R) treatment	downregulated	31985016
3579	Rat	rno-miR-532-5p	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	TUG1 silence ameliorated H/R-induced cardiomyocytes injury through regulating miR-532-5p/Sox8 axis.	32833900
3580	Rat	rno-miR-532-5p	miRNA	bortezomib	peripheral neuropathy	PC12 cells	bortezomib treatment	downregulated	31979371
3581	Rat	rno-miR-539	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	cerebral ischemia/reperfusion (I/R) injury	The rat microvascular endothelial cell line bEND.3	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	30276507
3582	Rat	rno-miR-539	miRNA	chronic constriction injury (CCI)	neuronal mechanisms	Sprague-Dawley rats anterior cingulate cortex (ACC)	chronic constriction injury (CCI) induce	downregulated	28379535
3583	Rat	rno-miR-539-5p	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	downregulated	27535721
3584	Rat	rno-miR-539-5p	miRNA	bushen huoxue decoction (BHD)	bone fractures	rat mesenchymal stem cells (rMSCs)	bushen huoxue decoction (BHD) treatment	downregulated	31341413
3585	Rat	rno-miR-539-5p	miRNA	laser photocoagulation	experimental choroidal neovascularization	retinal pigment epithelial/choroid/sclera tissues of laser-injured eyes	laser photocoagulation treatment	downregulated	29146732
3586	Rat	rno-miR-541	miRNA	SiO2	lung injury	lung	SiO2 treatment	downregulated	27689473
3587	Rat	rno-miR-541-5p	miRNA	TGF-¦Â	idiopathic pulmonary fibrosis (IPF)	pulmonary fibrosis rats	treat with TGF-¦Â treatment	downregulated	28816543
3588	Rat	rno-miR-542-3p	miRNA	Yiqifumai Injection (YQFM)	chronic heart failure (CHF)	H9c2 cells	Yiqifumai Injection (YQFM) treatment	upregulated	29467665
3589	Rat	rno-miR-542-3p	miRNA	kainic acid (KA)	epilepsy	hippocampal tissues	kainic acid (KA) treatment	downregulated	31702493
3590	Rat	rno-miR-542-3p	miRNA	light	focal retinal degeneration	right eye	light treatment	upregulated	25921151
3591	Rat	rno-miR-542-3p	miRNA	TGF-¦Â1	liver fibrosis	HSC©\T6 cells	transforming growth factor ¦Â1 (TGF¦Â1) treatment	upregulated	30368874
3592	Rat	rno-miR-542-5p	miRNA	hypoxia/reoxygenation (H/R)	hypoxia/reoxygenation (H/R) injury	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	we found that the miR-542-5p expression and the autophagy activation were significantly increased in H9c2 cells after H/R injury.	33394350
3593	Rat	rno-miR-543	miRNA	angiotensin II (Ang II)	cardiac fibrosis	cardiac fibroblasts	angiotensin II (Ang II) treatment	RNF7 promotes the cardiac fibrosis in rat model via miR-543/THBS1 axis and TGF¦Â1 activation.	31913855
3594	Rat	rno-miR-547*	miRNA	"3,3'-iminodipropionitrile (IDPN)"	neurotoxicity	pons and medulla	"3,3'-iminodipropionitrile (IDPN) treatment"	upregulated	27821907
3595	Rat	rno-miR-547-3p	miRNA	methamphetamine (METH)	methamphetamine (METH) addiction	brain tissues	Methamphetamine (METH) treatment	upregulated	32893733
3596	Rat	rno-miR-547-3p	miRNA	Jianpi Xiaoke (JPXK)	type 2 diabetes mellitus (T2DM)	rat	Jianpi Xiaoke (JPXK) treatment	upregulated	33456489
3597	Rat	rno-miR-551b	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
3598	Rat	rno-miR-551b-5p	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	neonatal rats cardiomyocytes	high glucose (HG) treatment	"DCRF can act as a competing endogenous RNA to increase PCDH17 expression by sponging miR-551b-5p, thus contributing to increased cardiomyocyte autophagy in DCM."	31285779
3599	Rat	rno-miR-551b-5p	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	rat heart tissues	streptozotocin treatment	"DCRF can act as a competing endogenous RNA to increase PCDH17 expression by sponging miR-551b-5p, thus contributing to increased cardiomyocyte autophagy in DCM"	31285779
3600	Rat	rno-miR-558	miRNA	isoproterenol	myocardial infarction (MI)	rat H9C2 cells	isoproterenol (ISO) treatment	lncRNA MALAT1 protected cardiomyocytes from ISO-induced apoptosis by sponging miR-558 thus promoting ULK1-dependent autophagy.	30536615
3601	Rat	rno-miR-558	miRNA	CoCl2	spinal cord injury (SCI)	PC12 cells	CoCl2 treatment	circ-HIPK3 relieves the neuronal cell apoptosis through regulating miR-588/DPYSL5 axis in SCI.	32247616
3602	Rat	rno-miR-582-5p	miRNA	propofol (PPF)	propofol-induced neurotoxicity	primary rat hippocampal neurons	Propofol treatment	miR-582-5p were decreased in a time-dependent manner after propofol treatment	32031069
3603	Rat	rno-miR-590	miRNA	ferulic acid (FA)	spinal cord injury (SCI)	neural stem cells (NSCs) of SCI rat	FA	downregulated	28642684
3604	Rat	rno-miR-590-3p	miRNA	hypoxia/reoxygenation (H/R)	acute myocardial infarction (AMI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	"ZFAS1 was upregulated in H9c2 cells subjected to I/R injury, and that ZFAS1 knockdown protected against I/R-induced myocardial cell apoptosis by directly interacting with miR-590-3p, via the NF-¦ÊB pathway."	32705215
3605	Rat	rno-miR-590-3p	miRNA	nuclear factor kappa-B (NF-¦ÊB)	myocarditis and heart dysfunction	heart tissues	NF-¦ÊB treatment	downregulated	26278103
3606	Rat	rno-miR-590-3p	miRNA	lipopolysaccharide (LPS)	sepsis	H9c2 cells	lipopolysaccharide (LPS) treatment	lncRNA NEAT1 accelerated apoptosis and inflammation in LPS-stimulated H9c2 cells via sponging miR-590-3p.	32855700
3607	Rat	rno-miR-592	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	astrocytes (ASTs) from AD rats	amyloid-¦Â (A¦Â) 25-35 treatment	upregulated	31759899
3608	Rat	rno-miR-592	miRNA	D-galactose (D-Gal)	Alzheimer's disease (AD)	astrocytes (ASTs) from AD rats	D-galactose treatment	upregulated	31759899
3609	Rat	rno-miR-592	miRNA	amyloid-¦Â (A¦Â) 25-35	Alzheimer's disease (AD)	hippocampus tissues	amyloid-¦Â (A¦Â) 25-35 treatment	upregulated	31759899
3610	Rat	rno-miR-593-5p	miRNA	hypoxia	hypoxic pulmonary hypertension (HPH)	lung tissues and pulmonary arterial smooth muscle cells (PASMCs)	hypoxia induce	downregulated	31081105
3611	Rat	rno-miR-612	miRNA	platelet derived growth factor-BB (PDGF-BB)	atherosclerosis (AS)	VSMCs isolated from the thoracic aortas of rat	platelet-derived growth factor-BB (PDGF-BB) treatment	downregulated	29399059
3612	Rat	rno-miR-612	miRNA	dexamethasone (DEX)	cartilage injury	articular cartilage	dexamethasone (DEX) treatment	miR-612 was downregulated compared with control group.	29207029
3613	Rat	rno-miR-612	miRNA	platelet derived growth factor-BB (PDGF-BB)	neointimal formation	vascular smooth muscle cells (VSMCs)	platelet-derived growth factor (PDGF)-BB treatment	"PDGF-BB significantly promoted the proliferation and migration of VSMCs, and decreased miR-612 levels in VSMCs"	29399059
3614	Rat	rno-miR-6215	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	downregulated	27919821
3615	Rat	rno-miR-6216	miRNA	doxorubicin (DOX)	ischemia/reperfusion (I/R) injury	rats cardiomyocytes	doxorubicin treatment	upregulated	27919821
3616	Rat	rno-miR-6216	miRNA	doxorubicin (DOX)	renal interstitial fibrosis (RIF)	kidneys	doxorubicin (ADR) induction	upregulated	32606425
3617	Rat	rno-miR-6216	miRNA	"kangxianling (KXL, anti-fibrin)"	renal interstitial fibrosis (RIF)	kidneys	"Kangxianling (KXL, anti-fibrin) treatment"	downregulated	32606425
3618	Rat	rno-miR-628	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	downregulated	27535721
3619	Rat	rno-miR-628	miRNA	burn injury	burn-induced skeletal muscle atrophy	rats	burn treatment	upregulated	27766036
3620	Rat	rno-mir-6314	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3621	Rat	rno-miR-6322	miRNA	ischemia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	ischemia buffer treatment	Hsa-circ-0068566 inhibited the development of myocardial ischemia reperfusion injury by regulating hsa-miR-6322/PARP2 signal pathway.	32633392
3622	Rat	rno-miR-6324	miRNA	tunicamycin (TM)	endoplasmic reticulum stress (ERS)	H9c2 cells	tunicamycin treatment	lncRNA Dancr overexpression protected cardiomyocytes against ERS injury via sponging miR-6324.	33300079
3623	Rat	rno-mir-6329	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3624	Rat	rno-miR-636	miRNA	caffeic acid	diabetic nephropathy (DN)	liver tissues	caffeic acid (CA) treatment	caffeic acid down regulates miR-636 expression level.	31391719
3625	Rat	rno-miR-636	miRNA	caffeic acid	diabetic nephropathy (DN)	kidney tissues	caffeic acid (CA) treatment	downregulated	31391719
3626	Rat	rno-miR-636	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin treatment	upregulated	31391719
3627	Rat	rno-miR-638	miRNA	resveratrol	pulmonary arterial hypertension (PAH)	rat pulmonary arterial smooth muscle cells (PASMCs)	resveratrol (RS) treatment	"MCT resulted in significant pulmonary vascular remodeling and downregulated of miR-638, which could be suppressed by resveratrol"	32057731
3628	Rat	rno-miR-652	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	PC12 cells; brain tissues	oxygen-glucose deprivation (OGD treatment	"The transcription factor NR4A2 mediates the expression of Mul1 through transcriptional repression of miR-652, thus promoting ischemic brain injury"	33116527
3629	Rat	rno-miR-652-3p	miRNA	valproic acid (VPA)	cell differentiation	primary cultured neural stem cells (NSCs)	valproate (VPA) treatment	upregulated	29575035
3630	Rat	rno-miR-652-3p	miRNA	huoxue jiedu formula (HXJDF)	diabetic retinopathy (DR)	retinal tissues	HuoXue JieDu Formula (HXJDF) treatment	miR-652-3p was upregulated in HuoXue JieDu Formula (HXJDF) treated group when compared with control mice.	33271246
3631	Rat	rno-miR-652-5p	miRNA	steroids	osteonecrosis	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	upregulated	26459755
3632	Rat	rno-miR-659-3p	miRNA	hypoxia	familial frontotemporal lobar degeneration (FTLD)	?rat cortices	Hypoxia treatment	downregulated	27199656
3633	Rat	rno-miR-663b	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia treatment	miR-663b inhibition protected cardiomyocytes against hypoxia-induced injury by targeting BCL2L1.	32346421
3634	Rat	rno-miR-664	miRNA	acarbose	diabetes mellitus (DM)	blood	acarbose? treatment	upregulated	24260283
3635	Rat	rno-miR-664-2	miRNA	danazol	precocious puberty (PP)	rat hypothalamus tissues	Danazol treatment	downregulated	30916745
3636	Rat	rno-miR-665	miRNA	propofol (PPF)	central nervous system (CNS) development	astroglia	propofol treatment	downregulated	26083276
3637	Rat	rno-miR-665	miRNA	hypoxia/reoxygenation (H/R)	myocardial infarction (MI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	upregulated	32132320
3638	Rat	rno-miR-666-3p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	inflammation	primary brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"?In particular, the expression levels of rno-miR-666-3p, rno-miR-92a-2-5p, and rno-miR-219a-2-3p decreased in OGD/R-exposed cells compared with those in the control"	33745435
3639	Rat	rno-miR-668	miRNA	hypoxia	acute kidney injury (AKI)	rat proximal tubular cells (RPTC)	hypoxia induce	upregulated	30325740
3640	Rat	rno-miR-668	miRNA	erythropoietin (EPO)	hydrocephalus	kaolin-induced obstructive hydrocephalus rats periventricular ependymal lining and cultured astrocytes	erythropoietin (EPO) treatment	downregulated	29982881
3641	Rat	rno-miR-668	miRNA	kaolin	hydrocephalus	periventricular ependymal lining and cultured astrocytes	kaolin treatment	upregulated	29982881
3642	Rat	rno-miR-671	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC12 cells	1-methyl-4-phenylpyridinium (MPP+) treatment	downregulated	32889692
3643	Rat	rno-miR-671	miRNA	exendin-4 (Ex-4)	parkinson's disease (PD)	1-methyl-4-phenylpyridinium (MPP+)-treated PC12 cells	Exendin-4 (Ex-4)?treatment	upregulated	32889692
3644	Rat	rno-miR-671	miRNA	exendin-4 (Ex-4)	neuronal cell injury	PC12 cells	Exendin-4 (Ex-4) treatment	Ex-4 downregulated 1-methyl-4 phenyl-pyridine ion (MPP+) -induced CDR1as expression in PC12 cells and upregulated miR-671 expression.	32889692
3645	Rat	rno-miR-672	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	primary cultured rat cardiomyocytes	angiotensin II (Ang II) treatment	downregulated	29339068
3646	Rat	rno-miR-672	miRNA	insulin-like growth factor 1 (IGF-1)	cardiac hypertrophy	primary cultured rat cardiomyocytes	insulin-like growth factor 1 treatment	downregulated	29339068
3647	Rat	rno-miR-672	miRNA	phenylephrine (PE)	cardiac hypertrophy	primary cultured rat cardiomyocytes	phenylephrine treatment	downregulated	29339068
3648	Rat	rno-miR-672	miRNA	perfluorooctane sulfonic acid (PFOS)	neural dysfunctions	rat brains	perfluorooctane sulfonic acid (PFOS) treatment	downregulated	22594572
3649	Rat	rno-miR-672-5p	miRNA	steroids	osteonecrosis	osteoblasts	steroid treatment	upregulated	27378744
3650	Rat	rno-miR-674-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3651	Rat	rno-miR-674-3p	miRNA	insulin-like growth factor 1 (IGF-1)	spinal cord injury (SCI)	Neural stem cells were obtained from E15 fetal rat cerebral cortex cultured supernatant exosomes	insulin growth factor-1 (IFG-1) treatment	upregulated	31848325
3652	Rat	rno-miR-674-5p	miRNA	valproic acid (VPA)	cell differentiation	primary cultured neural stem cells (NSCs)	valproate (VPA) treatment	upregulated	29575035
3653	Rat	rno-miR-675	miRNA	H2O2	aging-induced vascular dysfunction	H9C2 cells	H2O2 treatment	downregulated	30889706
3654	Rat	rno-miR-675	miRNA	adriamycin (ADR)	dilated cardiomyopathy (DCM)	rats?myocardial tissue	adriamycin (ADR) treatment	downregulated	28430627
3655	Rat	rno-miR-676	miRNA	bleomycin (BLM)	lung fibrosis	lung tissues	bleomycin (BLM) treatment	upregulated	33193637
3656	Rat	rno-mir-676	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3657	Rat	rno-miR-676-1	miRNA	fastigial nucleus stimulation (FNS)	focal cerebral ischemia	rat brain	fastigial nucleus stimulation (FNS)?treatment	upregulated	25783478
3658	Rat	rno-miR-680	miRNA	corticotrophin releasing factor (CRF) receptor I antagonist (BMS-764459)	hepatocellular carcinoma (HCC)	rat liver cells	"The corticotrophin releasing factor (CRF) receptor I antagonist, BMS-764459 treatment"	"MiR-680 and miR-29a were identified as potential regulators and biomarkers of atypical CYP1A1 induction by regulating Abcc3, CYP3A and CYP2B as well as a number of AhR targeted genes"	23831372
3659	Rat	rno-miR-682	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H92c cells	hypoxia/reoxygenation treatment	downregulated	32590403
3660	Rat	rno-miR-691	miRNA	nerve growth factor (Ngf)	neurodegenerative diseases	PC12 cells	100 ng/ml Ngf treatment	different regulation	24492999
3661	Rat	rno-miR-7	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	primary isolated endothelial cell (EC) and retinal pericyte (RP)	streptozotocin (STZ) treatment	downregulated	30058674
3662	Rat	rno-miR-7	miRNA	tricin	glioblastoma multiforme (GBM)	C6 glioma cells	tricin treatment	upregulated	29877083
3663	Rat	rno-miR-7	miRNA	hypoxia	ischemic stroke (IS)	hippocampal CA1 neurons	hypoxia induce	upregulated	30305621
3664	Rat	rno-miR-7	miRNA	atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine; ATR)	parkinson's disease (PD)	peripheral blood and brain tissue in a rat model of PD	Atrazine (2-chloro-4-ethylamino-6-isopropylamino-s-triazine; ATR) treatment	miR-7 was upregulated in brain tissue but downregulated in peripheral blood of rats with ATR-induced PD.	31185338
3665	Rat	rno-miR-7	miRNA	rotenone (ROT)	parkinson's disease (PD)	striatum of parkinsonian rats	rotenone exposure treatment	upregulated	30267378
3666	Rat	rno-miR-7	miRNA	crocin	parkinson's disease (PD)	striatal tissueS	crocin treatment	Crocin upregulated the expression of miRNA-7.	31811872
3667	Rat	rno-miR-702-3p	miRNA	SiO2	lung injury	lung	SiO2 treatment	upregulated	27689473
3668	Rat	rno-miR-702-3p	miRNA	propofol (PPF)	neural function	left cortex of the brain	Propofol treatment	significantly increased	26021509
3669	Rat	rno-miR-706	miRNA	palmitate and palmitate plus oleate.	insulin resistance (IR)	mouse myoblasts	palmitate and palmitate plus oleate treatment	upregulated	21183973
3670	Rat	rno-miR-708	miRNA	¦Â-ionone (¦ÂI)	hepatocellular carcinoma (HCC)	rats hepatocyte	¦ÂI (16 mg/100 g body weight) treatment	"upregulated(miR-122 , miR-34a) ;downregulated (miR-181b , miR-708)"	27061051
3671	Rat	rno-miR-708-3p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3672	Rat	rno-miR-708-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3673	Rat	rno-miR-708-5p	miRNA	nickel	steroidogenesis disturbance	Leydig cells	NiSO4 induce	dysregulated	31734292
3674	Rat	rno-miR-708-5p	miRNA	NiSO4	steroidogenesis disturbance	rat Leydig cells	NiSO4 treatment	upregulated	31948324
3675	Rat	rno-miR-709	miRNA	acetaminophen (APAP) and methapyrilene (MP)	liver damage	rats pericentral and periportal regions	acetaminophen (APAP) and methapyrilene (MP) treatment	upregulated	24863736
3676	Rat	rno-miR-709	miRNA	nerve growth factor (Ngf)	neurodegenerative diseases	PC12 cells	100 ng/ml Ngf treatment	different regulation	24492999
3677	Rat	rno-miR-71	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	neurotoxicity	brain tissues of rats	RDX at a dose(47 mg/kg) for 48 h treatment	upregulated	25559034
3678	Rat	rno-miR-7-1	miRNA	"1,3,5-tris-4-propyl-1H-pyrazole"	spinal cord injury (SCI)	VSC4.1 motoneurons	ER agonists treatment	upregulated	24157932
3679	Rat	rno-miR-711	miRNA	palmitate and palmitate plus oleate.	insulin resistance (IR)	mouse myoblasts	palmitate and palmitate plus oleate treatment	upregulated	21183973
3680	Rat	rno-miR-711	miRNA	pioglitazone	myocardial infarction (MI)	rat cardiac fibroblasts	pioglitazone treatment	upregulated	23633075
3681	Rat	rno-miR-711	miRNA	antimycin A (AA)	oxidative stress	H9c2 cells	antimycin A (AA) treatment	upregulated	32308692
3682	Rat	rno-miR-711	miRNA	CoCl2	oxidative stress	H9c2 cells	CoCl2 treatment	upregulated	32308692
3683	Rat	rno-miR-711	miRNA	H2O2	oxidative stress	H9c2 cells	H2O2 treatment	upregulated	32308692
3684	Rat	rno-miR-711	miRNA	hypoxia/reoxygenation (H/R)	oxidative stress	H9c2 cells	hypoxia/reoxygenation (H/R)) treatment	upregulated	32308692
3685	Rat	rno-miR-711	miRNA	etoposide (VP-16)	spinal cord injury (SCI)	primary cultured cortical neurons	etoposide treatment	upregulated	31685802
3686	Rat	rno-miR-711	miRNA	staurosporine	spinal cord injury (SCI)	primary cultured cortical neurons	staurosporine treatment	upregulated	31685802
3687	Rat	rno-miR-7134-5p	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
3688	Rat	rno-miR-714	miRNA	dexamethasone (DEX)	cartilage injury	articular cartilage	dexamethasone (DEX) treatment	miR-714was downregulated compared with control group.	29207029
3689	Rat	rno-miR-720	miRNA	acetaminophen (APAP) and methapyrilene (MP)	liver damage	rats pericentral and periportal regions	acetaminophen (APAP) and methapyrilene (MP) treatment	upregulated	24863736
3690	Rat	rno-miR-743b-5p	miRNA	artemisinin (ART)	ventricular arrhythmias (VA)	transverse aortic constriction (TAC) surgery treated rats left ventricle (LV) tissues	artemisinin (ART) treatment	upregulated	30595983
3691	Rat	rno-miR-7-5p	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia induce	downregulated	31264206
3692	Rat	rno-miR-7-5p	miRNA	hypoxia	acute myocardial infarction (AMI)	H9c2 cells	hypoxia treatment	ANRIL plays a protective part in hypoxia-induced H9c2 cell injury via modulating the miR-7-5p/SIRT1 axis	31264206
3693	Rat	rno-miR-7-5p	miRNA	icariside II (ICA II)	hypoxia-induced injury	H9c2 cells	Icariside II (ICS II) treatment	upregulated	32945347
3694	Rat	rno-miR-7-5p	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	rat H9C2 cells	hypoxia induce	downregulated of MEG3 protects myocardial cells against I/R-induced apoptosis through miR-7-5p/PARP1 pathway	31366567
3695	Rat	rno-miR-760	miRNA	verapamil	male fertility	testis	verapamil treatment	downregulated	32725937
3696	Rat	rno-miR-760	miRNA	hypoxia/reoxygenation (H/R)	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	miR-760 was downregulated in H9C2 cells exposed to H/R.	32160475
3697	Rat	rno-miR-760-3p	miRNA	nickel	steroidogenesis disturbance	Leydig cells	NiSO4 induce	dysregulated	31734292
3698	Rat	rno-miR-760-3p	miRNA	NiSO4	steroidogenesis disturbance	rat Leydig cells	NiSO4 treatment	downregulated	31948324
3699	Rat	rno-miR-760-5p	miRNA	guarana	adipogenesis	3T3L1 cells	guarana	downregulated	28632199
3700	Rat	rno-miR-764	miRNA	hypoxia/reoxygenation (H/R)	acute myocardial infarction (AMI)	H9c2 cells	hypoxia/reoxygenation (H/R) treatment	downregulated	33199822
3701	Rat	rno-miR-764	miRNA	hypoxia/reoxygenation (H/R)	acute myocardial infarction (AMI)	H9c2 cells	hypoxia reoxygenation (H/R) treatment	Mirt2 participated in the regulation of MI through the miR-764/PDK1 axis.	33199822
3702	Rat	rno-miR-764-5p	miRNA	high fat diet (HFD)	cardiac remodeling	heart tissues	high fat diet (HFD) feed	upregulated	29884823
3703	Rat	rno-miR-766-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	PC12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	33791020
3704	Rat	rno-miR-7a	miRNA	dexamethasone (DEX)	cartilage injury	articular cartilage	dexamethasone (DEX) treatment	miR-7a was downregulated compared with control group.	29207029
3705	Rat	rno-miR-7a	miRNA	palmitate and palmitate plus oleate.	insulin resistance (IR)	mouse myoblasts	palmitate and palmitate plus oleate treatment	upregulated	21183973
3706	Rat	rno-miR-7a-5p	miRNA	hypoxia	hypoxic/ischemic injury	Male Sprague Dawley rats	"were exposed to hypoxia (9.5-10% O2) for 1, 5, or 10 days"	upregulated	29262398
3707	Rat	rno-miR-7a-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3708	Rat	rno-miR-7a-5p	miRNA	recurrent insulin-induced hypoglycemia (RH)	sympathoadrenal response	ventromedial hypothalamus (VMH)	recurrent insulin-induced hypoglycemia (RH) treatment	downregulated	31619588
3709	Rat	rno-miR-7b	miRNA	hypoxia	acute myocardial infarction (AMI)	rat cardiomyoblast cells (H9c2)	hypoxia induce	downregulated	30548297
3710	Rat	rno-miR-7b	miRNA	ischemia	chronic heart failure (CHF)	Plasma	Ligation of the left anterior descendent coronary artery treatment	upregulated	26699387
3711	Rat	rno-miR-7b	miRNA	hypoxia	ischemia/reperfusion (I/R) injury	H9C2 cells	hypoxia induce	downregulated	30548297
3712	Rat	rno-miR-7b	miRNA	electroacupuncture (EA)	spinal cord injury (SCI)	spinal cords	electroacupuncture (EA) treatment	downregulated	32468009
3713	Rat	rno-miR-7c	miRNA	hypoxia	myocardial ischaemic injury	neonatal rat ventricular myocytes	hypoxia treatment	downregulated	26655604
3714	Rat	rno-miR-7g	miRNA	hypoxia	myocardial ischaemic injury	neonatal rat ventricular myocytes	hypoxia treatment	downregulated	26655604
3715	Rat	rno-miR-802	miRNA	palmitate	type 2 diabetes mellitus (T2DM)	INS-1 rat insulinoma cell line	palmitate for 48 h treatment	upregulated	31966484
3716	Rat	rno-miR-871-3p	miRNA	high fat diet (HFD)	aging-related non-alcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31899128
3717	Rat	rno-miR-873	miRNA	hypoxia	myocardial ischemia/reperfusion (I/R) injury (MIRI)	H9c2 cells	hypoxia induce	downregulated	31570671
3718	Rat	rno-miR-873-5p	miRNA	amyloid-¦Â (A¦Â) 1-42	Alzheimer's disease (AD)	PC12 cells	amyloid ¦Â1-42?(A¦Â) treatment	downregulated	29926354
3719	Rat	rno-miR-873-5p	miRNA	ginsenoside Rg1 (GRg1) and acori graminei Rhizoma (AGR)	Alzheimer's disease (AD)	A¦Â1-42-treated PC12 cells	Ginsenoside Rg1 (GRg1)/Acori graminei Rhizoma (AGR) treatment	upregulated	29926354
3720	Rat	rno-miR-874	miRNA	streptozocin (STZ)	diabetic nephropathy (DN)	kidney tissues	streptozotocin (STZ) treatment	downregulated	30171701
3721	Rat	rno-miR-874-3p	miRNA	streptozocin (STZ)	diabetes mellitus-induced erectile dysfunction (DMED)	Rat cavernosum tissues	streptozocin treatment	downregulated	31914690
3722	Rat	rno-miR-874-3p	miRNA	streptozocin (STZ)	diabetes mellitus-induced erectile dysfunction (DMED)	cavernosum tissues	streptozotocin (STZ) treatment	Epigenetic silencing of microRNA-874-3p implicates in erectile dysfunction in diabetic rats by activating the Nupr1/Chop-mediated pathway	31914690
3723	Rat	rno-miR-874-3p	miRNA	ischemia/reperfusion (I/R) 	ischemia/reperfusion (I/R) injury	PC12 cells	ischemia/reperfusion (I/R) treatment	LncRNA NEAT1 aggravates cerebral I/R injury by suppressing miR-874-3p expression.	32329323
3724	Rat	rno-miR-874-3p	miRNA	hypoxia	ischemic stroke (IS)	brain tissues	middle cerebral artery occlusion/reperfusion (MCAO/R) treatment	downregulated	31200256
3725	Rat	rno-miR-874-5p	miRNA	hypoxia	autophagy	Pulmonary artery smooth muscle cells (PASMCs)	hypoxia treatment	miR-874-5p was upregulated following hypoxia.	32805255
3726	Rat	rno-miR-875-3p	miRNA	doxorubicin (DOX)	cardiotoxicity	H9c2 cells	Doxorubicin (DOX) treatment	Knockdown of miRNA-875-3p decreased the proliferative ability of cardiomyocytes.	32010313
3727	Rat	rno-miR-875-3p	miRNA	doxorubicin (DOX)	doxorubicin (DOX)-induced cardiotoxicity	H9c2 cells	doxorubicin (DOX) treatment	downregulated	32010313
3728	Rat	rno-miR-877	miRNA	streptozocin (STZ)	diabetic cardiomyopathy (DCM)	Wistar rats left ventricle (LV)	STZ treatment	downregulated	28199183
3729	Rat	rno-mir-877	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3730	Rat	rno-miR-881-3p	miRNA	high fat diet (HFD)	aging-related non-alcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	upregulated	31899128
3731	Rat	rno-miR-9	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	endotoxin treatment	upregulated	26137246
3732	Rat	rno-miR-9	miRNA	epigallocatechin-3-gallate (EGCG)	chronic kidney disease (CKD)	NRK-49F cells	EGCG treatment	EGCG upregulated the Expression of MiR-9.	30468495
3733	Rat	rno-miR-9	miRNA	hypoxia	congenital heart disease (CHD)	H9c2 cells	hypoxia induce	upregulated	30639391
3734	Rat	rno-miR-9	miRNA	occlusion of the bilateral common carotid artery (2VO)	"dementia ,learning and memory"	hippocampus; cortex	occlusion of the bilateral common carotid artery (2VO) treatment	upregulated in both the hippocampus and cortex	28683457
3735	Rat	rno-miR-9	miRNA	emodin	diabetic foot ulcer (DFU)	PC-12 cells	emodin treatment	miR-9 was highly expressed in response to emodin treatment.	29577942
3736	Rat	rno-miR-9	miRNA	high glucose (HG)	diabetic cardiomyopathy (DCM)	H9C2 cells	high glucose treatment	downregulated	26898797
3737	Rat	rno-miR-9	miRNA	alcohol	fetal alcohol exposure (FAE)	pregnant Fisher 344 rats pituitary	liquid diet containing 6.7% alcohol between gestational days 7-21 (AF)	upregulated	28710248
3738	Rat	rno-miR-9	miRNA	serum	hepatopulmonary syndrome (HPS)	pulmonary artery smooth muscle cell (PASMC)	serum treatment	upregulated	26147104
3739	Rat	rno-miR-9	miRNA	hypoxia	hypoxia-induced cardiac dysfunctions	H9c2 cells	hypoxia treatment	"We found that miR-9 was increased, while CDK8 was decreased in hypoxia-treated H9c2 cells."	33737500
3740	Rat	rno-miR-9	miRNA	hypoxia	hypoxic/ischemic brain damage (HIBD)	brain tissues	8% O2 + 92% N2 and sugar-free medium for 60 minutes treatment	downregulated	25206848
3741	Rat	rno-miR-9	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	upregulated	27074745
3742	Rat	rno-miR-9	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	ischemic stroke (IS)	PC12 cells	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	SNHG7 was downregulated and miR-9 was upregulated by OGD/R treatment in PC12 cells	33262598
3743	Rat	rno-miR-9	miRNA	hypoxia	neonatal hypoxic-ischemic brain damage	PC12 cells; hippocampus	hypoxia treatment	upregulated	32470970
3744	Rat	rno-miR-9	miRNA	1-methyl-4-phenylpyridinium (MPP+)	parkinson's disease (PD)	PC12 cells	N-methyl-4-phenylpyridinium (MPP +) treatment	"MPP+ toxicity significantly caused upregulated in miR-34a, miR-141, and miR-9."	29631008
3745	Rat	rno-miR-9	miRNA	hypoxia	phenotypic switch of PASMCs	rats pulmonary artery smooth muscle cells (PASMCs)	hypoxia treatment	upregulated	24615545
3746	Rat	rno-miR-9	miRNA	retinoic acid (RA)	spina bifida	spinal cord of rat	Retinoic acid treatment	downregulated	17962954
3747	Rat	rno-miR-9	miRNA	matrine	spinal cord injury (SCI)	PC-12 cells	Matrine treatment	LPS reduced miR-9 expression about 60%.	32297823
3748	Rat	rno-miR-9*	miRNA	trimethyltin (TMT)	neurotoxicity	rats serum	were given a single administration of TMT treatment	upregulated	24777749
3749	Rat	rno-miR-9*	miRNA	high fat diet (HFD)	obesity	rats	high fat diet (HFD) feed	dysregulated	24517225
3750	Rat	rno-miR-9*	miRNA	retinoic acid (RA)	spina bifida	spinal cord of rat	Retinoic acid treatment	downregulated	17962954
3751	Rat	rno-miR-9119	miRNA	human chorionic gonadotrophin (hCG)	polycystic ovarian syndrome (PCOS)	ovarian granulosa cells (GCs)	human chorionic gonadotrophin (hCG) treatment	upregulated	31894528
3752	Rat	rno-miR-92	miRNA	butyrylated high-amylose maize starch (HAMSB)	colorectal cancer (CRC)	high-protein meat diet (HPM) fed rat colonic tissue	butyrylated high-amylose maize starch (HAMSB) feed	downregulated	31052187
3753	Rat	rno-miR-92	miRNA	high-amylose potato starch (HAPS)	colorectal cancer (CRC)	high-protein meat diet (HPM) fed rat colonic tissue	high-amylose potato starch (HAPS) feed	downregulated	31052187
3754	Rat	rno-miR-92a	miRNA	lipopolysaccharide (LPS)	acute lung injury (ALI)	lung tissues	lipopolysaccharide (LPS) treatment	upregulated	33015189
3755	Rat	rno-miR-92a	miRNA	hyperbaric oxygen (HBO)	acute myocardial infarction (AMI)	Rat cardiac myocytes	Hyperbaric oxygen (HBO) treatment	HBO-induced exosomes post-MI significantly reduced miR-92a expression compared with AMI alone at 14 days.	32939962
3756	Rat	rno-miR-92a	miRNA	bone marrow mesenchymal stem cells (BMSCs)	apoptosis	infarcted rats myocardium	bone marrow mesenchymal stem cells (BMSCs) treatment	downregulated	28662151
3757	Rat	rno-miR-92a	miRNA	H2O2	atherosclerosis (AS)	Vascular smooth muscle cells (VSMCs) were primarily cultured from rat thoracic aortas	hydrogen peroxide (H2O2) treatment	downregulated	29115493
3758	Rat	rno-miR-92a	miRNA	adenine	chronic kidney disease (CKD)	rats aortas; serum	adenine	upregulated	28696247
3759	Rat	rno-miR-92a	miRNA	tetrodotoxin and AP5	effect of tetrodotoxin and AP5	rats hippocampal neurons	tetrodotoxin and AP5 treatment	downregulated	25017011
3760	Rat	rno-miR-92a	miRNA	ethylene glycol monomethyl ether (EGME)	hyperglycemia	?testicle of rat	Ethylene glycol monomethyl ether (EGME) treatment	"miR-449a and miR-92a decreased obviously and, miR-320, miR-134 and miR-188 increased"	22008535
3761	Rat	rno-miR-92a	miRNA	losartan	ischemia/reperfusion (I/R) injury	heart tissues	losartan treatment	upregulated	26168042
3762	Rat	rno-miR-92a	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia treatment	"Hypoxia stimulation significantly inhibited H9c2 cell viability and proliferation, induced cell apoptosis and upregulated miR-92a expression."	31949700
3763	Rat	rno-miR-92a-1-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3764	Rat	rno-miR-92a-2-5p	miRNA	ethylenethiourea (ETU)	anorectal malformations (ARM)	Hindgut tissue was isolated from the gestational day 14 fetuses	ethylenethiourea (ETU) treatment	upregulated	30106085
3765	Rat	rno-miR-92a-2-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	inflammation	primary brain microvascular endothelial cells (BMECs)	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"?In particular, the expression levels of rno-miR-666-3p, rno-miR-92a-2-5p, and rno-miR-219a-2-3p decreased in OGD/R-exposed cells compared with those in the control"	33745435
3766	Rat	rno-miR-92a-3p	miRNA	cold	cold stress	rats serum	cold conditions (4¡æ for 12h)	downregulated	28477904
3767	Rat	rno-miR-92a-3p	miRNA	smoking	smoke inhalation injury (SII)	bronchoalveolar lavage fluid (BALF)	Smoke inhalation treatment	upregulated	30139538
3768	Rat	rno-miR-92b	miRNA	adriamycin (ADR)	nephrotic syndrome (NS)	kidney tissues	adriamycin (ADR) treatment	upregulated	30551379
3769	Rat	rno-miR-92b	miRNA	zhen-wu-tang (ZWT)	nephrotic syndrome (NS)	kidney tissues	Zhen-wu-tang (ZWT) treatment	downregulated	30551379
3770	Rat	rno-miR-92b	miRNA	zhen-wu-tang (ZWT)	nephrotic syndrome (NS)	kidney tissues	zhen-wu-tang (ZWT) treatment	ZWT can decrease the expression of miR-92b and reverse the effect of miR-92b on AQP2 in vitro.	30551379
3771	Rat	rno-miR-92b	miRNA	(+)-cholesten-3-one (CN)	osteoblastic differentiation	mesenchymal stem cells (MSCs)	(+)-cholesten-3-one (CN) treatment	downregulated	30373531
3772	Rat	rno-miR-92b	miRNA	insulin-like growth factor 1 (IGF-1)	post-stroke	brain tissues	Post-stroke ICV administration of IGF-1 to middle-aged female rats treatment	downregulated	24618563
3773	Rat	rno-miR-92b	miRNA	insulin-like growth factor 1 (IGF-1)	spinal cord injury (SCI)	Neural stem cells were obtained from E15 fetal rat cerebral cortex cultured supernatant exosomes	insulin growth factor-1 (IFG-1) treatment	upregulated	31848325
3774	Rat	rno-miR-92b-3p	miRNA	resveratrol	osteoporosis	rat bone marrow mesenchymal stem cells (BMSCs)	resveratrol (Res) treatment	upregulated	32674689
3775	Rat	rno-miR-92b-3p	miRNA	hypoxia	pulmonary arterial hypertension (PAH)	pulmonary artery smooth muscle cells (PASMCs)	hypoxia induce	downregulated	30149918
3776	Rat	rno-miR-92b-3p	miRNA	smoking	smoke inhalation injury (SII)	bronchoalveolar lavage fluid (BALF)	Smoke inhalation treatment	upregulated	30139538
3777	Rat	rno-miR-92b-3p	miRNA	insulin-like growth factor 1 (IGF-1)	spinal cord injury (SCI)	Neural stem cells were obtained from E15 fetal rat cerebral cortex cultured supernatant exosomes	insulin growth factor-1 (IFG-1) treatment	upregulated	31848325
3778	Rat	rno-miR-92b-3p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
3779	Rat	rno-miR-93	miRNA	17-AAG (tanespimycin)	apoptosis	tunicamycin-treated primary neonatal rat cardiomyocytes	?17-AAG (tanespimycin) treatment	upregulated	30556167
3780	Rat	rno-miR-93	miRNA	tunicamycin (TM)	apoptosis	primary neonatal rat cardiomyocytes	tunicamycin treatment	downregulated	30556167
3781	Rat	rno-miR-93	miRNA	estradiol-17¦Â (E2)	breast cancer	mammary tissues	estradiol-17¦Â (E2) treatment	upregulated	23492819
3782	Rat	rno-miR-93	miRNA	vitamin C	breast cancer	mammary tissues	vitamin C treatment	downregulated	23492819
3783	Rat	rno-miR-93	miRNA	TGF-¦Â1	cardiac fibrosis	primary rat cardiac fibroblasts	TGF-¦Â1 treatment	upregulated	29551367
3784	Rat	rno-miR-93	miRNA	angiotensin II (Ang II)	cardiac hypertrophy	cardiomyocytes	angiotensin II (Ang II) treatment	MIAT was upregulated and miR-93 was downregulated in AngII-treated cardiomyocytes.	29673400
3785	Rat	rno-miR-93	miRNA	platelet derived growth factor-BB (PDGF-BB)	cell proliferation and migration	rats vascular smooth muscle cell (VSMC)	platelet-derived growth factor-BB (PDGF-BB) treatment	upregulated	31754334
3786	Rat	rno-miR-93	miRNA	lipopolysaccharide (LPS)	endotoxin-induced uveitis (EIU)	macrophages	lipopolysaccharide (LPS) treatment	downregulated	24642374
3787	Rat	rno-miR-93	miRNA	furan	hepatotoxicity	liver	Furan treatment	upregulated	27371368
3788	Rat	rno-miR-93	miRNA	nerve growth factor (Ngf)	neurodegenerative diseases	PC12 cells	100 ng/ml Ngf treatment	different regulation	24492999
3789	Rat	rno-miR-93	miRNA	dopamine agonist (DA)	prolactinoma	MMQ cells; GH3 cells	dopamine agonist (DA) treatment	miRNA-93 expression was elevated in DA-resistant prolactinomas.	30389900
3790	Rat	rno-miR-93-3p	miRNA	lipopolysaccharide (LPS)	inflammation	H9c2 cells	lipopolysaccharide (LPS) treatment	downregulated	30195636
3791	Rat	rno-miR-93-5p	miRNA	insert a cannula connected with a saline container into the anterior chamber	acute ocular hypertension (AOH)	adult albino rats retinal ganglion cells (RGCs) and microglial cells	insert a cannula connected with a saline container into the anterior chamber	downregulated	27535721
3792	Rat	rno-miR-93-5p	miRNA	liraglutide	endothelial dysfunction	aortic endothelial in diabetic rats	liraglutide treatment	downregulated	30863684
3793	Rat	rno-miR-93-5p	miRNA	N-methyl-D-aspartate (NMDA)	glaucoma	rat retinal ganglion cells	N-me- thyl-D-aspartate (NMDA) treatment	The level of miR-93-5p in the retina of rats with injection of NMDA was gradually declined over time.	29421576
3794	Rat	rno-miR-93-5p	miRNA	IL-1¦Â	osteoarthritis (OA)	rat chondrocytes	IL-1¦Â treatment	upregulated	31253047
3795	Rat	rno-miR-93-5p	miRNA	lipopolysaccharide (LPS)	sepsis-induced myocardial injury	H9c2 cells	lipopolysaccharide (LPS) treatment	"H19 and SORBS2 were downregulated in H9C2 cells following LPS treatment, while miR-93-5p was upregulated."	32996061
3796	Rat	rno-miR-93-5p	miRNA	lipopolysaccharide (LPS)	sepsis-induced myocardial injury	H9C2 cells	lipopolysaccharide (LPS) treatment	H19 attenuated the development of sepsis-induced myocardial injury in vitro via modulation of the miR-93-5p/SORBS2 axis.	32996061
3797	Rat	rno-miR-93-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3798	Rat	rno-miR-939	miRNA	hypoxia	ischemic heart disease (IHD)	H9c2 cardiac muscle cells	hypoxia induce	downregulated	31321998
3799	Rat	rno-miR-93a-5p	miRNA	high fat diet (HFD)	obesity	white adipose tissues	high fat diet (HFD) feed	upregulated	32366215
3800	Rat	rno-miR-942-5p	miRNA	doxorubicin (DOX)	cardiomyocyte apoptosis	Primary cardiomyocytes	?doxorubicin (DOX) treatment	"SOX2-OT and DP5 were highly expressed, while miR-942-5p was downregulated in DOX-treated primary cardiomyocytes and rat model"	33603338
3801	Rat	rno-miR-9-5p	miRNA	streptozocin (STZ)	diabetes mellitus (DM)	INS-1 cells	streptozotocin (STZ) treatment	downregulated	33826088
3802	Rat	rno-miR-9-5p	miRNA	sevoflurane (SEV)	hepatic ischemia/reperfusion injury (HIRI)	liver ischemia/reperfusion (IR) rats liver tissues	sevoflurane treatment	upregulated	30906455
3803	Rat	rno-miR-9-5p	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia induce	downregulated	30101604
3804	Rat	rno-miR-9-5p	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia treatment	forced expression of miR-9-5p in H9c2 cells is concurrent with diminished expression of Fstl1 and vice versa.	30101604
3805	Rat	rno-miR-9-5p	miRNA	IL-6 and TNF-¦Á	rheumatoid arthritis (RA)	Schwann cells	TNF-¦Á treatment	"In IL-6- and TNF-¦Á-stimulated Schwann cells, apoptosis was induced, while the cell viability and level of miR-9-5p were inhibited."	30456455
3806	Rat	rno-miR-9-5p	miRNA	IL-6 and TNF-¦Á	rheumatoid arthritis (RA)	Schwann cells	0.1 ng/mL IL-6 and 20 ng/mL TNF-¦Á treatment	downregulated	30456455
3807	Rat	rno-miR-9-5p	miRNA	lithium (Li)	spinal cord injury (SCI)	spinal cord	lithium treatment	"Furthermore, lithium treatment alleviated the inflammatory response by inactivating the nuclear factor-kappa B (NF-¦ÊB) pathway and inhibited the expression of lncRNA brain-derived neurotrophic factor antisense (BDNF-AS) in SCI rats."	33464390
3808	Rat	rno-miR-9-5p	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	traumatic brain injury (TBI)	brain microvascular endothelial cells (BMECs); astrocytes	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	"upregulated of miRNA-9-5p alleviates BBB damage and neuroinflammatory responses by activating the Hedgehog pathway and inhibiting NF-¦ÊB/MMP-9 pathway, which promotes the recovery of neurological function after TBI"	33236776
3809	Rat	rno-miR-96	miRNA	sevoflurane (SEV)	cognitive impairment	hippocampus	sevoflurane treatment	upregulated	30217735
3810	Rat	rno-miR-96	miRNA	sevoflurane (SEV)	cognitive impairment	neonatal rats hippocampal neuron	sevoflurane treatment	upregulated	30217735
3811	Rat	rno-miR-96	miRNA	high fat diet (HFD)	diabetic peripheral neuropathy (DPN)	sciatic nerve tissues	high fat diet (HFD) feed	downregulated	29689688
3812	Rat	rno-miR-96	miRNA	streptozocin (STZ)	diabetic peripheral neuropathy (DPN)	sciatic nerve tissues	streptozotocin (STZ) treatment	downregulated	29689688
3813	Rat	rno-miR-96	miRNA	swimming	diabetic peripheral neuropathy (DPN)	diabetic rats sciatic nerve tissues	swimming exercise induce treatment	upregulated	29689688
3814	Rat	rno-miR-96	miRNA	streptozocin (STZ)	diabetic retinopathy (DR)	?retinas?tissues	streptozotocin (STZ) treatment	upregulated	22156553
3815	Rat	rno-miR-96	miRNA	lipopolysaccharide (LPS)	disseminated intravascular coagulation (DIC)	liver tissues	lipopolysaccharide (LPS) treatment	upregulated	24806323
3816	Rat	rno-miR-96	miRNA	adreno-cortico-tropic-hormone (ACTH)	hormonal regulation	adrenals?tissues	adreno-cortico-tropic-hormone (ACTH) treatment	upregulated	24205079
3817	Rat	rno-miR-96	miRNA	estradiol-17¦Â (E2)	hormonal regulation	adrenals?tissues	estradiol-17¦Â (E2) treatment	upregulated	24205079
3818	Rat	rno-miR-96	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	downregulated	27041227
3819	Rat	rno-miR-96	miRNA	oxygen-glucose deprivation and reoxygenation (OGD/R)	hypoxic/ischemic brain damage (HIBD)	PC12 cell	oxygen-glucose deprivation and reoxygenation (OGD/R) treatment	downregulated	28721600
3820	Rat	rno-miR-96	miRNA	carbon black nanoparticle (CBNP)	lung fibrosis	lung tissues and whole lung lavage fluid (WLL)	carbon black nanoparticle (CBNP) treatment	downregulated	31683435
3821	Rat	rno-miR-96	miRNA	retinal toxicant pan-CDK inhibitors	retinal toxicity	rats in renal	a single intravitreal (IVT) injection treatment	upregulated	24114799
3822	Rat	rno-miR-96	miRNA	colesevelam	zucker diabetic fatty (ZDF)	liver tissues	colesevelam treatment	upregulated	30160993
3823	Rat	rno-miR-96-5p	miRNA	high fat diet (HFD)	aging-related non-alcoholic fatty liver disease (NAFLD)	liver tissues	high fat diet (HFD) feed	downregulated	31899128
3824	Rat	rno-miR-96-5p	miRNA	particulate matter (PM2.5)	allergic rhinitis (AR)	nasal mucosa	particulate matter 2.5 (PM2.5) treatment	downregulated	32192351
3825	Rat	rno-miR-96-5p	miRNA	diethylnitrosamine (DEN)	liver fibrosis	liver tissues	diethylnitrosamine (DEN) treatment	upregulated	29236317
3826	Rat	rno-miR-96-5p	miRNA	oxymatrine	nonalcoholic fatty liver disease (NAFLD)	liver tissues	oxymatrine treatment	upregulated	32679144
3827	Rat	rno-miR-96-5p	miRNA	N-methyl-N-nitrosourea (MNU)	retinal lesions	serum	N-methyl-N-nitrosourea (MNU) treatment	"MNU at 50?mg/kg induced photoreceptor cell death, with elevation in serum miR-96-5p levels."	30336191
3828	Rat	rno-miR-96-5p	miRNA	N-methyl-N-nitrosourea (MNU)	retinal toxicity	serum	N-methyl-N-nitrosourea (MNU) treatment	upregulated	30336191
3829	Rat	rno-miR-97	miRNA	quercetin	oxidative stress	PC-12 cells	Quercetin treatment	downregulated	33343808
3830	Rat	rno-miR-98	miRNA	H2O2	acute myocardial infarction (AMI)	neonatal rat ventricular myocytes (NRVCs)	H2O2 treatment	downregulated	28784995
3831	Rat	rno-miR-98	miRNA	doxorubicin (DOX)	cardiotoxicity	neonatal rat ventricular myocytes	doxorubicin (DOX) treatment	we observed a significant increase in miR-98 expression in neonatal rat ventricular myocytes after DOX treatment	33617954
3832	Rat	rno-miR-98	miRNA	hypoxia	hypoxic pulmonary hypertension (HPH)	lung tissue and pulmonary artery (PA) smooth muscle cells (PASMCs)	hypoxia induce	downregulated	31322216
3833	Rat	rno-miR-98	miRNA	oxygen glucose deprivation (OGD)	ischemic brain injury	Hippocampal neuronal	oxygen-glucose deprivation (OGD) treatment	downregulated	27074745
3834	Rat	rno-miR-98	miRNA	"hexahydro-1,3,5-trinitro-1,3,5-triazine (RDX)"	neurotoxicity	brain tissues of rats	RDX at a dose(47 mg/kg) for 48 h treatment	upregulated	25559034
3835	Rat	rno-miR-98	miRNA	"quinacrine, erythromycin and tetracycline"	non-surgical sterilization	Wistar albino 12-14 week old female rats	"quinacrine, erythromycin , tetracycline treatment"	upregulated	25195052
3836	Rat	rno-miR-98	miRNA	steroids	osteonecrosis of femoral head (ONFH)	bone marrow mesenchymal stem cells (BMSCs)	steroid treatment	downregulated	27910957
3837	Rat	rno-miR-98	miRNA	sevoflurane (SEV)	cognitive impairment	BRL rat hepatocyte cell line	1 or 2 minimal alveolar concentrations sevoflurane for 4 or 8 h treatment	upregulated	28260068
3838	Rat	rno-miR-98	miRNA	arsenic trioxide (ATO)	lung fibrosis	PF rat	arsenic trioxide (As2O3) treatment	upregulated	25123535
3839	Rat	rno-miR-98	miRNA	streptozocin (STZ)	type 2 diabetes mellitus (T2DM)	aortas	streptozotocin (STZ) treatment	downregulated	26840039
3840	Rat	rno-miR-98-3p	miRNA	¦Á-Lipoic acid (LA)	longevity and neuroprotection	cerebral cortex	¦Á-Lipoic acid (LA) treatment	upregulated	26694192
3841	Rat	rno-miR-98-5p	miRNA	cold	cold stress	rats serum	cold conditions (4¡æ for 12h)	downregulated	28477904
3842	Rat	rno-miR-98-5p	miRNA	"2,4,6-trinitrobenzene sulfonic acid (TNBS)"	ulcerative colitis (UC)	colon tissues	"2, 4, 6-Trinitrobenzenesulfonic acid solution (TNBS) treatment"	upregulated	33394187
3843	Rat	rno-miR-98-5p	miRNA	herb-partitioned moxibustion	ulcerative colitis (UC)	UC rats colon tissues	herb-partitioned moxibustion	upregulated	28246536
3844	Rat	rno-miR-9995-3p	miRNA	bleomycin (BLM)	lung fibrosis	lung tissues	bleomycin (BLM) treatment	upregulated	33193637
3845	Rat	rno-miR-99a	miRNA	isoproterenol	cardiac hypertrophy	H9c2 cells	isoproterenol treatment	miR-99a was upregulated during ISO- induced pathological hypertrophy.	29481791
3846	Rat	rno-miR-99a	miRNA	nitrofen	hypoplastic lung	lung tissues	nitrofen treatment	upregulated	27041227
3847	Rat	rno-miR-99a	miRNA	hypoxia	myocardial infarction (MI)	H9C2 cells	hypoxia induce	downregulated	29745968
3848	Rat	rno-miR-99a	miRNA	hypoxia	myocardial infarction (MI)	H9c2 cells	hypoxia treatment	Hypoxia induced an increase of THRIL but a reduction of miR-99a and Brg1.	29745968
3849	Rat	rno-miR-99a	miRNA	isoflurane	oxidative stress	H9c2 cells	Isoflurane treatment	upregulated	29627934
3850	Rat	rno-miR-99a	miRNA	lithium chloride and pilocarpine	status epilepticus (SE)	rat hippocampus tissues	lithium-pilocarpine treatment	upregulated	21094214
3851	Rat	rno-miR-99a-5p	miRNA	ethylenethiourea (ETU)	anorectal malformations (ARM)	Hindgut tissue was isolated from the gestational day 14 and day 16 fetuses	ethylenethiourea (ETU) treatment	upregulated	30106085
3852	Rat	rno-miR-99a-5p	miRNA	steroids	osteonecrosis of femoral head (ONFH)	serum	steroid treatment	upregulated	29887962
3853	Rat	rno-miR-99a-5p	miRNA	lipopolysaccharide (LPS)	septic shock	heart tissue	lipopolysaccharide (LPS) treatment	dysregulated	31332662
3854	Rat	rno-miR-99b	miRNA	isoproterenol	cardiac hypertrophy	H9c2 cells	isoproterenol treatment	miR-99b was upregulated during ISO- induced pathological hypertrophy.	29481791
3855	Rat	rno-miR-99b	miRNA	deoxycorticosterone acetate (DOCA) -salt (sodium chloride)	hypertension	heart tissues	deoxycorticosterone acetate (DOCA) -salt (sodium chloride) treatment	downregulated	30290168
3856	Rat	rno-miR-99b	miRNA	metformin (Met)	hypertension	deoxycorticosterone acetate (DOCA) -salt (sodium chloride)-induced hypertension rats heart tissues	metformin (MF) treatment	upregulated	30290168
3857	Rat	rno-miR-99b	miRNA	deoxycorticosterone acetate (DOCA) -salt (sodium chloride)	hypertension-induced cardiac dysfunction	heart tissues	deoxycorticosterone acetate (DOCA) -salt (sodium chloride) treatment	downregulated	30290168
3858	Rat	rno-miR-99b	miRNA	metformin (Met)	hypertension-induced cardiac dysfunction	heart tissues	Metformin treatment	upregulated	30290168
3859	Rat	rno-miR-99b	miRNA	phosphodiesterase 5 (PDE5) inhibitor	nonalcoholic fatty liver disease (NAFLD)	plasma exosomes	phosphodiesterase 5 (PDE5) inhibitor treatment	upregulated	33396535
3860	Rat	rno-miR-99b-5p	miRNA	glucocorticoid (GC)	respiratory distress syndrome	lung	Glucocorticoids treatment	downregulated	26997989
3861	Rat	rno-miR-9a-5p	miRNA	hypoxia	cerebral ischemia injury (CII)	rats ischemic region	middle cerebral artery occlusion (MCAO) treatment	downregulated in the ischemic region	29316542
3862	Rat	rno-miR-9a-5p	miRNA	H2O2	myocardial infarction (MI)	cultured cardiomyocytes	H2O2 treatment	downregulated	31787746
